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1. Introduction 
 
The importance of chiral compounds is demonstrated by their auspicious widespread 
applications as building blocks or intermediates for the synthesis of pharmaceuticals, 
agrochemicals, polymers, natural compounds, auxiliaries, ligands and synthons in organic 
syntheses.1 To serve the growing demand of enantiomerically pure products various synthetic 
approaches were developed. Within the diverse consumers of chiral compounds the 
pharmaceutical industry provides one of the main impulses for new products, since nowadays 
only drugs containing single enantiomers are allowed to sign up for market.2 This 
requirement was initiated as a consequence of different pharmacological studies, which 
affirmed different behaviour of both enantiomers, and proven by accidents with racemic 
drugs.3 Hence, the development of new and improved methods for the preparation of 
enantiomerically pure compounds is an important target of industrial and academic research. 
Several synthetic approaches to optically active compounds have been realized in the past. 
Still one of the most practical approach is the separation of enantiomers via resolution, e.g. in 
the presence of chiral acids or enzymatic processes. The main drawback of this concept is the 
poor atom efficiency and the negative environmental impact, albeit nowadays promising 
efforts on dynamic kinetic resolutions have been established.4 A more attractive access is 
represented by applying enantiopure materials from the “chiral pool”. Another powerful 
strategy is the application of stereoselective syntheses in particular reactions catalyzed by 
transition metal complexes, biocatalysts, and in recent years by organocatalysts.1e-g,5 Within 
the different molecular transformations to chiral compounds transition metal catalyzed 
reactions offer an efficient and versatile strategy and presents a key technology for the 
advancement of “green chemistry”, specifically for waste prevention, reducing energy 
consumption, achieving high atom efficiency and generating advantageous economics.6 Since 
the mid of the last century manifold catalytic reactions have been reported, e.g. 
polymerization, metathesis, cross couplings, hydroformylations, aminations or epoxidations.1g 
One of the most popular and extensive studied catalytic reaction with respect to industrial 
applications is the asymmetric hydrogenation of unsaturated compounds containing C=C, 
C=O and C=N bonds since addition of molecular hydrogen provides high atom efficiency and 
the starting material are often readily available.7 In this regard, for activation of the molecular 
hydrogen or hydrogen donors and transfer of chiral information the use of transition metal 
catalysts containing chiral ligands is essential. Commonly, chiral phosphorous ligands were 
used as source of chirality since catalysts including phosphorous systems proved to be highly 
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active as well as enantioselective. Furthermore diverse representatives are available on large 
scale.8 The relevance of hydrogenation processes are impressively confirmed by several 
integrations in industrial applications (Scheme 1).
NH
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via C=O hydrogenation
and 
dynamic kinetic resolution
OH
COOMe
HN
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O
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HO
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1 2 3 4
OHC
Et
O
O
NHtBu
Crixivan
HIV protease inhibitor
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OH
Citronellol
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via C=C hydrogenation
OH
N
Bn
OH HCl
HO
Adrenaline
β-adrenergic receptor activator
(Boehringer-Ingelheim)
via C=C hydrogenation
5 6 7
 
Scheme 1. Selection of industrial important compounds synthesized via hydrogenation protocols in 
the presence of chiral catalysts containing chiral phosphines.9
 
However, the generality of asymmetric hydrogenation is deeply limited by the substrate-
structure and transferability of method since no universal catalyst is on hand, which shows 
extraordinary behaviour for most classes of substrates. Hence the discovery of new effective 
ligands is an important challenge for industrial and academic research.7,10 Furthermore the 
final breakthrough in industry is hampered by catalysts containing expensive and toxic late 
transition metals (Ir, Rh or Ru). Therefore, substitution by ubiquitous available, inexpensive 
and less toxic metals is one of the challenging objectives for future research. In this regard the 
use of iron catalysts is especially desirable.11
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2. Phosphorous containing ligands in the field of asymmetric hydrogenation 
 
“The inherent generality of this method offers almost unlimited opportunities for matching 
substrates with catalysts in a rational manner and we are hopeful that our current effort will 
result in real progress towards complete stereospecificity.”    W. S. Knowles and M. J. Sabacky12
 
Since the pioneering investigations on asymmetric hydrogenation by Knowles, Kagan, and 
others in the late 1960s of the last century extensive efforts were undertaken to develop this 
powerful method. In the early stage of investigations phosphorous ligands have been proven 
to be beneficial by supporting the catalyst activity and transferring the chiral information. A 
huge number of successful ligand concepts have been developed during the last decades. 
Nowadays they are most frequently used in the field of asymmetric C=C bond 
hydrogenations. However, even if several industrial applications on small to medium scale are 
established the final breakthrough is so far not reached, due to the low transferability of 
technique to novel demands. Therefore, tailor–made catalysts designed for well–defined tasks 
are important tools for achieving high activity and enantioselectivity. Based on this fact the 
discovery of new effective ligands is a key challenge for industrial and academic research. 
Innovative catalysts must fulfil several requirements for successful industrial applications. On 
the one hand an easy to adopt synthetic approach on large scale and straightforward structural 
variation of the ligand key structure must be available (ligand library). Furthermore, the 
catalyst must attain reasonable activity and enantioselectivity in the investigated reaction. On 
the other hand intellectual property should be accessible.13
In this regard, the development of new ligands for asymmetric hydrogenation has focused on 
the synthesis of bidentate ligands for nearly 30 years. However, at the end of the 20th century 
the predominant role of bidentate ligands changed and monodentate ligands received more 
attention.14,15 The advantages of monodentate phosphorous ligands are their easier synthesis 
and tunability compared to bidentate counterparts. The capabilities of monodentate ligands 
were successful demonstrated in several reactions.16 Nowadays monodentate ligands are 
accepted as additional tool in asymmetric hydrogenations. 
This review will focus on the application of monodentate phosphine ligands in asymmetric 
hydrogenations of C–C double bonds. 
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2.1. Monodentate phosphine ligands in rhodium–catalyzed asymmetric hydrogenation 
reactions of C–C double bonds 
 
“The considerable variation of yields with phosphine structure clearly shows the need for a 
match of catalyst and substrate.”             W. S. Knowles, M. J. Sabacky, and B. D. Vineyard17  
 
The beginning of homogenous hydrogenation started in the mid of the sixties of the last 
century and is connected with the groups of Wilkinson and Vaska. Thereby the group of 
Wilkinson reported the first successful application of a well–defined complex [RhCl(PPh3)3] 
(Wilkinson´s catalyst)18 in homogeneous hydrogenation of simple olefins with molecular 
hydrogen, while shortly after Vaska obtained similar results with Ir(CO)(PPh3)3 as catalyst 
(Vaska´s complex).19 Based on this seminal work a first chiral version was independently 
presented by the groups of Knowles and Horner20 in 1968 right after Mislow et al.21 and 
Horner et al.22 established an approach to P–chiral ligands via resolution of diastereomeric 
menthyl phosphinates and subsequent reaction with Grignard reagents and phosphine oxide 
reduction (Scheme 2). 
COOH
*
COOH0.15 mol% RhCl3(8a)3
3.5 mol% NEt3, H2
benzene-ethanol (1:1), 60 °C
15% ee
MentO
P R1
O
R2Horner and Mislow
MentO
P R1
O
R2 R
3 P R1
R2
resolution
1. R3MgX
2. HSiCl3
Knowles and Sabacky
Horner
8a: R1 = Ph, R2 = Me, R3 = i-Pr
8b: R1 = Ph, R2 = Me, R3 = n-Pr (MPPP)
8c: R1 = Ph, R2 = Me, R3 = Bn (BMPP)
8d: R1 = Ph, R2 = Me, R3 = o-Anisyl (PAMP)
R
*
R1/2 [Rh(cod)Cl]2 / (8b)
H2 (1 atm)
benzene, r.t.
12a: R = Et: 7-8% ee
12b: R = OMe: 3-4% ee
9 10
11a-b 12a-b
 
 
Scheme 2. Synthetic approach to chiral monodentate phosphines and first asymmetric hydrogenations 
carried out with homogeneous catalyst. 
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In the reduction of α–phenylacrylic acid 9 a promising enantiomeric excess of 15% was 
attained when using rhodium–complexes with ligands of type 8. Hereafter, various attempts, 
specially focused on modification of the ligand structure were carried out to improve the 
enantioselectivity but unfortunately no decisively enhancement was gained.23 Parallel to this 
work Horner et al. applied an in situ catalyst composed of [Rh(cod)Cl]2 and 4 equiv. of 
optical active methylphenyl–n–propylphosphine 8b in the asymmetric hydrogenation of α–
ethylstyrene 11a and α–methoxystyrene 11b, only low enantioselectivities (<8% ee) were 
observed. Later on, the group of Morison showed enantioselectivities up to 61% ee in the 
hydrogenation of (E)–β–methylcinnamic acid, when shifting the chiral information from 
phosphorous atom to the carbon–skeleton by synthesis of neomenthyldiphenylphosphine 
(NMDPP).24
However, the breakthrough in homogeneous asymmetric hydrogenation was reached in the 
early 1970s by Kagan et al. when bridging two monodentate phosphines to yield chelating 
bidentate phosphines. Extraordinary enantioselectivities up to 72% ee were obtained in the 
presence of a rhodium–DIOP–complex (Scheme 3).25
 
O
O
PPh2
PPh2
H
H
CO2H
R1
H
R2 1/2[Rh(cod)Cl]2 /13
H2 (1 atm)
benzene-ethanol, r.t.
* CO2H
R1
H
R2
a: R1 = H, R2 = Ph: 63% ee
b: R1 = Ph, R2 = NHAc: 72% ee
c: R1 = H, R2 = NHCOCH2Ph: 68% ee
DIOP (13) 14a-c 15a-c
 
 
Scheme 3. First asymmetric hydrogenation catalyzed by rhodium–diphosphine complexes.26
 
The improvement of this ligand concept was accompanied by two additional strategies. Since 
the ligand preparation based on chiral phosphorous atoms and further on the resolution of the 
P–chiral–enantiomers via diastereomers, which gave moderate optical purities, therefore great 
synthetic efforts were necessary to break-trough. The group of Kagan used as carrier for the 
chiral information tartaric acid which is accessible from the “chiral pool”. Thus the chiral 
information was moved from the phosphorous atom to the backbone of the ligand as 
previously discussed by Morison et al. Furthermore the complicated separation of ligand 
enantiomers was avoided. In the following period the concept of bidentate ligands was refined 
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to further improve the enantioselectivity in asymmetric hydrogenations. During the years 
various strategies for inducing the chirality were successfully demonstrated, for instance 
transfer of chirality by different sources, e.g. axial chirality or P–chirality. Furthermore, the 
bite angle model (phosphorous–metal–phosphorous angle) and the formed ring sizes of 
phosphorous–metal–phosphorous system displayed to be crucial. In Scheme 4 a selection of 
outstanding bidentate ligand systems is presented. Enantioselectivities greater then >99% ee 
for a tremendous number of substrates were reported. 
 
O
O PPh2
PPh2
H
H
P
P
MeO
OMe
PPh2
PPh2
P P
PPh2
H
PPh2
NorPhos (20)
(1981)
PPh2
PPh2
PPh2R
R PPh2
Ph2P
PCy2
Fe
JosiPhos (22)
(1994)
DIPAMP (17)
(1977)
BINAP (19)
(1980)
DuPhos (25)
(1990)
ChiraPhos (18)
(1977)
DIOP (13)
(1971)
N
Ph2P
PPh2
O O
BPPM (16)
(1976)
N
Ph2P PPh2
DeguPhos (21)
(1984)
BIPHEP (23)
(1988)
PPh2Fe
PPh2Et
Et
Et
Et
MandyPhos (24)
(1989)
P P
BPE (26)
(1990)  
 
Scheme 4. Selection of outstanding bidentate ligands.25,27
 
At the early stage of bidentate ligands, enantioselectivities up to 90% ee were obtained in the 
hydrogenation of phenyl alanine derivatives with monodentate CAMP ligand 29 by Knowles 
et al. by increasing the optical purity28 of P–chiral ligands and the introduction of o–anisyl 
group, which probably affords a hemilabile second coordination via methoxy–group.17, ,23 29
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0.03 mol% [Rh(1,5-hexadiene)]2 
 0.06 mol% 29
1 equiv. NaOH, H2 (55 psi)
2-PrOH, 50 °C
90% ee
MeO
HO
NH
COOH
O Ph
*MeO
HO
NH
COOH
O Ph
P
Me
OMe27 28
CAMP (29)  
Scheme 5. Asymmetric hydrogenation of α–dehydroamino acid derivatives to yield a L–DOPA 
precursor. 
 
Although this excellent enantioselectivities were gained, the displacement of monodentate 
ligands by bidentate systems could not be impeded and led to a resting state for approximately 
30 years (Scheme 6). Also the pioneers of this research area directed their efforts to bidentate 
ligands, e.g. Knowles and co–workers synthesized a dimeric version of the PAMP ligand 
(Scheme 2, 8d), so called DIPAMP 17 (Scheme 4) and achieved enantioselectivities up to 
96% ee.30
 
Knowles, 
Sabacky, Horner
ligand 8
Knowles, 
CAMP
Kagan, 
DIOP
Knowles, 
DIPAMP
Noyori, 
BINAP
Burk, 
DuPhos
19711968 1972 1977 1980 1994 since 2000
Renaissance
1993
Togni,
JosiPhos
Monodentate
Ligands
Bidentate
Ligands
 
 
Scheme 6. Historical classification of developments in ligand synthesis. 
 
Albeit from time to time attempts were undertaken to refocus on monodentate systems the 
situation did not change significantly. For instance at the end of the 70th the ligand concept 
presented in Scheme 2 was taken up again by Solodar for the asymmetric hydrogenation of 
challenging piperitenone 30, thereby monodentate ligands induced higher enantioselectivity 
than bidentate systems, even if the obtained enantiomeric excesses were comparatively low 
(up to 38% ee) (Scheme 7).31 The influence of reaction conditions on enantioselectivity and 
chemoselectivity were studied in detail but no considerable improvements were attained. 
Noteworthy, the chemoselectivity is crucial for this type of substrate, because as side products 
pulegone (hydrogenation of the endocyclic double bond), menthones (hydrogenation of both 
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double bonds) and menthols (hydrogenation of both double bonds and the ketone 
functionality) were observed. 
* OO
[Rh(cod)(29)2]BF4 
H2 (120 psig)
MeOH, 80 °C, 3 h
38% ee
conv. 72%, selectivity: 45%
30 31
P
Me
OMe
CAMP (29)  
Scheme 7. Synthesis of piperitone 31 via asymmetric hydrogenation. 
 
Valentine et al. used a similar ligand concept as described by Morison and co–workers24 for 
the reduction of ambitious compound 32 (Scheme 8), which resembles a precursor of α–
tocopherol (vitamin E) or phylloquinone (vitamin K1).32 As additional chiral carrier to the 
chiral menthyl–group a P–chirality was embedded and enantioselectivities up to 79% ee were 
attained with rhodium catalyst [Rh(cod)(34)2]BF4. Unfortunately, no information on the 
outcome of the reaction was given regarding the influence of ligand stereochemistry since 
matched and mismatched combinations are feasible. 
 
COOH COOH
0.7 mol% [Rh(cod)(34)2]BF4, 
H2 (2.75 atm)
NaOMe (1.1 equiv.), 
H2 (2.75 atm), MeOH, r.t.
P
Me
Ph
79% ee (R), 
conv. >99%, TOF = 2.4 h-1
N
HMe
NHAc
COOH
N
HMe
NHAc
COOH
O
OH
α-Tocopherol (35)
0.1 mol% [Rh(cod)Cl]2 0.2 mol% equiv. CAMP
H2 (2.75 atm)
MeOH, 23 °C, 36 h
67% ee
conv. >99%
32 33
34
36 37
 
Scheme 8. Asymmetric hydrogenations carried out by Valentine et al. 
 
Furthermore, α–dehydroamino acids precursors were hydrogenated in the presence of 
monodentate ligands, e.g. CAMP 29, in a comparative study with DIOP 13. The obtained 
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results led to a marginal higher enantioselectivity for DIOP (72% ee) compared to CAMP 
(67% ee). 
In the mid of the 1980s Morita et al. developed an approach to sugar–based monodentate 
phosphines.33 Initially started from readily available D–glucose a series of chemical 
transformations were carried out to attain ligand 38a. The catalytic potential was tested in the 
rhodium–catalyzed asymmetric hydrogenation of N–acetyl dehydrophenylalanine and the 
corresponding methyl ester (Scheme 9). Excellent enantioselectivity of 92% ee was obtained, 
albeit long reaction times were necessary. A competitive experiment performed with DIOP as 
ligand lead to somewhat lower enantioselectivity of 75% ee and demonstrated the 
extraordinary behaviour of monodentate ligand 38a under described conditions. The 
unfavourable long reaction times were overcome by increasing the initial hydrogen pressure, 
unfortunately accompanied by degradation of enantioselectivity. Furthermore, the influence 
of metal–ligand–ratio was studied. A significant effect on enantioselectivity as well as 
conversion was found when a ratio of 1:1 was used. The enantioselectivity decreased to 31% 
ee and a prolonged reaction time of one week was necessary to reach full conversion. Indeed, 
this result was approved by previous works by Knowles et al. concerning the necessity of 2 
equiv. ligands with respect to the metal, when a monodentate coordination mode is present. 
However, the catalytic behaviour of ligand 38b, synthesized by reduction of 38a, displayed a 
converse performance, since utilizing a metal–ligand–ratio of 1:1 a slight increase of 
enantioselectivity and a comparable conversion were observed. Interestingly, also the 
antipode enantiomer was detected. The authors assumed a bidentate coordination of the 
ligand, due to the attendance of the NH2–functionality and the construction of a six–
membered ring. In addition, both systems were tested in the hydrogenation of itaconic acid 
derivatives; thereby ligand 38a exhibited once more an extraordinary enantioselectivity up to 
90% ee. 
O
O
O
PPh2NC
H
O
O
O
PPh2
H
NH2
LiAlH4
Ph
NHAc
COOR
Ph *
NHAc
COOR
2 mol% [Rh(cod)2Cl] / 38
H2 (1 atm)
ligand: 38a (4 mol%)
15b: R = H: 92% ee (S), conv. 84% (72 h)
40: R = Me: 71% ee (S), conv. 51% (72 h)
ligand: 38b (2 mol%)
15b: R = H: 39% ee (R), conv. >99% (72 h)
40: R = Me: 16% ee (R), conv. >99% (72 h)
benzene-methanol (1:4), r.t.38a
38b
14b, 39 15b, 40
 
Scheme 9. Sugar–based monodentate ligands by Morita et al. 
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Marinetti and co–workers focused on the synthesis of chiral phosphiranes, which are 
interesting ligands, because of their high s–character of the phosphorous lone pair, but 
unfortunately accompanied by high cyclic strain, which causes easy ring opening.34 However, 
insertion of optical active phosphorous compounds into enantiopure styrene oxide yields 
molybdenum phosphirane complexes and subsequent transmetallation with rhodium 
complexes attained suitable precursors for asymmetric hydrogenation. The authors carried out 
a matched and mismatched study of all diasteriomeric combinations of ligand 41 in the 
hydrogenation of N–acetyl dehydrophenylalanine methyl ester 39 (Scheme 10). The best 
performance was shown by ligand 41b with an enantioselectivity of 76% ee, while all other 
combinations gained almost racemic mixtures. Marinetti et al. assume a better transfer of 
chirality, due to the cis–position of the phenyl group with respect to the metal, which causes 
steric interactions and in consequence a formation of a more stereospecific pocket. Changing 
the L–menthyl by t–butyl group (41e and 41f) confirmed the assumption, because trans–
system led to higher enantioselectivity. 
 
P
t-Bu
P
t-Bu
P
Men
Ph
NHAc
COOMe
Ph *
NHAc
COOMe
1 mol% [Rh(cod)(41)2]PF6
H2 (3.5 bar)
methanol, 25 °C
41e: cis 41f: trans
41a: P(S)C(S) (cis)
41b: P(R)C(S) (trans)
41c: P(R)C(R) (cis)
41d: P(S)C(R) (trans)
41a: 9% ee (+)
41b: 76% ee (-)
41c: 3% ee (-)
41d: 6% ee (+)
41e: 26% ee (-)
41f: 49% ee (-)
39 40
 
 
Scheme 10. Phosphiranes as ligand in asymmetric hydrogenation. 
 
Later the same group reported about an expansion of the ring size of the ligand.35 The 
synthesis of chiral phosphetanes of type 42 (Scheme 11) was carried out according to the 
McBride approach, by reaction of branched olefins with chlorophosphine–AlCl3 complexes. 
The stereochemistry was regulated by chiral induction of L–menthyl as auxiliary. The acidic 
protons adjacent to the phosphorous atom enable further functionalization, for instance 
deprotonation with n–butyl lithium and subsequent quenching with benzyl bromide yields 
ligand 42. Ligand 42 was subjected to hydrogenation benchmark tests, but unfortunately the 
standard protocol, e.g. hydrogenation of N–acetyl dehydrophenylalanine with rhodium 
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catalyst attained only low catalytic activity (8 days reaction time) and moderate enantiomeric 
excess of 40% ee. After switching to iridium as metal source, improved activity after 16 h was 
observed, but accompanied by lower enantioselectivity (<10% ee). 
 
P
Men
Ph
NHAc
COOR
Ph *
NHAc
COOR
cat. / H2
15b: R = H: 1.0 mol% [Rh(cod)(42)2]PF6, methanol, H2 (3.5 bar), r.t., 8 days, 40% ee
40: R = Me: 1.0 mol% [Ir(cod)(42)2]PF6, CH2Cl2, H2 (2.3 bar), r.t., 16 h, <10% ee
14b, 39 15b, 4042
 
 
Scheme 11. Monodentate phosphetane ligands for asymmetric hydrogenation. 
 
In 1997 the group of Kagan reported efforts on the synthesis of chiral ferrocene–based ligands 
(Scheme 12).36 Starting from ferrocenecarboxaldehyde a three step synthesis was affiliated to 
establish chiral acetal as chiral auxiliary, which was necessary to control the stereochemistry 
of ortho–substitution with Ph2PCl via lithiation protocol. The abilities of obtained ferrocene 
ligand 43a were investigated in the reduction of N–acetyl dehydrophenylalanine with cationic 
rhodium complexes under standard conditions. Good enantioselectivity of 87% ee and yield 
(87%) were achieved. Furthermore, Kagan et al. presented an access to hydroxy–ligand 43b 
by removal of the chiral auxiliary of ligand 43a and subsequent reduction with sodium 
borohydride. Obviously the free hydroxyl–functionality had a disordered effect on 
enantioselectivity (30% ee), while full conversion was reached in applied time frame. 
PPh2
O
O
OMe
H H
Fe
PPh2
OH
Fe
1. deprotection
2. reduction
Ph
NHAc
COOH
Ph *
NHAc
COOH
cat. / H2
ligand 43a: 87% ee (R), yield: 87%
1 mol% [Rh(cod)Cl]2 / 4 mol% 43a
ligand 43b: 30% ee (R), yield: >99%
2 mol% [Rh(cod)(43b)2]+, H2 (10 bar), methanol
43a
43b
14b 15b
 
 
Scheme 12. Ferrocene–based monodentate ligands. 
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Pioneering work in the second age of monodentate ligands was presented in the late 90th of 
the last century by the group of Fiaud applying a monodentate phospholane ligand (R,R)–45 
(Scheme 13), which resembles the structural motif of DuPhos 25.37 Albeit the group of Burk 
demonstrated in one of their early articles the potential of ligand substituted with methyl 
groups (R,R)–44 in the hydrogenation of 39 (60% ee (R)) and dimethyl itaconate (65% ee (R)) 
with catalyst activities up to 500 h-1, their research interest focused on the development of 
new chiral bisphosphines and 44 was mainly used as intermediate or building block.38 
However, Fiaud obtained an enantioselectivity of 82% ee in the rhodium–catalyzed 
hydrogenation of N–acetyl dehydrophenylalanine methyl ester using an in situ catalyst 
composed of 1 mol% [RhCl(cod)]2 and 2.1 mol% corresponding ligand. 
 
P
Ph
Ph
Ph
P Ph Burk et al.
Ph
NHAc
COOMe
Ph *
NHAc
COOMe
Fiaud et al.
cat. / H2 (atm.)
MeOH, 20-25 °C
Burk: 60% ee (R), TON = 1000, TOF = 333 h-1
(0.01 mol% [Rh(cod)(44)2]SbF4)
Fiaud: 82% ee (S)
(in situ: 1 mol% [Rh(cod)Cl]2, 2.1 mol% 45)
Fiaud: 93% ee (S), t1/2= 12 min
(in situ: 1 mol% [Rh(cod)2]BF4, 2.1 mol% 45)
44
45
39 40
 
 
Scheme 13. Asymmetric hydrogenation of N–acetyl dehydrophenylalanine methyl ester with 
monodentate phospholanes. 
 
Later on the same group reported efforts on improving the enantioselectivity, by switching 
from [RhCl(cod)]2 as metal source to [Rh(cod)2]BF4 which resulted in a significant increase of 
enantiomeric excess to 93% ee.39 Furthermore, the scope and limitation of ligand 45 was 
displayed by substrate variation, once dimethyl itaconate was hydrogenated in 55% optical 
yield, while for the corresponding acid a selectivity of 73% ee was attained. On the other hand 
N–acetyl enamides, for instance (Z)–N–(1–phenylprop–1–enyl)acetamide, were hydrogenated 
with good enantioselectivities up to 73% ee. In their ongoing research they became interested 
in stabilizing the air–sensitive phosphine by the phospholanium tetrafluoroborate counterpart 
and liberate the phosphine during the formation of the catalyst precursor. A slight decrease of 
enantioselectivity (86% ee (R)), accompanied by higher catalyst activities, was shown when 
applying this precursor in the hydrogenation of N–acetyl dehydrophenylalanine methyl ester 
with comparable reaction conditions as previous reported by them.40
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At the end of the 20th century the predominant role of bidentate ligands changed and 
monodentate ligands received more attention since first attempts by different groups have 
proven extraordinary transfer of chirality by applying monodentate phosphorous ligands 
based on binaphthol in asymmetric hydrogenation.41, ,42 43 The advantages of this type of 
monodentate phosphorous ligands are their easier synthesis and high tunability compared to 
bidentate phosphines, because designated target is accomplished in commonly 1–2 step 
synthesis starting from low cost chiral binaphthol. Scheme 14 illustrates some examples of 
monodentate phosphorous ligands for asymmetric hydrogenation based on the chiral 1,1´–
binaphthol skeleton. Important contributions in this area came independently from Feringa 
and de Vries et al.41 (phosphoramidites 46), Reetz et al.42 (phosphites 47), and Pringle and 
Claver et al.43 (phosphonites 48). Furthermore, excellent enantioselectivity was shown by 
Zhou and co–workers applying monodentate spiro phosphoramidites (SIPHOS, 49)44 and 
many others.45 The rediscovery of monodentate ligands was furthermore driven by conceptual 
review articles by Kagan and Börner, who assumed a better transfer of the chiral information 
due to the catalyst structure. Until now various systems based on the preliminary structure 
motif (46–48) have been proven to be highly active in diverse classes of asymmetric 
hydrogenations with enantioselectivities up to >99% ee and a few numbers of representatives 
have been commercialized. 
 
O
O
P NR1R2
O
O
P OR
O
O
P R
O
O
P
NR1R2
46 47 48 49  
Scheme 14. Selection of successful chiral monodentate ligands in asymmetric hydrogenations. 
 
However, during this time also some efforts on monodentate phosphines were reported. 
Marinetti and co–workers adopted the synthetic strategy of DuPhos–ligands, via formation of 
cyclic sulfates, for the synthesis of monodentate phosphetanes 50 (Scheme 15).46 A huge 
number of potential ligands were accessible. Three ligands were chosen for testing their 
abilities in asymmetric hydrogenation of N–acetyl dehydrophenylalanine. In comparison to 
former achievements with phosphetanes an improved enantioselectivity up to 86% ee was 
monitored, albeit the i–propyl–derivative gave only low selectivity. 
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P
R
R
50a: R = Me
50b: R = i-Pr
50c: R = Bn
Ph
NHAc
COOH
Ph *
NHAc
COOH
1 mol% [Rh(cod)(50)2]PF6 
H2 (3-5 bar)
Methanol, r.t., over night
50a: 80% ee, conv. >99%
50b: 10% ee, conv. >99% 
50c: 86% ee, conv. >99%
14a 15a
 
Scheme 15. Phosphetane ligands established by Marinetti et al. 
 
Afterwards Helmchen et al. exposed the extraordinary catalytic behaviour of 
oxaphosphinanes in asymmetric hydrogenation reactions (Scheme 16).47 The ligands were 
synthesized by mesylation of enantiopure diolethers and subsequent reaction with 
dilithiophenylphosphine. Because of oxygen–sensitivity a stabilization with BH3 was 
appropriated. The oxaphosphinanes boranes were deprotected with DABCO (1,4–
diazabicyclo[2.2.2]octane) before pre–catalyst formation was carried out. Preliminary 
experiments with ligand 51b pointed out moderate enantioselectivity of 47% ee for 
hydrogenation of N–acetyl dehydrophenylalanine. However, the authors assumed an 
unfavoured sterical shielding of the rhodium therefore the phenyl group was removed and 
substituted by hydrogen. Indeed, significant higher enantioselectivity (86% ee) and reaction 
rates were attained after re–starting the catalytic investigations with secondary phosphine 52b. 
This fact was further approved in the hydrogenation of itaconic acid 53, because 73% ee for 
51b and 93% ee for 52b, respectively, were achieved. Moreover, excellent enantioselectivity 
up to 96% ee was induced by variation of the α–position adjacent to the phosphorous atom. 
 
Ph
NHAc
COOH
Ph *
NHAc
COOH
[Rh(cod)(L)2]BF4 / H2 (1.1 bar)
P
O
RR
Ph BH3
P
O
RR
H BH3
51a: R = Me
51b: R = i-Pr
51c: R = Cy
52a: R = Me
52b: R = i-Pr
52c: R = Cy
1. Li
2. MeOH
20 °C, 24 h
ligand 51b: 47% ee (S) (1 mol% cat., MeOH)
ligand 52b: 86% ee (S) (1 mol% cat., MeOH)
ligand 52c: 90% ee (R) (1 mol% cat., CH2Cl2)
HOOC
COOH
HOOC
* COOH
[Rh(cod)(L)2]BF4 / H2 (1.1 bar)
20 °C, 24 h
ligand 51b: 73% ee (R) (1 mol% cat., MeOH)
ligand 52b: 93% ee (R) (0.2 mol% cat., 2-PrOH)
ligand 52c: 96%ee (S) (0.2 mol% cat., 2-PrOH)
P
O
RR
Ph
P
O
RR
H
14b 15b
53 54
DABCO
DABCO
 
 
Scheme 16. Oxaphosphinanes approached by Helmchen et al. 
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The group of Börner reported the synthesis and catalytic application of monodentate chiral 
phospholanes 55 (Scheme 17).48 Two general synthetic sequences were envisaged. On the 
one hand, as key step a heterogeneous arene hydrogenation of dibenzophosphole acid was 
carried out, but unfortunately only a single product was isolated, while in total five 
diastereomers could be formed. The X–ray structure analysis indicated a cis–selective 
hydrogenation. Secondly, an improved McCormack reaction was performed to build up the 
basic ligand structure, and follow up chemistry yields ligand 55. Further on epimerization was 
investigated theoretically as well as practically to broaden the access to other diastereomers. 
As predicted by calculations the stereocenter adjacent to the phosphorous atom allows 
epimerization in the presence of base and subsequent acidification. Transformation of 
received acids to the corresponding secondary phosphines yields two diastereomers, which 
were separated via borane adduct. Unfortunately, deprotection of the single diastereomers led 
to epimerization of the P–chiral phosphorous atom. However, the mixture of diastereomers 
was tested in the hydrogenation of dimethyl itaconate and N–acetyl dehydrophenylalanine 
methyl ester, thereby moderate enantioselectivities were attained. 
 
P
H
P
H
55
(mixture of epimers 
55a and 55b)
MeOOC
COOMe
MeOOC
* COOMe
1 mol% [Rh(cod)2]BF4 / 2 mol% 55
H2 (1 bar)
25 °C, 4 h
45% ee (R) (CH2Cl2)
52% ee (R) (MeOH)
Ph
NHAc
COOMe
Ph *
NHAc
COOMe
1 mol% [Rh(cod)2]BF4 / 2 mol% 55
H2 (1 bar)
25 °C, 4 h
23% ee (S) (CH2Cl2)
61% ee (S) (MeOH)
55a
55b
39 40
56 57
 
 
Scheme 17. Secondary phosphine based on phospholane in asymmetric hydrogenation. 
 
More recently, Börner et al. reported a second type of monodentate phospholes, based on 
tartaric acid, which allows easy integration of chiral informations.49 The key step was a 
double hydrophosphination. The obtained ligands were subjected to asymmetric 
hydrogenation of α– and β–dehydroamino acid derivates. Excellent enantioselectivity of 92% 
ee was attained for the hydrogenation of β–dehydroamino acid derivatives. 
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2 mol% [Rh(cod)2]BF4 / 4 mol% 58
H2 (1 bar)
r.t.
ligand 58a:
40: R1 = Ph, R2 = Me: 76% ee (S) (MeOH, 230 min)
60: R1 = H, R2 = Me: 81% ee (S) (CF3CH2OH, 17 min)
ligand 58b:
40: R1 = Ph, R2 = Me: 65% ee (S) (THF, 55 min)
60: R1 = H, R2 = Me: 78% ee (S) (THF, 6 min)
R1
NHAc
COOR2
R1 *
NHAc
COOR2
P
O OO O
P
O OO O
58a
58b
2 mol% [Rh(cod)2]BF4 / 4 mol% 58
H2 (1 bar)
CF3CH2OH, r.t.
NHAc
COOR3 *
NHAc
COOR3
ligand 58b:
62a: R3 = Me: 82% ee (S) (200 min)
62b: R3 = Bn: 92% ee (S) (180 min)
61a-b 62a-b
39, 59 40, 60
 
 
Scheme 18. Monodentate phospholane ligands based on tartaric acid. 
 
Breit et al. reported the synthesis of chiral phosphabarrelenes 62, which contain highly 
pyramidalized phosphorous atoms.50 The ligands were accessible by Diels Alder reaction of 
substituted phosphabenzene and benzyne and subsequent separation of isomers. 
Unfortunately, testing these monodentate ligands in asymmetric hydrogenation protocols only 
moderate enantioselectivities were obtained in the hydrogenation of itaconic acids. However, 
improvement of enantioselectivity up to 90% ee was attained when the phosphabarrelene 62d 
was reacted with compound 48 (Scheme 14, R = Cl) to yield a bidentate ligand system. 
 
62a: R1 = Ph, R2 = 2-Napthyl
62b: R1 = Ph, R2 = 3-MeO-C6H4
62c: R1 = Ph, R2 = 2-MeO-C6H4
62d: R1 = Ph, R2 = 2-HO-C6H4
1 mol% [Rh(cod)2]BF4, 2.8 mol% 62
H2 (1 bar)
CH2Cl2, r.t.
(+)-62a: 31% ee (R), conv. >99% (6 h)
(-)-62a: 31% ee (S), conv. >99% (4 h)
P
R2R1
Ph
HOOC
COOH
HOOC
* COOH
53 54
 
 
Scheme 19. Chiral phophabarrelene in asymmetric hydrogenation. 
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2.2. Monodentate ligands based on 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–
e]phosphepine motif in asymmetric hydrogenations of C–C double bonds 
 
“We can expect that they (monophosphines) will play a role of increasing importance in many 
aspects of organometallic catalysis.”                          F. Lagasse and H. B. Kagan
 
Ligands based on the 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine scaffold 66 are 
known since the early 90´s (Scheme 20) when Gladiali and co–workers reported the first 
successful synthesis of this ligand class.51 The synthetic route is presented in Scheme 20. As 
initial step 2,2´–dimethylbinapthyl was synthesized via nickel–catalyzed Kumada coupling 
reaction of 1–bromo–1–methylnapthaline 63 and the corresponding Grignard reagent 64. 
 
CH3
CH3
Br
CH3
MgBr
CH3
+
NiCl2(PPh3)2
1. n-BuLi, KOtBu, tmeda
2. Cl2PR
P R
66
P Ph
N
Pd
Cl
Pd
Cl
N
P
Ph
N
Pd
Cl
P
Ph
N
Pd
Cl
+
P Ph
P Ph
+
DPPE
DPPE
63
64
65
67
68a
66a
(R)-66a
(S)-66a
68b
 
 
Scheme 20. Approach to chiral phosphepines according to Gladiali et al. 
 
The racemic 2,2´–dimethylbinapthyl 65 was selectively double–lithiated on the methyl groups 
and subsequent quenched with dichlorophosphines to yield the racemic 4,5–dihydro–3H–
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dinaphtho[2,1–c;1´,2´–e]phosphepines 66. Resolution of the enantiomers was undertaken on 
racemic 66a and carried out by reacting the racemic mixture with (+)–di–μ−chloro-bis[(S)–
N,N–dimethyl–α–phenylethylamine–2C,–N]-dipalladium 6752 to form diastereomeric 
complexes 68a and 68b. The complexes were separated via crystallization. Finally, the 
enantiopure monodentate phosphine 66a (Ph–BINEPINE) was liberated by reacting the single 
diastereomeric complex with bidentate phosphines (e.g. DPPE). 
The potential of obtained enantiopure ligand (S)–66a was tested in asymmetric rhodium–
catalyzed hydroformylation of styrene 69 under standard conditions (Scheme 21). Good 
iso/n–ratio of aldehyde (70:71) was found (95:5) and even if low enantioselectivity up to 20% 
ee was reached until this point it was the highest enantiomeric excess induced by monodentate 
ligands for this type of reaction.51,53
 
P Ph *
O
+
0.2 mol% [Rh(acac)(CO)2]
1 mol% (S)-66a
CO/H2 (50 bar)
benzene, 30 °C, 3 h
O
iso-selectivity: 95%
20% ee
(S)-66a 69 70 71
 
Scheme 21. Enantioselective hydroformylation in the presence of catalyst containing ligand 66a. 
 
Some years later the group of Stelzer reported the synthesis of secondary phosphine based on 
phosphepine scaffold 66 (R = H) in good yields.54 The described achiral secondary phosphine 
was used as building block or precursor for various ligand systems. However, from practical 
point of view the approaches invented by Gladiali et al. and Stelzer et al. causes some 
difficulties with respect to up–scaling and industrial demands since expensive auxiliaries were 
used and a low overall yield of final ligand was achieved. 
Different attempts were reported on the synthesis of 2,2´–dimethylbinaphthyl 65 in an 
enantiomeric pure form.55 On the one hand various chiral versions were described for C–C 
bond formation via Kumada coupling by exchange of triphenylphosphine by chiral ligands, 
but so far best enantioselectivity of 95% ee was reported by Ito et al.56 Furthermore, few 
Suzuki coupling reactions were published with comparable low enantioselectivities (85% 
ee).57 Although some excellent enantioselectivities were demonstrated by C–C coupling 
methods, the up–scaling of these methods is limited by the availability of applied ligands. On 
the other hand a more convenient two step pathway starting from enantiomeric pure 2,2´–
binaphthol (98% ee) was lately established since nowadays the available of 2,2´–binaphthol is 
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feasible on large scale.58,59 The updated synthesis of binaphthophosphepines starts with 
diesterification of enantiomerically pure 2,2´–binaphthol 72 with trifluoromethanesulfonic 
acid anhydride in the presence of pyridine (Scheme 22).60 The corresponding diester was 
obtained in quantitative yield and subsequent nickel–catalyzed Kumada coupling with methyl 
magnesium bromide leads to 2,2´–dimethylbinaphthyl 65 in 95% yield.61 Two different 
synthetic strategies were established to obtain 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–
e]phosphepine ligands 66. On the one hand, double metallation of 2,2´–dimethylbinaphthyl 65 
with n–butyl lithium in the presence of tmeda (N,N,N´,N´–tetramethylethylenediamine) 
followed by quenching with commercially available dichlorophosphines gives ligands such as 
66a (P–phenyl) and 66b (P–t–butyl) in 60–83% yield.  
OH
OH
P RP NEt2
(CF3SO2)2O / Py
NiCl2(dppp) / MeMgBr
CH3
CH3
1. n-BuLi / tmeda
2. Cl2PNEt2
P Cl
RMgX or RLi
1. n-BuLi / tmeda
2. Cl2PR
66
72
69
74
65
HCl
 
Scheme 22. Synthetic approach to 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine developed 
by Beller et al.
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Both ligands have been synthesized on >10g–scale. In the second procedure the dilithiated 
2,2´–dimethylbinaphthyl 65 is quenched with diethylaminodichlorophosphine to produce the 
phosphepine 7362 which, upon treatment with gaseous HCl is converted into 4–chloro–4,5–
dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine 74 in 80% yield. This enantiomerically 
pure chlorophosphine is easily coupled with various Grignard or lithium reagents to render a 
broad selection of ligand 66. The limited number of commercially available 
dichlorophosphines and the large diversity of Grignard compounds make the access through 
4–chloro–4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine 74 the route of choice to a 
library of ligands 66 (Scheme 23).59
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CF3
FOCH3
OCH3OCH3
OCH3
F
F
F F
F
F
F
F F
H3C CH3
t-Bu t-Bu
D
D
D D
D
CH3H3C
CH3
CH3H3C
CH3
N(CH3)2
N NN
N
CH3
N
CH3
66a
66b
66f66d 66e66c 66g 66h
66k
66j66i 66n66m
66p 66q 66t66s
66r
66w66v 66y66x 66z
66
 
 
Schema 23. Ligand library based on 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine motif. 
 
Noteworthy, parallel to the work of Beller et al. the group of Zhang described a similar 
synthetic approach, but using monodentate system as intermediate since their research mainly 
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focused on bidentate ligands and preliminary unpromising results with ligand 66b in 
asymmetric hydrogenations were obtained (Scheme 24).63 Extraordinary enantioselectivity 
was obtained for bidentate ligands containing the phosphepine moiety (Scheme 24, 75–77).64
 
CH3
CH3
P Cl
1. n-BuLi
2. PCl3
P
t-BuMgBr
60%1. 50-60%
2. 40%
NHAc
COOMe
*
NHAc
COOMe
1 mol% [Rh(cod)]SbF6 
2 mol% 66b
H2 (60 psi)
MeOH, r.t., 24 h
6% ee
66b
PP
PBut
P tBuH
H
Fe
P
P
f-Binaphane (77)Binapine (76)Binaphane (75)
7465
59 60
 
 
Scheme 24. Synthesis of 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine by a protocol 
established by Zhang et al. 
 
Nevertheless, the group of Beller applied tool box 66 in various catalytic reactions. First set of 
catalytic experiments with ligand library 66 were dedicated to the rhodium–catalyzed 
asymmetric hydrogenation of α–amino acid precursors.59c Here, methyl (Z)–α–
acetamidocinnamate 39 and methyl α–acetamidoacrylate 59 were chosen as model systems. 
Representative results are summarized in Table 1 and Table 2. Surprisingly, initial experiment 
with different solvents pointed out a benefit for toluene even if toluene is an unusual solvent 
for hydrogenation purpose, due to catalyst inhibition.65 However, best enantioselectivities up 
to 95% ee were achieved in toluene with high catalyst activities (TOF 1000–6000 h-1). In 
some cases a slight improvement of enantioselectivity and reactivity was found when catalytic 
amount of tenside sodium dodecylsulfonate (SDS) were placed in the reaction (Table 1, 
entries 2 and 3). Analysis of presented results indicates a crucial influence of substitution 
pattern at the phosphorous atom. Best enantioselectivities were obtained with aryl systems, 
while alkyl derivatives lead to low enantiomeric excess (Table 1, entry 1). In the case of 
asymmetric hydrogenation of substrate 39 a detailed study of various ligands with 
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substituted–aryl groups connected to the phosphorous demonstrated no significant change in 
enantioselectivity, when electron–donating or electron–withdrawing functionalities were sited 
in the para–position. Analogous substitution in ortho–position decreased the 
enantioselectivity (Table 1). For the reduction of 59 a converse behaviour was attained since 
substitution on the aromatic unit improved the enantioselectivity (Table 2). 
 
Table 1. Asymmetric hydrogenation of 39 in the presence of catalysts containing ligand class 66. 
 
Ph
NHAc
COOMe
Ph
NHAc
COOMe
1 mol% [Rh(cod)2]BF4 
2 mol% 66
H2 (1 bar)
25 °C
39 40
P R
66a: R = Ph
66b: R = t-Bu
66c: R = 4-CH3O-C6H4
66e: R = 3,4-(CH3O)2C6H3
66i: R = 2-CH3O-C6H4
66n: R = 2-F-C6H4
66q: R = 3,5-(t-Bu)2C6H3
66s: R = 2-Naphthyl  
 
Entry Ligand Solvent t/2 [min] Conversion [%] ee [%] (R) 
1 66b Toluene 31 > 99 20 
2 66a Toluene 50 > 99 90 
3[a] 66a Toluene + SDS 33 > 99 95 
4 66c Ethyl acetate 4 > 99 88 
5[a] 66q Toluene + SDS 2 > 99 95 
6 66i Toluene 59 > 99 64 
7[a] 66n Toluene + SDS 53 > 99 91 
8[a] 66s Toluene + SDS 50 > 99 94 
9 66e Toluene  - > 99 93 
[a] 20 mol% SDS (sodium dodecylsulfonate). 
 
 
Table 2. Asymmetric hydrogenation of 59 in the presence of catalysts containing ligand class 66. 
 
NHAc
COOMe
NHAc
COOMe
1 mol% [Rh(cod)2]BF4 
2 mol% 66
H2 (1 bar)
25 °C
59 60
P R
66a: R = Ph
66c: R = 4-CH3O-C6H4
66i: R = 3-CH3O-C6H4
66n: R = 2-F-C6H4
66q: R = 3,5-(t-Bu)2C6H3
 
Entry Ligand Solvent t/2 [min] Conversion [%] ee [%] (R) 
1 66a Toluene 18 > 99 67 
2 66c Ethyl acetate 2 > 99 51 
3 66q Toluene 1 > 99 94 
4[a] 66n Toluene + SDS 20 > 99 84 
5[a] 66i Toluene + SDS 17 > 99 86 
[a] 20 mol% SDS (sodium dodecylsulfonate). 
 
 
Next the potential of ligand library 66 was tested in the asymmetric hydrogenation of 
dimethyl itaconate 56 (Table 3). Here, best reaction outcome was obtained in 
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dichloromethane as solvent, even if to some extend lower enantioselectivities up to 88% ee 
were observed. 
 
Table 3. Asymmetric hydrogenation of dimethyl itaconate 56. 
 
1 mol% [Rh(cod)2]BF4 
2 mol% 67
H2 (1 bar)
CH2Cl2, 25 °C
P R
66a: R = Ph
66c: R = 4-CH3O-C6H4
66i:  R = 3-CH3O-C6H4
66n: R = 2-F-C6H4
66q: R = 3,5-(t-Bu)2C6H3
66s: R = 2-Naphthyl
COOMe
COOMe
56 57
COOMe
COOMe
 
Entry Ligand Conversion [%] t/2 [min] ee [%] (S) 
1 66a > 99 56 86 
2 66c > 99 - 86  
3 66q > 99 16 83 
4 66n 86 16 77 
5 66s 29 34 70 
6 66i > 99 - 88 
 
A more convincing approach to enantiopure itaconic acid was quite recently reported by 
Gladiali and co–workers (Scheme 25).66 Excellent enantioselectivities up to 97% ee were 
attained when subjecting itaconic acid to a rhodium–catalyzed transfer hydrogenation under 
mild reaction conditions in the presence of well–defined cationic [Rh(nbd)(66a)2]+ 
complexes. As suitable source of hydrogen formic acid was chosen since carbon dioxide 
arises as only side product. Notably, by utilizing the corresponding dimethyl ester or the two 
possible monomethyl esters under same conditions a decrease of enantioselectivity was 
noticed, accompanied by a switch of product configuration. Furthermore, a comparative study 
was carried out by testing several monodentate as well as bidentate ligands. The presented 
results pointed out the potential of this ligand since only a BINAP complex achieved similar 
enantioselectivity. 
1.5 mol% [Rh(nbd)(66a)2]BF4 
HCOOH/NEt3 (5:2)
DMSO, 22 °C, 4 h
P Ph
COOR2
COOR1
COOR2
*
COOR1
66a
53: R1 = R2 = H: 97% ee (S), conv. >99%
56: R1 = R2 = Me: 13% ee (R), conv. 57%  
Scheme 25. Transfer hydrogenation of itaconic acid derivatives. 
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The application of ligand class 66 was furthermore demonstrated in the hydrogenation of N–
acyl enamide 78 by the group of Reetz (Scheme 26).67 The obtained enantioselectivities are 
comparable low, but surprisingly the tert–butyl–substituted ligand 66b (conversion: 94%; 
enantiomeric excess: 24% (R)) showed better selectivity and conversion than the phenyl–
substituted ligand 66a (conversion: 50%; enantiomeric excess: 14% (R)), while in other 
benchmark tests such as the asymmetric hydrogenation of α–amino acid precursors, dimethyl 
itaconate and β–ketoesters always the opposite behaviour was observed. However, in 
combination with BINOL–derived phosphites or phosphonites a significant enhancement of 
enantioselectivity up to 89% ee was found. This combinatorial approach displayed 
impressively one advantage of monodentate phosphorous ligands, as the reaction outcome can 
easily be tuned by different combination of ligands.42m,68  
P R1
O
O
P R2
66a: R1 = Ph
66b: R1 = t-Bu
48a: R2 = CH3
47a: R2 = OCH3
NHAc NHAc0.2 mol% [Rh(cod)2]BF4 0.2 mol% L1 / 0.2 mol% L2
H2 (1.3 bar)
CH2Cl2, 30 °C, 20 h
L1 = L2 = 66a: 14% ee (R), conv. 50%
L1 = L2 = 66b: 24% ee (R), conv. >99%
L1 = L2 = 47a: 76% ee (R), conv. >99%
L1 = L2 = 48a: 76% ee (R), conv. >99%
combinatorial approach
L1 = 66a, L2 = 47a: 57% ee (R), conv. >99%
L1 = 66b, L2 = 47a: 89%ee (R), conv. >99%
L1 = 66a, L2 = 48a: 53% ee (R), conv. >99%
L1 = 66b, L2 = 48a: 87% ee (R), conv. >99%
78 78
 
Scheme 26. Asymmetric hydrogenation of N–acyl enamides. 
 
Following the original work of Reetz et al. the group of Beller investigated the reaction in 
presence of chiral monodentate 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine 66 in 
more detail (Table 4).59f After optimization of different reaction parameters 
enantioselectivities up to 93% ee were achieved with rhodium catalyst containing 2 equiv. of 
ligand 66a. As shown in Table 4 the enantioselectivity is largely dependent on the nature of 
the substituent at the phosphorous atom. Further improvement up to 95% ee, which is up to 
now the highest enantiomeric excess obtained with monodentate phosphine ligands for this 
purpose, was attained when the substrate structure was modified by introduction of electron–
donating groups at the aromatic part of the substrate, while substrates containing electron–
withdrawing groups were hydrogenated with somewhat lower enantioselectivities. 
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Table 4. Extension of asymmetric hydrogenation of N–acyl enamides. 
 
1 mol% [Rh(cod)2]BF4 
2.1 mol% 66
H2 (2.5 bar)
toluene, 30 °C, 6 h
P R
66a: R = Ph
66b: R = t-Bu
66c: R = 4-CH3O-C6H4
66e: R = 3,4-(CH3O)2-C6H3
66h: R = 4-F-C6H4
66i: R = 2-CH3O-C6H4
66m: R = 3,5-(CH3)2-C6H3
66p: R = 4-F3C-C6H4
NHAc
*
NHAc
78 79
 
Entry Ligand Conversion [%] ee [%] 
1 66a >99 93 (R) 
2 66p >99 72 (R) 
3 66h >99 88 (R) 
4 66m >99 87 (R) 
5 66c >99 93 (R) 
6 66i >99 63 (R) 
7 66e >99 90 (R) 
8 66b >99 16 (S) 
 
Apart from α–amino acids β–amino acids received significant attention since they are useful 
building blocks for pharmaceuticals. Hence the groups of Beller and Gladiali reported on the 
successful application of ligand class 66 in the rhodium–catalyzed asymmetric hydrogenation 
of β–dehydroamino acids derivatives to give optical active β–amino acids derivatives.69 First 
experiments emphasized a necessity of different reaction conditions for the E– and Z–isomer 
(Table 5). Good enantioselectivity (79% ee (R)) for the E–isomer was obtained by using 2–
propanol at 2.5 bar hydrogen pressure, while higher pressure (50 bar) in ethanol was 
worthwhile for the Z–isomer (92% ee (R)). Noteworthy, a switch of product configuration 
was observed depending on the nature of the double bond, which has been scarcely 
reported.70 Furthermore, a higher reaction rate was monitored for the Z–isomer, while 
converse behaviour was demonstrated for most other catalysts.71 After separate optimization 
of reaction parameters for both isomers the ligand library 66 was subjected to catalytic 
reaction. Surprisingly, in the case of hydrogenation of E–61a good enantioselectivity was 
achieved with alkyl ligand 66b, while for other catalytic reactions (vide supra) poor to 
moderate enantioselectivities were reported (Table 5, entry 6). However, in the hydrogenation 
of the corresponding Z–isomer the catalyst containing ligand 66b was completely inactive. 
Here best enantiomeric excess was reached by ligand 66a (Table 5, entry 1). The usefulness 
of this concept was confirmed on the hydrogenation of several β–dehydroamino acids 
derivatives. An improved enantioselectivity of 94% ee was attained by replacement of methyl 
ester by ethyl ester. Some mechanistical attempts showed the necessity of 2 equiv. ligands per 
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metal, which is in agreement with previous findings by Knowles et al. This circumstance 
offers the possibility for a combinatorial ligand approach. Beller and Gladiali et al. adopted 
this concept and combined ligand 66a with achiral phosphorous ligands. Unfortunately, no 
significant positive effect was attained. 
Table 5. Hydrogenation of E–61a and Z–61a with different 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–
e]phosphepines 66. 
 
P R H2 (50 bar), EtOH, 10 °C, 24 h
NH
[Rh(cod)2]BF4 + 2.1 (66)
NH
O O
OMe
O
OMe
O
H2 (2.5 bar), 2-PrOH, 10 °C, 24 h
NH
[Rh(cod)2]BF4 + 2.1 (66)
NH
O O
OMe
O
MeO O
Z-61a
E-61a
(S)-62a
(R)-62a
66a: R = Ph
66b: R = t-Bu
66c: R = 4-CH3O-C6H4
66d: R = 3-CH3O-C6H4
66e: R = 3,4-(CH3O)2-C6H3
66m: R = 3,5-(CH3)2-C6H3
 
 
Entry Ligand Isomer[a] Conv. [%] ee [%] Isomer[b] Conv. [%] ee [%] 
1 66a E–61a >99 79 (R) Z–61a >99 92 (S) 
2 66m E–61a 80 69 (R) Z–61a >99 80 (S) 
3 66c E–61a >99 88 (R) Z–61a >99 86 (S) 
4 66d E–61a 91 81 (R) Z–61a 90 40 (S) 
5 66e E–61a >99 90 (R) Z–61a >99 89 (S) 
6 66b E–61a >99 87 (R) Z–61a 3 60 (S) 
 
In addition, the group of Beller carried out an enantioselective reduction of enol carbamates, 
which allows an alternative approach to chiral alcohols.72 Pioneering work in the field of 
asymmetric hydrogenation of enol carbamates has been reported by Feringa, de Vries, 
Minnaard and co–workers who have scored enantioselectivities up to 98% ee with rhodium-
catalysts containing monodentate phosphoramidites (MonoPhos–family).41l,73 Utilizing 
compound 80 as model substrate various reaction parameters were investigated in detail and 
enantioselectivities up to 96% ee were achieved with an in situ catalyst composed of 
[Rh(cod)2]BF4 and ligand 66a. Noteworthy, high thermal stability of the catalyst in the range 
of 10–90 °C was noticed with respect to enantioselectivity (94–96% ee). With these suitable 
conditions ligand library 66 was subjected to a series of enol carbamates. Despite all attempts 
only 66a displayed extraordinary selectivity. 
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Table 6. Hydrogenation of compound 80 with different 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–
e]phosphepines 66. 
 
P R
66a: R = Ph
66b: R = t-Bu
66c: R = 4-CH3O-C6H4
66k: R = i-Pr
66i: R = 2-CH3O-C6H4
66m: R = 3,5-(CH3)2-C6H3
66p: R = 4-F3C-C6H4
MeOH, 25 °C, 6 h
O
[Rh(cod)2]BF4 + 2.1 (66)
O
N
80
*
O O
N
81
H2 (25 bar)
 
 
Entry Ligand Conv. [%] Yield [%] ee [%] 
1 66a >99 >99 96 (S) 
2 66p 40 40 28 (S) 
3 66m >99 >99 66 (S) 
4 66c >99 >99 72 (S) 
5 66i >99 >99 51 (S) 
6 66k 40 40 12 (S) 
7 66c 41 41 50 (R) 
 
While the group of Beller mainly focused on the variation of substituent at the phosphorous in 
4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepines Widhalm et al. reported efforts on 
the α–substitution adjacent to the phosphorous atom (Scheme 27).74 Due to the rise of new 
stereocenters which are closer to the metal a better transfer of chiral information was 
assumed. Starting from 66a, which was synthesized according to literature procedures, the 
corresponding sulfide 82 was prepared. In addition, a deprotonation protocol was established 
which offers a huge variety of mono– as well as disubstituted ligands after reduction since 
simple quenching with electrophils are displayed. The substitution was highly stereoselective, 
because only single diastereomers were obtained. With these ligands in hand a comparative 
study was carried out to explore the influence of α– and α,α´–substitution. In the rhodium–
catalyzed hydrogenation of 14a and 39 only with the α,α´–dimethyl ligand 86b comparable 
enantioselectivities to unsubstituted system were reported, while monosubstituted and other 
disubstituted representatives lead to moderate selectivity. Interestingly, similar 
enantioselectivity and activity was attained by utilization of only 1 equiv. of ligand with 
respect to rhodium. Noteworthy, substitution gained a switch of product configuration. 
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CH3
CH3
1) n-BuLi
2) Cl2PPh
3) S8 P
Ph
S
1) t-BuLi
P
Ph
S
P
Ph
S
R1
R1
2) (R1)X
P Ph
R1
Raney-Ni
1) t-BuLi
2) R2X
P
Ph
S
R1
R2
P Ph
R1
Raney-Ni
R2
82
83a 83b
8586
84a: R1 = TMS
84b: R1 = Me
84c: R1 = Et
84d: R1 = Bn
84e: R1 = i-Pr
86a: R1 = R2 = TMS
86b: R1 = R2 = Me
86c: R1 = R2 = Et
86d: R1 = R2 = Bn
86e: R1 = R2 = i-Pr
65
Ph
NHAc
COOR3
Ph *
NHAc
COOR3
1 mol% [Rh] 
2 mol% 66a or 86b
H2 (3 bar)
r.t.
15a: R3 = H
[Rh(cod)Cl]2/NaOCl4 , MeOH/CH2Cl2
ligand 66a: 91% ee (R), conv. 99%
ligand 86b: 91% ee (S), conv. 99%
40: R3 = Me 
[Rh(cod)2]BF4 , 2 mol% ligand, toluene 
ligand 66a: 85% ee (R), conv. 99%
ligand 86b: 55% ee (S), conv. 98%  
 
Scheme 27. Synthesis of α–substituted and α,α´–substituted phosphepine ligands. 
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2.2.1. Monodentate ligands based on 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–
e]phosphepine scaffold in asymmetric synthesis 
 
Apart from numerous attempts on asymmetric hydrogenation of C–C double bonds further 
asymmetric catalytic applications have been demonstrated the usefulness of monodentate 
phosphines based on 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine motif e.g. the 
ruthenium-catalyzed asymmetric hydrogenation of β–ketoesters,75 asymmetric borylation, 
asymmetric Suzuki coupling reactions catalyzed by palladium complexes, the Pd–catalyzed 
umpoled–allylation of aldehydes76 and the Pt–catalyzed alkoxycyclization of 1,5–enynes.77 
The ligand itself without any metal has been proven as efficient organocatalyst for the 
enantioselective acylation of diols, [3+2] cycloadditions and [4+2] annulations (Scheme 
27).78
P R
CHO
NHAc
NHAc
COOMe
R COOR
OH
R1
COOR1
COOR
ROOC
ROOC
H
HO
Ph
Ph
Ph
OH
N
COOEt
Ts
COOEtPh
CO2Et
R
R1
O
[3+2] Cycloaddition 
of Allenes with Enones
Fu et al.
Hydroformylation
Gladiali et al.
Beller et al.
Hydrogenation
Beller et al.
Transfer Hydrogenation
Gladiali et al.
Hydrogenation
Beller et al.
Hydrogenation
Beller et al.
Transfer Hydrogenation
Gladiali et al.
Hydrogenation
Beller et al.
[4+2] Annulation
of Imines with Allenes
Fu et al.
Allylation
Zanoni et al.
Alkoxycyclization
Michelet, Gladiali, Genet et al.
Ph OH
OAcPh
Acylation
Vedejs et al.
48% ee 95% ee 95% ee
97% ee
95% ee
22% ee
95% ee
99% ee
85% ee
70% ee
66
R1
NHAc
COOR
94% ee
O
Hydrogenation
Beller et al.
96% ee
Hydrogenation
Beller et al.
NR1R2
O
 
Scheme 27. Applications of ligand class 66 in asymmetric synthesis. 
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2.3. Concluding remarks 
 
The rediscovery of monodentate phosphorous ligands displayed a milestone in asymmetric 
hydrogenation since high activities, enantioselectivities and ligand combinations for tuning 
the outcome of the reaction are feasible. In the case of chiral monodentate phosphines until 
now only a few number of ligands have been proven to entrance enantioselectivities above 
90% ee. Here ligands with 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine structure 
motif demonstrated excellent enantioselectivities up to 96% ee in several catalytic 
applications. However, the discovery of new effective phosphines will be an important 
challenge for future research due to there superior stability in comparison to monodentate 
phosphoramidites, phosphites and phosphonites. 
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3.1. Introduction 
 
Within the different molecular transformations reduction processes plays one of the major 
roles in organic chemistry. Apart from stoichiometric reactions, transition metal catalyzed 
reactions offer an efficient and versatile strategy and present a key technology for the 
advancement of “green chemistry”, specifically for waste prevention, reducing energy 
consumption, achieving high atom efficiency and creating advantageous economics.1 Among 
the most popular and extensive studied catalytic reactions with respect to industrial 
applications is the hydrogenation of unsaturated compounds containing C=C, C=O and C=N 
bonds since addition of molecular hydrogen provides high atom efficiency.2 In this regard, for 
activation of the molecular hydrogen or hydrogen donors, transition metal catalysts are 
essential. Commonly expensive and rare late transition metals (Ir, Rh or Ru) are applied as 
catalyst core. Therefore, substitution by ubiquitous available, inexpensive and less toxic 
metals is one of the major challenges for future research. Consequently, the use of iron 
catalysts is especially desirable.3 This chapter will summarize the impact of iron catalysts on 
hydrogenation and hydrosilylation chemistry and mainly directed to the reduction of C=C, 
C=O and C=N bonds. Further catalytic applications were summarized elsewhere e.g. 
reduction of nitro compounds or dehalogenations.4 
 
3.2. Hydrogenation of carbonyl compounds 
 
The relevance of carbonyl hydrogenation processes is impressively emphasized by the broad 
scope of applications for example as building blocks and synthons for pharmaceuticals, 
agrochemicals, polymers, synthesis of natural compounds, auxiliaries, ligands and key 
intermediates in organic syntheses  (Scheme 1).5  
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Scheme 1. Selected pharmaceuticals based on chiral alcohols.6 
 
In the past this field has been dominated by ruthenium, rhodium and iridium catalysts with 
extraordinary activities and furthermore superior enantioselectivities, however some 
investigations were carried out with iron catalysts. Early efforts were reported on the 
successful use of hydridocarbonyliron complexes (HFem(CO)n-) as reducing reagent for α,β-
unsaturated carbonyl compounds, dienes and C=N double bonds, albeit complexes were used 
in stoichiometric amounts.7 The first catalytic approach was presented by Markó and co-
workers on the reduction of acetone in the presence of Fe3(CO)12 or Fe(CO)5.8 In this reaction 
the hydrogen is delivered by water under more drastic reaction conditions (100 bar, 100 °C). 
Addition of NEt3 as co-catalyst was necessary to obtain reasonable yields. The authors 
assumed a reaction of Fe(CO)5 with hydroxide ions to yield HFe(CO)4- under liberation of 
carbon dioxide since basic conditions are present, and excluded formation of molecular 
hydrogen via water gas shift reaction. HFe(CO)4- is believed to be the active catalyst, which 
transferred the hydride to the acceptor. The presented catalyst displayed activity in the 
reduction of several ketones and aldehydes (Scheme 2).9 
 
R1 R2
O 10 mol% Fe(CO)5NEt3
100 bar (H2:CO 98.5:1.5)
150 °C, 3 h
R1 R2
OH
5a: R1 = CH3; R2 = CH3:         conv.: >99%
5b: R1 = C6H5; R2 = CH3:         conv.: 62%
5c: R1 = i-Bu; R2 = CH3:           conv.: 30%
5d: R1 = C6H5; R2 = H:             conv.: 95%
5e: R1 = n-Pr; R2 = H:               conv.: 98%
6: cyclohexanone:                   conv.: >99%4 5
Scheme 2. Reduction of ketones and aldehydes by using the Fe(CO)5/NEt3 system according 
to Markó et al. 
 
Later on, the group of Vancheesan referred on transfer hydrogenation of ketones utilizing 2-
propanol or 1-phenylethanol as hydrogen source (Scheme 3).10 A phase transfer catalyst was 
essential to support the hydrogenation catalyst Fe3(CO)12 or Fe(CO)5 since a liquid-liquid 
biphasic system was used as solvent. Under mild reaction conditions several ketones were 
hydrogenated to the corresponding alcohols with turnover frequencies up to 13 h-1. 
Mechanistic investigations indicated a similar process as reported by Markó et al.8 
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R1 R2
O
4 mol% Fe3(CO)12
PTC: BzEt3NCl or Aliquat 336
NaOH
water/2-PrOH
or water/1-phenylethanol
28 °C, 2.5-3 h
R1 R2
OH 5b: R1 = C6H5; R2 = CH3:           yield: 36%
5f: R1 = 4-Cl-C6H4; R2 = CH3:   yield: 42%
5g: R1 = 4-Me-C6H4; R2 = CH3:  yield: 28%
5h: R1 = Et; R2 = CH3:                yield: 20%
6: cyclohexanone:                     yield: 78%4 5
Schema 3. Phase transfer catalyzed transfer hydrogenation of ketones by Vancheesan et al.   
 
More recently, Gao et al. reported in a special chinese journal an asymmetric transfer 
hydrogenation (Scheme 4) based on [Et3NH][HFe3(CO)11] and chelating chiral ligands.11 In 
the presence of enantiopure diaminodiphosphine iron catalysts they claim good conversion 
and enantioselectivity up to 98% ee (substrate 5j). 
 
R1 R2
O
1 mol% [Et3NH][HFe3(CO)11]
ligand 6
6 mol% KOH
2-PrOH
45-82 °C, 3-21 h
R1
*
R2
OH
NH HN
PPh2 Ph2P
(S,S)-6
(R,R)-6
ligand: (S,S)-6
5b: R1 = C6H5; R2 = CH3:            56% ee (R), yield: 92% (82 °C, 7 h)
5i: R1 = C6H5; R2 =C(CH3)3:      93% ee (S), yield: 19% (82 °C, 7 h)
5j: R1 = CH(C6H5)2; R2 =CH3:    98% ee (S), yield: 18% (65 °C, 21 h)
5k: R1 = C6H5; R2 =Cy:               78% ee (S), yield: 73% (82 °C, 17 h)
ligand: (R,R)-6
5m: R1 = C6H5; R2 = C2H5:          72% ee (S), yield: 87% (45 °C, 4.5 h)
5n:  R1 = C6H5; R2 = CH(CH3)2:   78% ee (S), yield: 98% (45 °C, 3 h)
4 5
 
Schema 4. Enantioselective transfer hydrogenation catalyzed by iron complexes by Gao et al.   
 
In 2006 we reported the application of an easy to adopt in situ concept composed of an iron 
source e.g. FeCl2 or Fe3(CO)12, monodentate phosphines and tridentate nitrogen ligands in the 
transfer hydrogenation of aliphatic and aromatic ketones using 2-propanol as hydrogen source 
(Scheme 5).12 The influence of different reaction parameters on the reduction of model 
substrate acetophenone 5b were studied in detail. A crucial influence of base and base 
concentration was displayed since only sodium isopropoxide gave reasonable amount of 
product. In comparison to ruthenium-based transfer hydrogenations a higher temperature is 
necessary. Notably, the advantage of this in situ concept is underlined by easy tuneability of 
the iron catalyst, due to the broad availability of simple phosphines and amines. Plenty of 
phosphorous and amine ligands were subjected to the model reaction. However, best results 
were found with a catalyst composed of Fe3(CO)12, triphenylphosphine and 2,2´:6´,2´´-
terpyridine or, surprisingly, 3 equiv. of pyridine with respect to iron. The later one resembles 
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a straightforward catalyst regarding to industrial applications. After several optimization steps 
an active catalyst was developed which exhibit comparable activity to Ru3(CO)12 based 
catalysts and was successfull for the reduction of several ketones with good to excellent 
conversions.13 
 
4
R1 R2
O
0.5 mol% FeCl2
0.5 mol% PPh3/0.5 mol% TerPy 
25 mol% NaO-i-Pr
2-PrOH, 100 °C, 7 h
R1 R2
OH
5
5b: R1 = C6H5; R2 = CH3:               yield: 95%
5f: R1 = 4-Cl-C6H4; R2 = CH3:       yield: 97%
5g: R1 = 4-Me-C6H4; R2 = CH3:      yield: 83%
5m: R1 = C6H5; R2 = C2H5:            yield: 92%
5o: R1 = 4-MeO-C6H4; R2 = CH3:   yield: 75%
5p: R1 = 2-MeO-C6H4; R2 = CH3: yield: >99%
5q: R1 = C6H5; R2 = CH2Cl:          yield: 8%
5r: R1 = Cy; R2 = CH3:                 yield: 93%
5s: R1 = t-Bu; R2 = CH3:               yield: >99%
Scheme 5. In situ catalyst based on FeCl2/terpy/PPh3 in the transfer hydrogenation of ketones. 
 
Very recently the effectiveness of FeCl2/terpy/PAr3 catalysts is proven in the hydrogenation 
of α-substituted ketones, which are interesting 1,2-diol precursors (Scheme 6).14 Excellent 
yields, chemoselectivities and activities (TOF: up to 2000 h-1) were achieved under optimized 
conditions. 
  
R1
O
1 mol% FeCl2
1 mol% P(4-F-C6H4)3/1 mol% TerPy 
50 mol% NaOH
2-PrOH, 100 °C, 1 h
8a: R1 = C6H5; R2 = CH3:                   yield: 92%
8b: R1 = C6H5; R2 = C6H5:                 yield: 94%
8c: R1 = C6H5; R2 = 4-Cl-C6H4:          yield: >99%
8d: R1 = C6H5; R2 = 2,6-(i-Pr)2C6H4:  yield: 45%
8e: R1 = 4-Me-C6H5; R2 = C6H5:        yield: 99%
8f:  R1 = 4-MeO-C6H5; R2 = C6H5:     yield: 85%
8g: R1 =  t-Bu; R2 = C6H5:                  yield: 22%
OR2
R1
OH
OR2
7 8
 
Scheme 6. Reduction of α-substituted ketones in the presence of iron catalyst. 
 
Apart from synthetic aspects we attained some useful informations concerning the 
mechanism, even if the “real” catalyst structure is so far unclear. Various experiments proved 
the presence of a homogeneous catalyst. Following the original works on Ru-, Rh- or Ir-
catalyst, deuterated hydrogen donors were applied since for transfer hydrogenation two 
common mechanisms are established, nominated as direct hydrogen transfer via formation of 
a six-membered cyclic transition state constituted of metal, hydrogen-donor and -acceptor, 
and secondly the hydridic route, which is subdivided into two pathways, the monohydride and 
dihydride mechanism (Scheme 7). More specifically, the formation of monohydride-metal-
complexes promote an exclusive hydride transfer from carbon (donor) to carbonyl carbon 
(acceptor), whereas a hydride transfer via dihydride-metal-complexes leads to no accurate 
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prediction of hydride resting state, for the reason that the former hydride was transferred to 
carbonyl carbon (acceptor) as well as to the carbonyl oxygen (acceptor).15 
 
O O
*H
H
[M-H*]
O O
*H
H
[H-M-H*]
OH
H*
OH
H*
OH*
H
monohydride mechanism dihydride mechanism
-acetone -acetone
50% 50%
 
Scheme 7. Hydridic route established for transfer hydrogenation with Rh-, Ru- and Ir-
catalysts. 
 
To specify the position and the nature of the transferred hydride, the reaction was performed 
with 2-propanol-d1 as solvent/donor, sodium 2-propylate as base and Fe3(CO)12/PPh3/TerPy 
as catalyst under optimized conditions. In the transfer hydrogenation of acetophenone a 
mixture of two deuterated 1-phenylethanols was obtained (Scheme 8, 9a and 9b). The ratio 
between 9a and 9b (85:15) indicated a specific migration of the hydride, albeit some 
scrambling was detected. However, the incorporation is in agreement with the monohydride 
mechanism, implying a formation of metal monohydride species in the catalytic cycle. 
 
O
H
D O
D
H
2-PrOD, 100 °C
+
9a: 85% 9b:15%
O
[Fe]/NaO-i-Pr
5b  
 
Scheme 8. Deuterium incorporation catalyzed by Fe3(CO)12/terpy/PPh3 system under transfer 
hydrogenation conditions. 
 
Parallel to the work on in situ three component catalysts we developed a nature inspired in 
situ catalyst based on iron porphyrin complexes since a high stability of the complexes are 
known and inertness against oxygen and moisture is feasible.16 The porphyrin catalysts 
achieved even higher activities than three component system in the transfer hydrogenation of 
ketones (Scheme 9). After optimization of reaction parameters turnover frequencies up to 642 
h-1 at low catalyst loadings (0.01 mol%) were attained. A ligand screening emphasized 
porphyrin 10 as module of a highly active catalyst and makes it suitable for further 
investigations on substrate variation. Various ketones were reduced in good to excellent 
yields. Notably, also naturally occurring hemin has been used in this study. Even if lower 
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activity was gained it is a worthwhile system, due to the abundance and easy handling. 
Advantageously, no pre-catalyst formation is necessary. 
 
 
R1 R2
O
0.17 mol% Fe3(CO)12
0.5 mol% 10 
8.5 mol% NaO-i-Pr
2-PrOH
100 °C, 7 h
R1 R2
OH
5f: R1 = 4-Cl-C6H4; R2 = CH3:        yield: 95%
5b: R1 = C6H5; R2 = CH3:               yield: 94%
5g: R1 = 4-Me-C6H4; R2 = CH3:      yield: 68%
5o: R1 = 4-MeO-C6H4; R2 = CH3:   yield: 72%
5p: R1 = 2-MeO-C6H4; R2 = CH3:   yield: >99%
5m: R1 = C6H5; R2 = C2H5:            yield: 87%
5r: R1 = Cy; R2 = CH3:                   yield: 89%
5s: R1 = t-Bu; R2 = CH3:                yield: 90%
N
NH N
HN
N
N
N
N 10
 
Scheme 9. Biomimetic transfer hydrogenation of ketones with iron porphyrin catalysts. 
 
Applying Fe porphyrin catalysts and 2-propanol as hydrogen donor various α-hydroxyl-
protected ketones are reduced to the corresponding mono protected 1,2-diols in good to 
excellent yield after optimization (Scheme 10).17 Remarkable, addition of small amounts of 
water (5–10 mol%) boosted the catalysts activity up to 2500 h-1 at low catalyst loadings (0.01 
mol%). 
 
N
NH N
HN
11
Cl
Cl
Cl
Cl
R1
O
1 mol% FeCl2
1 mol% 11 
50 mol% NaOH
2-PrOH, 100 °C, 2 h
8a: R1 = C6H5; R2 = CH3:                   yield: >99%
8b: R1 = C6H5; R2 = C6H5:                 yield: 92%
8c: R1 = C6H5; R2 = 4-Cl-C6H4:          yield: >99%
8d: R1 = C6H5; R2 = 2,6-(i-Pr)2C6H4:  yield: 74%
8e: R1 = 4-Me-C6H5; R2 = C6H5:        yield: >99%
8f:  R1 = 4-MeO-C6H5; R2 = C6H5:     yield: 83%
8g: R1 =  t-Bu; R2 = C6H5:                  yield: 48%
OR2
R1
OH
OR2
 
Scheme 10. Reduction of α-substituted ketones in the presence of iron porphyrin catalysts. 
 
3.3. Hydrogenation of Carbon-Carbon Double Bounds 
 
Since the 60th of the last century tremendous efforts were undertaken in the field of 
homogeneous hydrogenation of C-C double bonds emphasized by innumerable reports and 
later on rewarded by integrations in several industrial processes (Scheme 11). However, an 
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even broader use in industry is expected by the availability of similar active and selective 
hydrogenation catalysts containing inexpensive metals (e.g. Fe and Cu). 
 
H
N COOMe
O
H2N
COOH
O N
Cl
F
O
O
O
N
H
COOH
SH
Aspartam (14)
artificial sweetener
N-Acetylcystein (13)
mucolytic therapy
Flamprop-isopropyl (15)
herbizide
OH
HO NH2
OH
O
L-DOPA  (12)
anti Parkinson´s disease  
Scheme 11. Selected pharmaceuticals, which are accessible by asymmetric C-C double bond 
hydrogenation.5,18 
 
Indeed iron catalysts are known to transfer hydrogen to C-C double bonds. Early examples 
were carried out with metal salts activated by aluminium compounds in the hydrogenation of 
non-funtionalized olefins at comparable mild reaction conditions (0–35 °C and low hydrogen 
pressure).19 Some research groups focused on the application of iron carbonyls due to the 
easier removal of the carbonyl ligands, for generating an active site, compared to halogens 
and avoidance of activating reagents.20 Unsaturated carboxylic acid derivatives, for instance 
methyl linoleate and methyl linolenate, which contain two or three non-conjugated double 
bonds, respectively, were described in the mid of the 1960s (Scheme 12).21,22 As catalyst 
precursor Fe(CO)5 was utilized at high temperature. The authors proposed as first step an 
isomerization of the double bonds catalyzed by Fe(CO)5 to obtain various dienes or trienes. 
Hydrogenation process was observed in case of conjugated dienes to yield monoenes via an 
iron-carbonyl-diene complex 18, while dienes were formed for the hydrogenation of methyl 
linolenate 16. The activity of the system was improved, when the iron-carbonyl-diene-
complex 18 is used as precursor instead of Fe(CO)5. Analysis of the reaction mixture 
displayed mononenes as major products with unselective double bond distribution 
accompanied by small amounts of fully saturated compounds. Later on, Cais and co-worker 
studied the reaction of methyl hexa-2,4-dienoate as a model for fatty acids in more detail and 
reported several mechanistic considerations.23 
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10 mol% Fe(CO)5
cyclohexane, H2 (28 bar), 180 °C, 7 h 17
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(CH2)4CH3 (CH2)7COOMe
H3C(H2C)4 (CH2)7COOMe
(CH2)yCOOMe
H3C(H2C)x
Fe(CO)5
Fe(CO)5
18
(CH2)yCOOMeH3C(H2C)x Fe
CO
OC CO
(CH2)wCOOMe
H3C(H2C)v
 
Scheme 12. Fe-catalyzed hydrogenation of methyl linoleate. 
 
Tajima and Kunioka described the hydrogenation of conjugated diolefins, in particular 1,3-
butadiene in the presence of activated [CpFe(CO)2Cl].24 AlEt3 and PhMgBr were tested as 
activation reagents, thereby the AlEt3-activated complex showed the best performance. The 
authors proposed the formation of iron-alkyl species which undergoes hydrogenolysis to 
create an active metal-hydride. The composition of the final mixture is dominated by cis-but-
2-ene and trans-but-2-ene (ratio ~1:1). Furthermore traces of 1-butene were observed, 
whereas the catalyst was completely inactive for the hydrogenation of the mono-olefin to 
yield n-butane. 
benzene, H2, 40-45 °C, 6 h
2.5 mol% CpFe(CO)2Cl
19
6 mol% AlEt3 or 8.8 mol% PhMgBr
AlEt3  conversion: 99%
20a: 2%; 20b: 46%;20c: 52%
PhMgBr  conversion: 85%
20a: 1%; 20b: 38%; 20c: 37%
20c20b20a
+ +
 
Scheme 13. Hydrogenation of butadiene with CpFe(CO)2Cl (Cp = cyclopentadienyl). 
 
Nishiguchi and Fukuzumi reported on the transfer hydrogenation of 1,5-cyclooctadiene (cod) 
in the presence of catalytic amounts of  FeCl2(PPh3)2 (10 mol%) at high temperature (up to 
240 °C).25 As hydrogen source polyhydroxybenzenes, for instance pyrogallol, pyrocatechol or 
hydrochinone, have been proven to be superior for this reaction, while primary and secondary 
alcohols led to lower conversion. The hydrogenation of 1,5-cyclooctadiene led to cyclooctane 
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as main-product, but the unsaturated cyclooctene and isomerization products were also 
observed. 
Later on Wrighton and co-workers recognized a reactivity increase with respect to 
hydrogenation rate when Fe(CO)5 was treated with light.26,27 The authors assumed an 
expulsion of one carbonyl ligand to form an unsaturated species induced by near-ultraviolet 
irradiation. After complexation of the olefin again activation by light removed another 
carbonyl ligand to allow hydrogen coordination/activation. A number of unsubstituted olefins 
(e.g. ethylene, propylene, cis-3-hexene, cyclopentene, cyclooctene), were hydrogenated to 
give alkanes in moderate yield (up to 50%), while the catalyst is inactive for sterical 
demanding olefins (e.g. 1,2-dimethylcyclohexene) or aldehydes and nitriles. Furthermore, 
acetylenes were subjected to this photo-catalyzed reduction. However, only low yield (<5%) 
of the corresponding olefin was obtained. 
Inspired by the properties of metalloproteins and metalloenzymes in biological processes the 
group of Inoue established a hydrogenation protocol based on active sites of enzyme 
hydrogenases, which contain an iron-sulfur cluster (Scheme 14).28,29 For their biomimetic 
approach the Fe4S4-cluster 24 was used as an active-site model and tested in the 
hydrogenation of octene 21 and stilbene 23 with molecular hydrogen. A necessity for 
activation of the cluster with phenyl-lithium was reported. The amount of activation-reagent 
played a crucial role for the catalytic activity and selectivity; thereby an optimum in the 
hydrogenation of octene was attained when 12.5 mol% phenyl-lithium and 75 mol% for 
stilbene hydrogenation, respectively, were applied. Noteworthy, in the case of defined internal 
octenes an isomerization of the double bond takes place to obtain different internal octenes, 
due to β-hydride elimination. 1-Octene is extracted to some extend faster out of this melange 
by hydrogenation.28 The final composition of cis-stilbene hydrogenation indicated also an 
isomerization, because significant amounts of trans-stilbene are observed, while the 
hydrogenation of trans-stilbene is unaffected by isomerization.29 
 
Et2O, H2, r.t., 20 h
C6H13
2 mol% [Fe4S4Cl4][N(n-Bu)]2
21 22
C6H138 mol%-32 mol% PhLi
8 mol% PhLi   yield: 49%
32 mol% PhLi   yield: 55%
12.5 mol% PhLi   yield: 92%
Et2O, H2, r.t., 3 h
Ph
6 mol%-25 mol% [Fe4S4Cl4][N(n-Bu)]2
23 24
75 mol%-200 mol% PhLi
6 mol% cat.; 75 mol% PhLiPh
Ph
Ph
cis-stilbene  yield: 92%
trans-stilbene  yield: 38%
Fe
S
S
S
Fe
Fe
Fe
S
Cl
Cl
Cl
Cl
[N(n-Bu)4]2
25  
 
Scheme 14. Bio-inspired iron catalyst in the hydrogenation of C-C double bonds. 
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At the beginning of the 90th of the last century a switch to iron catalysts stabilized by either 
phosphines or nitrogen ligands took place. Here, Bianchini and co-workers carried out a 
detailed comparative study on the transfer hydrogenation of α,β-unsaturated ketones by 
nonclassical trihydride iron, ruthenium and osmium complexes containing tetradentate 
phosphines (Scheme 15).30,31 In the presence of cyclopentanol as hydrogen donor several α,β-
unsaturated ketones were hydrogenated to the corresponding saturated ketones with good to 
excellent selectivity under mild reaction conditions (Scheme 15). In some cases, e.g. 
benzylideneacetone or 2,3-cyclohexenone, the unsaturated or saturated alcohols were formed 
by the catalyst 26, thereby also good selectivity was noticed. Noteworthy, no co-catalyst, e.g. 
base, was necessary to activate the catalyst or the hydrogen donor, which is needed for other 
catalyst systems. However, for carbonyl hydrogenation, e.g. acetophenone and 
cyclohexanone, the iron catalyst displayed only low activity. No activity was found for 
aldehydes and C=C systems without additional carbonyl functionality. 
 
Fe
P1
P1
P1
P
H
P1 = PPh2
H
H
26
R1
O
R R1
O
R R1
OH
RR1
OH
R
1 mol% 26
cyclopentanol
dioxane, 
80 °C, 1-7 h
27a: R = C6H5; R1 = CH3:   conv.: 95%, B: 95%
27b: R = C6H5; R1 = C6H5: conv.: 30%, A: 30%
27c: R = CH3; R1 = C6H5:   conv.: 7%, A: 7%
27d: R = CH3; R1 = C2H5:   conv.: 19%, A: 19%
27e: R = CH3; R1 = CH3:     conv.: 100%, A: 100%
28: 2-cyclohexene:              conv.: 72%, B: 44%, C: 28%
29: 2-cyclopentene:             conv.: 100%, A: 84%, B: 16%
A B C
++
 
Scheme 15. Application of nonclassical iron trihydride complex in transfer hydrogenation 
according to Bianchini and co-workers. 
 
Reduction of styrene was reported by Kano et al. using NaBH4 as hydrogen source in the 
presence of iron porphyrin complex 30 (Scheme 16).32 Good turnover frequencies up to 81 h-1 
and good chemoselectvities are obtained in protic solvents with catalyst loading of 1 mol% at 
room temperature. The reaction has been proven to be a radical process since to some extent 
2,3-diphenylbutane was detected. A similar approach was carried out by Sakaki and co-
workers on the hydrogenation of α,β-unsaturated esters, who reported improvement of the 
catalyst activity (turnover frequency, tof = 4580 h-1).33 A detailed study of the reaction 
mechanism displayed a crucial influence of the protic solvent because the hydride is assigned 
by NaBH4 and the proton by methanol. 
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OEt
O 0.02 mol% 30
200 mol% NaBH4
THF-MeOH (9:1)
30 °C, 1 hN
N N
N
30
OEt
O
Fe+
Cl-
TOF = 4580 h-1
31 32
  
Scheme 16. Reduction of α,β-unsaturated ester catalyzed by iron porphyrin 30. 
 
More recently, the group of Chirik have shown elegantly the application of low valent iron 
complexes in the hydrogenation of various C-C double and C-C triple bounds.34 Based on the 
mentioned work of Wrighton et al. an approach to stabilized 14 electron L3Fe(0) fragments 
was presented. The catalyst precursors were synthesized by reduction of dihalogen complexes 
33 containing a tridentate pyridinediimine ligand with sodium amalgam or with sodium 
triethylborohydride under an atmosphere of nitrogen (Scheme 17). The obtained bis-
dinitrogen complexes 34 are relative labile compounds and a loss of one equivalent of 
dinitrogen in solution at room temperature or an easy exchange against hydrogen or alkynes 
occurred. The catalyst activity was studied in the field of C-C double and C-C triple bond 
hydrogenation. Applying 0.3 mol% of the iron catalyst simple olefins such as 1-hexene or 
cyclohexene were hydrogenated with high turnover frequencies up to 1814 mol/h under 
comparatively mild reaction conditions (4 atm of hydrogen pressure and room temperature). 
The reaction was also carried out under preferred solvent-free conditions in neat substrates 
and leading to comparable activity. The scope and limitation of the catalyst system was 
demonstrated in the hydrogenation of various olefin units enclosing geminal, internal and 
trisubstituted olefins and furthermore diolefins. In the course of this it was ascertained that 
best activity was attained for terminal olefins > internal olefins = geminal olefins > 
trisubstituted olefins. In addition, one example of a functionalized olefin was mentioned. 
However, only a diminished activity was observed for dimethyl itaconate, albeit using higher 
catalyst loadings. In the case of cyclohexene some detailed investigations emphasized a 
deactivation of the catalyst by arene complexation either from the solvent or the aryl groups in 
the ligand.35 Noteworthy, when comparing activity of catalyst 34 (1814 mol/h) with common 
catalysts e.g. Pd/C (TOF = 366 mol/h), RhCl(PPh3)3 (10 mol/h) or [Ir(cod)(PCy3)(py)]PF6 (75 
mol/h) in the hydrogenation of 1-hexene under optimized conditions a significant higher value 
was reached with the iron catalyst. 
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36e: R1 = -COOCH3; R2 = CH2COOMe: TOF = 3 mol/h
37:   cylohexene:                                     TOF = 57 mol/h
R1 R2
35 36
Ar = 2,6-(iPr)2C6H3
 
Scheme 17. Preparation of catalyst precursors containing tridentate nitrogen ligands and 
abilities in catalytic reaction according to Chirik and co-workers. 
Further on the group of Chirik studied the influence of replacing the imino functionalities in 
ligand system 34 by phosphino groups (Scheme 18).36 A different coordination mode was 
found since only one nitrogen ligand was replaced by hydrogen. The unstable complex 38 was 
also tested in the hydrogenation of 1-hexene, but no improvement of activity was observed. 
 
N
PiPr2
PiPr2
Fe
N2
35c
0.3 mol% 37
H2 (4 atm)
pentane, 23 °C, 3 h
H
H
38
conv.: 98%
36c
 
Scheme 18. Application of iron aminodiphosphine complexes in hydrogenation reaction. 
Using the same synthetic method as described for catalyst 34 also diime complexes 39 were 
attainable (Scheme 19).37 Due to the instability of dinitrogen complexes stabilization was 
carried out by introducing more suitable ligands e.g. alkynes, olefins or diolefins. However, in 
the hydrogenation of 1-hexene under comparable conditions only low activities were 
observed. Apart from synthesis and application of low valent iron complexes Chirik et al. 
carried out some mechanistic investigations. The suggestion of the catalytic cycle is presented 
in Scheme 20. Initially, an unsaturated iron complex is formed by expulsion of both 
dinitrogen molecules. 
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35c
0.3 mol% 39
H2 (4 atm)
pentane, 22 °C, 3 h
36c
N
Fe
N
Ar
Ar
L
39a: Ar = 2,6-(iPr)2C6H3; L = (Me3Si)2C2  TOF = 4 mol/h
39b: Ar = 2,6-(iPr)2C6H3; L = cod              TOF = 90 mol/h
39c: Ar = 2,6-(iPr)2C6H3; L = coe              TOF = 90 mol/h
39
 
 
Scheme 19. Hydrogenation with low valent iron complexes. (cod = 1,5-cyclooctadiene, coe = 
cyclooctene). 
 
Next coordination of olefin takes place, which is preferred since also activation of hydrogen is 
feasible. After olefin coordination oxidative addition of hydrogen yields a formally 18 
electron complex. Insertion of the olefin obtained an alkyl complex, which recreate the 
starting complex via reductive elimination. Notably, the olefin complex also supports an 
isomerization of the double bond; hence an extension of possible intermediates is conceivable. 
 
[Fe](N2)2
[Fe]
-2N2 R
R
[Fe]
R
H[Fe]
H
[Fe]
H
R
H2
R
 
Scheme 20. Mechanism for the hydrogenation process proposed by Chirik et al. 
 
 
3.4. Hydrogenation of imines and similar compounds 
 
Until today only a scarce number of hydrogenations of unsaturated CN functionalities have 
been described utilizing iron catalysts. On the one hand hydrogenation of N-
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benzylideneaniline to yield N-benzylaniline was carried out by Markó et al. in presence of 
catalytic amounts of [NEt3H][HFe(CO)4], which was also applied for ketones/aldehydes 
reduction (vide supra).38 Even if good to excellent activities were obtained in various 
solvents, for proceeding the reaction harsh conditions are required (150 °C, 100 bar). On the 
other hand Kaesz and co-workers reported the reduction of nitrogen heterocycles under water-
gas shift conditions.39 As catalyst Fe(CO)5 was used under high temperature and pressure. 
Moderate turnover numbers in the range of 18–37 were obtained. In the case of isoquinoline 
42 as main product the formylated compound 43 is observed. 
 
N
N
N
H
1.8 mol% Fe(CO)5, KOH
H2O, MeOH
CO (500 psi), 150 °C, 15 h
N
1.8 mol% Fe(CO)5, KOH
H2O, MeOH
CO (500 psi), 150 °C, 15 h
O
40 41 42 43
 
Scheme 21. Hydrogenation of aromatic nitrogen heterocycles. 
 
3.5. Catalytic hydrosilylations 
 
In addition to catalytic reductions with molecular hydrogen or hydrogen donors also silanes 
represent useful reducing agents.40 
Most examples in literature for hydrosilylation with iron complexes as catalyst are known for 
Fe(CO)5 or related iron carbonyl compounds.41 The first use of iron pentacarbonyl was 
reported for the reaction of silicon hydrides with olefins at 100–140 °C to form saturated and 
unsaturated silanes according to Scheme 22.42,43 
 
Fe(CO)5
R3SiH   +   RCH=CH2
R3SiCH2CH2R
R3SiCH=CHR   +   H2
R = Cl, OC2H5, C2H5
44
45
neat, 100-140 °C
 
Scheme 22.  Fe-catalyzed hydrosilylation of C-C double bonds. 
 
An excess of olefin favours the formation of the unsaturated product 44 while the silylated 
compound 45 dominated at higher ratio of silane to alkene. The described reaction was also 
carried out in the presence of colloidal iron and lead to results similar to those obtained with 
Fe(CO)5. Hydrosilylation of vinyltrimethylsilane 46 with chlorosilanes R3SiH using the 
modified iron carbonyl complex (CH2=CHSiMe3)Fe(CO)444,45 gave a mixture of α- and β-
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isomers of the silylated product 47 and the unsaturated product 48 attained by 
dehydrogenative silylation (Scheme 23). 
 
2.5-5 mol% 
(CH2=CHSiMe3)Fe(CO)4
R3SiH   +  Me3SiCH=CH2
+        Me3SiCH2CH2SiR3
Me3SiCH=CHSiR3   +   EtSiMe3
α-47
48
Me3SiCHSiR3
CH3
β-47
46
neat, 70-80 °C, 3-4 h
 
Scheme 23. Hydrosilylation of vinyltrimethylsilane 46. 
 
The ratio of formed compounds α-47, β-47 and 48 depends on the nature of the used 
hydrosilane R3SiH. There exists an indirect relationship between the yield of the unsaturated 
silane 48 and the catalytic activity of R3SiH (Cl3SiH > Cl2MeSiH > ClMe2SiH > Me3SiH). 
With exception of Me3SiH the α-isomer is mainly formed in all studied reactions. Iron 
pentacarbonyl is known to hydrosilylate functionalized olefins (Scheme 24).46 For instance 
hydrosilylation of acrolein 49 with Et3SiH gave up to 95% of a mixture of cis- and trans-
MeCH=CHOSiEt3 50 while acrolein diethyl acetal 51 forms the Markovnikov product 
Et3SiCH2CH2CH(OEt)2 52 and Et3SiOEt via C-O bond cleavage. Allylic alcohol reacts in the 
presence of Fe(CO)5 to give CH2=CHCH2OSiEt3 54 and propylOSiEt3 55. 
 
  CH2=CHCHO    +   Et3SiH
1-4 mol% Fe(CO)5
neat, 140 °C, 4 h
  CH3CH=CHOSiEt3
  CH2=CHCH(OEt)2    +   Et3SiH
1 mol% Fe(CO)5   Et3SiCH2CH2CH(OEt)2
  CH2=CHCH2OH    +   Et3SiH
1 mol% Fe(CO)5
  CH2=CHCH2OSiEt3   +   CH3(CH2)2OSiEt3
49
5251
50
5453 55
neat, 140 °C, 4 h
neat, 140 °C, 4 h
 
Scheme 24. Hydrosilylation of functionalized olefins. 
 
In 1993 the group of Murai has examined the effectiveness of the iron-triad carbonyl 
complexes, Fe(CO)5, Fe2(CO)9, Fe3(CO)12, as catalysts for the reaction of styrene with 
triethylsilane.47 While Fe(CO)5 showed no catalytic activity Fe2(CO)9, and Fe3(CO)12 form 
selectively β-silylstyrene and ethylbenzene. Interestingly, Fe3(CO)12 is the catalyst that 
exhibited the highest selectivity. This trinuclear iron carbonyl catalyst was also successful 
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applied for the reaction of different p-substituted styrenes with Et3SiH giving only the (E)-β-
triethylstyrenes in 66–70% yield. 
 
R
0.3 or 0.7 mol% 
Fe2(CO)9 or Fe3(CO)12
benzene, 40-80 °C, 
24-72 h R
R
SiEt3
  +   Et3SiH   +
56 5857a: R = H;       yield: 36-89%
57b: R = CH3;   yield: 67%
57c: R = Cl;       yield: 66%
57a: R = OCH3; yield: 70%  
Scheme 25. Hydrosilylation of styrene derivatives. 
 
Hydrosilylation reactions catalyzed by iron carbonyl compounds often occur under drastic 
thermal conditions. Wrighton et al. have reported a photocatalyzed reaction of trialkylsilanes 
with alkenes in the presence of Fe(CO)5 at low temperature (0–50 °C).48 It is well known that 
irradiation of mononuclear metal carbonyls leads to efficient dissociative loss of CO to yield 
coordinative unsaturated, 16-electron, intermediates (Scheme 26).26 
 
 
Fe(CO)5
hv
Fe(CO)4
-CO
Fe(CO)4R3Si
H
Fe(CO)3R3Si
H
+   CO
Fe(CO)4
Fe(CO)3 +   CO
+
- + HSiR3
- HSiR3
hv hv
+ HSiR3 +
Fe(CO)3R3Si
H
Scheme 26. Formation of the catalytic active species by irradiation. 
 
Irradiation of Fe(CO)5 in the presence of trialkylsilane R3SiH and alkene initially yields a 
mixture of Fe(CO)4(alkene) and (H)(SiR3)Fe(CO)4 which were determined by infrared 
spectroscopy. (H)(SiR3)Fe(CO)3(alkene) is postulated to be the catalytic active species 
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photogenerated from these intermediates according to Scheme 26. Continuous irradiation is 
needed to maintain a steady-state concentration of the repeating unit “Fe(CO)3”. Such an iron 
tricarbonyl complex was also detected by infrared spectroscopy in the photoinduced addition 
of R3SiH to 1,3-butadiene with Fe(CO)5.49 Polymer-anchored ironcarbonyl species were 
described to catalyze the hydrosilylation of 1-pentene with HSiEt3 to give a mixture of pentyl- 
and pentenylsilanes.50 The different pathways of the mechanism of transition metal-catalyzed 
hydrosilylation are summarized in Scheme 27. A commonly proposed mechanism involves 
the insertion of the olefin into the Fe-H bond of complex (H)(SiR3)Fe(CO)3(alkene)  followed 
by reductive elimination of the alkyl and the silyl group to form an alkylsilane (pathway B). 
In an alternative mechanism insertion of the olefin into the Fe-Si bond of complex 
(H)(SiR3)Fe(CO)3(alkene) is discussed (pathway A). This route which is also suggested for 
the use of Fe3(CO)12 explains the formation of vinylsilanes as by-product in 
ydrosilylations.51 
 
h
Fe(CO)3R3Si
H
Fe(CO)3H
Fe(CO)3R3Si
R3Si
Fe(CO)3
H
SiR3
H
Fe(CO)3H
H
Fe(CO)3H
SiR3
R3Si
+ HSiR3
SiR3
+ HSiR3
+
+ HSiR3
A B
C
 
 
Scheme 27. Proposed catalytic cycle for the hydrosilylation of olefins in the presence of 
Fe(CO)5. 
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The photoinduced alkene insertion into the Fe-Si bond of (η5-C5Me5)Fe(CO)R was shown to 
be reversible (reaction C).52 A reactivity study of complex (H)Fe(CO)4SiPh3 with 
nucleophiles allowed a better understanding of the underlying reaction processes.53 Under 
photochemical conditions the activation or the substitution of the carbonyl ligands supports 
the classical mechanism involving insertion of the coordinated olefin in the Fe-Si (A) or the 
Fe-H (B) bonds. Under thermal conditions, however, a direct addition of the Fe-H group by a 
radical or ionic process can occur as observed in the reaction of (H)Fe(CO)4SiPh3 with 
isoprene. These mechanistic investigations for photo-generated hydrosilylation have been 
transmitted to the reaction of the iron carbonyl complex (CH2=CHSiMe3)Fe(CO)4 with 
vinylsilane and R3SiH.45 Tetrahedral heterometallic clusters containing iron have proven to be 
suitable catalysts in the photoinitiated hydrosilylation of acetophenone with triethylsilane.54 
Although a chiral FeCoMoS tetrahedron was used only racemic product and racemic cluster 
have been isolated. This fact can be explained by photo-racemization of the chiral catalyst 
which proceeds faster than hydrosilylation reaction. Instead of irradiation metal vapour 
generation at -196 °C was described as activation method for transition metal catalysts.55 Iron 
vapour co-condensed with isoprene catalyzed the hydrosilylation with triethoxysilane. Not 
surprisingly exclusive 1,4-addition is observed. 
The group of Brunner investigated the influence of thermal or photoinduced activation of 
Fe(Cp)(CO) complexes in the hydrosilylation of acetophenone 4b with diphenylsilane 
forming quantitatively the silylated 1-phenylethanol 59 (Scheme 28).56,57 
  
  +   Ph2SiH2
O
OSiHPh2
OSiHPh2
59
60
Fe
CO CH3
Cp`
L
Fe
CO C
Cp`
L
CH3
O
Fe
CO CH3
Cp`
OC
61 62
63
Cp(OC)Fe
Men2
P
H
64
Fe
CO
4b
0.5-1 mol% 62, 63, 64: 
neat, 50-80 °C, 24 h
0.3 mol% 65: 
neat, 23 h, hv
Men = Menthyl
 
Scheme 28. Asymmetric hydrosilylation with chiral iron complexes. 
 
The absence of silyl enol ether 60 can be explained by a hydrosilylation mechanism involving 
a Fe-Si-H three-centre bond rather than a Fe-H species. Although optically active ligands of 
type 61, 62 and 63 containing chiral iron atoms were used, only poor enantioselectivities 
below 10% ee have been achieved (L = DIOP [O-isopropyliden-2,3-dihydroxy-1,4-
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bis(diphenylphosphino)butane]).58 The rate determining step in this reaction is the thermal 
loss of the phosphine ligand L in 61 and 62 and methyl migration in 63, followed by addition 
of phenylsilane and subsequent reaction with acetophenone. Under photo-irradiation 
conditions hydrosilylation occured very fast with complex 64 as catalyst producing the 
silylated (S)-1-phenylethanol 59 in 33% ee. This was the first appreciable example for an 
enantioselective iron-catalyzed hydrosilylation of ketones. Very recently, Nishiyama et al. 
pursued a different elegant strategy to find an efficient catalytic system based on iron.59 They 
combined Fe(OAc)2 and multi-nitrogen-based ligand such as N,N,N´,N´-
tetramethylethylendiamine (tmeda), bis-tert-butyl-bipyridine (bipy-tb), or 
bis(oxazolinyl)pyridine (pybox) to catalyze the hydrosilylation of ketones to give the 
corresponding alcohol after acidic cleavage of the silyl ether (Scheme 29). The reaction was 
carried out under mild condition (THF at 65 °C, 24 hours) producing yields up to 95%. Using 
tmeda as nitrogen ligand hydrosilylation works also with other aromatic ketones. 
 
OH
5b: R = H         yield: 93%
5o: R = 4-MeO  yield: 94%
5t: R = 4-PhO   yield: 90%
R
OH OH
OMe
5p: yield: 94% 5u: yield: 72%
OH
5w: yield: 62%
OH
5v: yield: 94%
OH
MeO
5x: yield: 91%
n-C5H11
OH
5y: yield: 94%
OH
5k: yield: 89%  
Scheme 29. Substrate cope of the Fe-catalyzed hydrosilylation of ketones in the presence of 
tmeda. 
 
*
5 mol% Fe(OAc)2  
nitrogene ligand 
(EtO)2MeSiH
O OH
PhPh
THF, 65 °C, work 
up with H3O+
N
N
O
N
O
BnBn
pybox-bn 
67
N
H
O
N N
O
R R
68: R = i-Pr    bopa-ip    
69: R = t-Bu   bopa-tb
6665
Scheme 30. Asymmetric hydrosilylation of ketone 65 with iron catalysts according to 
Nishiyama and co-workers. 
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The application of chiral tridentate nitrogen ligands leads to the enantioselective reduction of 
methyl 4-phenylphenylketone 65. While pybox-bn 67 gives 37% ee of 66, bopa-ip 68 and tb 
69 increased the enantioselectivity up to 57% ee and 79% ee, respectively. Recent results 
from our group revealed that it is possible to perform Fe-catalyzed hydrosilylations of 
acetophenone also in the presence of chiral phosphine ligands. Here enantioselectivities up to 
80% ee have been achieved.60 
Iron-catalyzed hydrosilylations of olefins in the presence of nitrogen ligands were first 
realized by Chirik et al.34,35 They investigated the reaction of 1-hexene with PhSiH3 or Ph3SiH 
in the presence of iron catalyst 34 containing a tridentate pyridinediimine ligand (Scheme 17) 
which produce hydrosilylation over a course of minutes at ambient temperature. In both cases, 
the anti-Markovnikov product was formed exclusively. On the basis of these results a series of 
olefins (see Scheme 17) was examined. Terminal alkenes such as 1-hexene and styrene react 
most rapidly followed by gem-disubstituted olefins and internal olefins. The silylation of 
alkynes was also examined and proceeds efficiently under mild conditions to the 
corresponding silylalkene. 
 
3.6. Concluding Remarks 
 
Since the beginning of transition metal catalyzed hydrogenations and hydrosilylations more 
than 40 years ago a tremendous number of studies were directed to develop powerful methods 
for organic synthesis. In the past Rh, Ir and Ru clearly constitute the metals of choice for such 
transformations. Several hundreds of catalysts are nowadays commercially available for 
chemists around the world. However, the accelerated costs and the stronger requirements for 
pharmaceuticals cast a shadow on these commonly used transition metals. 
For the mid-term future we expect an increased use of more available and “biomimetic” 
metals. Clearly, iron is an ideal example for this. Unfortunately simple method transfer from 
Rh, Ir and Ru to Fe is not readily possible. So far iron based hydrogenations and 
hydrosilylations are far off to be general methods for organic chemistry. Typically 
comparably high catalyst loadings and harsh reaction conditions are required. In order to 
allow for more synthetic applications especially more functional group tolerance and also 
efficient control of stereoselectivity is needed. There are some promising developments like 
the recent work of Chirik and Nishiyama who demonstrates that these goals can be achieved. 
It will be interesting to take part in this renaissance of iron chemistry. 
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4. Objectives of the work 
4.1. Application of monodentate phosphine ligands in asymmetric hydrogenations 
 
Since earlier works have proven an excellent behaviour of ligands containing 4,5–dihydro–
3H–dinaphtho[2,1–c;1´,2´–e]phosphepine scaffold in the asymmetric hydrogenation of α–
amino acid precursors, itaconic acid derivatives and β–ketoesters, we focused our attention on 
extension of scope and limitation of this ligand tool box. Several challenging substrate 
classes, based on unsaturated C-C bonds, were synthesized and subjected to catalytic 
reduction. 
 
4.1.1. Asymmetric hydrogenation of N–acyl enamides 
 
Until the end of 2004 only two reports were published dealing with the rhodium–catalyzed 
hydrogenation of N–acyl enamides in the presence of monodentate phosphines. On the one 
hand the utilization of chiral phospholanes by Fiaud and co–workers, which attained good 
enantioselectivities up to 73% ee, when (Z)–N–(1–phenylprop–1–enyl)acetamide was 
hydrogenated.1 On the other hand, Reetz et al. described the rhodium–catalyzed 
hydrogenation of N–(1–phenylvinyl)–acetamide with ligands based on 4,5–dihydro–3H–
dinaphtho[2,1–c;1´,2´–e]phosphepine (vide supra).2 Surprisingly, the tert–butyl–substituted 
ligand showed better selectivity and yield than the phenyl–substituted ligand, which is in 
contrast to other benchmark tests such as the asymmetric hydrogenation of α–amino acid 
precursors, dimethyl itaconate and β–ketoesters where always the opposite behaviour was 
observed. The interesting results of Reetz and co–workers stimulated us to study the potential 
of our ligand library in the field of asymmetric hydrogenation of N–acyl enamides in more 
detail. 
 
4.1.2. Asymmetric hydrogenation of β–dehydroamino acid derivatives 
 
Since, β–amino acids are interesting building blocks for the synthesis of biologically active 
compounds the synthesis via asymmetric hydrogenation of unsaturated precursors offers a 
versatile and powerful approach. Currently bidentate phosphorous ligands have been proven 
to be effective in the asymmetric hydrogenation of β–dehydroamino acid derivatives with 
enantioselectivities up >99% ee, while a monodentate version is so far scarcely reported. Here 
only the group of Börner accounted enantioselectivities up to 93% ee with monodentate 
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phospholane ligand.3 We became interested in studying the behaviour of chiral monodentate 
44,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine in the rhodium–catalyzed 
asymmetric hydrogenation of various β–dehydroamino acid derivatives to give optically 
active β–amino acids.  
 
4.1.3. Asymmetric hydrogenation of enol carbamates 
 
Pioneering work in the field of enantioselective hydrogenation of enol carbamates, which are 
suitable precursors for chiral alcohols, has been reported by Feringa, de Vries, Minnaard and 
co–workers applying rhodium–catalysts containing monodentate phosphoramidites 
(MonoPhos–family) and obtaining enantioselectivities up to 98% ee.4 However, until today 
no additional studies on the reduction of enol carbamates were reported. Hence, we became 
interested in testing our ligand library in this purpose. 
 
4.2. Transfer hydrogenation 
4.2.1. Homogeneous iron catalyst in reduction chemistry 
 
With regard to future catalyst developments a fundamental challenge will be the 
substitution of expensive and rare transition metals by inexpensive and abundantly available 
metals such as iron. So far, homogeneous iron catalysts have been most frequently applied for 
carbon–carbon coupling reactions, such as olefin polymerizations, cross couplings, and 
cycloadditions. However, much less attention was directed towards iron–catalyzed (transfer) 
hydrogenations, albeit the relevance of such reductions is evident even with respect to 
industrial applications. Until today only a few number of research groups reported the 
application of iron salts and iron complexes in the reduction of α,β–unsaturated carbonyl 
compounds and ketones using a transfer hydrogenation protocol.5 For tuning the activity and 
selectivity of these catalysts oxygen and moisture sensitive tetradentate phosphines or 
aminophosphines have been predominantly applied as ligands. Our goal was to develop a 
practical iron hydrogenation catalyst system, which should be easily prepared and highly 
tuneable. Thus, the use of commercially available iron complexes in combination with two 
different ligands (phosphines and amines) instead of tetradentate ligands seemed to be a 
useful approach. Furthermore inspired by nature we thought that multidentate nitrogen ligands 
should be also suitable ligands for stabilizing iron as metal center in transfer hydrogenations. 
The influence of different reaction parameters on the catalytic activity will be investigated in 
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the transfer hydrogenation of aliphatic and aromatic ketones utilizing 2–propanol as hydrogen 
donor in the presence of base.  
 
4.2.2. Transfer hydrogenation of ketones with ruthenium catalysts 
4.2.2.1. Transfer hydrogenation with ruthenium carbene catalysts 
 
With regard to transfer hydrogenations different carbene or carbene-phosphine–systems 
containing Rh, Ir, Ru or Ni have been reported. Excellent turnover frequencies up to 120000 
h-1 were reported by the groups of Baratta and Herrmann applying a ruthenium–carbene–
phosphine–catalyst.6 However, for reduction of a typical substrate, e.g. acetophenone, with 
phosphine–free ruthenium–carbene catalysts lower turnover frequencies (TOF 333 h-1)7 were 
achieved in comparison to iridium (500 h-1)8 and rhodium systems (583 h-1).9 Due to the 
economical benefit of ruthenium metal compared to rhodium or iridium and the advantages of 
phosphine–free systems, it will be an important goal to search for more active ruthenium 
carbene catalysts.  
 
4.2.2.2. Asymmetric transfer hydrogenation with ruthenium catalysts 
 
Significantly less is known of the transfer of chiral information for tridentate ligands, while 
transfer hydrogenation is dominated by highly active bidentate systems.10 Up to now only a 
limited number of auspicious tridentate nitrogen-containing N,N,N–ligands were established. 
For example (R)–phenyl–ambox and different pyridinebisoxazoline (pybox) ligands have 
been applied for the reduction of acetophenone. More recently, a new class of chiral tridentate 
amines so called pybim (parent structure: 2,6-bis–([4R,5R]–4,5–diphenyl–4,5–dihydro–1H–
imidazol–2-yl)–pyridine) for the ruthenium–catalyzed epoxidations was introduced by Beller 
et al.11 The resemblance between pybim and pybox stimulated our research to study the 
potential of this class of ligands in the transfer hydrogenation of aromatic and aliphatic 
ketones. 
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The rhodium-catalyzed asymmetric hydrogenation of dif-
ferent acyclic and cyclic N-acyl enamides to give N-acyl-pro-
tected optically active amines has been examined for the first
time in detail in the presence of chiral monodentate 4,5-dihy-
dro-3H-dinaphthophosphepines 5a–i. The enantioselectivity
is largely dependent on the nature of the substituent at the
Introduction
The importance of chiral amines is demonstrated by their
broad scope of applications as building blocks and syn-
thons for pharmaceuticals and agrochemicals. In addition,
they are of significant use for the synthesis of natural com-
pounds, chiral auxiliaries, and optically active ligands.[1]
Hence, the development of new and improved methods for
the preparation of enantiomerically pure amines is an im-
portant target of industrial and academic research. Several
synthetic approaches to optically active amines have been
established in the past. Still one of the most practical ap-
proaches is the separation of enantiomers through resolu-
tion, e.g. in the presence of chiral acids. The main drawback
of this concept is the poor atom efficiency and the negative
environmental impact. A more attractive access is repre-
sented by applying enantiomerically pure starting materials
from the “chiral pool”. Another powerful strategy is the
application of stereoselective syntheses in particular reac-
tions catalyzed by transition-metal complexes.[2] Examples
of such transition-metal-catalyzed reactions, which offer a
versatile and elegant approach to enantiomerically pure
amines, are the alkylation or arylation of imines, hydrocy-
anation of carbon–carbon double bonds and aziridina-
tion.[2c] However, the most popular catalytic reaction with
respect to industrial applications is the asymmetric hydro-
genation of imines or N-protected enamines and en-
amides.[3]
Pioneering work in the field of enantioselective hydro-
genation of enamides has been reported by Kagan and co-
[a] Leibniz-Institut für Katalyse an der Universität Rostock e.V.,
Albert-Einstein-Str. 29A, 18059 Rostock, Germany
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© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim Eur. J. Org. Chem. 2006, 2912–29172912
phosphorus atom and the enamide substrate. Applying opti-
mized conditions up to 95% ee and catalyst activity up to
2000 h–1 (TOF) have been achieved.
(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2006)
workers. Applying diphosphane rhodium catalysts enantio-
selectivity up to 90% has been obtained.[4] Over a period of
nearly 30 years the development of new ligands for asym-
metric hydrogenation has focused on the synthesis of biden-
tate ligands. During this time several effective bidentate
phosphanes such as Me-DuPhos, Me-BPE, DIOP, BINAP
and others were developed for the hydrogenation of en-
amides.[4,5] At the end of the 20th century the predominant
role of bidentate ligands changed and monodentate ligands
received more attention.[6,7] The advantages of mono-
dentate phosphorus ligands are their easier synthesis and
tunability compared to bidentate phosphanes. Scheme 1 il-
lustrates some examples of monodentate phosphorus li-
gands for asymmetric hydrogenation on the basis of the chi-
ral 1,1-binaphthol skeleton. Important contributions in
this area came independently from Feringa and de Vries et
al.[8] (phosphoramidites 1), Reetz et al.[9] (phosphites 2),
and Pringle and Claver et al.[10] (phosphonites 3). Further-
more, excellent enantioselectivity was shown by Zhou and
co-workers applying monodentate spiro phosphoramidites
(SIPHOS).[11]
Following the original work of Gladiali[12] and parallel
to Zhang,[13] we have established the synthesis of various
monodentate phosphanes based on a 4,5-dihydro-3H-di-
naphtho[2,1-c;1,2-e]phosphepine framework (4 and 5a–i),
which resembles the 1,1-binaphthol core.[14] Recently, we
have shown that asymmetric hydrogenation of amino acid
precursors, dimethyl itaconate and β-keto esters proceeds
with enantioselectivities up to 95% ee in the presence of
ligand 5a.[13] Moreover, other groups demonstrated the use-
fulness of these ligands in several catalytic asymmetric reac-
tions.[15]
To the best of our knowledge there exists only one publi-
cation dealing with the hydrogenation of enamides in the
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Scheme 1. Chiral monodentate ligands with 2,2-binaphthyl frame-
work.
presence of monodentate phosphepines. Here, Reetz et
al.[16] described the rhodium-catalyzed hydrogenation of N-
(1-phenylvinyl)acetamide (6a) with ligands 5a [conversion:
50%; enantiomeric excess: 14% (R)] and 5i [conversion:
94%; enantiomeric excess: 24% (R)] in dichloromethane. To
our surprise the tert-butyl-substituted ligand 5i showed bet-
ter selectivity and yield than the phenyl-substituted ligand
5a. In our benchmark tests, for instance, in the asymmetric
hydrogenation of amino acid precursors, dimethyl itaconate
and β-keto esters, we always observed the opposite behav-
iour.
Discussion
The interesting results of Reetz and co-workers[15] stimu-
lated us to study the potential of our ligand library 5a–i in
the field of asymmetric hydrogenation of enamides in more
detail. In general, the ligands are prepared by metallation of
2,2-dimethylbinaphthyl with two equiv. of n-butyllithium,
followed by quenching with diethylamino(dichloro)phos-
phane. Deprotection with gaseous HCl produced 4-chloro-
4,5-dihydro-3H-dinaphtho[2,1-c;1,2-e]phosphepine in a
yield of 80%. This enantiomerically pure chlorophosphane
is easily coupled with various Grignard reagents to give a
broad selection of ligands of type 5.
Unsubstituted and substituted N-(1-phenylvinyl)acet-
amides 6a–6e were obtained by reacting the corresponding
benzonitrile with a methyl Grignard followed by addition
of acetic anhydride.[8e] The cyclic N-acyl enamide 6f was
synthesized by a standard protocol implying transformation
of the ketone to the corresponding oxime and subsequent
reductive acylation with iron in the presence of acetic acid
anhydride.[17]
Initial studies on the influence of reaction conditions
were carried out with N-(1-phenylvinyl)acetamide (6a) as
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substrate and 4-phenyl-4,5-dihydro-3H-dinaphtho[2,1-
c;1,2-e]phosphepine (5a) as our standard ligand. Typically,
we used an in situ pre-catalytic mixture of 1 mol-%
[Rh(cod)2]BF4 and 2.1 mol-% of the corresponding ligand.
All hydrogenation reactions were carried out in an 8fold
parallel reactor array with 3.0 mL reactor volume.[18]
At first, we focused our attention on the influence of
different solvents, such as dichloromethane, methanol, ethyl
acetate, toluene, and also variation of the initial pressure
(1.0 bar, 5.0 bar and 10 bar). Selected results are presented
in Figure 1.
Figure 1. Solvent and pressure variation. Reactions were carried
out at 30 °C for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol
ligand 5a and 0.24 mmol substrate in 2.0 mL solvent. Conversion
and ee values were determined by GC [50 m Lipodex E (Macherey–
Nagel), 80 °C, (R)-7a 26.7 min, (S)-7a 28.3 min]. The absolute con-
figuration was determined by comparing the sign of specific rota-
tion with reported data and the original sample (Aldrich).[5i]
For all solvents best enantioselectivity (80–90% ee) is
achieved at 1.0 bar, but without complete conversion within
reasonable time (24 h). Increasing the pressure of hydrogen
to 5.0 bar or 10.0 bar accelerated the reaction and full con-
version is reached, but at somewhat lower selectivity. The
results also indicated toluene as the solvent of choice for
our model reaction (conversion: 96%; enantioselectivity:
91%).
To find the optimum of the enantioselectivity−pressure
dependency we performed a fine tuning of the hydrogen
pressure in toluene. At 2.5 bar hydrogen pressure both good
enantioselectivity (93% ee) and acceptable reaction time
(6 h) have been achieved.
Next, we investigated the influence of the temperature on
the selectivity and yield as described in Figure 2. Applying
our model ligand 5a there is no pronounced effect on the
selectivity between 10 and 30 °C.[19] At higher temperatures
a decrease of the ee is observed (87% ee at 50 °C and 83%
ee at 70 °C).
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Figure 2. Dependency of enantioselectivity vs. temperature. Reac-
tions were carried out at the corresponding temperature for 1–24 h
with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand 5a and
0.24 mmol substrate in 2.0 mL toluene. Conversion and ee values
were determined by GC [50 m Lipodex E (Macherey–Nagel),
80 °C, (R)-7a 26.7 min, (S)-7a 28.3 min].[5i]
To estimate the activity of the catalyst in more detail the
ratio between metal and substrate was varied starting from
initially 1:100 to 1:2000. At 50 °C and 2.5 bar of hydrogen
complete conversion was observed within one hour, which
corresponds to a turnover frequency (TOF) of 2000 h–1.
In order to evaluate the substituent effect at the phos-
phorus atom of the ligand, we studied the asymmetric hy-
drogenation of N-(1-phenylvinyl)acetamide (6a) in the pres-
ence of nine different 4,5-dihydro-3H-dinaphtho[2,1-c;1,2-
e]phosphepines (5a–5i) using the optimized reaction condi-
tions (2.5 bar hydrogen pressure, toluene, 30 °C, 6 h). These
results are presented in Table 1.
In agreement with our previous studies, it appeared
that for obtaining good enantioselectivity aryl-substituted
phosphepine ligands are necessary, while alkyl-substituted
ligands showed significantly lower selectivity. Substitution
on the phenyl ring at the phosphorus atom with electron-
withdrawing (5b, 5c) as well as electron-donating groups
(5d–5g) resulted in decreased selectivity in comparison to
the phenyl ligand 5a. Here, only ligand 5e represented an
exception (Table 1, Entry 5), which led to 93% ee.
Interestingly, the behaviour of the tert-butyl ligand 5i is
quite different in the hydrogenation of 6a. In contrast to
the results obtained by Reetz et al., under our reaction con-
ditions compound 5i induced a change in the absolute con-
figuration of the product to the opposite (S)-enantiomer,
albeit with significantly lower ee.
In addition to the ligands 5, we also tested the commer-
cially available (S)-MonoPhos ligand (1, R1 = R2 = Me),
which gives excellent enantioselectivity in various hydrogen-
ations of prochiral double bonds.[8,20] However, in the pres-
ent test reaction we obtained only poor yield and enantio-
selectivity (Table 1, Entry 10).
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Table 1. Hydrogenation of N-(1-phenylvinyl)acetamide (6a).[a]
Entry Ligand Conversion [%][b] ee [%][b,c]
1 5a 99 93 (R)
2 5b 99 72 (R)
3 5c 99 88 (R)
4 5d 99 87 (R)
5 5e 99 93 (R)
6 5f 99 63 (R)
7 5g 99 90 (R)
8 5h 99 30 (R)
9 5i 99 16 (S)
10 1 4 19 (S)
[a] All reactions were carried out at 30 °C under 2.5 bar pressure
of hydrogen for 6 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol
ligand and 0.24 mmol substrate in toluene (2.0 mL). [b] Conversion
and ee values were determined by GC [50 m Lipodex E (Macherey–
Nagel), 80 °C, (R)-7a 26.7 min, (S)-7a 28.3 min]. [c] The absolute
configuration was determined by comparing the sign of specific
rotation with reported data and the original sample (Aldrich).[5i]
To demonstrate the scope and limitations of our ligand
toolbox we performed the asymmetric hydrogenation of
four different N-(1-phenylvinyl)acetamides (Table 2). Re-
garding the substrates both electron-donating substituents
at the phenyl group, in particularly a methoxy group in
para- as well as in meta-position and electron-withdrawing
substituents such as para-fluoro or para-trifluoromethyl
have been tested. Enantioselectivity up to 95% ee is ob-
tained with ligands 5a (Table 2, Entry 1) and 5e (Table 2,
Entry 5) for electron-rich substrates. In general, aryl phos-
phepines with electron-donating substituents showed better
selectivity than phosphepines having electron-withdrawing
groups.
The introduction of electron-withdrawing substituents in
N-(1-phenylvinyl)acetamide 6d and 6e decreased the
enantioselectivity compared to the non-substituted N-(1-
phenylvinyl)acetamide (6a). Here, the best selectivities of
83–86% ee are obtained with ligands 5a, 5e and 5g.
Again for all substrates 6a–6e the alkyl-substituted 4,5-
dihydro-3H-dinaphtho[2,1-c;1,2-e]phosphepines gave sig-
nificantly lower selectivity.
Next, the hydrogenation of the sterically more hindered
N-(3,4-dihydro-1-naphthyl)acetamide (6f) was tested
(Scheme 2). The use of different pre-catalysts including
[Rh(5a)2(cod)]BF4, [Rh(5e)2(cod)]BF4 and [Rh(5i)2(cod)]
BF4 gave an excellent yield (99%) of 7f.
However, the observed enantioselectivity is significantly
lower [5a: 15% (S); 5e: 11% (S); 5i: 35% (R)] when com-
pared to 1,1-disubstituted enamides. These results indicate
a crucial influence of the substitution pattern on the en-
amide group.
It is important to note that in comparison to bidentate
ligands the application of monodentate ligands offers an
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Table 2. Asymmetric hydrogenation of substituted N-(1-phenyl-
vinyl)acetamides 6b–6e.[a]
7b 7c
Entry Ligand (R1 = CH3O; R2 = H) (R1 = H; R2 = CH3O)
ee [%][b,c] ee [%][b,d]
1 5a 91 (R) 95 (R)
2 5b 63 (R) 72 (R)
3 5c 79 (R) 84 (R)
4 5d 87 (R) 87 (R)
5 5e 92 (R) 89 (R)
6 5f 33 (R) 53 (R)
7 5g 89 (R) 89 (R)
8 5h rac 26 (R)
9 5i 21 (S) 23 (S)
Entry Ligand 7d (R1 = F) 7e (R1 = CF3)
ee [%][b,c] ee [%][b,c]
10 5a 86 (R) 78 (R)
11 5b 51 (R) 62 (R)
12 5c 71 (R) 73 (R)
13 5d 71 (R) 65 (R)
14 5e 86 (R) 78 (R)
15 5f 34 (R) 68 (R)
16 5g 83 (R) 85 (R)
17 5h 4 (R) 44 (R)
18 5i rac 25 (S)
[a] All reactions were carried out at 30 °C under 2.5 bar pressure
of hydrogen for 6 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol
ligand and 0.24 mmol substrate in 2.0 mL toluene. [b] Conversion
(99%) was determined by GC (Agilent Technologies, 30 m, 50–
300 °C), ee values were determined by GC [50 m Lipodex E (Mach-
erey–Nagel), 100–180 °C, (R)-7b 36.1 min, (S)-7b 36.4 min, (R)-7c
34.8 min, (S)-7c 35.0 min, (R)-7d 31.0 min, (S)-7d 31.2 min, (R)-
7e 32.4 min, (S)-7e 32.7 min]. [c] The absolute configurations were
determined by comparing the sign of specific rotation with re-
ported data.[5i] [d] Absolute configuration of product was assigned
by analogy.
Scheme 2. Asymmetric hydrogenation of N-(3,4-dihydro-1-naph-
thyl)acetamide (6f). All reactions were carried out at 30 °C under
2.5 bar pressure of hydrogen for 6 h with 0.0024 mmol [Rh(cod)2]-
BF4, 0.005 mmol ligand and 0.24 mmol substrate in 2.0 mL tolu-
ene. Conversion was determined by GC (Agilent Technologies,
30 m, 50–300 °C) and ee values were determined by HPLC [AD-
H Chiralpak (Agilent Technologies), n-hexane/ethanol, 95:5, rate
1.0 mL/min, (S)-7f 6.2 min, (R)-7f 7.2 min]. The absolute configu-
ration was determined by comparing the sign of specific rotation
with reported data.
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opportunity to replace one equiv. of the ligand by other chi-
ral or achiral monodentate ligands. This remarkable combi-
natorial approach was introduced by Reetz et al.,[9d–9f,15,21]
and Feringa et al.[22] for different transition-metal-catalyzed
reactions.[23]
We followed this concept and used 4-phenyl-4,5-dihydro-
3H-dinaphtho[2,1-c;1,2-e]phosphepine (5a) with different
achiral phosphanes in a ratio of 1.05 to 1.05 equiv. in the
presence of 1.0 equiv. of [Rh(cod)2]BF4. The results ob-
tained for the hydrogenation of N-(1-phenylvinyl)acetamide
(6a) under optimized reaction conditions are presented in
Table 3.
Table 3. Application of ligand mixtures in the asymmetric hydro-
genation of N-(1-phenylvinyl)acetamide (6a).[a]
Entry Ligand B Conversion [%][b] ee [%][b,c]
1 5a 99 93 (R)
2 PPh3 99 85 (R)
3 P(p-MeO-C6H4)3 99 88 (R)
4 P(p-Me-C6H4)3 99 81 (R)
5 PCy3 99 74 (R)
[a] All reactions were carried out at 30 °C under 2.5 bar pressure
of hydrogen for 6 h with 0.0024 mmol [Rh(cod)2]BF4, 0.0025 mmol
ligand 5a, 0.0025 mmol achiral ligand and 0.24 mmol substrate in
2.0 mL toluene. [b] Conversion and ee values determined by GC
[50 m Lipodex E (Macherey–Nagel), 80 °C, (R)-7a 26.7 min, (S)-7a
28.3 min]. [c] The absolute configuration was determined by com-
paring the sign of specific rotation with reported data and the origi-
nal sample (Aldrich).[5i]
In general, we observed a slight decrease in enantio-
selectivity from that observed when using 2.1 equiv. of li-
gand 5a. On the assumption that probably three different
metal complexes could be formed, in particular, two homo-
combination products, the chiral [Rh(5a)(5a)(cod)]BF4 and
the achiral [Rh(L)(L)(cod)]BF4, and the hetero-combina-
tion product [Rh(L)(5a)(cod)]BF4, we deduce a significantly
lower reaction rate or inactivity for the achiral complex
[Rh(L)(L)(cod)]BF4 relative to complex [Rh(5a)(5a)(cod)]-
BF4 or [Rh(L)(5a)(cod)]BF4. Tricyclohexylphosphane
(Table 3, Entry 5) was found to be the only exception, as
we noticed a more pronounced decrease of the enantio-
meric excess.
Conclusions
We demonstrated the application of monodentate 4,5-di-
hydro-3H-dinaphtho[2,1-c;1,2-e]phosphepines 5 in the
rhodium-catalyzed asymmetric hydrogenation of various
enamides. The influences of different reaction parameters
are presented. For the first time high enantioselectivity (up
to 95% ee) for such reactions is obtained in the presence of
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monodentate phosphanes. Best results were observed with
aryl-substituted phosphepine ligands for reduction of N-(1-
phenylvinyl)acetamide, while alkyl-substituted phosphepine
ligands yielded only low selectivity.
Experimental Section
All manipulations were performed under argon using standard
Schlenk techniques. Diethyl ether and toluene were distilled from
sodium benzophenone ketyl under argon. Methanol was distilled
from Mg under argon. Dichloromethane was distilled from CaH2
under argon. The ligands 5 were synthesized according to our pre-
viously published protocols.[13] [Rh(cod)2]BF4 (purchased from
Fluka) was used without further purification.
General Procedure for the Synthesis of Substituted N-(1-Phenylvinyl)-
acetamides 6a–6e: To a stirred solution of methylmagnesium bro-
mide (17.0 mmol, 3.0 mol/L diethyl ether, 6.0 mL) in diethyl ether
(50 mL) at 0 °C a solution of the corresponding benzonitrile
(17.0 mmol) in diethyl ether (20 mL) was added dropwise during a
period of 30 minutes. After complete addition the solution was re-
fluxed for eight hours. Within a few hours a yellow precipitate was
formed. After refluxing the reaction mixture was cooled to 0 °C,
and a solution of acetic anhydride (17.0 mmol) in diethyl ether
(20 mL) was added carefully over 30 minutes. The reaction mixture
was refluxed for eight hours. To the resulting suspension methanol
was added at room temperature whilst stirring until all precipitates
were dissolved (approximately 50 mL). The homogeneous solution
was mixed with water/ethyl acetate (1:1, 100 mL). After phase sepa-
ration the aqueous layer was extracted three times with ethyl ace-
tate (50 mL). The combined organic layers were dried with MgSO4.
After removing of the solvents the semi crystalline crude oil was
purified by column chromatography (n-hexane/ethyl acetate, 1:1).
Removal of the solvent yielded the crystalline products. [yields: (6a)
1.51 g (55%), (6b) 1.66 g (51%), (6c) 1.50 g (46%), (6d) 1.52 g
(50%), (6e) 1.91 g (49%)]
General Procedure for the Synthesis of the Cyclic N-Acyl Enamide
6f: A stirred solution of the corresponding ketone (30.3 mmol), hy-
droxylamine–hydrochloride (73 mmol) and pyridine (62.2 mmol) in
ethanol (40 mL) was heated to 85 °C for a period of 16 hours. The
solvent was removed, and the residue was dissolved in ethyl acetate/
water. The organic phase was washed two times with water (20 mL)
and dried with MgSO4. After removal of the solvents the product
was recrystallized from toluene. The corresponding ketoximine
(18.6 mmol) was solved in toluene (30 mL) under argon. To the
stirred solution acetic acid anhydride (55.9 mmol), acetic acid
(55.9 mmol), and Fe powder (37.3 mmol, Aldrich 325 mesh) were
added and then heated to 70 °C for 4 hours. The mixture was fil-
tered through a plug of celite after cooling to room temperature.
Dichloromethane was added to the filtrate, followed by washing
with 2.0  NaOH (2 ×25 mL) at 0 °C. The separated organic phase
was concentrated to half volume. The crystalline product was ob-
tained after 12 hours at 0 °C. The crystals were filtered and dried
in vacuo. [overall yield: 2.05 g (59%)]
General Procedure for the Catalytic Hydrogenation of Enamides: A
solution of enamide (0.24 mmol) and 1.0 mL solvent was transfer-
red via syringe into the secured autoclave. Because of the poor
solubility in toluene at room temperature the solution was heated
to 50 °C before it was transferred. The catalyst was generated in
situ by mixing [Rh(cod)2]BF4 (0.0024 mmol) and the corresponding
4,5-dihydro-3H-dinaphthophosphepine ligands (0.005 mmol) in
1.0 mL solvent for a period of 10 min, and afterwards, it was trans-
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ferred via syringe into the autoclave. Then, the autoclave was
charged with hydrogen and the mixture was stirred at the required
temperature. After the predetermined time the hydrogen was re-
leased and the reaction mixture passed through a short plug of
silica gel. The enantioselectivity and conversion were measured by
GC or HPLC without further modifications.
Acknowledgments
We thank M. Heyken, S. Buchholz and Dr. C. Fischer (all Leibniz-
Institut für Katalyse e. V. an der Universität Rostock) for excellent
technical assistance and Prof. Dr. S. Gladiali for general dis-
cussions. Generous financial support from the state of Mecklen-
burg-Western Pomerania and the BMBF is gratefully acknowl-
edged.
[1] a) Y.-G. Zhou, P.-Y. Yang, X. W. Han, J. Org. Chem. 2005, 70,
1679–1683; b) P. Harrison, G. Meek, Tetrahedron Lett. 2004,
45, 9277–9280; c) S. A. Lawrence, Amines, Cambridge Univer-
sity Press, Cambridge, 2004; d) F. Fache, E. Schulz, M. L. Tom-
masino, M. Lemaire, Chem. Rev. 2000, 100, 2159–2231; e) H.-
P. Jacqueline, Chiral Auxiliaries and Ligands in Asymmetric
Synthesis, John Wiley & Sons, New York, 1995; f) M. Nógradi,
Stereoselective Synthesis, Wiley-VCH, Weinheim, 2nd ed., 1995;
g) D. M. Tschaen, L. Abramson, D. Cai, R. Desmond, U.-H.
Dolling, L. Frey, S. Karady, Y.-J. Shi, T. R. Verhoeven, J. Org.
Chem. 1995, 60, 4324–4330; h) P. A. Chaloner, M. A. Es-
teruelas, F. Joó, L. A. Oro, Homogeneous Hydrogenation,
Kluwer, Dordrecht, 1994; i) M. Kitamura, Y. Hsiao, M. Ohta,
M. Tsukamoto, T. Ohta, H. Takaya, R. Noyori, J. Org. Chem.
1994, 59, 297–310; j) H. P. Buser, B. Pugin, F. Spindler, M.
Sutter, Tetrahedron 1991, 47, 5709–5716; k) R. Noyori, M.
Ohta, Y. Hsiao, M. Kitamura, T. Ohta, H. Takaya, J. Am.
Chem. Soc. 1986, 108, 7117–7119.
[2] a) R. Noyori, Asymmetric Catalysis in Organic Synthesis, Wiley,
New York, 1994; b) M. Beller, C. Bolm (Eds.), Transition Met-
als for Organic Synthesis, Wiley-VCH, Weinheim, 2nd ed., 2004;
c) E. N. Jacobsen, A. Pfaltz, H. Yamamoto (Eds.), Comprehen-
sive Asymmetric Catalysis, Springer, Berlin, 1999.
[3] H.-U. Blaser, B. Pugin, F. Spindler, J. Mol. Catal. A 2005, 231,
1–20.
[4] a) H. B. Kagan, N. Langlois, T. P. Dang, J. Organomet. Chem.
1975, 90, 353–365; b) D. Sinou, H. B. Kagan, J. Organomet.
Chem. 1976, 114, 325–337.
[5] a) M. J. Burk, J. E. Feaster, W. A. Nugent, R. L. Harlow, J.
Am. Chem. Soc. 1993, 115, 10125–12138; b) A. Miyashita, A.
Yasuda, H. Takaya, K. Toriumi, T. Ito, T. Souchi, R. Noyori,
J. Am. Chem. Soc. 1980, 102, 7932–7934; c) W. Li, X. Zhang,
J. Org. Chem. 2000, 65, 5871–5874; d) W. Hu, M. Yan, C.-P.
Lau, S. M. Yang, A. S. C. Chan, Tetrahedron Lett. 1999, 40,
973–976; e) Z. Zhang, G. Zhu, Q. Jiang, D. Xiao, X. Zhang,
J. Org. Chem. 1999, 64, 1774–1775; f) P. Dupau, P. Le Gendre,
C. Bruneau, P. H. Dixneuf, Synlett 1999, 11, 1832–1834; g) G.
Zhu, X. Zhang, J. Org. Chem. 1998, 63, 9590–9593; h) T. Mori-
moto, M. Chiba, K. Achiwa, Chem. Pharm. Bull. 1992, 40,
2894–2896; i) M. J. Burk, Y. M. Wang, J. R. Lee, J. Am. Chem.
Soc. 1996, 118, 5142–5143; j) F.-Y. Zhang, C.-C. Pai, A. S. C.
Chan, J. Am. Chem. Soc. 1998, 120, 5808–5809; k) M. Hayashi,
Y. Hashimoto, H. Takezaki, Y. Watanabe, K. Saigo, Tetrahe-
dron: Asymmetry 1998, 9, 1863–1866.
[6] F. Lagasse, H. B. Kagan, Chem. Pharm. Bull. 2000, 48, 315–
324.
[7] I. V. Komarov, A. Börner, Angew. Chem. 2001, 113, 1237–1240.
[8] a) L. A. Arnold, R. Imobos, A. Manoli, A. H. M. de Vries, R.
Naasz, B. Feringa, Tetrahedron 2000, 56, 2865–2878; b) M.
van den Berg, A. J. Minnaard, E. P. Schudde, J. van Esch,
A. H. M. de Vries, J. G. de Vries, B. L. Feringa, J. Am. Chem.
Soc. 2000, 122, 11539–11540; c) A. J. Minnaard, M.
Enantioselective Hydrogenation of Enamides in the Presence of Phosphanes FULL PAPER
van den Berg, E. P. Schudde, J. van Esch, A. H. M. de Vries,
J. G. de Vries, B. Feringa, Chim. Oggi 2001, 19, 12–13; d) D.
Peña, A. J. Minnaard, J. G. de Vries, B. L. Feringa, J. Am.
Chem. Soc. 2002, 124, 14552–14553; e) M. van den Berg, R. M.
Haak, A. J. Minnaard, A. H. M. de Vries, J. G. de Vries, B. L.
Feringa, Adv. Synth. Catal. 2002, 344, 1003–1007; f) M.
van den Berg, A. J. Minnaard, R. M. Haak, M. Leeman, E. P.
Schudde, A. Meetsma, B. L. Feringa, A. H. M. de Vries,
C. E. P. Maljaars, C. E. Willans, D. Hyett, J. A. F. Boogers,
H. J. W. Henderickx, J. G. de Vries, Adv. Synth. Catal. 2003,
345, 308–323; g) D. Peña, A. J. Minnaard, A. H. M. de Vries,
J. G. de Vries, B. L. Feringa, Org. Lett. 2003, 5, 475–478; h)
X. Jiang, M. van den Berg, A. J. Minnaard, B. Feringa, J. G.
de Vries, Tetrahedron: Asymmetry 2004, 15, 2223–2229; i) R.
Eelkema, R. A. van Delden, B. L. Feringa, Angew. Chem. Int.
Ed. 2004, 43, 5013–5016; j) A. Duursma, J.-G. Boiteau, L. Le-
fort, J. A. F. Boogers, A. H. M. de Vries, J. G. de Vries, A. J.
Minnaard, B. L. Feringa, J. Org. Chem. 2004, 69, 8045–8052;
k) H. Bernsmann, M. van den Berg, R. Hoen, A. J. Minnaard,
G. Mehler, M. T. Reetz, J. G. de Vries, B. L. Feringa, J. Org.
Chem. 2005, 70, 943–951.
[9] a) M. T. Reetz, T. Sell, Tetrahedron Lett. 2000, 41, 6333–6336;
b) M. T. Reetz, G. Mehler, Angew. Chem. Int. Ed. 2000, 39,
3889–3891; c) M. T. Reetz, G. Mehler, G. Meiswinkel, T. Sell,
Tetrahedron Lett. 2002, 43, 7941–7943; d) M. T. Reetz, G.
Mehler, G. Meiswinkel, T. Sell, Angew. Chem. Int. Ed. 2003,
42, 790–793; e) M. T. Reetz, G. Mehler, Tetrahedron Lett. 2003,
44, 4593–4596; f) M. T. Reetz, G. Mehler, A. Meiswinkel, Tet-
rahedron: Asymmetry 2004, 15, 2165–2167; g) M. T. Reetz,
X. G. Li, Tetrahedron 2004, 60, 9709–9714; h) M. T. Reetz, J.-
A. Ma, R. Goddard, Angew. Chem. Int. Ed. 2005, 44, 412–414.
[10] a) C. Claver, E. Fernandez, A. Gillon, K. Heslop, D. J. Hyett,
A. Martorell, A. G. Orpen, P. G. Pringle, Chem. Commun.
2000, 961–962; b) A. Martorell, R. Naasz, B. L. Feringa, P. G.
Pringle, Tetrahedron: Asymmetry 2001, 12, 2497–2499.
[11] A.-G. Hu, Y. Fu, J.-H. Xie, H. Zhou, L.-X. Wang, Q.-L. Zhou,
Angew. Chem. 2002, 114, 2454–2456.
[12] a) S. Gladiali, A. Dore, D. Fabbri, O. De Lucchi, M. Man-
assero, Tetrahedron: Asymmetry 1994, 5, 511–514; b) L. Char-
ruault, V. Michelet, R. Taras, S. Gladiali, J.-P. Genet, Chem.
Commun. 2004, 850–851; c) G. Zanoni, S. Gladiali, A. March-
etti, P. Piccinini, I. Tredici, G. Vidari, Angew. Chem. Int. Ed.
2004, 43, 846–849.
[13] a) Y. Chi, X. Zhang, Tetrahedron Lett. 2002, 43, 4849–4852; b)
W. Tang, W. Wang, Y. Chi, X. Zhang, Angew. Chem. Int. Ed.
Eur. J. Org. Chem. 2006, 2912–2917 © 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.eurjoc.org 2917
2003, 42, 3506–3509; c) Y. Chi, Y.-G. Zhou, X. Zhang, J. Org.
Chem. 2003, 68, 4120–4122; d) D. Xiao, X. Zhang, Angew.
Chem. Int. Ed. 2001, 40, 3425–3428; e) D. Xiao, Z. Zhang, X.
Zhang, Org. Lett. 1999, 1, 1679–1681.
[14] a) K. Junge, G. Oehme, A. Monsees, T. Riermeier, U. Dingerd-
issen, M. Beller, Tetrahedron Lett. 2002, 43, 4977–4980; b) K.
Junge, G. Oehme, A. Monsees, T. Riermeier, U. Dingerdissen,
M. Beller, J. Organomet. Chem. 2003, 675, 91–96; c) K. Junge,
B. Hagemann, S. Enthaler, A. Spannenberg, M. Michalik, G.
Oehme, A. Monsees, T. Riermeier, M. Beller, Tetrahedron:
Asymmetry 2004, 15, 2621–2631; d) K. Junge, B. Hagemann,
S. Enthaler, G. Oehme, M. Michalik, A. Monsees, T. Riermeier,
U. Dingerdissen, M. Beller, Angew. Chem. 2004, 116, 5176–
5179; Angew. Chem. Int. Ed. 2004, 43, 5066–5069.
[15] a) G. Zanoni, S. Gladiali, A. Marchetti, P. Piccinini, I. Tredici,
G. Vidari, Angew. Chem. 2004, 116, 864–867; b) R. P. Wurz,
G. C. Fu, J. Am. Chem. Soc. 2005, 127, 12234–12235; c) L.
Charruault, V. Michelet, R. Tarras, S. Gladiali, J.-P. Genêt,
Chem. Commun. 2004, 850–851; d) E. Vedejs, O. Daugulis, S. T.
Diver, J. Org. Chem. 1996, 61, 430–431.
[16] M. T. Reetz, G. Mehler, A. Meiswinkel, Tetrahedron: Asym-
metry 2004, 15, 2165–2167.
[17] M. J. Burk, G. Casy, N. B. Johnson, J. Org. Chem. 1998, 63,
6084–6085.
[18] Institute of Automation (IAT), Richard Wagner Str. 31/ H. 8,
18119 Rostock-Warnemünde, Germany.
[19] X. Jia, X. Li, L. Xu, Q. Shi, X. Yao, A. S. C. Chan, J. Org.
Chem. 2003, 68, 4539–4541.
[20] MonoPhos is commercially available by Strem.
[21] a) M. T. Reetz, X. Li, Angew. Chem. Int. Ed. 2005, 44, 2959–
2962; b) M. T. Reetz, X. Li, Angew. Chem. Int. Ed. 2005, 44,
2962–2964.
[22] a) A. Duursma, R. Hoen, J. Schuppan, R. Hulst, A. J. Min-
naard, B. L. Feringa, Org. Lett. 2003, 5, 3111–3113; b) A. Du-
ursma, D. Peña, A. J. Minnaard, B. L. Feringa, Tetrahedron:
Asymmetry 2005, 16, 1901–1904; c) D. Peña, A. J. Minnaard,
J. A. F. Boogers, A. H. M. de Vries, B. L. Feringa, Org. Biomol.
Chem. 2003, 1, 1087–1089.
[23] a) C. Monti, C. Gennari, U. Piarulli, J. G. de Vries, A. H. M.
de Vries, L. Lefort, Chem. Eur. J. 2005, 11, 6701–6717; b) K.
Ding, H. Du, Y. Yuan, J. Long, Chem. Eur. J. 2004, 10, 2872–
2884.
Received: January 13, 2006
Published Online: April 26, 2006
5. Application of monodentate phosphine ligands in asymmetric hydrogenation 76
 
 
5.2. Development of Practical Rhodium Phosphine Catalysts for the 
Hydrogenation of β–Dehydroamino Acid Derivates 
 
 
Stephan Enthaler, Giulia Erre, Kathrin Junge, Jens Holz, Armin Börner, Elisabetta Alberico, 
Ilenia Nieddu, Serafino Gladiali*, and Matthias Beller*, Org. Process Res. Dev. 2007, 11, 
568–577. 
 
Contributions 
Dr. Jens Holz carried out preliminary experiments with BINEPINE–ligands which are not 
stated in the article. Investigations with different metal precursors and defined complexes for 
instance catalysis with [Rh(6a)2(nbd)]SO3CF3 and [Rh(nbd)2]BF4 were realized by the group 
of Prof. Gladiali. Furthermore, ligands (R)–6a and 6e were synthesized by Dr. B. Hagemann. 
Development of Practical Rhodium Phosphine Catalysts for the Hydrogenation
of â-Dehydroamino Acid Derivatives
Stephan Enthaler,† Giulia Erre,† Kathrin Junge,† Jens Holz,† Armin Bo¨rner,†,‡ Elisabetta Alberico,§ Ilenia Nieddu,|
Serafino Gladiali,*,| and Matthias Beller*,†
Leibniz Institut fu¨r Katalyse an der UniVersita¨t Rostock e.V., Albert-Einstein Strasse 29a, 18059 Rostock, Germany,
Institut fu¨r Chemie der UniVersita¨t Rostock, Albert-Einstein Strasse 3a, 18059 Rostock, Germany, Istituto di Chimica
Biomolecolare - CNR, traV. La Crucca 3, 07040 Sassari, Italy, and Dipartimento di Chimica, UniVersita` di Sassari,
Via Vienna 2, 07100 Sassari, Italy
Abstract:
The rhodium-catalyzed asymmetric hydrogenation of various
â-dehydroamino acid derivatives to give optically active â-amino
acids has been examined. Chiral monodentate 4,5-dihydro-3H-
dinaphthophosphepines, which are easily tuned and accessible
in a multi-10-g scale, have been used as ligands. The enantio-
selectivity is largely dependent on the nature of the substituent
at the phosphorous atom and on the structure of the substrate.
Applying optimized conditions up to 94% ee was achieved.
Introduction
The discovery of new effective drugs is an important
challenge for industrial and academic research. During the
last decades an intense area of research in medicinal
chemistry was the development of peptide-based therapeutics,
mainly constructed by R-amino acids. More recently, sig-
nificant attention was also directed to non-natural â-amino
acids, which are interesting building blocks for the synthesis
of biologically active compounds such as â-lactam antibio-
tics, the taxol derivatives, and â-peptides (Scheme 1).1 In
view of the growing demand of chiral â-amino acids, an
increasing number of synthetic methods have been estab-
lished for their preparation such as homologation of R-amino
acids, conjugate addition of amines to carbonyl compounds,
Mannich reaction, hydrogenation etc.1c,2 Within these meth-
odologies, asymmetric catalytic hydrogenation constitutes the
most attractive and versatile technology as to industrial
applications due to the remarkable improvements achieved
in the past few years in the asymmetric hydrogenation of
â-dehydroamino acid derivatives. Good-to-excellent enan-
tioselectivities have been obtained in this reaction by
applying rhodium- or ruthenium-catalysts with chiral diphos-
phines such as MeDuPhos, catASium M, BINAP, BINAPO,
BICP, TunaPhos, FerroTane, JosiPhos, DIOP, BPPM, P-Phos
and others.3
A current trend in asymmetric catalysis is to switch from
chiral bidentate to chiral monodentate phosphines because
the latter are more easily accessible and tuneable than the
bidentate counterparts.4,5 Seminal contributions in this field
have come from Feringa and de Vries et al.6 (phosphora-
midites), Reetz et al.7 (phosphites), and Pringle and Claver
et al.8 (phosphonites). Furthermore, excellent enantioselec-
tivities were reported by Zhou and co-workers applying
monodentate spiro phosphoramidites (SIPHOS).9,10
Following the first report by Gladiali11 and parallel to the
work of Zhang,12 we have focused in recent years on different
monodentate phosphines based on a 4,5-dihydro-3H-dinaph-
tho[2,1-c;1′,2′-e]phosphepine framework (5 and 6a-j)
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(Scheme 3).13 The first catalytic application of such a ligand
(Ph-BINEPINE; 6a) in the Rh-catalyzed asymmetric hydro-
formylation of styrene was reported by one of us (S.G.) in
the early 1990s.11a In the following years, the Rostock group
has expanded the structural diversity of the BINEPINE ligand
family 6 into a library of ligands which has been screened
with remarkable success (ee up to 95%) in the asymmetric
hydrogenation with Rh- and Ru-catalysts of R-amino acid
precursors, dimethyl itaconate, enamides and â-ketoesters.13
In the meantime, the utility of Ph-BINEPINE 6a has been
demonstrated in a range of asymmetric reactions catalyzed
by different transition metals such as the Pd-catalyzed
umpoled-allylation of aldehydes and the Pt-catalyzed alkoxy-
cyclization of 1,5-enynes. The ligand itself without any metal
is an efficient chiral catalyst for the enantioselective acylation
of diols, and for [3 + 2] cycloadditions and [4 + 2]
annulations (Scheme 2).11d,e,14 Quite recently excellent enan-
tioselectivities have been scored in the Rh-catalyzed transfer
hydrogenation of R-amino acid precursors and itaconic acid
derivatives using formic acid as H-donor. Under these
conditions â-dehydroamino acids derivatives have also been
successfully hydrogenated, albeit in modest stereoselectivity.11f
Pursuing our ongoing research in hydrogenation chem-
istry, we report herein on the Rh-catalyzed asymmetric
hydrogenation of â-dehydroamino acid derivatives. A multi-
10-g scale synthesis of binaphthophosphepines is described,
which allowed these ligands to be commercialized last year.15
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Scheme 1. Selection of biologically active compounds containing â-amino acid units
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Results and Discussion
The synthesis of binaphthophosphepines starts with di-
esterification of enantiomerically pure 2,2′-binaphthol16 (98%
ee) with trifluoromethanesulfonic acid anhydride in the
presence of pyridine (Scheme 3). The corresponding diester
was obtained in 99% yield, and subsequent nickel-catalyzed
Kumada coupling with methyl magnesium bromide led to
2,2′-dimethylbinaphthyl in 95% yield.13,17 Two different
synthetic strategies were established to obtain 4,5-dihydro-
3H-dinaphtho[2,1-c;1′,2′-e]phosphepine ligands 6. On the one
hand, double metalation of 2,2′-dimethylbinaphthyl with
n-butyl lithium in the presence of TMEDA (N,N,N′,N′-
tetramethylethylenediamine) followed by quenching with
commercially available dichlorophosphines gives ligands 6a
(P-phenyl) and 6i (P-tert-butyl) in 60-83% yield. Both
ligands have been synthesized on >10-g scale. In the second
procedure the dilithiated dimethyl binaphthalene is quenched
with diethylaminodichlorophosphine, giving the phosphepine
5 which, upon treatment with gaseous HCl, is converted into
4-chloro-4,5-dihydro-3H-dinaphtho[2,1-c;1′,2′-e]phosphe-
pine in 80% yield. This enantiomerically pure chlorophos-
phine is easily coupled with various Grignard or lithium
reagents to give a broad selection of ligand 6. The limited
number of commercially available dichlorophosphines and
the large diversity of Grignard compounds make the access
through 4-chloro-4,5-dihydro-3H-dinaphtho[2,1-c;1′,2′-e]-
phosphepine the route of choice to a library of ligands 6.
The syntheses of â-acetamido acrylates 7-11 and 14 were
carried out according to literature protocols by reaction of
the corresponding â-ketoester with NH4OAc followed by
acylation of the â-amino acrylate intermediate.3c,d E/Z-
Isomers were separated by crystallization and column chro-
matography. Ethyl 3-acetamido-3-phenyl-2-propenoate (12)
and methyl 3-benzamido butenoate (13) were synthesized
by reaction of the corresponding â-amino acrylate with acyl
chloride or benzoyl chloride.3l
To compare the behaviour of the Z- and E-isomers, initial
catalytic runs were carried out separately on the (Z)- and
(E)-methyl 3-acetamido butenoates (Z-7 and E-7, respec-
tively) as substrates and 4-phenyl-4,5-dihydro-3H-dinaphtho-
[2,1-c;1′,2′-e]phosphepine (6a) as our standard ligand.13
Typically, we used an in situ precatalytic mixture of 1
mol % [Rh(cod)2]BF4 and 2.1 mol % of the corresponding
ligand. All hydrogenation reactions were carried out in an
8-fold parallel reactor array with a reactor volume of 3.0
mL.18
We first focused our attention on the influence of the
solvent and the hydrogen pressure. The first set of reactions
was run at constant concentration in toluene, dichlo-
romethane, methanol, ethanol,19 and 2-propanol at three
(15) The ligands Ph-BINEPINE (6a) and t-Bu-BINEPINE (6i) are commercially
available by Degussa DHC (Degussa Homogeneous Catalysis, Rodenbacher
Chaussee 4, building 097, 63457 Haunau (Wolfgang), Germany, (ww-
w.creavis.com/site_dhc/de/default.cfm)) with the product names catASium
KPh (6a) and catASium KtB (6i).
(16) Optically pure 2,2′-binaphthol is available on large scale from RCA (Reuter
Chemische Apparatebau KG), Engesserstr. 4, 79108 Freiburg, Germany.
(17) The synthesis of 2,2′-bistriflate-1,1′-binaphthyl (1.2 mol, 615 g, 92%) and
2,2′-dimethyl-1,1′-binaphthyl (0.74 mol, 201 g, 96%) was carried out in
large scale by the group of Zhang (See ref 11b).
(18) Institute of Automation (IAT), Richard Wagner Str. 31/ H. 8, 18119 Rostock-
Warnemu¨nde, Germany.
Scheme 2. Applications of ligand class 6 in asymmetric synthesis
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different pressures (2.5, 10.0, and 50.0 bar). Selected results
are presented in Figure 1.
In the case of hydrogenation of E-7 the best enantiose-
lectivity was consistently achieved at the lowest pressure (2.5
bar) and ranged between 42-79% ee, depending on the
solvent. After 24 h the reaction was complete only in
2-propanol, whereas lower conversions were observed in
ethanol, methanol, and toluene.20 No reaction at all took place
in dichloromethane. The stereoselectivity decreased upon
increasing the pressure of hydrogen to 10.0 bar or 50.0 bar.
From these results 2-propanol and 2.5 bar were selected as
solvent and pressure of choice, respectively, for the hydro-
genation of the E-isomer (conversion: >99%; enantioselec-
tivity: 79%). The hydrogenation of Z-7 resulted in higher
enantioselectivities in all the solvents (up to 92% ee).
Notably, compared to E-7 the configuration of the prevailing
enantiomer was always opposite. Furthermore, in ethanol and
in methanol the enantioselectivity/pressure trend was re-
versed, the top value (92% ee) having been reached at the
highest pressure (50.0 bar) compared to 86% ee at 2.5 bar.
Full conversions were obtained in all the experiments, except
in toluene (37%) and in dichloromethane (45%). These
results indicated ethanol and methanol as the best solvents
and 50.0 bar as the pressure of choice for the hydrogenation
of the Z-isomer (conversion: >99%; enantioselectivity:
92%).
No incorporation of deuterium in the product was noticed
upon running the reaction in methanol-d4. This is in line with
the absence in the reduction process of any interference of
transfer hydrogenation as well as of protonolysis of the
Rh-C bond of an alkyl rhodium intermediate.21 Two facets
deserving mention are (1) the Z-isomer gives higher ee’s than
the E-isomer, whereas in most cases the opposite behaviour
has been reported3 and (2) the configuration switches
depending on the different geometry of the double bond,
which has been scarcely reported.3c,22
Next, we investigated the influence of temperature on
enantioselectivity and conversion as shown in Figure 2.23
Applying our model ligand 6a we found a pronounced
negative effect on the enantioselectivity at higher tempera-
tures for both isomers. Interestingly, the loss of enantiose-
lectivity for the hydrogenation of E-7 is higher than for Z-7
(10 °C: E-7 79% ee (R) and Z-7 88% ee (S); 90 °C: E-7
rac and Z-7 60% ee (S)).
(19) The hydrogenation performed in ethanol and 2-propanol led exclusively to
product 7. No transesterification was observed.
(20) In the case of toluene we assume an inhibition of the catalyst by the solvent,
due to the formation of catalytical inactive rhodium-arene complexes.
Heller, D.; Drexler, H.-J.; Spannenberg, A.; Heller, B.; You, J.; Baumann,
W. Angew. Chem., Int. Ed. 2002, 41, 777-780.
(21) Tsukamoto, M.; Yoshimura, M.; Tsuda, K.; Kitamura, M. Tetrahedron 2006,
62, 5448-5453.
(22) Hu, X.-P.; Zheng, Z. Org. Lett. 2005, 7, 419-422.
(23) Jerphagnon, T.; Renaud, J.-L.; Demonchaux, P.; Ferreira, A.; Bruneau, C.
Tetrahedron: Asymmetry 2003, 14, 1973-1977.
Scheme 3. Synthetic approach to 4,5-dihydro-3H-dinaphtho[2,1-c;1′,2′-e]phosphepine ligands 6
Vol. 11, No. 3, 2007 / Organic Process Research & Development ¥ 571
For estimating the feasible enantioselectivity at lower
temperature we analysed the corresponding Eyring plot24 for
both isomers. As a consequence we considered 10 °C as
temperature of choice, because of good enantioselectivity
and also acceptable reaction times.
The original protocol used for the synthesis of methyl
3-acetamido butenoate (7) gives a mixture of E- and
Z-isomers whose composition depends on the reaction
conditions.1f Although separation of the isomers by fractional
crystallization is feasible, the selective hydrogenation of the
mixture is clearly advantageous. This prompted us to explore
the hydrogenation of different E/Z ratios including the
mixture obtained from the synthesis (Figure 3). The results
showed a linear decrease of enantioselectivity for all mixtures
and demostrated that the hydrogenation of the single isomers
led to highest enantioselectivity.
Recently, Heller and Bo¨rner have reported kinetics and
mechanistic investigations for the hydrogenation of E-7 and
Z-7 through the use of bidentate phosphine ligands. The
mentioned results modified the existent declaration that the
(24) Buschmann, H.; Scharf, H.-D.; Hoffmann, N.; Esser, P. Angew. Chem. 1991,
103, 480-518.
Figure 1. Solvent and pressure variation. Reactions were
carried out at 10 °C for 24 h with 0.0024 mmol [Rh(cod)2]BF4,
0.005 mmol ligand 6a and 0.24 mmol substrate in 2.0 mL of
solvent. Conversions and ee’s were determined by GC (50 m
Chiraldex â-PM, 130 °C, (S)-7a 15.1 min, (R)-7a 16.4 min). The
absolute configuration was determined by comparison with
reported data.3l
Figure 2. Dependency of enantioselectivity versus temperature.
Reactions were carried out at corresponding temperature for
1-24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand
6a and 0.24 mmol substrate in 2.0 mL of 2-propanol. Conver-
sions and ee’s were determined by GC (50 m Chiraldex â-PM,
130 °C, (S)-7a 15.1 min, (R)-7a 16.4 min).
Figure 3. Dependency of enantioselectivity versus E/Z ratio.
Reactions were carried out at 10 °C for 24 h with 0.0024 mmol
[Rh(cod)2]BF4, 0.005 mmol ligand 6a and 0.24 mmol substrate
in 2.0 mL of ethanol. Conversions and ee’s were determined
by GC (50 m Chiraldex â-PM, 130 °C, (S)-7a 15.1 min, (R)-7a
16.4 min).
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reaction rate for hydrogenation of E-isomers is higher than
that for the Z-isomers, because in some cases the opposite
behaviour was observed.3g
To classify ligand 6a we recorded the hydrogen uptake
in relation to the reaction time for the asymmetric hydro-
genation of E-7 and Z-7 with our catalyst in isobaric condi-
tions and under normal pressure of hydrogen (Figure 4).
To minimize the interfering effect of cyclooctadiene (cod),
the precatalyst was stirred for 10 min under hydrogen
atmosphere before adding the substrate E-7 or Z-7. We were
surprised to see that, unlike the case of most bidentate
ligands, in our case at 50% conversion it was the Z-isomer
which was hydrogenated faster (about 3.5 times the E-
isomer).
For gaining an insight into the structure of the catalyst,
the hydrogenation of Z-7 was perfomed using the preformed
complex [Rh(6a)2(nbd)]+CF3SO3- as the catalyst. This
cationic complex was prepared as previously reported by
us,11f and the reaction was run in MeOH at 5 bar at 25 °C.
Under these conditions, Z-7 was completely hydrogenated
in 12 h to give the (S)-enantiomer in 92% ee. This result is
quite close to the one obtained with the catalysts prepared
in situ by adding 2 equiv of the ligand 6a either to
[Rh(nbd)2]+BF4- (89% ee) or to [Rh(cod)2]+BF4- (88% ee).
From this it follows that the catalytically active species most
likely contain two monodentate P-ligands per Rh center and
that the ancillary diolefin ligand has a negligible effect, if
any, on the stereoselectivity, while the anion may exert some
influence. Further support to the presence of two ligands
around the metal comes from the search of nonlinear effect
(NLE) in the model reaction.25 A set of hydrogenations was
performed on both the isomers using various samples of
ligand 6a of different enantiomeric purity, and the ee’s
observed have been plotted against the enantiomeric purity
of the ligand (Figure 5). For both Z-7 and E-7 a positive
nonlinear effect, which implies the bonding of at least two
ligands to the rhodium, is clearly apparent. Similar results
were reported by Reetz,7i Zhou,9b and Feringa6f for the
asymmetric hydrogenation of itaconic esters or R-amino acid
derivatives by the use of different monodentate P-donor
ligands. To verify the positive nonlinear effect we decreased
the amount of ligand to 1 equiv with respect to rhodium.
Here, we observed a diminished reaction rate compared to
the rate of hydrogenation with 2 equiv of ligand. In addition,
the amount of ligand was increased to 4 equiv with respect
to rhodium, but also in this case a reduced reaction rate was
monitored.
In previous studies we have shown the pronounced effect
that the substitution pattern at the P-centre of BINEPINE
ligands has on the stereoselectivity of the asymmetric
process.13 In order to evaluate this substituent effect the
asymmetric hydrogenation of E-7 and Z-7 was performed
in the optimized conditions previously devised with nine
different 4,5-dihydro-3H-dinaphtho[2,1-c;1′,2′-e]phosphep-
ines (6a-6i) (E-7: 2.5 bar hydrogen pressure, 2-propanol,
10 °C, 24 h; Z-7: 50.0 bar, ethanol, 10 °C, 24 h) (Table 1).
In the hydrogenation of E-7 the best enantioselectivities
up to 90, 88, and 87% ee, respectively, were achieved with
ligands 6g, 6d, and much to our surprise, with 6i (Table 1,
entries 7, 4, and 9). The last one has always given quite poor
results in the other benchmark tests where it has been
screened. The presence of electron-donating groups on the
P-aryl substituent has a positive effect on the stereoselectivity
(Table 1, entries 4, 6, and 7), whereas the opposite occurs
for electron-withdrawing groups (Table 1, entry 2). This trend
(25) (a) Girard, C.; Kagan, H. B.; Angew. Chem. 1998, 110, 3088-3127. (b)
Faller, J. W.; Parr, J. J. Am. Chem. Soc. 1993, 115, 804-805.
Figure 4. Dependency of hydrogen consumption versus reac-
tion time. Reactions were carried out under isobaric conditions
(1.0 bar) at 25 °C. [Rh(cod)2]BF4 (0.0072 mmol) and 0.015 mmol
ligand 6a were stirred for 10 min under hydrogen atmosphere
in 10.0 mL of methanol. Afterwards the substrate (0.72 mmol)
was added in 1.0 mL of methanol. The conversions and ee’s
were determined by GC (50 m Chiraldex â-PM, 130 °C, (S)-7a
15.1 min, (R)-7a 16.4 min).
Figure 5. Dependency of the optical purity of ligand 6a on
product selectivity. Reactions were carried out at 10 °C for 24 h
with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand 6a and
0.24 mmol substrate in 2.0 mL of methanol. Conversions and
ee’s were determined by GC (50 m Chiraldex â-PM, 130 °C,
(S)-7a 15.1 min, (R)-7a 16.4 min).
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is similar to the one observed in the hydrogenation of Z-7
although in that case the best ee was scored with the plain
phenyl ligand 6a. Alkyl-substituted phosphepines 6h and 6i
produced catalysts of negligible activity in hydrogenation
of this substrate (Table 1, entries 8 and 9).
To explore scope and limitation of our ligand toolbox,
the asymmetric hydrogenation of a range of â-dehydroamino
acids derivatives was performed under optimized conditions
(Table 2). First the influence of the ester-group on the
hydrogenation of both Z- and E-isomers was investigated in
detail. For E-7 changing from methyl to isopropyl ester
resulted consistently in a slight decrease of stereoselectivity,
whereas in the case of the Z-isomer no reliable correlation
between ester functionality and enantioselectivity was de-
tected. Notably, a diminished yield for all hydrogenations
of Z-9 was attained (Table 2).
Finally, the influence of â3- and â2-substitution was
investigated on a set of seven different substrates (Scheme
4 and Table 3). While substitution of a methyl with an ethyl
group has negligible effects, an increase in the branching of
the alkyl group resulted in an improved selectivity with
ligands 6g and 6i. Furthermore, we also carried out a
substitution in the â3-position by an aromatic group (com-
pound Z-12). As a tendency, depletion of conversion and
enantioselectivity was observed in comparison to Z-8 (Table
1, entries 1-7 and Table 2, entries 15-21). A similar
negative effect was found after substitution of the acyl
protecting group by benzoyl and subjecting Z-13 in the
hydrogenation reaction (Table 3, entries 15-21).
As an example for tetra-substituted â-dehydroamino acid
precursor (â3- and â2-substitution) we tested methyl2-
acetamidocyclopent-1-enecarboxylate (14)26 under optimized
conditions for Z-isomers (Scheme 4). In the majority of cases
excellent diastereoselectivities up to >99% de were achieved,
accompanied by good to moderate conversions. Best enan-
tioselectivities up to 76% ee were obtained by utilizing
ligands 6a and 6b (Scheme 4).
An additional possibility offered by monodentate ligands
from which one can profit in asymmetric catalysis is the
possibility to introduce in the coordination sphere of the
(26) Tang, W.; Wu, S.; Zhang, X. J. Am. Chem. Soc. 2003, 125, 9570-9571.
Table 1. Hydrogenation of E-7 and Z-7 with different
4,5-dihydro-3H-dinaphtho[2,1-c;1′,2′-e]phosphepines (6a-6i)
entry ligand isomera conv. [%]b ee [%]b isomerc conv. [%]b ee [%]b
1 6a E >99 79 (R) Z >99 92 (S)
2 6b E 91 40 (R) Z >99 32 (S)
3 6c E 80 69 (R) Z >99 80 (S)
4 6d E >99 88 (R) Z >99 86 (S)
5 6e E >99 20 (R) Z >99 rac
6 6f E 91 81 (R) Z 90 40 (S)
7 6g E >99 90 (R) Z >99 89 (S)
8 6h E >99 76 (R) Z 5 38 (S)
9 6i E >99 87 (R) Z 3 60 (S)
a All reactions were carried out at 10 °C under 2.5 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and 0.24 mmol
substrate in 2-propanol (2.0 mL). b Conversions and ee’s were determined by
GC (50 m Chiraldex â-PM, 130 °C, (S)-7a 15.1 min, (R)-7a 16.4 min). The
absolute configuration was determined by comparing with reported data.3l c All
reactions were carried out at 10 °C under 50.0 bar pressure of hydrogen for 24
h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and 0.24 mmol substrate
in ethanol (2.0 mL).
Table 2. Influence of ester group on conversion and
enantioselectivity
entry ligand isomera conv. [%]b ee [%]b isomerc conv. [%]b ee [%]b
1 6a E-8 98 83 (R) Z-8 >99 94 (S)
2 6b E-8 79 46 (R) Z-8 >99 rac
3 6c E-8 65 20 (R) Z-8 >99 36 (S)
4 6d E-8 98 84 (R) Z-8 >99 83 (S)
5 6g E-8 97 84 (R) Z-8 >99 85 (S)
6 6h E-8 >99 66 (R) Z-8 >99 rac
7 6i E-8 >99 80 (R) Z-8 >99 rac
8 6a E-9 >99 70 (R) Z-9 52 78 (S)
9 6b E-9 63 40 (R) Z-9 23 46 (S)
10 6c E-9 73 20 (R) Z-9 61 24 (S)
11 6d E-9 >99 76 (R) Z-9 69 91 (S)
12 6g E-9 92 72 (R) Z-9 55 73 (S)
13 6h E-9 >99 66 (R) Z-9 34 rac
14 6i E-9 >99 76 (R) Z-9 32 6 (S)
a All reactions were carried out at 10 °C under 2.5 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and 0.24 mmol
substrate in 2-propanol (2.0 mL). b Conversions and ee’s were determined by
GC (8 (25 m Lipodex E, 70/40-8-180, (R)-8a 33.2 min, (S)-8a 33.4 min), 9 (25
m Lipodex E, 70/25-10-180, (R)-9a 33.2 min, (S)-9a 33.4 min). The absolute
configurations were determined by comparing the sign of specific rotation with
reported data.3d c All reactions were carried out at 10 °C under 50.0 bar pressure
of hydrogen for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and
0.24 mmol substrate in ethanol (2.0 mL).
Scheme 4. Asymmetric hydrogenation of methyl
2-acetamidocylopent-1-enecarboxylate (14)a
a All reactions were carried out at 10 °C under 50.0 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and 0.24 mmol
substrate in ethanol (2.0 mL). Conversion, de’s and ee’s were determined by
GC (25 m Chirasil Val, 120 °C, 14a1 26.8 min, 14a2 27.6 min, 14a3 52.1 min,
14a4 53.0 min).
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metal two different ligands and to play the game of
matching-mismatching combinations of chiral elements.
This opens the way to a combinatorial approach as developed
by Reetz et al.7d-f,27 and Feringa et al.28 for different transition
metal-catalyzed reactions.29
To foster this possibility, we have selected 6a and 6i as
the pivotal ligands for the hydrogenation of Z-7 and E-7,
respectively, in combination with achiral phosphines and
phosphites. The catalysts were prepared in situ using a ratio
of 1.05 to 1.05 equiv of the two ligands with respect to 1.0
equiv of [Rh(cod)2]BF4, and the reactions were carried out
under the optimized conditions defined above. As a general
trend, the heterocombination of monodentate ligands was
always less stereoselective compared to the homocombina-
tion of the pivotal ligands (Table 4). There was just one
notable exception for the system 6i/tricyclohexylphosphine
(Table 4, entry 6) which gave the same ee as obtained when
6i was used alone. Even if these results do not permit to
draw any substantial conclusion, we may infer that in these
conditions the catalytic activity of the different complexes
which are formed in solution lies in the same range and that
they compete for the substrate.
Summary
In conclusion, we have shown that monodentate chiral
4,5-dihydro-3H-dinaphtho[2,1-c;1′,2′-e]phosphepine ligands
can be synthesized on multi-10-g scale from 2,2′-binaphthol.
They can be tuned easily by variation of the substituent at
the P-atom. This class of ligands can be used for various
rhodium- and ruthenium-catalyzed hydrogenations. For the
first time their application towards the synthesis of â-amino
acid derivatives is shown, and enantioselectivities up to 94%
ee were achieved.
Experimental Section
All manipulations were performed under argon
atmosphere using standard Schlenk techniques. Toluene,
n-hexane, and diethyl ether were distilled from sodium
benzophenone ketyl under argon. Methanol was distilled
from magnesium under argon. Ethanol and 2-propanol were
(27) (a) Reetz, M. T.; Li, X. Angew. Chem., Int. Ed. 2005, 44, 2959-2962. (b)
Reetz, M. T.; Li, X. Angew. Chem., Int. Ed. 2005, 44, 2962-2964.
(28) (a) Duursma, A.; Hoen, R.; Schuppan, J.; Hulst, R.; Minnaard, A. J.; Feringa,
B. L. Org. Lett. 2003, 5, 3111-3113. (b) Duursma, A.; Pen˜a, D.; Minnaard,
A. J.; Feringa, B. L. Tetrahedron: Asymmetry 2005, 16, 1901-1904. (c)
Pen˜a, D.; Minnaard, A. J.; Boogers, J. A. F.; de Vries, A. H. M.; Feringa,
B. L. Org. Biomol. Chem. 2003, 1, 1087-1089.
(29) (a) Monti, C.; Gennari, C.; Piarulli, U.; de Vries, J. G.; de Vries, A. H. M.;
Lefort, L. Chem. Eur. J. 2005, 11, 6701-6717. (b) Ding, K.; Du, H.; Yuan,
Y.; Long, J. Chem. Eur. J. 2004, 10, 2872-2884.
Table 3. Influence of â3-substitution on conversion and
enantioselectivity
entry ligand isomera conv. [%]b ee [%]b isomerc conv. [%]b ee [%]b
1 6a E-10 >99 78 (R) Z-10 98 86 (S)
2 6b E-10 91 44 (R) Z-10 96 58 (S)
3 6c E-10 95 60 (R) Z-10 >99 20 (S)
4 6d E-10 >99 78 (R) Z-10 97 50 (S)
5 6g E-10 >99 75 (R) Z-10 93 48 (S)
6 6h E-10 >99 72 (R) Z-10 97 rac
7 6i E-10 >99 84 (R) Z-10 47 24 (R)
8 6a E-11 >99 26 (R) Z-11 >99 78 (S)
9 6b E-11 39 42 (R) Z-11 99 68 (S)
10 6c E-11 88 70 (R) Z-11 99 28 (S)
11 6d E-11 50 60 (R) Z-11 94 26 (S)
12 6g E-11 >99 88 (R) Z-11 94 68 (S)
13 6h E-11 98 34 (R) Z-11 67 rac
14 6i E-11 >99 90 (R) Z-11 10 58 (R)
15 6a Z-12 99 70 (R) Z-13 19 70 (-)
16 6b Z-12 46 26 (R) Z-13 9 4 (-)
17 6c Z-12 90 47 (R) Z-13 7 46 (+)
18 6d Z-12 95 52 (R) Z-13 <1 n.d.
19 6g Z-12 91 38 (R) Z-13 11 48 (-)
20 6h Z-12 25 54 (R) Z-13 <1 n.d.
21 6i Z-12 33 36 (R) Z-13 10 40 (-)
a All reactions were carried out at 10 °C under 2.5 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and 0.24 mmol
substrate in 2-propanol (2.0 mL). b Conversion was determined by GC or 1H
NMR. The enantiomeric excess was determined by GC or HPLC (10 (25 m
Lipodex E, 120/30, (R)-10a 31.8 min, (S)-10a 32.2 min), 11 (25 m Lipodex E,
130/20, (R)-11a 33.2 min, (S)-11a 33.4 min), 12 (OD-H, n-hexane/ethanol 98:
2, 1.3 mL/min, (S)-12a 27.8 min, (R)-12a 36.8 min), 13 (Chiralcel OB-H,
n-hexane/2-propanol 90:10, 1.0 mL/min, (+)-13a 15.9 min, (-)-13a 18.8 min)).
The absolute configuration was determined by comparing with reported data or
by reported sign of specific rotation.3d,l c All reactions were carried out at 10
°C under 50.0 bar pressure of hydrogen for 24 h with 0.0024 mmol [Rh(cod)2]BF4,
0.005 mmol ligand and 0.24 mmol substrate in ethanol (2.0 mL).
Table 4. Application of ligand mixtures in the asymmetric
hydrogenation of Z-7 and E-7
entry L1 L2 isomer conv. [%]c ee [%]c
1 6a 6a Za >99 92 (S)
2 6a PPh3 Za >99 76 (S)
3 6a PCy3 Za >99 78 (S)
4 6i 6i Eb >99 87 (R)
5 6i PPh3 Eb >99 34 (R)
6 6i PCy3 Eb >99 88 (R)
7 6i 15d Eb 21 12 (R)
a All reactions were carried out at 10 °C under 50.0 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and 0.24 mmol
substrate in ethanol (2.0 mL). b All reactions were carried out at 10 °C under
2.5 bar pressure of hydrogen for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005
mmol ligand and 0.24 mmol substrate in 2-propanol (2.0 mL). c Conversions
and ee’s were determined by GC (50 m Chiraldex â-PM, 130 °C, (S)-7a 15.1
min, (R)-7a 16.4 min). The absolute configuration was determined by comparing
with reported data.3l d 15 ) tris(2,4-di-tert-butylphenyl)phosphite.
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distilled from sodium under argon. Methylene chloride was
distilled from CaH2 under argon. Ligands 6 were synthesized
according to our previously published protocols.13 [Rh(cod)2]-
BF4 (purchased from Fluka) was used without further
purification. The synthesis of (S)-2,2′-dimethyl-1,1′-binaph-
thyl in a 200-g scale has been described in the literature.12b
Synthesis of 4-Phenyl-4,5-dihydro-3H-dinaphtho[2,1-
c;1′,2′-e]phosphepine (6a) and 4-tert-Butyl-4,5-dihydro-
3H-dinaphtho[2,1-c;1′,2′-e]phosphepine (6i) on 10-g Scale.
Synthesis of the Dilithio Species. A solution of n-BuLi (0.19
mol, 120 mL, 1.6 M in n-hexane) was concentrated under
vacuum and the residual oil dissolved in diethyl ether (60
mL). After cooling the mixture to 0 °C a solution of (S)-
2,2′-dimethyl-1,1′-binaphthyl (74.5 mmol, 21 g) in diethyl
ether (140 mL) was added over a dropping funnel during 20
min to give a red solution. Afterwards TMEDA (192 mmol,
28.6 mL, distilled over CaH2) was added slowly, and the
resulting solution was kept for 24 h at room temperature,
yielding deep red crystals. The supernatant solution was
decanted via a tube. The crystals were washed two times
with dry n-hexane (30 mL, removed by a tube) and dried
under vacuum to give 60-80% yield (24.6-37.8 g).
Synthesis of the 4-Phenyl-4,5-dihydro-3H-dinaphtho[2,1-
c;1′,2′-e]phosphepine (6a). Starting with the dilithium salt of
(S)-2,2′-dimethyl-1,1′-binaphthyl (24.5 g, 44.4 mmol) in n-hex-
ane (130 mL) a solution of phenyl dichlorophosphine (6.8 mL,
50.3 mmol) in n-hexane (55 mL) was added at 0 °C. After
2 h refluxing, the reaction mixture was quenched with water/
toluene. The organic layer was separated and dried over
MgSO4. The ligand 6a was purified by column chromatogra-
phy in dry toluene and gave light-yellow foam (12.9 g; 75%).
Synthesis of the 4-tert-Butyl-4,5-dihydro-3H-dinaphtho-
[2,1-c;1′,2′-e]phosphepine (6i). Starting with the dilithium
salt of (S)-2,2′-dimethyl-1,1′-binaphthyl (24.5 g, 44.4 mmol)
in n-hexane (130 mL) a solution of tert-butyl dichlorophos-
phine (8 g, 50.3 mmol) in n-hexane (55 mL) was added at
0 °C. After 3 h refluxing, the reaction mixture was quenched
with water/toluene. The organic layer was separated and dried
over MgSO4. The ligand 6i was purified by crystallization
from toluene (13.2 g; 81%).
General Synthesis of â-Dehydroamino Acid Deriva-
tives 7-11 and 14.3c To a solution of NH4OAc (0.36 mol)
in methanol, ethanol, or 2-propanol (depending on the ester-
functionality (100 mL)) was added the corresponding â-ke-
toester (0.07 mol). After stirring for 60 h at room temperature
the solvent was removed, and a mixture of CHCl3 and water
was added. The organic layer was washed with water (3 
50 mL) and brine (50 mL) and dried over Na2SO4. The
solvent was evaporated under reduced pressure, yielding the
corresponding 3-amino-2-alkenoate. The 3-amino-2-alk-
enoate (0.07 mol), pyridine (0.13 mol), and acetic anhydride
(0.32 mol) were dissolved in THF (50 mL) and stirred for
12 h at 70 °C (procedure A) or 95 °C (procedure B). The
solution was reduced to half of the volume and ethylacetate
was added. After washing with water, HCl, NaHCO3, brine
and drying over Na2SO4, the solvent was removed.
Procedure A (E-Isomer Enriched Residue). Dissolving the
residue in ethylacetate/n-hexane (1:1) and storing the solution
overnight at -20 °C yielded the E-isomers of â-dehy-
droamino acid derivatives 7-11, which were recrystallized
three times from ethylacetate/n-hexane (1:1) to give colorless
crystals [yield of the main fraction referred to â-ketoester:
E-7: 1.4 g (11%), E-8: 1.2 g (10%), E-9: 1.5 g (11%),
E-10: 1.4 g (12%), E-11: 1.8 g (14%)].
Procedure B (Z-isomer Enriched Residue). The pure
Z-isomer was obtained by column chromatography (eluent:
ethylacetate/n-hexane, 1:1 or 1:2) [yield referred to â-ke-
toester: Z-7: 4.3 g (39%), Z-8: 1.2 g (35%) (0.035 mmol
â-ketoester), Z-9: 6.0 g (46%), Z-10: 1.6 g (26%) (0.035
mmol â-ketoester), Z-11: 4.0 g (31%)]. In the case of methyl
2-acetamidocyclopent-1-enecarboxylate (14) purification was
carried out by crystallization (3) from ethylacetate/n-hexane
(1:1), yielding brown crystals [yield of the main fraction:
4.1 g (32%)].
Synthesis of Ethyl 3-Acetamido-3-phenyl-2-propenoate
(Z-12).3l To a solution of NH4OAc (0.65 mol) in ethanol
(100 mL) was added the corresponding â-ketoester (0.13
mol). After stirring for 60 h at room temperature the solvent
was removed, and a mixture of CHCl3 and water was added.
The organic layer was washed with water (3  50 mL) and
brine (50 mL) and dried over Na2SO4. The solvent was
evaporated under reduced pressure, yielding the correspond-
ing 3-amino-2-alkenoate. To a stirred solution of the corre-
sponding 3-amino-2-alkenoate (0.026 mmol) and pyridine
(0.046 mol) in toluene (50 mL) was added dropwise a
solution of acetyl chloride (0.027 mol) in toluene (10 mL)
at 0 °C. The mixture was stirred for 48 h at 25 °C. A further
amount of acetylchloride (0.027 mol) in toluene (10 mL)
was added at 0 °C, and the resulting mixture was stirred for
48 h. After quenching with aqueous NH4H2PO4 solution the
mixture was extracted with ethylacetate (3  50 mL). The
organic layer was washed with water (2  50 mL) and dried
over Na2SO4. The solvents were removed in vacuo, and the
obtained yellow oil was purified by column chromatography
(eluent: ethylacetate/n-hexane, 1:1), yielding yellow crystals
[yield: Z-12: 0.59 g (10%)].
Synthesis of Methyl 3-Benzamido-2-butenoate (Z-13).3l
To a solution of NH4OAc (0.65 mol) in ethanol (100 mL)
was added the corresponding â-ketoester (0.13 mol). After
stirring for 60 h at room temperature the solvent was
removed, and a mixture of CHCl3 and water was added. The
organic layer was washed with water (3  50 mL) and brine
(50 mL) and was dried over Na2SO4. The solvent was
evaporated under reduced pressure, yielding the correspond-
ing 3-amino-2-alkenoate. To a stirred solution of the corre-
sponding 3-amino-2-alkenoate (0.026 mmol) and pyridine
(0.046 mol) in diethylether (70 mL) was added dropwise a
solution of benzoyl chloride (0.027 mol) in toluene (10 mL)
at -30 °C. The mixture was stirred for 12 h at -30 °C and
for 24 h at room temperature. After quenching with aqueous
water the mixture was extracted with ethylacetate (3  50
mL). The organic layer was washed with HCl (1 mol/L) and
brine and dried over Na2SO4. The solvents were removed in
vacuo, and the obtained yellow oil was purified by column
chromatography (eluent: ethylacetate/n-hexane, 1:1), yield-
ing crystals [yield: Z-13: 2.9 g (9%)].
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General Procedure for the Catalytic Hydrogenation
of â-Dehydroamino Acid Derivatives. A solution of the
â-dehydroamino acid derivative (0.24 mmol) and 1.0 mL of
solvent was transferred via syringe into an autoclave charged
with argon. The catalyst was generated in situ by stirring
[Rh(cod)2]BF4 (0.0024 mmol) and the corresponding 4,5-
dihydro-3H-dinaphthophosphepine ligand (0.005 mmol) in
1.0 mL of solvent for a period of 10 min and afterwards
transferring via syringe into the autoclave. The autoclave was
then charged with hydrogen and stirred at the required
temperature. After the predetermined time the hydrogen was
released, and the reaction mixture passed through a short
plug of silica gel. The conversion was measured by GC or
1H NMR and the enantioselectivity by GC or HPLC.
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Received 27 March 2007; accepted 1 June 2007Abstract—The rhodium-catalyzed asymmetric hydrogenation of different acyclic and cyclic enol carbamates to give optically active car-
bamates has been examined in the presence of chiral monodentate ligands based on a 4,5-dihydro-3H-dinaphthophosphepine motif 4.
The enantioselectivity is largely dependent upon the reaction conditions, the nature of substituents on the phosphorus ligand and struc-
ture of the enol carbamate. By applying the optimized reaction conditions, enantioselectivities of up to 96% ee have been achieved.
 2007 Elsevier Ltd. All rights reserved.1. Introduction
The importance of enantiomerically pure compounds is
demonstrated by their widespread application as either
building blocks or intermediates for the synthesis of phar-
maceuticals, agrochemicals, polymers, natural compounds,
auxiliaries, ligands and synthons in organic syntheses.1 To
serve the growing demand for enantiomerically pure com-
pounds, various synthetic approaches have been developed.
Within the different molecular transformations to chiral
compounds, catalytic reactions offer an efficient and
versatile strategy and present a key technology for the
advancement of ‘green chemistry’, specifically for waste
prevention, reducing energy consumption, achieving high
atom efficiency and generating advantageous economics.2
In this regard, the use of molecular hydrogen in reductions
of C@C, C@O and C@N bonds is one of the most exten-
sively studied fields. For activation of the hydrogen and
transfer of chirality, the use of transition metal catalysts
containing chiral ligands are essential. Over a period of
nearly 30 years, the synthesis of new ligands focused mainly
on bidentate phosphorus systems, because of the promising
results in the first few years of homogeneous asymmetric
hydrogenation. However, at the end of the 20th century,
the situation changed and monodentate ligands received0957-4166/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetasy.2007.06.001
* Corresponding author. Tel.: +49 381 1281 113; fax: +49 381 1281
5000; e-mail: Matthias.Beller@catalysis.demore attention.3,4 The advantages of monodentate phos-
phorus ligands compared to bidentate ligands are their eas-
ier synthesis, high tunability and even a higher efficiency in
the transfer of chiral information as observed in several
cases. Important contributions in this field with excellent
enantioselectivities for various classes of substrates were re-
ported by Feringa and de Vries et al.5 (phosphoramidites),
Reetz et al.6 (phosphites), Pringle and Claver et al.7 (phos-
phonites) and Zhou et al. (spiro phosphoramidites).8
Following the effort of one of us (S.G.)9 and parallel to the
work of Zhang,10 we constructed a ligand library of
approximately 25 different monodentate phosphines based
on a 4,5-dihydro-3H-dinaphtho[2,1-c;1 0,2 0-e]phosphepine
framework 4 (Scheme 1), which is reminiscent of the 1,1 0-
binaphthol core, which is present in the ligands mentioned
above (Scheme 1).11 The potential of this ligand class 4 in
asymmetric hydrogenation with molecular hydrogen, such
as the reduction of a-amino acid precursors, dimethyl
itaconate, enamides and b-ketoesters achieving enantio-
selectivities up to 95% ee was previously reported by us.11
Moreover, other groups demonstrated the usefulness of
these ligands in several catalytic asymmetric reactions.12
The promising results obtained in the asymmetric hydro-
genation of N-(1-phenylvinyl)acetamides with enantioselec-
tivities of up to 95% ee and catalyst activities up to
2000 h1 (TOF) motivated us to explore our ligand library
4 in the hydrogenation of structurally similar enol carba-
mates, which offer an alternative approach to chiral
P RP NEt2
4a: R = Ph
4b: R = p-CF3C6H4
4c: R = 3,5-(CH3)2C6H3
4d: R = p-CH3OC6H4
4e: R = o-CH3OC6H4
4f: R = iPr
4g: R = tBu
2
CH3
CH31. n-BuLi/
   TMEDA
2. Cl2PNEt2
P Cl
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Scheme 1. General synthesis of ligands with 2,2 0-binaphthyl framework.
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hydrogenation of enol carbamates has been reported by
Feringa, de Vries and Minnaard et al. who have scored
enantioselectivities of up to 98% ee with rhodium-catalysts
containing monodentate phosphoramidites (MonoPhos-
family).2. Results and discussion
2.1. Ligand synthesis
In general, the ligands were prepared by double metallation
of 2,2 0-dimethylbinaphthyl 1 with 2 equiv of n-butyl lith-
ium, followed by quenching with diethylaminodichloro-
phosphine or with aryl and alkyl dichlorophosphines.
Deprotection of the diethylamino phosphine 2 with gaseous
HCl produced 4-chloro-4,5-dihydro-3H-dinaphtho[2,1-
c;1 0,2 0-e]phosphepine 3 in 80% yield. This enantiomerically
pure chlorophosphine is easily coupled with various Grig-
nard reagents or organo-lithium compounds to give a broad
selection of ligands 4. In order to expand the application of
this class of ligands, we prepared derivatives of 1, bearingTable 1. Selected bond lengths [A˚] and angles [] of the phosphepine oxides 5
5a 6
P1–C1 1.812(5) P1–C25
P1–C7 1.813(4) P1–C22
P1–C28 1.814(5) P1–C1
P1–O1 1.481(3) P1–O1
C7–P1–C1 109.6(2) C25–P1–C22
C28–P1–C1 104.0(2) C25–P1–C1
C7–P1–C28 103.1(2) C22–P1–C1
a Values of the second molecule in the asymmetric unit are in brackets.substituents on the aliphatic carbon at the a-position to
the phosphorus. The desired bis-methylated product 7 has
been obtained via a deprotonation–alkylation protocol.
After the preliminary step of oxidation of 4-phenyl-4,5-
dihydro-3H-dinaphtho[2,1-c;1 0,2 0-e]phosphepine 4a with
H2O2, lithiation and alkylation were performed by the addi-
tion of LDA (3 equiv) and CH3I (2 equiv) at room temper-
ature. The reaction is completely stereoselective, and only
one of the possible dialkylated products is obtained
(Scheme 1).
Recently, Widhalm et al. reported a similar approach to
the synthesis of compound 7, via the phosphepine sulfide
instead of the oxide.13 To compare the two procedures,
the stereochemistry of the new stereogenic centres in the
phosphepine oxide 6 was studied in detail.
The stereochemistry of compound 6 was confirmed by
NMR spectroscopy. The initial 31P NMR measurements
displayed the occurrence of exclusively one enantiomer
for 6 and 7 in each case, since only one single signal was
found and racemization of the binaphthyl backbone over
the course of reactions was excluded. In a two-dimensionala, 5b and 6
5ba
1.799(3) P1–C1 1.824(4)
[P2–C30] [1.825(4)]
1.832(2) P1–C29 1.833(4)
[P2–C58] [1.846(4)]
1.834(2) P1–C8 1.837(4)
[P2–C37] [1.819(4)]
1.483(2) P1–O1 1.444(3)
[P2–O3] [1.407(5)]
108.6(1) C1–P1–C29 107.9 (2)
[C30–P2–C37] [107.2 (2)]
104.2(1) C1–P1–C8 105.4(2)
[C30–P2–C58] [103.0(2)]
108.8 (1) C29–P1–C8 102.3(2)
[C58–P2–C37] [100.8(2)]
Figure 1. ORTEP plot of compounds 5a, 6 and 5b. Hydrogen atoms are omitted for clarity. The thermal ellipsoids correspond to 30% probability. With
respect to compound 5b, only one of the two symmetry-independent molecules of the asymmetric unit is depicted.
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Figure 2. Solvent and pressure variation. Reactions were carried out at
25 C for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand 4a and
0.24 mmol 8 in 2.0 ml solvent.
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tons were observed: o-Ph with H-3 0, H-11 0 and Me(12); H-3
with H-11 and H-3 0 with H-11 0, respectively, indicating the
bis-axial orientation of both methyl groups. The spatial
proximity of the methyl group Me(12) and of the phenyl
group is also reflected by the difference in 1H chemical shift
values of both methyl groups (dMe(12) = 0.61 and
Me(12 0) = 0.95). The high-field shift of the signal for the
methyl group Me(12) can be explained by the anisotropic
effect of the phenyl substituent on the phosphorus.
In addition, useful structural data were gained by X-ray
crystallography of oxide 6. For comparison, X-ray struc-
ture analyses of the corresponding unsubstituted systems
5a and 5b were determined. Selected bond lengths and an-
gles are shown in Table 1. The molecular structures of the
three oxides are given in Figure 1. In the case of 5b, two
molecules have been found in the asymmetric unit with
similar structural features. As expected in all compounds
the substituents show an approximately tetrahedral
arrangement at the phosphorus atom. The a,a-disubsti-
tuted phosphepine oxide 6 features shorter exocyclic
(P1–C25 1.799(3) A˚) than the endocyclic P–C bonds
(P1–C22 1.832(2) A˚ and P1–C1 1.834(2) A˚) in comparison
with the unsubstituted system 5a where all P–C bonds are
equally long (Table 1). Furthermore, the a,a-substitution
promotes a pronounced expansion of the endocyclic
C–P–C angle up to 108.8(1) (6) from 103.1(2) (5a).
In accordance with the NMR studies and the X-ray struc-
ture analysis, the configuration of compound 6was assigned
to be (S,S,Sa). The stereochemistry of ligand 7 was allotted
in analogy to the one of the corresponding oxide.2.2. Catalytic experiments
The synthesis of enol carbamates 8–14 was carried out in
analogy to literature protocols, by reacting the correspond-
ing ketone with NaH and subsequent addition of the corre-
sponding carbamoyl chloride.5m,14
Initial studies on the influence of reaction conditions were
performed with 1-phenylvinyl N,N-diethylcarbamate 8
as substrate and 4-phenyl-4,5-dihydro-3H-dinaphtho[2,1-
c;1 0,2 0-e]phosphepine 4a as our standard ligand. Typically,we used an in situ pre-catalytic mixture of 1.0 mol %
[Rh(cod)2]BF4 and 2.1 mol % of the ligand. All hydrogena-
tion reactions were carried out in an eightfold parallel reac-
tor array with a 3.0 ml reactor volume.15
First we investigated the influence of different solvents,
such as methylene chloride, methanol, ethanol and 2-pro-
panol in combination with a variation of the initial hydro-
gen pressure (1.0, 5.0, 10.0, 25.0 and 50.0 bar). Selected
results are presented in Figure 2.Surprisingly, by applying toluene as solvent in the hydro-
genation of enol carbamate 8 no reaction occurred, while
in previous studies toluene was found to be the solvent of
choice for the hydrogenation of enamides and a-amino
acids.11c,e The best enantioselectivities of up to 96% ee were
obtained with methanol as solvent with a hydrogen pres-
sure of 25 bar.
Two different pressure-enantioselectivity-dependencies
have been noticed. In ethanol and 2-propanol, the enantio-
selectivity decreased when increasing the hydrogen pressure
(1 bar: ethanol: 74% ee, 2-propanol: 74% ee, 50 bar: ethanol:
24 h, H2 (25 bar)
O
[Rh(cod)2 ]BF4 + 2.1 (4a)
O
N
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N
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Figure 4. Dependency of enantioselectivity versus temperature. Reactions
were carried out at corresponding temperature for 1–24 h with
0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand 4a and 0.24 mmol 8 in
2.0 ml methanol.
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and methanol, the reverse behaviour was observed (1 bar:
methanol: 72% ee, methylene chloride: 66% ee, 50 bar:
methanol: 92% ee, methylene chloride: 86% ee). With the
exception of 2-propanol (>99%), moderate to good conver-
sions (60–90%) were observed at lower pressures within a
reasonable time (24 h), while at higher pressure a complete
conversion was achieved. The results indicated methanol as
the solvent of choice (conversion: >99%; enantioselectivity:
96% ee). In addition, in order to estimate the effect of the
protic solvent on the product structure the reaction was
performed in methanol-d4. Analysis of the
1H NMR spec-
tra showed that no incorporation of deuterium in the prod-
uct had occurred. Therefore, one can rule out any
interference of the solvent in the catalytic cycle due to
transfer hydrogenation and/or protonolysis of Rh-C-
species.16
In order to assess the optimum reaction conditions, a
detailed pressure investigation was performed (Fig. 3).
The results illustrated a constant range of enantioselectivity
(74% ee) between initial pressures of 1–18 bar, followed
by an increase of up to a maximum of 96% ee at 25 bar.
A further increase in the hydrogen pressure did not result
in any improvement while enantioselectivities ranged
between 92% and 94% ee in the region of 30–50 bar.25 ºC, 24 h, H2
O
[Rh(cod)2]BF4 + 2.1 (4a)
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Figure 3. Study of pressure-enantioselectivity-dependency. Reactions were
carried out at 25 C for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol
ligand 4a and 0.24 mmol 8 in 2.0 ml methanol.
Table 2. Hydrogenation of compound 8 with different 4,5-dihydro-3H-
dinaphtho[2,1-c;1 0,2 0-e]phosphepines 4a–4g and ligand 7a
MeOH, 6 h, H2 (25 bar)
O
[Rh(cod)2]BF4 + 2.1 (4 or 7)
O
N
8
O O
N
8a
Entry Ligand Conv. (%) Yield (%) ee (%)
1 4a >99 >99 96 (S)
2 4b 40 40 28 (S)
3 4c >99 >99 66 (S)
4 4d >99 >99 72 (S)
5 4e >99 >99 51 (S)
6 4f 40 40 12 (S)
7 4g 41 41 50 (R)
8b 7 >99 >99 42 (R)
a All reactions were carried out at 25 C under 25 bar pressure of hydrogen
for 6 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and
0.24 mmol 8 in methanol (2.0 ml).
b 24 h.The optimal reaction conditions devised in the solvent-
pressure investigation (methanol as solvent and 25 bar as
initial hydrogen pressure) were applied in a temperature
study (Fig. 4). With the model ligand 4a in the hydrogena-
tion of compound 8, we observed a high stability of the
enantioselectivity (94–96% ee) in the range of 10–90 C
albeit with a reduction of conversion at 90 C. A further
increase to 110 C produced a racemic mixture of 8a, pro-
bably as a result of ligand degradation.17
In order to evaluate the substituent effect at the phosphorus
atom of the ligand, we studied the model reaction of 1-phen-ylvinyl N,N-diethylcarbamate 8 in the presence of eight
different 4,5-dihydro-3H-dinaphtho[2,1-c;1 0,2 0-e]phosphe-
pines 4a–4g and 7 using the optimized reaction conditions
(2.5 bar hydrogen pressure, methanol, 30 C, 6 h). The
results are presented in Table 2. In the hydrogenation of
8, the best enantioselectivities of up to 90% and 72% ee,
respectively, were achieved with ligand 4a and 4d (Table
2, entries 1 and 4). The presence of electron-donating
groups, as well as electron-withdrawing groups onto the
P-aryl substituent, led to a significant decrease of the
stereoselectivity (Table 1, entries 2–5).Catalysts containing alkyl-substituted phosphepines 4f or
4g gave a significant lower activity and enantioselectivity
compared to aryl-substituted phosphepines. Interestingly,
in the case of ligand 4g and 7, the opposite enantiomer is
formed during the reaction. A similar behaviour of the
1292 S. Enthaler et al. / Tetrahedron: Asymmetry 18 (2007) 1288–1298tert-butyl ligand 4g was previously reported for other
asymmetric hydrogenations.11c,f
To explore the scope and limitation of our ligand toolbox,
the asymmetric hydrogenation of a range of enol carb-
amates was performed under optimized conditions (Tables
3 and 4). First the influence of the substitution at the car-
bamoyl-nitrogen was investigated (Table 3).Table 3. Variation of the protecting group in the substrate moietya
MeOH, 24 h, H2 (25 bar)
O
[Rh(cod)2]BF4 + 2.1 (4 and 7)
O
N
R1 R2
9:   R1=R2=Me      
10: R1=Me R2=Ph 
11: R1=Ph R2=Ph
O O
N
R1 R2
9a-11a
Entry Ligand R1 R2 Conv. (%) Yield (%) ee (%)
1 4a Me Me >99 >99 68 (S)
2 4b Me Me 33 33 26 (S)
3 4c Me Me 87 87 65 (S)
4 4d Me Me >99 >99 75 (S)
5 4e Me Me 99 99 40 (S)
6 4f Me Me 26 26 17 (S)
7 4g Me Me 44 44 33 (R)
8 7 Me Me 80 80 27 (R)
9 4a Me Ph >99 >99 58 (S)
10 4b Me Ph 98 98 37 (S)
11 4c Me Ph >99 >99 61 (S)
12 4d Me Ph >99 >99 65 (S)
13 4e Me Ph >99 >99 42 (S)
14 4f Me Ph 53 53 4 (S)
15 4g Me Ph >99 >99 45 (R)
16 7 Me Ph >99 >99 53 (R)
17 4a Ph Ph >99 88 10 (S)
18 4b Ph Ph 98 77 Rac
19b 4c Ph Ph 89 75 41 (S)
20 4d Ph Ph >99 87 11 (S)
21 4e Ph Ph >99 87 55 (S)
22 4f Ph Ph 98 62 4 (S)
23 4g Ph Ph >99 98 70 (R)
24 7 Ph Ph >99 98 76 (R)
a All reactions were carried out at 25 C under 25 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and
0.24 mmol substrate in methanol (2.0 ml).
b Reaction was carried out for 6 h.
Table 4. Variations of the substituent in the olefina
O O
N
12
O O
N
O O
N
13 14
Entry Lig. 12a 13a 14a
Conv.
(%)
eeb
(%)
Conv.
(%)
ee
(%)
Conv.
(%)
ee
(%)
1 4a 94 50 (S) <1 n.d. >99 48
2 4b 10 12 (R) <1 n.d. 24 1
3 4c 7 8 (S) <1 n.d. 90 39
4 4d 93 72 (S) <1 n.d. 89 48
5 4e 29 14 (S) <1 n.d. 81 Rac
6 4f 1 n.d. <1 n.d. 39 11
7 4g 2 n.d. <1 n.d. 44 42
8 7 37 6 (R) 30 n.d. 98 67
a All reactions were carried out at 25 C under 25 bar pressure of hydrogen
for 24 h with 0.0024 mmol [Rh(cod)2]BF4, 0.005 mmol ligand and
0.24 mmol substrate in methanol (2.0 ml).
b The absolute configuration was assigned by analogy.All substrates were hydrogenated under the optimized con-
ditions with eight different ligands 4a–4g and 7. The enol
carbamates 9–11 undergo the reaction with good conver-
sion in most cases (Table 3). The negative influence on
the activity was again observed by the electron-withdraw-
ing substituent on the phenyl (entries 2, 10 and 18) and
by the alkyl group on the phosphorus, mainly i-Pr (Table
3, entries 6, 7, 14 and 22). On the other hand in some cases
a positive effect on the selectivity by substitution with elec-
tron donating groups was observed (Table 3, entries 4 and
12). Again the stereoselectivity was reversed in the case of
ligand 7 and 4g, with 7 being the higher inducer of chirality
for system 11. The overall results for the three substrates
9–11 are comparable, showing little influence of the differ-ent substituents on the carbamoyl nitrogen on the reaction
path.
Finally, the sensitivity on the variations in the double bond
was investigated. Table 4 summarizes the results for three
substrates with different substitutions: substitution of the
phenyl-group by an alkyl-group 14, substitution in the 2-
position of the 1,1-olefin 12 and a cyclic substrate 13. Sub-
strate Z-12 was hydrogenated with excellent conversion
and good enantioselectivity by ligand 4d, while 13, which
is structurally related to the E-isomer of substrate 12, fails
to be hydrogenated with all the ligands but exceptionally
ligand 7 (Table 4, entry 8). The alkyl enol carbamate 14
is best hydrogenated by ligands 4a and 7, again leading
to an inversion of enantioselectivity with ligand 7. In gen-
eral the behaviour of substrates 12 and 14 is comparable
to that of the previous enol carbamates.3. Conclusions
Monodentate phosphine ligands based on a 4,5-dihydro-
3H-dinaphtho[2,1-c;1 0,2 0-e]phosphepines structure 4 and 7
have been successfully exploited in the rhodium-catalyzed
asymmetric hydrogenation of various enol carbamates.
The influences of different reaction parameters have been
investigated. For the first time in this reaction a high
enantioselectivity (up to 96% ee) was obtained in the pres-
ence of monodentate phosphines.4. Experimental
4.1. General
1H, 13C and 31P NMR spectra were recorded on Bruker
Spectrometer AVANCE 500, 400 and 300 (1H: 500.13
MHz, 400.13 MHz and 300.13 MHz; 13C: 125.8 MHz,
100.6 MHz and 75.5 MHz; 31P: 162.0 MHz). The calibration
S. Enthaler et al. / Tetrahedron: Asymmetry 18 (2007) 1288–1298 1293of 1H and 13C spectra was carried out on solvent signals
(d(CDCl3) = 7.25 and 77.0). The
31P chemical shifts are
referenced to 85% H3PO4. Mass spectra were recorded on
an AMD 402 spectrometer. Optical rotations were
measured on a Gyromat-HP polarimeter. IR spectra were
recorded as KBr pellets or Nujol mulls on a Nicolet Magna
550. All manipulations with air sensitive compounds were
performed under argon atmosphere using standard
Schlenk techniques. Toluene was distilled from sodium
benzophenone ketyl under argon. Methanol was distilled
from Mg under argon. Ethanol and 2-propanol were
distilled from Na under argon. Methylene chloride was dis-
tilled from CaH2 under argon. Dimethyl sulfoxide (on
molecular sieves) and [Rh(cod)2]BF4 were purchased from
Fluka and used without further purifications. Ligands 4
were synthesized according to our previously published
protocols.11
4.2. Synthesis of ligands
4.2.1. (S)-4-Phenyl-4,5-dihydro-3H-dinaphtho[2,1-c:1 0,2 0-e]-
phosphepine oxide 5a. Ligand 4a (1.5 g, 3.86 mmol) were
dissolved in acetone (10 ml) and 7.7 ml of 10% sol. H2O2
(23 mmol) were added carefully, cooling with ice-bath.
After few minutes stirring at room temperature, the solu-
tion was refluxed at 100 C for 1 h. The solvent was evap-
orated and the resulting yellow oil taken up with CH2Cl2
and dried over MgSO4. Purification by column chromatog-
raphy (eluent: ethyl acetate/petroleum ether 4:1) yielded
1.17 g (75%) of white solid. Mp: 167–168 C. 1H NMR
(500 MHz, CDCl3) d = 8.02 (d, 1H,
3J3,4 = 8.5 Hz, H-4);
7.96, 7.95 (2d, 2H, 3J5,6 = 8.2 Hz,
3J 50 ;60 ¼ 8:2 Hz, H-5,
H-5 0); 7.90 (d, 1H, 3J 30;40 ¼ 8:5 Hz, H-4 0); 7.70 (d, 1H,
3J3,4 = 8.5 Hz, H-3); 7.53–7.35 (m, 7H, H-6, H-6
0, Ph);
7.29–7.21 (m, 3H), 7.16 (d, 1H, 3J = 8.5 Hz, H-7, H-7 0,
H-8, H-8 0); 7.21 (d, 1H, 3J 30 ;40 ¼ 8:5 Hz, H-3 0); 3.36 (dd,
1H, 2JH,H = 14.2 Hz,
2JP,H = 8.2 Hz, H-11a); 3.32 (dd,
1H, 2JP,H = 22.5 Hz,
2JH,H = 14.2 Hz, H-11
0a); 3.22 (dd,
1H, 2JH,H = 14.2 Hz,
2JP,H = 13.0 Hz, H-11b); 3.21 (dd,
1H, 2JP,H = 16.0 Hz,
2JH,H = 14.2 Hz, H-11
0b). 13C NMR
(125.8 MHz, CDCl3): d = 134.0 (d, J = 4.0 Hz), 133.4 (d,
J = 4.0 Hz), 133.0 (d, J = 1.8 Hz), 132.9 (d, J = 1.8 Hz),
132.4 (d, J = 2.5 Hz), 132.2 (d, J = 1.8 Hz), 130.4 (d,
J = 8.2 Hz), 129.6 (d, J = 10.0 Hz, C-1, C-1 0, C-2, C-2 0,
C-9, C-9 0, C-10, C-10 0); 132.1 (d, J = 2.5 Hz, p-Ph); 132.0
(d, J = 88.0 Hz, i-Ph); 130.9 (d, J = 8.5 Hz, o-Ph); 129.4
(d, J = 1.8 Hz, C-4); 128.6 (d, J = 1.8 Hz, C-4 0); 128.5 (d,
J = 11.0 Hz, m-Ph); 128.5 (d, J = 3.5 Hz, C-3); 128.4,
128.2 (C-5, C-5 0); 128.3 (d, J = 4.5 Hz, C-3 0); 127.1,
126.7, 126.5, 126.3 (C-7, C-7 0, C-8, C-8 0); 125.9 (C-6);
125.6 (C-6 0); 37.4 (d, J = 65.0 Hz, C-11 0); 36.0 (d,
J = 64.0 Hz, C-11). 31P NMR (121.5 MHz, CDCl3)
d = 54.0. IR (KBr, cm1): 3052 m; 3008 w; 2951 w; 1618
w; 1592 w; 1508 m; 1435 m; 1405 m; 1359 w; 1328 w;
1251 m; 1221 s; 1199 m; 1159 m; 1114 m; 1102 m; 1061
w; 1026 w; 998 w; 973 w; 960 w; 931 w; 884 w; 866 w;
836 s; 833 m; 820 s; 802 w; 770 m; 752m; 742 s; 726 w;
713 w; 703 m; 694 m; 672 w; 661 m; 622 m; 586 w; 568
w; 544 m; 523 m; 496 w; 470 m; 436 w; 424 w. MS (ESI):
m/z (%) = 404 ([M+], 100); 365 (6); 266 (34); 202 (4); 139
(4); 73 (7). HRMS calcd for C28H21O1P: 404.13245, found:
404.132628. ½a22D ¼ þ79:0 (c 0.46, CHCl3). Retention time:64.6 min (30 m HP Agilent Technologies 50-8-260/5-8-280/
5-8-300/5).
4.2.2. (S)-4-(4-Methoxy)phenyl-4,5-dihydro-3H-dinaphtho-
[2,1-c:1 0,2 0-e]phosphepine oxide 5b. (S)-4-(4-Methoxy)-
phenyl-4,5-dihydro-3H-dinaphtho[2,1-c:10,20-e]phosphepine
4d (4.2 mmol) was dissolved in acetone (15 ml) and a mix-
ture of water (1.1 ml) and 35% sol. H2O2 (5.0 mmol) was
added carefully. After stirring for 4 h at room temperature,
the solvent was evaporated and the residue dissolved in
dichloromethane. The organic phase was washed with
water, brine and dried over MgSO4. The solvent was
removed to obtain an off-white foam. Yield: 99%. Mp:
112–115 C. 1H NMR (300 MHz, CDCl3) d = 8.03–7.89
(m, 4H); 7.69 (dd, 1H, J = 8.5 Hz, J = 1.2 Hz); 7.51–7.41
(m, 2H); 7.40–7.31 (m, 2H, C6H4); 7.29–7.15 (m, 5H);
6.89 (m, 2H, C6H4); 3.83 (s, 3H, OMe); 3.37–3.12
(m, 4H, CH2).
13C NMR (75.5 MHz, CDCl3) d = 162.5
(d, J = 3.0 Hz, C6H4); 133.9 (d, J = 3.8 Hz); 133.5 (d,
J = 3.8 Hz); 132.9 (d, J = 2.0 Hz); 132.7 (d, J = 2.0 Hz);
132.7 (d, J = 10.2 Hz, C6H4); 132.4 (d, J = 2.5 Hz); 132.1
(d, J = 2.0 Hz); 130.6 (d, J = 8.2 Hz); 129.8 (d,
J = 9.5 Hz); 129.3 (d, J = 1.8 Hz); 128.6 (d, J = 1.8 Hz);
128.4 (d, J = 3.8 Hz); 128.4; 128.3 (d, J = 4.5 Hz); 128.2;
127.1; 126.7; 126.5; 126.3; 125.8; 125.6; 123.0 (d,
J = 93.5 Hz, C6H4); 114.0 (d, J = 12.0 Hz, C6H4); 55.3
(OMe); 37.7 (d, J = 66.0 Hz, CH2); 36.3 (d, J = 64.2 Hz,
CH2).
31P NMR (121.5 MHz, CDCl3) d = 54.1. IR (KBr,
cm1): 3053 m; 2957 w; 2836 w; 1596 s; 1569 w; 1503 s;
1460 m; 1441 m; 1407 m; 1294 m; 1255 s; 1217 m; 1178 s;
1117 s; 1027 m; 931 w; 871 w; 816 s; 744 m; 684 w; 660
w; 623 w; 567 w; 544 m; 527 m; 496 w; 457 w; 419 w.
MS (EI): m/z (%) = 434 ([M+], 100); 282 (20); 279 (37);
266 (32); 121 (27). HRMS calcd for C29H23O2P:
434.14302, found: 434.142805. ½a22D ¼ 293 (c 0.25,
CHCl3).
4.2.3. (S,S,Sa)-3,5-Dimethyl-4-phenyl-4,5-dihydro-3H-di-
naphtho[2,1-c:1 0,2 0-e]phosphepine oxide 6. Phosphepine
oxide 5 (1.37 g, 3.4 mmol) is dissolved in 14 ml of THF,
followed by the addition of 0.42 ml (6.8 mmol) of methyl
iodide. To the well stirred solution, 22 ml of LDA
(11 mmol, 0.5 M) are added slowly at room temperature.
The dark red solution was stirred for 1 h and afterwards
quenched with few drops of water. The solvents were evap-
orated under reduced pressure. The product was taken up
with 50 ml of CH2Cl2, washed with 50 ml of H2O and the
water phase extracted with CH2Cl2 (2 · 50 ml). The organ-
ic phases are dried over MgSO4 and the solvents evapo-
rated, yielding 1.45 g of light yellow foam. Purification by
column chromatography on SiO2, eluting with acetone/
petroleum ether 1:1 yielded 0.56 g (38%) of a white solid.
Mp: 292–305 C. 1H NMR (500 MHz, CDCl3) d = 8.02
(d, 1H, 3J 30;40 ¼ 8:5 Hz, H-4 0); 7.97 (d, 1H, 3J3,4 = 8.5 Hz,
H-4); 7.95 (d, 1H, 3J5,6 = 8.2 Hz, H-5); 7.92 (d, 1H,
3J 50 ;60 ¼ 8:2 Hz, H-5 0); 7.72–7.68 (m, 2H, o-Ph); 7.65 (d,
1H, 3J3,4 = 8.5 Hz, H-3); 7.55 (d, 1H,
3J 30 ;40 ¼ 8:5 Hz, H-
3 0); 7.50–7.39 (m, 5H, H-6, H-6 0, m-, p-Ph); 7.24–7.18 (m,
3H), 7.05 (d, 1H, 3J = 8.5 Hz, H-7, H-7 0, H-8, H-8 0); 3.62
(m, 1H, 2JP,H = 15.0 Hz,
3J 110 ;120 ¼ 7:7 Hz, H-11 0); 3.43
(dq, 1H, 2JP,H = 22.0 Hz,
3J11,12 = 7.7 Hz, H-11); 0.95
(dd, 1H, 3JP,H = 14.0 Hz,
3J 110 ;120 ¼ 7:7 Hz, H-12 0); 0.61
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13C
NMR (125.8 MHz, CDCl3): d = 135.2 (d, J = 3.2 Hz, C-
1 0); 134.5 (d, J = 5.0 Hz, C-2 0); 134.0 (d, J = 7.0 Hz, C-2);
133.9 (d, J = 3.0 Hz), 133.8 (d, J = 1.8 Hz), 133.4 (d,
J = 1.8 Hz), 133.0 (d, J = 1.5 Hz), 132.8 (d, J = 1.5 Hz,
C-1, C-9, C-9 0, C-10, C-10 0); 133.2 (d, J = 83.0 Hz, i-Ph);
131.7 (d, J = 2.5 Hz, p-Ph); 131.1 (d, J = 8.2 Hz, o-Ph);
130.1 (d, J = 5.0 Hz, C-3); 129.3 (d, J = 6.8 Hz, C-3 0);
129.2 (C-4); 129.1 (C-4 0); 128.2, 128.0 (C-5, C-5 0); 128.2
(d, J = 10.0 Hz, m-Ph); 127.0, 126.6, 126.5, 126.3 (C-7, C-
7 0, C-8, C-8 0); 126.1 (C-6); 125.7 (C-6 0); 46.4 (d,
J = 59.5 Hz, C-11); 43.2 (d, J = 63.0 Hz, C-11 0); 17.0 (C-
12); 14.6 (d, J = 4.5 Hz, C-12 0). 31P NMR (121.5 MHz,
CDCl3) d = 51.3. IR (KBr, cm
1): 3039 m; 2990 m; 2931
m; 2874 w; 1618 w; 1594 m; 1568 w; 1504 m; 1455 w;
1436 m; 1375 w; 1341 w; 1325 w; 1292 w; 1253 m; 1225
w; 1184 m; 1166 s; 1112 m; 1092 m; 1057 m; 1028 w; 999
w; 957 w; 915 w; 896 m; 871 w; 838 m; 820 s; 796 w; 768
w; 756 m; 739 s; 711 m; 704 m; 689 m; 667 s; 632 w; 583
w; 564 s; 534 m; 520 w; 509 w; 482 m; 459 m; 418 w; 403
w. MS (ESI): m/z (%) = 432 ([M+], 44); 417 (2); 388 (2);
360 (1); 328 (2); 293 (15); 278 (100); 265 (15); 231 (4); 208
(12); 179 (2); 145 (16); 132 (33); 77 (7); 47 (4). HRMS calcd
for C30H25OP: 432.16375, found: 432.163562. ½a22D ¼ þ93:5
(c 0.25, CHCl3). Retention time: 58.6 min (30 m HP Agi-
lent Technologies 50-8-260/5-8-280/5-8-300/5).
4.2.4. (S,S,Sa)-3,5-Dimethyl-4-phenyl-4,5-dihydro-3H-di-
naphtho[2,1-c:1 0,2 0-e]phosphepine 7. Phosphepine oxide 6
(0.08 g, 0.2 mmol) was dissolved in dry toluene (6 ml)
and triethylamine (0.2 ml, 1.4 mmol) was added to the
solution. The mixture was cooled to 0 C with an ice-bath
and HSiCl3 (0.1 ml, 1 mmol) was added. After the addition
was complete, the solution was refluxed for 4 h. The reac-
tion was quenched by 5 ml basic aqueous solution, and
the aqueous phase washed with toluene (2 · 5 ml). The
organic phase was dried over Na2SO4 and the solvent
evaporated under reduced pressure. Yield 70 mg (91%).
Mp: 212 C. 1H NMR (300 MHz, CDCl3) d = 8.04–7.90
(m, 4H); 7.73–7.63 (m, 3H); 7.55 (d, 1H, J = 8.5 Hz);
7.51–7.38 (m, 5H); 7.26–7.16 (m, 3H); 7.06 (d, 1H, J =
8.5 Hz); 3.62 (m, 1H, 2JP,H = 15.5 Hz,
3JH,Me = 7.5 Hz,
CHMe); 3.43 (dq, 1H, 2JP,H = 22.0 Hz,
3JH,Me = 7.5 Hz,
CHMe); 0.95 (dd, 3H, 3JP,H = 13.9 Hz,
3JH,Me = 7.5 Hz,
Me); 0.61 (dd, 3H, 3JP,H = 16.0 Hz,
3JH,Me = .5 Hz, Me).
13C NMR (75.5 MHz, CDCl3) d = 141.2 (d, J = 2.5 Hz);
138.5 (d, J = 1.0 Hz); 138.5 (d, J = 25.8 Hz); 134.7 (d,
J = 5.8 Hz); 134.3; 133.9; 133.86 (d, J = 2.8 Hz); 132.8 (d,
J = 19.5 Hz); 132.7; 132.2; 128.9 (d, J = 3.0 Hz); 128.8;
128.6 (d, J = 1.0 Hz); 128.4; 128.3 (d, J = 3.2 Hz); 128.2;
128.1; 127.9; 126.6; 126.5; 126.0; 126.0; 125.2; 125.1; 39.3
(d, J = 20.0 Hz, CHMe); 36.6 (d, J = 20.0 Hz, CHMe);
22.3 (d, J = 35.5 Hz, Me); 14.0 (d, J = 3.5 Hz, Me). 31P
NMR d = 31.46 (s). MS (ESI): m/z (%): 416 ([M+], 100),
360 (10), 265 (38), 149 (9). HRMS: calcd for C30H25P
416.16884, found: 416.167881. ½a25D ¼ þ87:5 (c 0.2,
CHCl3).
4.3. General synthesis of enol carbamate derivates 8–1414,5m
A solution of sodium hydride (0.11 mol) in dry dimethyl
sulfoxide (200 ml) was stirred for 2 h at 50 C under anatmosphere of argon. The grey suspension was added drop-
wise to the corresponding ketone (0.1 mol) in 25 ml of di-
methyl sulfoxide at room temperature. The orange
solution was stirred for 15 min at room temperature and
then cooled to 10 C. The addition of the corresponding
carbamoyl chloride (0.11 mol) in dimethyl sulfoxide
(0.11 mol) was carried out in 30 min while maintaining
the temperature at 10 C. After stirring overnight at room
temperature, the solution was carefully quenched with
water (250 ml), extracted with n-hexane or heptane
(3 · 250 ml), washed with brine (250 ml) and dried over
MgSO4 or Na2SO4. The solvents were removed in vacuo
and the obtained yellow oil purified by column chromatog-
raphy or crystallization.
4.3.1. 1-Phenylvinyl N,N-diethylcarbamate 8. Purification
by column chromatography (eluent: ethylacetate/n-hexane
1:10) yielded a yellow oil. Yield: 18%. 1H NMR
(300 MHz, CDCl3) d = 7.44–7.39 (m, 2H, Ph); 7.30–7.19
(m, 3H, Ph); 5.35 (d, 1H, J = 2.0 Hz, @CH2); 4.96 (d,
1H, J = 2.0 Hz, @CH2); 3.35 (q, 2H, J = 7.0 Hz, CH2);
3.25 (q, 2H, J = 7.0 Hz, CH2); 1.20 (t, 3H, J = 7.0 Hz,
CH3); 1.10 (t, 3H, J = 7.0 Hz, CH3).
13C NMR
(75.5 MHz, CDCl3) d = 153.8; 153.4; 135.2; 128.6; 128.4;
124.8; 101.3; 42.0; 41.7; 14.3; 13.3. IR (KBr, cm1):
3059 w; 3027 w; 2975 m; 2934 m; 2876 w; 1719 s; 1641
m; 1600 w; 1577 w; 1495 m; 1474 m; 1457 m; 1420 s;
1380 m; 1351 w; 1314 w; 1255 s; 1225 m; 1158 s; 1097 m;
1076 m; 1050 m; 1027 w; 981 w; 902 w; 869 m; 787 m;
771 m; 759 m; 703 m; w; 638 w; 578 w. MS (ESI): m/z
(%) = 219 ([M+], 9); 103 (12); 100 (100); 77 (16); 72 (72);
44 (16). HRMS calcd for C13H17O2N: 219.1254, found:
219.1253. Retention time: 17.8 min (30 m HP Agilent
Technologies 50-8-260/5-8-280/5-8-300/5).
4.3.2. 1-Phenylvinyl N,N-dimethylcarbamate 9. Purifica-
tion by column chromatography on silica gel eluting with
hexane/ethyl acetate 4:1 yielded 6.4 g of an orange oil.
Yield: 34%. 1H NMR (300 MHz, CDCl3) d = 7.48–7.28
(m, 5H, Ph); 5.41 (1H, d, J = 2.0 Hz, @CH2); 5.02 (d,
1H, J = 2.0 Hz, @CH2); 3.10 (s, 3H, CH3); 2.96 (s, 3H,
CH3).
13C NMR (75.5 MHz, CDCl3) d = 154.5; 153.4;
135.1; 128.7; 128.5; 124.9; 101.6; 36.7; 36.4. IR (KBr,
cm1): 3084 w, 3058 w, 3023 w, 2934 m, 1958 w, 1724 s,
1643 m, 1601 w, 1577 m, 1494 s, 1445 s, 1391 s, 1313 m,
1295 m, 1262 s, 1168 s, 1098 m, 1076 m, 1030 m, 928 m,
875 m, 858 m, 772 s, 759 m, 708 m, 692 m, 641 w, 581 w.
MS (ESI): m/z (%) = 191 ([M+], 12); 103 (4); 91 (4); 77
(7); 72 (100); 51 (5). HRMS calcd for C11H13O2N:
191.09408, found: 191.09370. Retention time: 16.8 min
(30 m HP Agilent Technologies 50-8-260/5-8-280/5-8-300/
5).
4.3.3. 1-Phenylvinyl N-methyl N-phenylcarbamate 10.
Purification by column chromatography on silica gel elut-
ing with n-hexane/ethyl acetate 1:1 followed by crystalliza-
tion with acetone/diethylether/n-hexane 1:2:4. Yield: 25%.
Mp: 56–59 C. 1H NMR (300 MHz, CDCl3) d = 7.42–
7.26 (m, 10H, Ph); 5.39 (1H, d, J = 1.7 Hz, @CH2); 5.06
(d, 1H, J = 1.7 Hz, @CH2); 3.38 (br s, 3H, CH3).
13C
NMR (75.5 MHz, CDCl3) d = 153.6; 153.4; 143.0; 134.9;
129.2; 128.8; 128.4; 126.7 (br); 126.0 (br); 125.0; 101.6;
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w; 3037 w; 2975 w; 2937 w; 2557 w; 1966w; 1891 w; 1813 w;
1717 s; 1643 m; 1592 m; 1578 w; 1493 s; 1446 m; 1420 m;
1370 s; 1294 m; 1257 s; 1180 w; 1146 s; 1088 m; 1072 m;
1050 w; 1025 m; 1004 w; 981 m; 916 w; 875 m; 840 w;
827 w; 771 m; 754 m; 705 s; 687 m; 602 w; 588 m; 563 w;
529 w; 429 w; 408 m. MS (ESI): m/z (%) = 253 ([M+], 4);
134 (100); 119 (4); 106 (37); 91 (6); 77 (38); 65 (4); 51
(10); 39 (3). HRMS calcd for C16H15O2N: 253.10973,
found: 253.10977. Retention time: 23.1 min (30 m HP Agi-
lent Technologies 50-8-260/5-8-280/5-8-300/5).
4.3.4. 1-Phenylvinyl N,N-diphenylcarbamate 11. Crystalli-
zation from acetone/diethylether/n-hexane 1:2:5 yielded
white-greenish crystals. Yield: 38%. Mp: 72–75 C. 1H
NMR (300 MHz, CDCl3) d = 7.26–7.21 (m, 15H, Ph);
5.40 (1H, d, J = 2.2 Hz, @CH2); 5.14 (1H, d, J = 2.2 Hz,
@CH2).
13C NMR (75.5 MHz, CDCl3) d = 153.2; 152.5;
142.2; 134.7; 129.1; 128.8; 128.4; 126.8; 126.5; 125.0;
101.6. IR (KBr, cm1): 3088 w; 3057 m; 1952 w; 1879 w;
1801 w; 1721 s; 1646 m; 1590 m; 1492 s; 1451 m; 1384 w;
1347 s; 1328 m; 1307 m; 1293 m; 1256 s; 1201 s; 1184 m;
1172 m; 1097 m; 1078 m; 1044 m; 1032 m; 1024 m; 913
w; 870 m; 836 w; 770 s; 761 s; 694 s; 638 m; 620 w; 597
m; 566 w; 530 m; 512 m; 443 w; 412 w. MS (ESI): m/z
(%) = 315 ([M+], 13); 196 (100); 168 (46); 103 (17); 91 (4);
77 (22); 51 (7). HRMS calcd for C21H17O2N: 315.12538,
found: 315.12538. Retention time: 28.2 min (30 m HP Agi-
lent Technologies 50-8-260/5-8-280/5-8-300/5).
4.3.5. (Z)-1-Phenylprop-1-enyl N,N-diethylcarbamate 12.18
Colourless oil was obtained after column chromatography
(eluent: ethyl acetate/n-hexane 1:10). Yield: 38%. 1H NMR
(500 MHz, CDCl3) d = 7.40 (m, 2H, o-Ph); 7.30 (m, 2H, m-
Ph); 7.23 (m, 2H, p-Ph); 5.85 (q, 1H, 3J1,2 = 7.0 Hz, H-2);
3.49, 3.36 (2q, 4H, H-5, H-5 0); 1.74 (d, 3H, 3J1,2=7.0 Hz,
H-1); 1.29, 1.17 (2t, 6H, 3J5,6 = 7.0 Hz,
3J 50 ;60 ¼ 7:0 Hz,
H-6, H-6 0). 13C NMR (125.8 MHz, CDCl3) d = 153.4
(C@O); 147.3 (C–O); 136.0 (i-Ph); 128.3 (m-Ph); 127.6 (p-
Ph); 124.3 (o-Ph); 112.4 (C-2); 42.1, 41.7 (C-5, C-5 0);
14.4, 13.4 (C-6, C-6 0); 11.4 (C-1). IR (KBr, cm1): 3058
w; 2975 m; 2934 m; 2875 w; 1717 s; 1673 m; 1600 w;
1577 w; 1495 m; 1474 m; 1458 m; 1420 s; 1380 m; 1351
w; 1313 m; 1258 s; 1225 m; 1158 s; 1116 m; 1097 m; 1061
m; 1033 w; 1006 m; 972 w; 951 w; 926 w; 851 w; 793 w;
753 s; 692 m; 652 w; 637 w; 574 w. MS (ESI): m/z
(%) = 233 ([M+], 6); 115 (9); 105 (8); 100 (100); 77 (12);
72 (52); 44 (12). HRMS calcd for C14H19O2N: 233.14103,
found: 233.14101. Retention time: 19.3 min (30 m HP Agi-
lent Technologies 50-8-260/5-8-280/5-8-300/5). Retention
time (HPLC): 8.72 min (eluent: n-hexane/ethanol 98:2;
flow: 1.0 ml/min).
4.3.6. 1H-Inden-3-yl N,N-diethyl carbamate 13. An
orange oil was obtained after column chromatography
(eluent: ethyl acetate/n-hexane 1:10). Yield: 58%. 1H
NMR (300 MHz, CDCl3) d = 7.34–7.10 (m, 4H); 6.19 (t,
1H, J = 2.3 Hz, CH); 3.41–3.27 (m, 4H, CH2CH3); 3.29
(d, 2H, J = 2.3 Hz, CH2CH); 1.22–1.08 (m, 6H, CH3).
13C NMR (75.5 MHz, CDCl3) d = 153.0; 149.4; 141.9;
139.7; 126.1; 125.4; 124.0; 117.8; 113.6; 42.3; 42.1; 34.8;
14.3; 13.4. IR (KBr, cm1): 3074 w; 3024 w; 2975 m;2934 m; 2890 m; 1726 s; 1653 w; 1616 m; 1605 m; 1577
m; 1474 m; 1459 m; 1420 s; 1380 m; 1361 m; 1316 m;
1267 s; 1235 m; 1223 m; 1204 m; 1172 s; 1156 s; 1118 m;
1098 m; 1076 m; 1017 w; 973 m; 953 m; 932 m; 915 w;
844 w; 761 s; 717 m; 635 w; 593 w; 553 w; 511 w; 467 w;
412 w. MS (ESI): m/z (%) = 231 ([M+], 6); 131 (10); 115
(6); 103 (11); 100 (100); 77 (14); 72 (62); 44 (17). HRMS
calcd for C14H17O2N: 231.12538; Found: 231.124840.
Retention time: 21.3 min (30 m HP Agilent Technologies
50-8-260/5-8-280/5-8-300/5).
4.3.7. 3,3-Dimethylbut-1-en-2-yl N,N-diethyl carbamate 14.
A colourless oil was obtained after column chromatogra-
phy (eluent: ethyl acetate/n-hexane 1:3). Yield: 27%. 1H
NMR (400 MHz, CDCl3) d = 4.76 (d, 1H, J = 1.9 Hz,
@CH2); 4.64 (d, 1H, J = 1.9 Hz, @CH2); 3.31 (q, 4H,
J = 7.0 Hz, CH2CH3); 1.16–1.12 (br, 6H, CH2CH3);
1.10 (s, 9H, CH3).
13C NMR (100.6 MHz, CDCl3)
d = 163.0; 154.1; 96.2; 42.0; 41.6; 36.2; 27.9; 14.2; 13.4.
IR (KBr, cm1): 3125 w; 2973 s; 2936 m; 2876 m; 1720 s;
1653 m; 1555 w; 1506 w; 1474 m; 1461 m; 1419 s; 1380
m; 1362 m; 1317 m; 1264 s; 1225 m; 1148 s; 1097 m; 1054
m; 979 m; 938 w; 859 m; 786 m; 756 m; 703 w; 655 w;
593 w; 488 w. MS (ESI): m/z (%) = 199 ([M+], 1); 118
(1); 100 (100); 85 (2); 72 (50); 67 (3); 55 (5); 44 (15). HRMS
calcd for C11H21O2N: 199.15668, found: 199.155983.
Retention time: 11.5 min (30 m HP Agilent Technologies
50-8-260/5-8-280/5-8-300/5).
4.4. General procedure for the catalytic hydrogenation of
enol carbamates
The catalyst was generated in situ by stirring [Rh(cod)2]-
BF4 (0.0024 mmol) and the corresponding 4,5-dihydro-
3H-dinaphthophosphepines ligand (0.005 mmol) in 1.0 ml
of solvent for a period of 10 min and afterwards transfer-
ring via syringe into the autoclave. A solution of the enol
carbamate (0.24 mmol) and 1.0 ml solvent was transferred
via syringe into the autoclave. Then, the autoclave was
charged with hydrogen and stirred at the required temper-
ature. After a predetermined time the hydrogen was re-
leased and the reaction mixture passed through a short
plug of silica gel. The conversion and enantioselecti-
vity were measured by GC and HPLC without further
modifications.
4.4.1. 1-Phenylethyl N,N-diethylcarbamate 8a. Colourless
oil. 1H NMR (300 MHz, CDCl3) d = 7.31–7.11 (m, 5H,
Ph); 5.73 (d, 1H, J = 6.5 Hz, CH); 3.20 (q, 4H,
J = 7.0 Hz, CH2); 1.44 (d, 3H, J = 6.5 Hz, CH3); 1.02 (t,
6H, J = 7.0 Hz, CH3).
13C NMR (75.5 MHz, CDCl3)
d = 155.1; 142.6; 128.2; 127.3; 125.7; 72.6; 41.5; 41.1;
22.7; 14.0; 13.4. IR (KBr, cm1): 3087 w; 3064 w; 3033
w; 2977 s; 2933 m; 2875 w; 1700 s; 1630 m; 1586 w; 1539
w; 1495 m; 1476 s; 1457 s; 1425 s; 1379 m; 1316 m; 2174
s; 1227 m; 1210 m; 1172 s; 1069 s; 1030 m; 1010 m; 998
m; 973 m; 940 w; 911 w; 877 w; 787 m; 766 m; 700 s; 630
w; 576 w; 535 m. MS (ESI): m/z (%) = 221 ([M+], 2); 105
(100); 100 (5); 77 (16); 72 (5); 58 (7); 51 (6); 44 (8). HRMS
calcd for C13H19O2N: 221.14103, found: 221.140593.
½a23D ¼ 146:1 (c 0.5, CH2Cl2/MeOH, 96% ee (S)). Conver-
sions were determined by GC (Agilent Technologies, 30 m,
1296 S. Enthaler et al. / Tetrahedron: Asymmetry 18 (2007) 1288–129850–300 C, (50-8-260/5-8-280/5-8-300/5)) and ees by HPLC
(Whelk (R,R), (S)-8a 8.29 min and (R)-8a 28.7 min (eluent:
n-hexane/ethanol 99:1; flow: 1.0 ml/min)).
4.4.2. (S)-1-Phenylethyl N,N-diethylcarbamate 8a. To a
solution of (S)-1-phenylethanol (3.3 mmol) in THF
(10 ml) was added NaH (3.4 mmol). The solution was stir-
red for 30 min at room temperature under an argon atmo-
sphere. The solution was cooled to 0 C and N,N-diethyl
carbamoyl chloride (3.4 mmol) in THF (5 ml) was added.
After stirring for 2 h at room temperature the reaction
was quenched with water. The mixture was extracted with
ethylacetate/n-hexane (1:1), washed with brine and dried
over Na2SO4. The solvents were removed in vacuum and
the crude oil was purified by flash column chromatography
(ethylacetate/n-hexane 1:1) to yield a colourless oil (yield:
56%). The analytical data are in agreement with 8a
obtained by the hydrogenation protocol.
4.4.3. 1-Phenylethyl N,N-dimethylcarbamate 9a. Oil. 1H
NMR (400 MHz, CDCl3) d = 7.34–7.22 (m, 5H, Ph); 5.78
(q, 1H, J = 6.6 Hz, CH); 2.93 (br s, 3H, CH3); 2.88 (br s,
3H, CH3); 1.51 (d, 3H, J = 6.6 Hz, CH3).
13C NMR
(100.6 MHz, CDCl3) d = 156.0; 142.7; 128.5; 127.6; 125.9;
73.1; 36.4; 35.9; 22.9. IR (KBr, cm1): 3033 w; 2980 w;
2932 w; 1704 s; 1495 m; 1450 m; 1393 m; 1273 w; 1191 s;
1069 m; 1030 w; 1007 w; 995 w; 894 w; 844 w; 766 m;
700 m; 638 w; 569 w; 532 w. MS (ESI): m/z (%) = 193
([M+], 6); 134 (13); 121 (1); 105 (100); 90 (1); 77 (13); 63
(1); 51 (4). HRMS calcd for C11H15O2N: 193.10973, found:
193.109345. ½a22D ¼ 2:9 (c 0.3, CHCl3, 75% ee (S)). Con-
versions were determined by NMR and ees by HPLC
(Chiralpak AD-H, (R)-9a 23.6 min and (S)-9a 31.3 min,
eluent: n-hexane/ethanol 99:1; flow: 1.0 ml/min). The abso-
lute configuration was assigned by analogy.
4.4.4. 1-Phenylethyl N-methyl N-phenylcarbamate 10a.
Oil. 1H NMR (300 MHz, CDCl3) d = 7.35–7.16 (m, 10H,
Ph); 5.83 (q, 1H, J = 6.5 Hz, CH); 3.28 (s, 3H, CH3);
1.47 (d, 3H, J = 6.5 Hz, CHCH3).
13C NMR (75.5 MHz,
CDCl3) d = 155.0; 143.4; 142.3; 128.8; 128.4; 127.6; 125.9
(br); 125.8; 125.7 (br); 73.8; 37.7; 23.0. IR (KBr, cm1):
3064 w; 3033 w; 3980 m; 2932 w; 1706 s; 1598 m; 1496 s;
1453 m; 1437 m; 1422 m; 1374 s; 1327 m; 1299 s; 1277 s;
1210 m; 1159 s; 1113 m; 1063 s; 1029 m; 1010 m; 997 m;
974 m; 912 w; 885 w; 819 w; 762 s; 698 s; 665 w; 625 w;
599 w; 544 m. MS (ESI): m/z (%) = 255 ([M+], 1); 211
(2); 196 (7); 151 (1); 134 (2); 105 (100); 91 (1); 77 (20); 65
(2); 51 (7). HRMS calcd for C16H17NO2: 255.12538, found:
255.125229. ½a22D ¼ þ19:9 (c 0.26, CHCl3, 65% ee (S)).
Conversions were determined by NMR and ees by HPLC
(Chiralcel OD-H, (R)-10a 25.4 min and (S)-10a 47.2 min,
eluent: n-hexane/ethanol 99:1; flow: 1.0 ml/min). The abso-
lute configuration was assigned by analogy.
4.4.5. 1-Phenylethyl N,N-diphenylcarbamate 11a. Crys-
tals. Mp: 76–78 C. 1H NMR (300 MHz, CDCl3)
d = 7.32–7.14 (m, 15H, Ph), 5.88 (q, 1H, J = 6.5 Hz,
CH), 1.47 (d, 3H, J = 6.5 Hz, CH3).
13C NMR
(75.5 MHz, CDCl3) d = 154.1; 142.6; 141.9; 128.9; 128.4;
127.7; 127.0; 126.1; 125.9; 74.3; 22.9. IR (KBr, cm1):
3064 w; 3033 m; 2984 m; 2934 w; 1702 s; 1591 s; 1491 s;1450 m; 1369 s; 1343 s; 1325 s; 1299 s; 1281 s; 1220 s;
1208 s; 1178 m; 1159 w; 1128 w; 1058 s; 1048 s; 1023 s;
1008 m; 993 m; 951 w; 913 w; 901 w; 860 m; 837 w; 814
w; 781 m; 764 s; 758 s; 693 s; 672 m; 642 w; 622 w; 603
w; 548 s; 516 m; 492 w. MS (ESI): m/z (%) = 317 ([M+],
2); 273 (2); 258 (2); 196 (1); 169 (41); 139 (1); 105 (100);
77 (12); 51 (5). HRMS calcd for C21H19O2N: 317.14103,
found: 317.141098. ½a21D ¼ 16:8 (c 0.33, CHCl3, 76% ee
(R)). Conversions were determined by NMR and ees by
HPLC (Chiralcel OD-H, (R)-11a 6.8 min and (S)-11a
9.6 min, eluent: n-hexane/ethanol 99.5:0.5; flow: 1.0 ml/
min). The absolute configuration was assigned by analogy.
4.4.6. 1-Phenylpropyl N,N-diethylcarbamate 12a. Colour-
less oil. Yield: 98%. 1H NMR (400 MHz, CDCl3)
d = 7.28–7.16 (m, 5H, Ph); 5.54 (1H, dd, J = 6.4 Hz,
J = 7.2 Hz, CHCH2); 3.23 (br, 4H, NCH2); 1.83 (m, 2H,
CHCH2CH3); 1.06 (br, 6H, NCH2CH3); 0.83 (t, 3H,
J = 7.4 Hz, CHCH2CH3).
13C NMR (100.6 MHz, CDCl3)
d = 155.5; 141.6; 128.3; 127.5; 126.4; 77.8; 41.8; 41.3;
29.9; 14.3; 13.6; 9.9. IR (KBr, cm1): 2972 m; 2934 m;
2877 w; 1700 s; 1475 m; 1457 m; 1424 m; 1380 w; 1273 s;
1226 w; 1171 s; 1063 m; 987 m; 903 w; 763 w; 700 m; 528
w. MS (ESI): m/z (%) = 235 ([M+], 9); 162 (15); 119 (54);
100 (12); 91 (100); 77 (7). HRMS calcd for C14H19O2N:
235.15668, found: 235.157242. ½a23D ¼ 143:7 (c 0.5,
CH2Cl2/MeOH, 50% ee). Conversions and ees were deter-
mined by GC (Retention time: 17.9 min, 30 m HP Agilent
Technologies 50–300 C: 50-8-260/5-8-280/5-8-300/5) and
HPLC (Whelk (R,R), n-hexane/ethanol 98:2, flow 1.0 ml/
min, (S)-12a 4.84 min and (R)-12a 10.10 min).
4.4.7. 3,3-Dimethylbutan-2-yl N,N-diethylcarbamate 14a.
Oil. 1H NMR (300 MHz, CDCl3) d = 4.56 (q, 1H,
J = 6.4 Hz, CH); 3.25 (br d, 4H, CH2); 1.12 (d, 3H,
J = 6.4 Hz, CH3); 1.10 (t, 6H, CH2CH3); 0.90 (s, 9H,
CH3).
13C NMR (75.5 MHz, CDCl3) d = 155.9; 78.1;
41.6; 34.4; 25.9; 15.3; 14.2. IR (KBr, cm1): 2971 s; 2935
m; 2874 w; 1696 s; 1653 w; 1559 w; 1540 w; 1506 w; 1475
m; 1457 m; 1423 s; 1395 w; 1378 m; 1365 w; 1316 w;
1275 m; 1227 w; 1210 w; 1174 m; 1076 m; 1007 w; 972 w;
893 w; 824 w; 783 w; 768 w; 744 w; 697 w; 617 w; 537 w.
MS (ESI): m/z (%) = 201 ([M+], 7); 186 (3); 144 (2); 116
(16); 100 (100); 85 (44); 72 (25); 58 (21); 43 (46). HRMS
calcd for C11H23O2N: 201.17233, found: 201.172292.
½a22D ¼ þ135 (c 0.04, CHCl3/MeOH, 67% ee). Conversions
and ees were determined by GC (50m Chiraldex b-PH, 50.0
m · 250 lm · 0.25 lm, 100/25-4-180/5, ()-14a 25.6 min
and (+)-14a 26.0 min).
4.5. X-ray crystallographic studies of 5a, 5b and 6
Data were collected with a STOE-IPDS diffractometer
using graphite-monochromated Mo Ka radiation. The
structures were solved by direct methods19 and refined by
full-matrix least-squares techniques against F2.20 XP
(BRUKER AXS) was used for graphical representations.
The crystallographic data have been deposited with the
Cambridge Crystallographic Data Centre as supplemen-
tary publication no. CCDC 641493–641495. Copies of the
data can be obtained free of charge on application to
http://www.ccdc.cam.ac.uk/data_request/cif.
S. Enthaler et al. / Tetrahedron: Asymmetry 18 (2007) 1288–1298 12974.5.1. Compound 5a. Space group P3121, trigonal, a =
11.174(2), c = 32.520(7) A˚, V = 3516(1) A˚3, Z = 6,
qcalcd = 1.230 g cm
3, 18,941 reflections measured, 3621
were independent of symmetry, of which 2550 were ob-
served (I > 2r(I)), R1 = 0.055, wR2 (all data) = 0.145, 281
parameters, Flack parameter x = 0.05(18).
4.5.2. Compound 5b. Space group P21, monoclinic, a =
7.985(2), b = 11.407(2), c = 12.625(3) A˚, b = 98.27(3),
V = 1138.0(4) A˚3, Z = 2, qcalcd = 1.262 g cm
3, 15,617
reflections measured, 4452 were independent of symmetry,
of which 2645 were observed (I > 2r(I)), R1 = 0.034, wR2
(all data) = 0.059, 289 parameters, Flack parameter
x = 0.02(8).
4.5.3. Compound 6. Space group P21, monoclinic, a =
9.445(2), b = 16.801(3), c = 14.081(3) A˚, b = 91.75(3),
V = 2233.4(8) A˚3, Z = 4, qcalcd = 1.292 g cm
3, 13,676
reflections measured, 7244 were independent of symmetry,
of which 5881 were observed (I > 2r(I)), R1 = 0.047, wR2
(all data) = 0.118, 577 parameters, Flack parameter x =
0.07(10).Acknowledgements
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An Environmentally Benign Process for the Hydrogenation of Ketones with
Homogeneous Iron Catalysts
Stephan Enthaler, Bernhard Hagemann, Giulia Erre, Kathrin Junge, and
Matthias Beller*[a]
Introduction
Catalysis is a key technology for the advancement of green
chemistry, specifically for waste prevention, decreasing
energy consumption, achieving high atom efficiency and
generating advantageous economics.[1] There is an increasing
interest in substituting toxic and expensive late transition
metals by readily available and less-toxic metals. In this
regard, the use of iron catalysts is especially desirable.[2] So
far, homogeneous iron catalysts have been successfully ap-
plied for various CC coupling reactions such as Friedel–
Crafts-type reactions, olefin polymerizations, cross-cou-
plings, cycloadditions, and substitution reactions.[3] However,
much less is known in the area of industrially important cat-
alytic reductions. Here, comparatively few Fe-catalyzed hy-
drogenations have been established, mainly for the reduc-
tion of olefins[4] and nitro compounds.[5] Clearly, the quest
for practical hydrogenation catalysts based on Fe complexes
constitutes a major challenge for the development of more
sustainable reductions.
Recently, we became interested in applying homogeneous
Fe catalysts with respect to CH functionalization reactions
of arenes.[6] Based on that work and our ongoing research in
hydrogenation chemistry,[7] we started to explore Fe cata-
lysts for transfer hydrogenations[8] of carbonyl compounds.
To the best of our knowledge, only iron carbonyls[9,10] or
complexes that contain tetradentate aminophosphines[11] or
phosphines[12] have been described for the transfer hydroge-
nations of ketones and a,b-unsaturated carbonyl com-
pounds. In the latter case, mainly hydrogenation of the
olefin occurred.[9,12]
Our goal is to develop a practical Fe hydrogenation cata-
lyst system, which should be easy to prepare and tunable.
Thus, the use of commercially available Fe complexes in
combination with two different ligands (phosphines and
amines) instead of tetradentate ligands seems to be a useful
approach. Based on this idea, we report herein the applica-
tion of new three-component iron catalysts prepared in situ
based on iron salts, 2,2’:6’,2’’-terpyridine (terpy), and PPh3.
These catalysts give excellent yield and selectivity in the re-
duction of aromatic and aliphatic ketones to alcohols.
Results and Discussion
As a starting point, 2-propanol-based transfer hydrogenation
of acetophenone (1) was examined with Fe catalysts in the
presence of combinations of nitrogen and phosphorus li-
gands. In exploratory experiments, terpy and PPh3 were
used as ligands. Typically, the precatalyst was prepared
in situ by stirring a solution of [Fe3(CO)12] (0.3 mol%),
terpy (1 mol%), and PPh3 (1 mol%) in 2-propanol (1.0 mL)
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for 16 h at 65 8C. Initially, we investigated the influence of
terpy and PPh3 in the presence of [Fe3(CO)12], which can be
easily handled without special precautions (Table 1). To our
delight, a 1:1 mixture of terpy and PPh3 gave an active cata-
lyst for the test reaction that was superior to all other com-
binations (Table 1, entry 2). Notably, low catalytic activity
was observed without the use of any ligands (Table 1,
entry 1). Increasing the ligand concentration resulted in a
significant decrease in activity (Table 1, entries 7 and 8). Im-
portantly, the catalyst systems differ mainly with respect to
reactivity, as the chemoselectivity was excellent in all cases.
Next, the influence of base and the iron precatalyst was
investigated in more detail (Table 2). The best results were
obtained with [Fe2(CO)9] and [Fe3(CO)12] in the presence of
catalytic amounts of sodium 2-propylate or sodium tert-bu-
ACHTUNGTRENNUNGtylate (Table 2, entries 1, 6, 16). Surprisingly, the most com-
monly used bases for transfer hydrogenation, such as
NaOH, KOH, and tBuOK, showed only low activity in this
model reaction (Table 2, entries 3–5). Furthermore, different
inorganic bases such as K2CO3, Cs2CO3, and K3PO4
(Table 2, entries 7–9) as well as nitrogen-containing organic
bases, for instance, pyridine, NEt3, N ACHTUNGTRENNUNG(iPr)2Et, DBU, and
DABCO (Table 2, entries 10–14), did not prove to be effec-
tive. As expected, no transfer of hydrogen was observed in
the absence of base (Table 2, entry 15).
To improve the catalytic system, various iron sources with
different oxidation states (0, +2, and +3) were tested. Be-
sides [Fe2(CO)9] and [Fe3(CO)12], FeCl2 (Table 2, entry 20)
also produced reasonable conversion. To facilitate the for-
mation of active iron hydride complexes, we tested [Et3NH]-
ACHTUNGTRENNUNG[HFe(CO)4]
[13] as precatalyst, but only limited conversion
was detected (Table 2, entry 19).
Following these results, we focused on the nature of the li-
gands. The results in Table 3 indicate no improvement of
conversion when PPh3 was substituted by other phosphorus
ligands. Variation in the substitution pattern of PPh3 with
electron-donating (Table 3, entry 2) or electron-withdrawing
groups (Table 3, entries 3–5) as well as more-basic and steri-
cally hindered phosphines (Table 3, entries 6–9) decreased
the yield of 1-phenylethanol (2). We also applied diphos-
phine ligands in the model reaction. Good activity was ob-
tained with 1,1-bis-(diphenylphosphanyl)methane (dppm)
and 1,2-bis(diphenylphosphanyl)ethane (dppe) (Table 3, en-
tries 12–13). Next, we explored the nature of the nitrogen-
containing ligand. To our surprise, substituted terpyridines
such as 4’-chloro-2,2’:6’,2’’-terpyridine (3), 6,6’-dibromo-
2,2’:6,6’-terpyridine (4), and 4,4’,4’’-tri-tert-butyl-2,2’:6,2’’-ter-
pyridine (5) led to a significant decrease in alcohol forma-
tion (Table 4, entries 1–4). Similarly, the application of struc-
turally related N,N’,N’’-ligands 6 and 7 showed no pro-
nounced activity (Table 4, entries 5 and 6). However, in the
presence of pyridine (3 mol%) and tri ACHTUNGTRENNUNGphenylphosphine, a
reasonable yield of 2 (54%) was obtained. Clearly, Fe/pyri-
dine/PPh3 represents one of the least demanding homoge-
nous transfer-hydrogenation catalysts around. Furthermore,
Table 1. Transfer hydrogenation of acetophenone (1) with
ACHTUNGTRENNUNG[Fe3(CO)12]/terpy/PPh3 catalyst.
[a]
Entry Terpy[b] PPh3
[b] Yield [%][c] Selectivity [%][d]
1 – – 23 >99
2 1 1 78 >99
3 1 – 18 >99
4 – 1 6 >99
5 – 2 21 >99
6 – 10 29 >99
7 5 1 27 >99
8 1 5 24 >99
[a] Reaction conditions: in situ catalyst (0.0038 mmol) ([Fe3(CO)12]
(0.0013 mmol), terpy (0.0038 mmol), PPh3 (0.0038 mmol), 2-propanol
(2.0 mL) for 16 h at 65 8C), iPrONa (0.019 mmol), 5 min at 100 8C, then
addition of 1 (0.38 mmol), 7 h at 100 8C. [b] Ligand to Fe ratio. [c] Yield
was determined by GC (50 m Lipodex E, 95–200 8C) with diglyme as in-
ternal standard (yield is equivalent to conversion). [d] Selectivity refers
to chemoselectivity.
Table 2. Influence of different bases and iron sources in the Fe-catalyzed
transfer hydrogenation of 1.[a]
Entry Iron source Base Yield [%][b]
1 ACHTUNGTRENNUNG[Fe3(CO)12] iPrONa 78
2 ACHTUNGTRENNUNG[Fe3(CO)12] LiOH 2
3 ACHTUNGTRENNUNG[Fe3(CO)12] NaOH <1
4 ACHTUNGTRENNUNG[Fe3(CO)12] KOH <1
5 ACHTUNGTRENNUNG[Fe3(CO)12] tBuOK 12
6 ACHTUNGTRENNUNG[Fe3(CO)12] tBuONa 76
7 ACHTUNGTRENNUNG[Fe3(CO)12] K2CO3 3
8 ACHTUNGTRENNUNG[Fe3(CO)12] Cs2CO3 3
9 ACHTUNGTRENNUNG[Fe3(CO)12] K3PO4 <1
10 ACHTUNGTRENNUNG[Fe3(CO)12] pyridine 1
11 ACHTUNGTRENNUNG[Fe3(CO)12] NEt3 2
12 ACHTUNGTRENNUNG[Fe3(CO)12] N ACHTUNGTRENNUNG(iPr)2Et <1
13 ACHTUNGTRENNUNG[Fe3(CO)12] DBU <1
14 ACHTUNGTRENNUNG[Fe3(CO)12] DABCO <1
15 ACHTUNGTRENNUNG[Fe3(CO)12] – 0
16 ACHTUNGTRENNUNG[Fe2(CO)9] iPrONa 84
17 [Fe(CO)5] iPrONa 2
18 ACHTUNGTRENNUNG[CpFe(CO)2I] iPrONa 3
19 ACHTUNGTRENNUNG[Et3NH] ACHTUNGTRENNUNG[HFe(CO)4] iPrONa 11
20 FeCl2 iPrONa 45
21 FeCl3·xH2O iPrONa <1
22 FeBr2 iPrONa 9
23 FeSO4·7H2O iPrONa 9
24 Fe ACHTUNGTRENNUNG(acac)2 iPrONa 17
25 Fe ACHTUNGTRENNUNG(acac)3 iPrONa 3
[a] Reaction conditions: in situ catalyst (0.0038 mmol) ([Fe3(CO)12]
(0.0013 mmol), terpy (0.0038 mmol), PPh3 (0.0038 mmol), 2-propanol
(2.0 mL) for 16 h at 65 8C), base (0.019 mmol), 5 min at 100 8C, then addi-
tion of 1 (0.38 mmol), 7 h at 100 8C. [b] Yield was determined by GC
(50 m Lipodex E, 95–200 8C) with diglyme as internal standard (yield is
equivalent to conversion). acac=Acetylacetonate, Cp=cyclopentadienyl,
DABCO=1,4-diazabicyclo ACHTUNGTRENNUNG[2.2.2]octane, DBU=1,8-diazabicyclo ACHTUNGTRENNUNG[5.4.0]-
undec-7-ene.
Chem. Asian J. 2006, 1, 598 – 604 F 2006 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim www.chemasianj.org 599
the combination of ()-sparteine and triphenylphosphine
provided an active catalyst system (Table 4, entries 11–12).
Next, the optimized general protocol for transfer hydroge-
nations was applied to aromatic and aliphatic ketones. Here,
both [Fe3(CO)12]/terpy/PPh3 and FeCl2/terpy/PPh3 were
tested for the reduction of 10 different ketones (Table 5).
Acetophenone, 4-chloroacetophenone, 2-methoxyaceto-
ACHTUNGTRENNUNGphenone, and propiophenone were hydrogenated in excel-
lent yield and selectivity (92–99%) (Table 5, entries 1, 2, 5,
6). Acetophenones with electron-donating substituents in
the para position gave good but somewhat lower yields (75–
83%). A chloro substituent in the a position to the carbonyl
group proved to be problematic and deactivated both cata-
lysts (Table 5, entry 7). Aliphatic ketones are more challeng-
ing substrates than aromatic ketones, but they also react in
excellent yield (95–99%).
Notably, similar activities for the reduction of ketones
with regard to our [Fe3(CO)12]-based system were reported
when other transition-metal carbonyl complexes, for in-
stance, [Ru3(CO)12]-based catalysts, were applied.
[14] The
[Fe3(CO)12]- and FeCl2-based catalysts showed no significant
difference in productivity. Hence, we assume the formation
of a similar active species. Indeed, the two catalyst systems
produced similar conversion curves (Figure 1). At the start
of the reaction, we observe in both cases an induction
period of nearly one hour, whereby the FeCl2 system
showed a slightly lower reaction rate, probably due to the
slower elimination of chlorides and the change of oxidation
state. The induction period can be shortened by increasing
the catalyst preformation time. Thus, when the precatalyst
([Fe3(CO)12]/terpy/PPh3) was treated with a base for one
hour instead of 5 min at the reaction temperature, an in-
crease in conversion into 1-phenyl ACHTUNGTRENNUNGethanol from 18% to
32% in the first hour was recorded.
Next, we focused our attention on the reaction mecha-
nism. To exclude the formation of heterogeneous Fe cata-
lysts,[15] a large excess of Hg(0) was added to the well-stirred
reaction mixture after the reaction had proceeded for one
hour, so that the “real” catalyst should be formed.[16,17] No
significant suppression of the reaction rate in the reduction
of 1 was observed (73% yield after 7 h), whereas a positive
poisoning of the catalyst should have led to approximately
18% of 2 (see also Figure 1). In another experiment, the re-
action was carried out under standard conditions and fil-
tered through celite after one hour.[18] The filtrate was al-
lowed to react for a further six hours. Thereafter, the ap-
plied celite was stirred with fresh 2-propanol, sodium 2-pro-
pylate, and 1 under reaction conditions for another six
hours. The results obtained showed no suppression of reac-
tion rate for the filtrate (92%), whereas no conversion was
detected (<1%) with the celite system. Consequently, both
experiments indicate a definite homogeneous catalyst.
Various methods (1H, 31P, and 13C NMR and IR spectros-
copy and MS) were used for the characterization of the
active catalyst species. Unfortunately, the structural compo-
sition of the catalyst is still unclear. No evidence for an Fe
H species was detected by 1H NMR spectroscopy after reac-
tion of the precatalyst with base (5 equiv).[19] The 31P NMR
spectrum of the precatalyst in [D4]MeOH or [D8]iPrOH
showed three singlets with a ratio of 20:1:10 at 5.3 ppm
Table 3. Influence of phosphorus ligands in the Fe-catalyzed transfer
ACHTUNGTRENNUNGhydrogenation of 1.[a]
Entry Phosphine Conversion [%][b]
1 PPh3 78
2 P(p-MeO-C6H4)3 13
3 P(p-Me-C6H4)3 22
4 P ACHTUNGTRENNUNG(p-F-C6H4)3 23
5 P(3,4-CF3-C6H3)3 5
6 PCy3 11
7 P ACHTUNGTRENNUNG(tBu)3 32
8 34
9 31
10 P ACHTUNGTRENNUNG(OPh)3 8
11 P ACHTUNGTRENNUNG(OiPr)3 7
12 Ph2PCH2PPh2 64
13 Ph2P ACHTUNGTRENNUNG(CH2)2PPh2 50
14 Ph2P ACHTUNGTRENNUNG(CH2)4PPh2 3
15 Ph2P ACHTUNGTRENNUNG(CH2)6PPh2 3
[a] Reaction conditions: in situ catalyst (0.0038 mmol) ([Fe3(CO)12]
(0.0013 mmol), terpy (0.0038 mmol), phosphorus ligand (0.0038 mmol), 2-
propanol (2.0 mL) for 16 h at 65 8C), iPrONa (0.019 mmol), 5 min at
100 8C, then addition of 1 (0.38 mmol), 7 h at 100 8C. [b] Yield was deter-
mined by GC (50 m Lipodex E, 95–200 8C) with diglyme as internal stan-
dard (yield is equivalent to conversion). Cy=cyclohexyl.
Figure 1. Conversion–time behavior of the different precatalysts contain-
ing [Fe3(CO)12] and FeCl2. Reaction conditions: in situ catalyst
(0.0038 mmol) ([Fe3(CO)12] (0.0013 mmol) or FeCl2 (0.0038 mmol), terpy
(0.0038 mmol), and PPh3 (0.0038 mmol) in 2-propanol (2.0 mL), 16 h at
65 8C), iPrONa (0.38 mmol), 5 min at 100 8C, then addition of 1
(0.76 mmol), reaction at 100 8C. Conversion was determined by GC (50 m
Lipodex E, 95-200 8C) with diglyme as internal standard (conversion is
equivalent to yield). ^= [Fe3(CO)12]/terpy/PPh3, &=FeCl2/terpy/PPh3.
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(free PPh3) and two unknown signals at 32.9 and
71.3 ppm.[20] The addition of 5 equivalents of base (sodium
2-propylate) with respect to iron and stirring of the mixture
for 5 min at 100 8C did not affect the chemical shift and
ratio of the observed 31P NMR signals.[19] Mass spectrometric
investigations also gave no clear information about the com-
position of the precatalyst, because indications for a number
of possible candidates or fragments of labile complexes
were detected, such as compounds containing terpy, PPh3,
CO, and Fe in a ratio of 1:1:1(2):1 or terpy, CO, and Fe in a
ratio of 1:3:1. The utilization of [Fe3(CO)12] represents a po-
tential option for IR spectroscopy. Hence, we recorded the
IR spectra of our precatalyst in a solution of 2-propanol.
The activation of the precatalyst by sodium 2-propylate
(10 equiv) for 5 min at 100 8C resulted in the http://
www.dict.cc/?s=disappearance of absorption signals at 1889
and 1718 cm1. Addition of 1 to the activated precatalyst led
to the http://www.dict.cc/?s=disappearance of the signal at
1654 cm1 and emergence of a signal at 1679 cm1. Interest-
ingly, a similar behavior was described by Gao and co-work-
ers when they followed the formation of the transfer-hydro-
genation catalyst composed of [Fe3(CO)12] and tetradentate
aminophosphines in 2-propanol in the presence of base.[11]
Although the nature of the active FeH species remains
unclear, we turned our attention to the mechanism of the
hydride transfer. To exclude a radical-type reduction, the re-
action of cyclopropyl phenyl ketone was examined in more
detail (“radical clock” substrate) (Table 5, entry 8). In the
presence of [Fe3(CO)12]/terpy/PPh3 catalyst, the correspond-
ing cyclopropyl phenyl alcohol 14 was detected by 1H NMR
spectroscopy in >99% purity. There was apparently no radi-
cal-induced reduction, because no opening of the cyclopro-
ACHTUNGTRENNUNGpyl ring occurred.[21] Consequently, a radical-reduction
mechanism promoted by sodium alkoxides, whereby the
transition metal plays a marginal role, can also be exclud-
ed.[22]
In general, for transition-metal-catalyzed transfer hydro-
genation, two mechanisms are accepted: direct hydrogen
transfer via formation of a six-membered cyclic transition
state composed of metal and hydrogen donor and acceptor,
and the hydridic route, which is subdivided into two path-
ways, the monohydride and the dihydride mechanism
(Scheme 1). More specifically, the formation of monohy-
dride metal complexes promote an exclusive hydride trans-
fer from carbon (donor) to carbonyl carbon (acceptor)
(Scheme 1, pathway A), whereas a hydride transfer from
carbon (donor) to carbonyl carbon (acceptor) as well as car-
bonyl oxygen (acceptor) was proposed for the formation of
dihydride metal complexes (Scheme 1, pathway B).[8a,c,e] Evi-
dence for both pathways (hydridic route) were determined
by various researchers when investigating the hydride trans-
fer catalyzed by metal complexes of, for example, Ru, Rh,
or Ir.[23] So far nothing is known with respect to iron cata-
lysts in transfer hydrogenations.
To rule out an exchange of hydrogen atoms, for example,
by CH activation, we investigated the transfer hydrogena-
tion with a completely deuterated donor molecule.[24] The
[Fe3(CO)12]/terpy/PPh3 precatalytic system was dissolved in
[D8]iPrOH and treated with [D7]iPrONa for 5 min at 100 8C.
After addition of 1, the solution was stirred for 5 h at
100 8C. Only alcohol 17 was detected as product by 1H NMR
spectroscopy (Scheme 2; >99%).[25] This result indicates an
exclusive transfer of the deuterium into the carbonyl group.
Apparently no CH activation processes and enol formation
occurred under the described conditions.[26]
To clarify the pathway of hydrogen transfer from the hy-
drogen donor to the substrate molecule, we used [D]iPrOH
(the hydroxy group was deuterated) as solvent/donor and
sodium 2-propylate as base in the transfer hydrogenation of
1 (Scheme 2). We obtained a mixture of two different deu-
terated 1-phenylethanols 18 and 19 in the ratio 85:15.[27]
Table 4. Variation of nitrogen ligands in the Fe-catalyzed transfer
ACHTUNGTRENNUNGhydrogenation of 1.[a]
Entry Ligand Ligand/metal Conversion [%][b]
1 terpy 1 78
2 3 1 23
3 4 1 28
4 5 1 14
5 6 1 13
6 7 1 7
7 2,2’-bipyridine 1 8
8 2,2’-bipyridine 2 6
9 tmeda[c] 1 18
10 tmeda[c] 2 13
11 ()-sparteine 1 43[d]
12 ()-sparteine 2 38[d]
13 pyridine 3 54
14 pyridine 6 5
[a] Reaction conditions: in situ catalyst (0.0038 mmol) ([Fe3(CO)12]
(0.0013 mmol), nitrogen ligand (0.0038 mmol), PPh3 (0.0038 mmol), 2-
propanol (2.0 mL) for 16 h at 65 8C), iPrONa (0.019 mmol), 5 min at
100 8C, then addition of 1 (0.38 mmol), 7 h at 100 8C. [b] Yield was deter-
mined by GC (50 m Lipodex E, 95–200 8C) with diglyme as internal stan-
dard (yield is equivalent to conversion). [c] tmeda=N,N,N’,N’-tetrameth-
ACHTUNGTRENNUNGylethylendiamine. [d] A racemic mixture of 2 was detected.
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This specific migration is in agreement with the described
monohydride mechanism, which implies that a major forma-
tion of the metal monohydride in the catalytic cycle occur-
red, albeit with a small amount of 19.[8c] This H/D scram-
bling is explained by the reversibility of the hydrogen-trans-
fer process due to the hydrogen-donating ability of
1-phenylethanol (low oxidation potential).[8c]
Conclusions
We have developed the first general homogeneous Fe cata-
lyst system for the transfer hydrogenation of aliphatic and
aromatic ketones. In the presence of 1 mol% of [Fe3(CO)12]/
terpy/PPh3 or FeCl2/terpy/PPh3, the corresponding alcohols
are obtained in good to excellent yield and chemoselectivity.
The active catalyst systems are easily generated in the pres-
ence of cheap available nitrogen and phosphorus ligands.
Mechanistic experiments indicate a transfer of hydrogen
from the donor molecule to the substrate by a monohydride
mechanism. Further work in the direction of stereoselective
Fe-based hydrogenation catalysts is under way in our labo-
ratories.
Experimental Section
General
All manipulations were performed under argon atmosphere with stan-
dard Schlenk techniques. Unless otherwise specified, all chemicals are
commercially available and used as received. 2-Propanol, pyridine, and
triethylamine were used without further purification (purchased from
Fluka, dried over molecular sieves). Sodium 2-propylate and sodium tert-
butylate were prepared by treating sodium with 2-propanol or tert-buta-
nol under argon atmosphere (stock solution). Ketones 1, 8, 9, 11, 12, 14,
Scheme 1. Monohydride (pathway A) and dihydride (pathway B) mecha-
nisms of transition-metal-catalyzed transfer hydrogenation of acetophe-
none.
Scheme 2. Deuterium incorporation into acetophenone (1) catalyzed by
[Fe3(CO)12]/terpy/PPh3 in the presence of base.
Table 5. ACHTUNGTRENNUNG[Fe3(CO)12]/terpy/PPh3- and FeCl2/terpy/PPh3-catalyzed
ACHTUNGTRENNUNGhydrogenation of ketones.[a]
Entry Alcohol Yield [%][b]
ACHTUNGTRENNUNG[Fe3(CO)12]
Yield [%][b]
FeCl2
1 95 91
2 >99 97
3 84 83
4 63 75
5 >99 >99
6 81 92
7 5 8
8 48 57
9 95 93
10 >99 >99
[a] Reaction conditions: in situ catalyst (0.0038 mmol) ([Fe3(CO)12]
(0.0013 mmol) or FeCl2 (0.0038 mmol), terpy (0.0038 mmol), PPh3
(0.0038 mmol) in 2-propanol (2.0 mL), 16 h at 65 8C), iPrONa
(0.38 mmol), 5 min at 100 8C, then addition of ketone (0.76 mmol), reac-
tion for 7 h at 100 8C. [b] Yield was determined by GC (2 : 50 m Lipodex
E, 95–200 8C, 8 : 25 m Lipodex E, 100 8C, 9 : 50 m Lipodex E, 90–105 8C,
10 : 25 m Lipodex E, 80–180 8C, 11, 14, 15, and 16 : 30 m, HP Agilent
Technologies, 50–300 8C, 12 : 25 m Lipodex E, 90–180 8C, 13 : 50 m Lipo-
dex E, 90–180 8C) with diglyme as internal standard (yield is equivalent
to conversion).
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15, and 16 were dried over CaH2, distilled under vacuum, and stored
under argon. Ketones 10 and 13 were treated with vacuum/argon cycles
and stored under argon. Tmeda was distilled under Argon. [Et3NH]-
ACHTUNGTRENNUNG[HFeCO4],
[13] BuP(adamantyl)2,
[28] and N-phenyl-2-(di-tert-butylphos-
ACHTUNGTRENNUNGphanyl)pyrrole[29] were synthesized according to literature protocols.
[D8]- and [D]iPrOH were dried over CaH2 and distilled under argon at-
mosphere.
General Procedure for Transfer Hydrogenation of Ketones
In a Schlenk tube (10 mL), the catalyst (0.0038 mmol) was generated
in situ by stirring a solution of [Fe3(CO)12] (0.0013 mmol), terpy
(0.0038 mmol), and PPh3 (0.0038 mmol) in 2-propanol (1.0 mL) for 16 h
at 65 8C. The precatalytic system was treated with sodium 2-propylate
(0.38 mmol) at 100 8C for 5 min. After addition of the corresponding
ketone (0.38 or 0.76 mmol), the reaction mixture was stirred for 7 h at
100 8C. The solution was cooled to room temperature and filtered over a
plug of silica. The conversion was measured by GC without further pu-
rification.
Procedures for Distinguishing Homogeneous and Heterogeneous Catalysts
Mercury poisoning: In a Schlenk tube (10 mL), a solution of [Fe3(CO)12]
(0.0013 mmol), terpy (0.0038 mmol), and PPh3 (0.0038 mmol) in 2-propa-
nol (1.0 mL) was stirred for 16 h at 65 8C. The precatalyst was treated at
100 8C with sodium 2-propylate (0.38 mmol) in 2-propanol (0.5 mL) for
5 min, followed by 1 (0.76 mmol) in 2-propanol (0.5 mL). The reaction
mixture was kept for 1 h at 100 8C. After that, a drop of mercury, which
was degassed and stored under argon, was added, and the reaction was
continued for 7 h. The reaction mixture was cooled to room temperature
and filtered over a plug of silica gel. The conversion was determined by
GC without further purification.
Maitlis test: In a Schlenk tube (10 mL), a solution of [Fe3(CO)12]
(0.0013 mmol), terpy (0.0038 mmol), and PPh3 (0.0038 mmol) in 2-propa-
nol (1.0 mL) was stirred for 16 h at 65 8C. The precatalyst was treated at
100 8C with sodium 2-propylate (0.38 mmol) in 2-propanol (0.5 mL) for
5 min, followed by 1 (0.76 mmol) in 2-propanol (0.5 mL). The reaction
mixture was kept for 1 h at 100 8C. After that, the solution was filtered
under an atmosphere of argon through a filter supported by a plug of
celite (heated in vacuum and stored under argon). The filtrate was
heated again to 100 8C and the reaction allowed to proceed for another
6 h. The celite phase was transferred into a Schlenk tube (10 mL) and
mixed with 2-propanol (1.0 mL), sodium 2-propylate (0.38 mmol) in 2-
propanol (0.5 mL), and 1 (0.76 mmol) in 2-propanol (0.5 mL). After the
reaction was complete, both mixtures were cooled to room temperature
and filtered over a plug of silica gel. The conversion was determined by
GC without further purification.
Transfer Hydrogenation with [D8]iPrOH as Hydride Source
In a Schlenk tube (10 mL), [Fe3(CO)12] (0.0013 mmol), terpy
(0.0038 mmol), and PPh3 (0.0038 mmol) in [D8]iPrOH (1.0 mL) were stir-
red for 16 h at 65 8C. After mixing the precatalytic solution with
[D7]iPrONa (0.38 mmol, prepared by reacting sodium (0.38 mmol) with
[D8]iPrOH (0.5 mL)) at 100 8C for 5 min, a solution of 1 (0.76 mmol) in
[D8]iPrOH (0.5 mL) was added. The reaction mixture was kept for 5 h at
100 8C, then cooled to room temperature and filtered over a plug of
silica. The conversion was determined by 1H NMR spectroscopy.
Transfer Hydrogenation with [D]iPrOH as Hydride Source
In a Schlenk tube (10 mL), [Fe3(CO)12] (0.0013 mmol), terpy
(0.0038 mmol), and PPh3 (0.0038 mmol) in [D]iPrOH (1.0 mL) were stir-
red for 16 h at 65 8C. After mixing the precatalytic solution with sodium
2-propylate (0.38 mmol, prepared by treating sodium (0.38 mmol) with
[D]iPrOH (0.5 mL)) at 100 8C for 5 min, a solution of 1 (0.76 mmol) in
[D]iPrOH (0.5 mL) was added. The reaction mixture was kept for 5 h at
100 8C. (To avoid side effects, for instance, scrambling, the reaction was
stopped before full conversion.) The solution was cooled to room temper-
ature and filtered over a plug of silica. The solvent was removed under
vacuum, and the residue was dissolved in CDCl3. The conversion was de-
termined by 1H NMR spectroscopy. The ratio of 18 to 19 was based on
the integrals of the 1H NMR signals of the CH3 groups.
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Available online 4 October 2006Abstract—For the first time in situ generated iron porphyrins have been applied as homogeneous catalysts for the transfer hydro-
genation of ketones. Using 2-propanol as hydrogen source various ketones are reduced to the corresponding alcohols in good to
excellent yield and selectivity. Under optimized reaction conditions high catalyst turnover frequencies up to 642 h1 are achieved.
 2006 Elsevier Ltd. All rights reserved.Alcohols are key intermediates for the synthesis of phar-
maceuticals, agrochemicals, polymers and new materi-
als.1,2 Starting from carbonyl compounds various
catalytic approaches toward the synthesis of alcohols
have been developed. Typical examples are the addition
of organometallic compounds to aldehydes, hydrosilyl-
ation, and hydrogenation of aldehydes or ketones.2
Among these transformations hydrogenations represent
the most atom-efficient and environmentally benign
methodology. In particular, transfer hydrogenation is
a powerful strategy because of the ease of performance
and general applicability.3 More specifically, a broad
scope of alcohols is available by transfer hydrogenation
using non-toxic hydrogen donors, for example, 2-propa-
nol or HCOOH/NEt3, under mild reaction conditions in
the presence of precious metal catalysts based on Ir, Rh,
Ru, or Ni.4
With regard to the upcoming catalyst developments a
fundamental challenge is the substitution of these expen-
sive and rare transition metals by less toxic, inexpensive
and abundantly available metals such as iron.5 Until
now, homogeneous iron catalysts have been most fre-
quently applied for carbon–carbon coupling reactions,
such as olefin polymerizations, cross-couplings and cyc-
loadditions as well as reductions of nitro compounds.6
However, much less attention was directed toward
iron-catalyzed (transfer) hydrogenations, although the
relevance of such reductions is evident even with respect0040-4039/$ - see front matter  2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2006.09.058
* Corresponding author. Tel.: +49 381 1281 113; fax: +49 381 1281
5000; e-mail: matthias.beller@catalysis.deto industrial applications. To the best of our knowledge
only the groups of Noyori,7 Vancheesan,8 Bianchini9
and Gao10 reported the utilization of iron salts and iron
complexes in the reduction of a,b-unsaturated carbonyl
compounds and ketones. For tuning the activity and
selectivity of these catalysts, oxygen and moisture sensi-
tive tetradentate phosphines9 or aminophosphines10
have been predominantly applied as ligands.
Inspired by nature we thought that multidentate nitro-
gen ligands should be also suitable ligands for stabilizing
iron as metal centre in transfer hydrogenations. In the
past biomimetic ligand toolboxes were invented, which
are based on natural sources or similar structural motifs,
for example, amino alcohols, quinidines, bisoxazolines
and porphyrins.11 Within these potential ligands,
porphyrins, which are involved in manifold biological
redox processes, seemed of special interest to us due to
their strong ability to stabilize the iron centre.12,13
Stimulated by our ongoing research in catalytic hydro-
genations15 we became interested in developing new
hydrogenation catalysts based on iron. Thus, we report
herein for the first time a combination of iron and por-
phyrins as catalysts for the efficient reduction of various
ketones (Scheme 1).
In exploratory experiments, 2-propanol-based transfer
hydrogenation of acetophenone was examined using
an easy to adopt in situ catalyst system comprising
Fe3(CO)12 and porphyrin 1a. Typically, the active cata-
lyst is prepared by stirring a solution of 1 mol % iron
source and 1 mol % 1a in 2-propanol (1.0 mL) for 16 h
Scheme 1. Selection of applied porphyrins.14
8096 S. Enthaler et al. / Tetrahedron Letters 47 (2006) 8095–8099at 65 C. After the addition of 50 mol % base the
mixture is heated for 5 min at 100 C and the standard
substrate acetophenone 4 is added.16
Initially, the influence of temperature and various bases
on the reaction rate was investigated. An optimal cata-
lyst activity is obtained at 100 C (Table 1, entries 1–
3). In general, sodium and potassium alkoxides gave
an excellent yield of 1-phenylethanol (96–99%, Table
1, entries 4–8). Noteworthy from a practical point of
view is that NaOH and K2CO3 also led to a high prod-
uct yield. However, in the presence of organic bases such
as NEt3 and pyridine (Table 1, entries 10 and 11) no
significant amount of product is formed in reasonable
time. Diminishing the base concentration resulted in a
decrease of 1-phenylethanol. In the absence of a base,
no transfer of hydrogen was observed.Table 1. Catalytic transfer hydrogenation of acetophenone 4
Entry Iron source Base Temperature (C) Yield (%)a
1 Fe3(CO)12 2-PrONa 80 56
2 Fe3(CO)12 2-PrONa 90 68
3 Fe3(CO)12 2-PrONa 100 96
4 Fe3(CO)12 NaOH 100 98
5 Fe3(CO)12 KOH 100 42
6 Fe3(CO)12 LiOH 100 5
7 Fe3(CO)12 K-t-OBu 100 99
8 Fe3(CO)12 Na-t-OBu 100 97
9 Fe3(CO)12 K2CO3 100 89
10 Fe3(CO)12 NEt3 100 <1
11 Fe3(CO)12 Pyridine 100 <1
Standard reaction conditions: 0.0038 mmol in situ catalyst
(0.0013 mmol Fe3(CO)12 and 0.0038 mmol 1a in 2.0 mL 2-propanol for
16 h at 65 C), 0.19 mmol base, 5 min at described temperature, then
the addition of 0.38 mmol acetophenone 4, 7 h at described
temperature.
a Yield and conversion were determined by GC analysis (50 m Lipodex
E, 95–150 C) with diglyme as an internal standard.Interestingly, the transfer hydrogenation proceeds
highly chemoselectively (>99%). In no case significant
amounts (>1%) of by-products (e.g., aldol condensation
products) are obtained.
Next, attempts were made concerning the iron source
(Table 2).17 The best activity was obtained for
Fe3(CO)12, FeBr2, Fe(acac)3 and [Et3NH][HFe(CO)4].
18
Surprisingly, no reliable correlation between the oxida-
tion state and reaction rate was observed as high activity
was detected for Fe(0)-, Fe(II)- and Fe(III)-salts. Hence,
the formation of the active catalyst species is complete
for the various pre-catalysts under the applied condi-
tions. However, studying the dependency of conversion
versus reaction time in the presence of Fe3(CO)12
revealed an induction period of nearly 2 h.Table 2. Influence of iron sources in the transfer hydrogenation of
acetophenone 4
Entry Iron source Yield (%)a
1 Fe3(CO)12 96
2 FeBr2 98
3 FeCl2 90
4 FeCl3 86
5 Fe(acac)2 74
6 Fe(acac)3 97
7 CpFe(CO)2I 44
8 FeSO4 46
9 [Et3NH][HFe(CO)4] 97
Standard reaction conditions: 0.0038 mmol in situ catalyst
(0.0038 mmol Fe-source or 0.0013 mmol Fe3(CO)12 and 0.0038 mmol
1a in 2.0 mL 2-propanol for 16 h at 65 C), 0.19 mmol base, 5 min at
100 C, then the addition of 0.38 mmol acetophenone 4, 7 h at 100 C.
a Yield and conversion were determined by GC analysis (50 m Lipodex
E, 95–150 C) with diglyme as an internal standard.
Table 4. Fe-catalyzed reduction of various ketones in the presence of
porphyrins 1b and 1e
Entry Product 1b Yield (%)a 1e Yield (%)a
1 46 72
2 >99 >99
3 93 95
4 50 68
5 92 87
6 21 22
7 <1 <1
S. Enthaler et al. / Tetrahedron Letters 47 (2006) 8095–8099 8097In the case of Fe(acac)2 and Fe(acac)3 a favourable
conversion was observed for the Fe(III)-salt. Comparing
the results of FeCl2 and FeBr2, a small influence of the
corresponding halide was also detected.
Next, we focused our attention on the influence of the
metal–ligand ratio. Even without any ligand some cata-
lytic activity is obtained (54% of 5). The addition of 0.5
or 0.2 equiv of 1a (with respect to Fe) increased the yield
of 1-phenylethanol to 74% and 86%, respectively. The
highest yield is obtained at a metal–ligand ratio of 1:1.
A further increase of the number of ligand with respect
to iron (2:1) resulted in a slight decrease of activity (89%
of 5).
In order to further improve the catalyst system, we
applied different porphyrin ligands (1a–3) in the model
reaction in the presence of 0.5 mol % Fe catalyst
(Fe3(CO)12, sodium 2-propylate, 100 C). As shown in
Table 3, best yields were achieved with meso-substituted
porphyrins 1b and 1e (Table 3, entries 3 and 6). Substi-
tution in the meso-phenylic system of porphyrin 1b with
electron withdrawing groups (1a, 1c, and 1d) displayed a
decrease in activity (Table 3, entries 1, 3 and 4).
In addition, porphyrins substituted in the b-pyrrolenic
positions were employed in the reduction of acetophe-
none. The activity of the symmetric coproporphyrin I
2 was to some extend lower when compared with
meso-substituted porphyrins. The natural complex chlo-
roprotoporphyrin IX Fe(III) 3 was utilized without cat-
alysts pre-formation as described for all other ligands,
and a moderate yield of 1-phenylethanol was detected
(Table 3, entry 8). Nevertheless, complex 3 is an interest-
ing catalyst for such reactions due to easier handling and
availability.Table 3. Testing of different porphyrins in the transfer hydrogenation
of acetophenone 4
Entry Porphyrin Catalyst
loading (mol %)
Yield (%)a TOF (h1)b
1 1a 0.5 90 26
2 1a 0.01 45 642
3 1b 0.5 93 27
4 1c 0.5 68 19
5 1d 0.5 56 16
6 1e 0.5 94 27
7 2 0.5 45 13
8 3 0.5 51 15
Standard reaction conditions: 0.0038 mmol or 0.000038 mmol in situ
catalyst (0.0013 mmol or 0.000013 mmol Fe3(CO)12 and 0.0038 mmol
or 0.000038 mmol porphyrin in 2.0 mL 2-propanol for 16 h at 65 C),
0.19 mmol or 0.0019 mmol sodium 2-propylate, 5 min at 100 C, then
the addition of 0.76 mmol acetophenone 4, 7 h at 100 C.
a Conversion was determined by GC analysis (50 m Lipodex E, 95–
150 C) with diglyme as an internal standard.
b Turnover frequencies were determined after 7 h.
8 26 [71]b 89
9 11 [55]b 90
Standard reaction conditions: 0.0038 mmol in situ catalyst (0.0013
mmol Fe3(CO)12 and 0.0038 mmol porphyrin in 2.0 mL 2-propanol for
16 h at 65 C), 0.19 mmol sodium 2-propylate, 5 min at 100 C, then
addition of the corresponding ketone (0.76 mmol), 7 h at 100 C.
a Conversion was determined by GC analysis (entry 1 (25 m Lipodex E,
80–180 C), entries 2, 6, 8 and 9 (30 m, HP Agilent Technologies, 50–
300 C), entry 3 (25 m Lipodex E, 100 C), entry 4 (50 m Lipodex E,
90–105 C), entry 5 (25 m Lipodex E, 90–180 C), entry 7 (50 m
Lipodex E, 90–180 C)) with diglyme as internal standard.
b In brackets the results after 24 h reaction time.In order to demonstrate the utility of our concept, we
selected ligand 1b and 1e and used the correspond-
ing Fe pre-catalysts in the reduction of nine aliphatic
and aromatic ketones (Table 4). When using 0.5 mol %
pre-catalyst in the presence of 50 mol % sodium 2-pro-
pylate, most substrates were hydrogenated in a good
yield. Only disappointing activities were obtained for ke-
tones substituted adjacent to the carbonyl group by a
chloromethyl or a cyclopropyl group (Table 4, entries
8098 S. Enthaler et al. / Tetrahedron Letters 47 (2006) 8095–80996 and 7). Comparing different substitutions on the
phenyl ring no reliable relationship between electron
donating and electron withdrawing substituents and
activity was observed (Table 4, entries 1–4). Similar to
the model reaction, in all cases conversion and yield
were nearly identical.
In agreement with previous findings the highest yield is
obtained with 2-methoxyacetophenone due to the pres-
ence of a second coordination site.19
In addition to aryl alkyl ketones, we also examined more
challenging dialkyl ketones in this iron-catalyzed trans-
fer hydrogenation. Good conversion and yield (89–
90%) were observed for both substrates applying an iron
catalyst containing 1e as ligand. In general, ligand 1e
gave better results compared to 1b. This effect is espe-
cially pronounced for the dialkyl substrates (Table 4,
entries 8 and 9).
In conclusion, we have demonstrated for the first time
the successful application of in situ prepared iron
porphyrin catalysts in the transfer hydrogenation of
ketones. The catalyst system is easily prepared and mim-
ics biologically occurring Fe complexes. Under opti-
mized conditions turnover frequencies up to 642 h1
were achieved. The scope and limitation of the catalyst
were demonstrated on the reduction of nine different
ketones with good to excellent yields.Acknowledgements
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1. Introduction 
The relevance of 1,2-diols is impressively shown by the 
production of ethylene and propylene glycol on multi-
million-ton scale for the synthesis of polymers and anti-
freeze compounds. In addition, more complex 1,2-diols and 
their derivatives constitute interesting building blocks for a 
variety of biologically active compounds.  
In general, synthetic approaches to 1,2-diols are based on 
oxidative processes of olefins. Typical processes include 
the epoxidation of C=C double bonds with peracids or 
hydroperoxides and subsequent hydrolysis, and secondly 
the dihydroxylation of olefins in the presence of osmium 
catalysts (Scheme 1).1  
Scheme 1. Possible approaches to 1,2-diols. 
A much less explored reaction is the transition metal-
catalyzed reduction of 1,2-hydroxyketones. Among the 
different reductions, the transfer hydrogenation with 2-
propanol as non-toxic hydrogen donor is practical and easy 
to perform.2,3 Until now only a few number of applications 
were reported using Rh or Ru based metal catalysts in the 
reduction of hydroxy-protected 1,2-hydroxyketones, which 
is in contrast to the well-studied reduction of 
acetophenone.4  
A major challenge for catalytic hydrogenations is the 
substitution of expensive and rare transition metals (Ir, Rh, 
Ru) by ubiquitous available, inexpensive and less toxic 
metals. Consequently, the use of iron catalysts is especially 
desirable.5 Up to now, homogeneous iron catalysts have 
been mostly used for carbon-carbon bond formation, such 
as olefin polymerizations, cross couplings, and 
cycloadditions as well as reduction of nitro compounds.6 
However, much less attention was directed towards iron-
catalyzed transfer hydrogenation. Only the groups of 
Noyori,7 Vancheesan,8 Bianchini,9 and Gao10 reported the 
utilization of iron salts and iron complexes, containing 
tetradentate phosphines9 or aminophosphines10, in the 
reduction of ketones to obtain alcohols and α,β-unsaturated 
carbonyl compounds to yield α,β-saturated carbonyl 
compounds.  R1
O
OR5
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R4
R2
R3
R1
R4
R2
R3
O
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R3
HO OHDihydroxylation
Epoxidation Ring-
opening
Hydrogenation
R3 R2
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O
O
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More recently, we established two iron-based methods for 
the effective transfer hydrogenation of aryl alkyl as well as 
alkyl alkyl ketones utilizing 2-propanol as the hydrogen 
source.11 On the one hand we applied a combination of iron 
salts, tridentate amines and phosphines as catalysts.11a On 
the other hand an in situ catalyst composed of an iron salt 
and porphyrins has been used (Scheme 2).11b Unfortunately, 
both catalyst systems faced some difficulties with α-
substituted alkyl aryl ketones.  Herein we report for the first 
time the successful hydrogenation of α-alkoxy- and α-
aryloxy-substituted acetophenones in the presence of iron-
porphyrin-complexes.  
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1a R = p-Cl-C6H4
1b R = C6H5
1c R = p-C6H4NMe3Tos
1d R = C6F5
1e R = 4-pyridyl
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Scheme 2. Selection of applied porphyrin ligands.11b 
2. Results and Discussion 
For exploratory experiments the hydrogenation of 2-
methoxyacetophenone was used as a model reaction. 
Typically, the pre-catalyst is prepared by stirring a solution 
of 1 mol% iron salt and 1 mol% 1a in 2-propanol (1.0 mL) 
for 16 h at 65 °C. After addition of 50 mol% base the 
mixture is heated for 5 minutes at 100 °C and the substrate 
2-methoxyacetophenone 4 is added. At first, the influence 
of different iron precursors on the reaction rate was studied 
(Table 1). To our delight full conversion is obtained in all 
cases within 4 h. Obviously, the formation of the active 
catalyst is independent from the Fe-salt and is complete for 
all stated pre-catalysts under the standard conditions. 
Without any Fe present no conversion took place, also 
using FeCl2 without ligand gave only 37% yield. From a 
practical point of view we chose FeCl2 as iron source for 
further investigations.  
It is well known, that the kind and also the amount of base 
are important parameters for obtaining reasonable 
quantities of product in transfer hydrogenations. Thus, we 
investigated frequently used bases, such as NaOH, KOH 
and KOtBu. In all cases excellent yields are achieved, 
except for LiOH and Cs2CO3 (Table 2, entries 1–9). 
Diminishing the base concentration to 5–10 mol% resulted 
in a decrease of yield of 2-methoxy-1-phenylethanol 5, 
while 25 mol% base still gave excellent yield within two 
hours. Noteworthy, in the absence of base no transfer of 
hydrogen occurred (Table 2, entry 15). In addition, 
nitrogen-containing bases (e.g. pyridine, NEt3, DBU) were 
tested, but only unsatisfactory results were attained 
(conversion: <1%).  
Next, we focused our attention on the influence of the 
reaction temperature (Table 2, entries 1 and 11–14). An 
optimal catalyst activity was obtained in the range of 60–
100 °C. However, even at lower temperature a moderate 
yield was attained (40 °C, conversion: 18%). To support 
the formation of the active catalyst at low temperature two 
different activation methods were carried out.  
 
Table 1: Influence of iron salts in the transfer hydrogenation of 2-
methoxyacetophenone 4.  
O
[Fe]/1a
NaOH, 2-PrOH 
4 h, 100 °C4 5
OMe
OH
OMe
 
Entry Iron source Yield [%]a)
1 - <1 
2 FeF2 >99 
3 FeCl2 >99 
4b) FeCl2 37 
5 FeCl3 >99 
6 FeBr2 >99 
7 FeI2 >99 
8 Fe(acac)2 >99 
9 Fe(acac)3 >99 
10 FeSO4 7H2O >99 
11 CpFe(CO)2I >99 
12c) Fe(III)citrate H2O >99 
13 Fe3(CO)12 >99 
Reaction conditions: 0.0038 mmol in situ catalyst (0.0038 mmol Fe-source 
or 0.0013 mmol Fe3(CO)12 and 0.0038 mmol 1a in 1.0 mL 2-propanol for 
16 h at 65 °C), 0.19 mmol NaOH in 0.5 mL 2-propanol, 0.38 mmol 2-
methoxyacetophenone 4 in 0.5 mL 2-propanol, 4 h at 100 °C. a) Yield was 
determined by GC analysis (30 m HP Agilent Technologies 50–300 °C) 
with diglyme as internal standard. b) No ligands are added. c) Fe(III)citrate 
was recrystallized before use.12 
 
On the one hand, substitution of strong coordinating 
chloride ligands by weaker BF4- ligands via addition of 
AgBF4 was done. On the other hand activation of the 
catalyst by light irradiation (Perkin–Elmer PE300BF lamp 
with hot mirror, ~380–770 nm) has been tried. 
Surprisingly, both procedures led to complete deactivation 
of the catalysts with respect to hydrogenation reaction. 
In order to further improve the catalyst system we applied 
different porphyrin ligands (1a–3) under the optimized 
conditions, namely 0.5 mol% Fe catalyst or 0.01 mol%, 
respectively, (FeCl2 and the corresponding porphyrin in a 
ratio of 1:1), sodium hydroxide (25 mol% or 0.5 mol%) at 
100 °C (Table 3). In case of 0.5 mol% catalyst loading for 
all iron-porphyrin catalysts excellent conversion was 
attained. For 0.01 mol% catalyst loading best performance 
was achieved with the meso-substituted porphyrin 1a 
(Table 3, entry 2). Substitution at the meso-phenylic system 
of porphyrin with electron withdrawing groups (1c and 1d) 
lowered the catalyst activity. Furthermore, an excellent 
turnover frequency of 1850 h-1 was observed with a 
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porphyrin substituted at the β−pyrrolenic positions (Table 
3, entry 12). The complex chloroprotoporphyrin IX Fe(III) 
3 was utilized without catalysts pre-formation as described 
for all other representatives, and good turnover numbers 
were determined (Table 3, entries 13–14). Reducing the 
catalyst loading to 0.01 mol% turnover frequencies up to 
2100 h-1 were realized (Table 3, entries 1–3).  
O
FeCl2/1a
NaOH, 2-PrOH, 2 h
4 5
OMe
OH
OMe
 
Table 2: Influence of temperature and base in the Fe-catalyzed transfer 
hydrogenation of 2-methoxyacetophenone 4.  
O
FeCl2/1a
base, 2-PrOH, 4 h
4 5
OMe
OH
OMe
 
Entry Base Base 
[mol%] 
Temp.   
[°C] 
Yield   [%]a)
1 NaOH 50 100 >99 
2 KOH 50 100 >99 
3 LiOH 50 100 49 
4 NaOiPr 50 100 >99 
5 KOtBu 50 100 >99 
6b) NaOtBu 50 100 >99 
7 K2CO3 50 100 >99 
8 Na2CO3 50 100 97 
9 Cs2CO3 50 100 37 
10c) NaOH 50 25 <1 
11 NaOH 50 40 18 
12d) NaOH 50 40 <1 
13 NaOH 50 60 >99 
14 NaOH 50 80 >99 
15e) - - 100 <1 
16e) NaOH 5 100 17 
17e) NaOH 10 100 55 
18e) NaOH 25 100 >99 
19e) NaOH 50 100 >99 
Reaction conditions: 0.0038 mmol in situ catalyst (0.0038 mmol FeCl2 and 
0.0038 mmol 1a in 1.0 mL 2-propanol for 16 h at 65 °C), 0.19 mmol base 
in 0.5 mL 2-propanol, 0.38 mmol 2-methoxyacetophenone 4 in 0.5 mL 2-
propanol, 4 h at described temperature. a) Yield was determined by GC 
analysis (30 m HP Agilent Technologies 50–300 °C) with diglyme as 
internal standard. b) A mixture of solvents was used t-BuOH and 2-
propanol 1:4. c) Light assisted reaction, thereby only the visible range was 
applied since the ultraviolet range was shielded. d) Addition of 2 equiv. 
AgBF4 with respect to FeCl2. e) Reaction time: 2 h.  
 
Notably, the addition of small amounts of water (5 mol% to 
10 mol%) accelerated the transfer hydrogenation compared 
to the water-free conditions and turnover frequencies up to 
2500 h-1 were achieved. Higher amounts of water (up to 
500 mol%) hampered the reaction. 
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Figure 1. The influence of water addition on hydrogenation of 2-
methoxyacetophenone 4. Reaction conditions: 0.038 μmol in situ catalyst 
(0.038 μmol FeCl2 and 0.08 μmol 1a in 1.0 mL 2-propanol for 16 h at 65 
°C), 1.9 μmol NaOH in 0.5 mL 2-propanol, the corresponding amount of 
water, 0.38 mmol substrate in 0.5 mL 2-propanol, temperature: 100 °C , 
reaction time: 2 h. a) Yield was determined by GC analysis (30 m HP 
Agilent Technologies 50–300 °C) with diglyme as internal standard.  
 
Under optimized conditions (vide supra), FeCl2, 1a, NaOH, 
100 °C, we compared the activity of the catalytic system 
for the reduction of acetophenone 6, ortho-
methoxyacetophenone 8 and 2-methoxyacetophenone 4. 
Here, the yield of 1-phenylethanol 7, ortho-methoxy-1-
phenylethanol 9 and 2-methoxy-1-phenylethanol 5 was 
monitored during the reaction.  
The attained curves are shown in Figure 2. The reduction of 
2-methoxyacetophenone proceeded without any induction 
period or deactivation process. Similar behaviour was 
observed for ortho-methoxyacetophenone, albeit a slight 
deceleration occurred after nearly 100 min. Nevertheless, 
full conversion was reached after 7 hours. In case of 
acetophenone the reduction process was significantly 
slower. After 8 hours a deactivation took place. Notably, 
the activities are in agreement with the oxidation potentials 
of the applied ketones (2-methoxyacetophenone, E0 = 213 
mV; ortho-methoxyacetophenone, E0 = 141 mV13; 
acetophenone, E0 = 118 mV). 
In order to demonstrate the usefulness of our concept the 
catalyst containing ligand 1a was tested in the 
hydrogenation of several hydroxy-protected 1,2-
hydroxyketones (Table 4).  
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Table 3: Screening of different porphyrins in the Fe-catalyzed transfer 
hydrogenation of 2-methoxyacetophenone 4.  
O
FeCl2/Porphyrin
NaOH, 2-PrOH, 2 h
4 5
OMe
OH
OMe
 
 
O
[Fe]/1a
Na-2-OPr, 2-PrOH, 100 °C
R2
OH
R2
4 R1 = H; R2 = OMe
6 R1 = H; R2 = H
8 R1 = OMe; R2 = H
5 R1 = H; R2 = OMe
7 R1 = H; R2 = H
9 R1 = OMe; R2 = H
R1 R1Entry Ligand Catalyst 
loading [mol%]
Yield [%]a) TOF [h-1]b)
1 1a 0.5 >99 >99 
2 1a 0.01 42 2100 
3 1b 0.5 >99 >99 
4 1b 0.01 30 1500 
5 1c 0.5 >99 >99 
6 1c 0.01 18 900 
7 1d 0.5 >99 >99 
8 1d 0.01 23 1150 
9 1e 0.5 >99 >99 
10 1e 0.01 24 1200 
11 2 0.5 >99 >99 
12 2 0.01 37 1850 
13 3 0.5 >99 >99 
14 3 0.01 26 1300 
Reaction conditions: 0.0019 mmol or 0.038 mmol in situ catalyst (0.0019 
mmol or 0.038 μmol FeCl2 and 0.0019 mmol or 0.038 μmol porphyrin in 
1.0 mL 2-propanol for 16 h at 65 °C), 0.095 mmol or 0.0019 mmol 
sodium hydroxide in 0.5 mL 2-propanol, 0.38 mmol 2-
methoxyacetophenone 4 in 0.5 mL 2-propanol, 2 h at 100 °C. a) Yield was 
determined by GC analysis (30 m HP Agilent Technologies 50–300 °C) 
with diglyme as internal standard. b) Turnover frequencies were 
determined after 2 h. 
 
In general, the substrates were synthesized by reacting 2-
bromo ketones with different alcohols in the presence of 
base.14 A first set of experiments was dedicated to the 
variation of the protecting group. Good to excellent yield 
was obtained by changing the methoxy-group by phenoxy 
substituents. Best results were achieved with the p-
chlorophenoxy substituent (Table 4, entry 2). Increasing the 
bulkiness at 2- and 6-position the conversion decreased 
significantly (Table 4, entry 4), while substitution only at 2-
position led to excellent conversion of the desired product. 
Substitution on the acetophenone skeleton by a p-methyl or 
p-methoxy group gave good to full conversion. In addition, 
indanone and pinacolin based substrates were synthesized 
and tested in this transfer hydrogenation, thereby moderate 
conversions were obtained (Table 4, entries 7 and 8). 
Unfortunately, variation of the hydroxyl protecting group to 
common acetyl and tert-butyldimethylsilyl groups 
displayed an inactivity of presented catalyst (Table 4, 
entries 11 and 12). The hydrogenation of 2-hydroxy-
acetophenone 20 and 2-hydroxy-2-methyl-1-phenylpropan-
1-one 21 were not successful since decomposition was 
observed. In addition, 2-morpholino-acetophenone 22, 
which is a promising precursor for 1,2-amino alcohols, was 
subjected to the transfer hydrogenation protocol. 
Unfortunately, no conversion was observed even if the 
reaction time was extended to 24 hours (Table 4, entry 15).  
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Figure 2. Comparative study between acetophenone 6, ortho-
methoxyacetophenone 8 and 2-methoxyacetophenone 4. Reaction 
conditions: 0.0038 mmol in situ catalyst (0.0038 mmol FeCl2 and 0.0038 
mmol 1a in 1.0 mL 2-propanol for 16 h at 65 °C), 0.19 mmol base in 0.5 
mL 2-propanol, 0.76 mmol substrate in 0.5 mL 2-propanol, temperature: 
100 °C. a) Yield was determined by GC analysis (7: 50 m Lipodex E, 95–
150 °C, 7: 50 m Lipodex E, 90–180 °C, 9: 30 m HP Agilent Technologies 
50–300 °C) with diglyme as internal standard.  
 
In order to get further informations about the presented 
catalytic system we carried out electrochemical 
investigations of the in situ catalysts containing ligands 1a-
e. Cyclic voltammetry has been established as a useful tool 
for studying the electrochemical properties of porphyrins 
and metalloporphyrins.15 The measurement conditions were 
as close to the reaction conditions as possible. However, 
under strong basic conditions, no reliable measurements 
were possible, due to low catalyst solubility at room 
temperature. Therefore measurements were performed in 
the absence of base. The temperature dependence of the 
potentials according to the Nernst equation have to be 
similar for all Fe-porphyrins and should be in the range of 
20 to 30 mV between room temperature and the reaction 
temperature of 100 °C. The electrochemical analysis is 
presented in Figure 3.  
All cyclic voltammograms illustrate clearly the oxidation of 
Fe(II) to Fe(III) in the potential range above ca. 0.2 V vs. 
SCE. The small (negative) reduction currents result 
probably from Fe(III) contamination of the FeCl2 or from 
oxidation of FeCl2 from other impurities (e.g. O2). From the 
 Tetrahedron  5
colour of the solutions (light brown to red-brown) and the 
height of oxidation current (compared to 5 mmol/L FeCl2) 
the curves result from free FeCl2 (light yellow coloured 
solution) or incomplete Fe(II)-porphyrin formation can be 
excluded.16 
 
Table 4: Reduction of α-substituted ketones in the presence of 
iron catalyst containing porphyrin 1a.  
R1
O
FeCl2/1a
NaOH, 2-PrOH, 100 °C, 2 h
X
R3R2
R4 R1
OH
X
R3R2
R4
 
 
Run Substrate Product conv. 
[%] 
1 
O
OMe
4
 
OH
OMe
5
 
>99 
2 
O
O
10  
OH
O
10a  
92 
3 
O
O
Cl
11  
OH
O
Cl
11a
 
>99a)
4 
O
O
t-Bu
12
 
OH
O
t-Bu
12a
 
97 
6 
O
O
i-Pr
i-Pr
13  
OH
O
i-Pr
i-Pr
13a  
74a)
7 
O
O
14  
OH
O
14a  
43 
8 
O
O
15  
OH
O
15a  
48 
9 
O
O
16
 
OH
O
16a
 
>99a)
10 
O
O
Ph
MeO 17
 
OH
O
Ph
MeO 17
 
83a)
11 
O
OAc
18
 
OH
OAc
18a
 
<1a)
12 
O
O
19
Si
 
OH
O
19a
Si
 
<1a)
13 
O
OH
20
 
OH
OH
20a
 
<1b)
14 
Ph
O
OH
21  
Ph
OH
OH
21a  
<1b)
15 
O
N
O
22  
 
OH
N
O
22a  
3 
(<1)c)
Reaction conditions: 0.0019 mmol in situ catalyst (0.0019 mmol FeCl2 and 
0.0019 mmol porphyrin in 1.0 mL 2-propanol for 16 h at 65 °C), 0.095 
mmol sodium hydroxide in 0.5 mL 2-propanol, 0.34 mmol substrate in 0.5 
mL 2-propanol, 2 h at 100 °C. Yield was determined by GC analysis (30 
m HP Agilent Technologies 50–300 °C) a) 1H NMR b) Decomposition. c) 
Reaction time: 24 h. 
 
Most likely the difference in oxidation currents results from 
different solubilities of the Fe-porphyrins, since the 
diffusion coefficients should be similar. The porphyrins 
without FeCl2 (violet coloured solution) generate only a 
small oxidation current in the region above ca. 0.6 V which 
is shown by the cyclic voltammogram of the porphyrin 1a 
without FeCl2 (Figure 3). This oxidation current was also 
observable in the curves of the Fe(II)-porphyrins in the 
same potential range.  
 
 
Figure 3. Cyclic voltammograms of porphyrins with FeCl2 in 
0.1 mol/L TBA BF4 in 2-PrOH. Start at 0 V in positive direction 
with 10 mV/s at platinum microelectrode. 
The second oxidation steps visible in all curves (0.5 to 0.6 
V) cannot clearly be interpreted under the applied 
conditions. Most likely the second oxidation step is caused 
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by formation of other complexes, since 2-propanol and 
chloride ions are present in the solution, which are possible 
ligands for the axial position. During oxidation of Fe(II)- to 
Fe(III)-porphyrin one anion has to fulfil the unsaturated 
situation at the Fe(III) center analogue to compound 3 in 
Scheme 2. At the same time it has to be considered that 
Fe(II)-porphyrins can also be coordinated with two axial 
ligands (six-coordinate Fe(II)).15,17 The small amount of 
dissolved chlorid results maybe in slower kinetics of the 
Fe(III)-porphyrin formation, seen by the reversible 
potential values (Table 5).  
Table 5: Half-wave potentials and values for reversibility. 
Compound TOF E1/2 vs. SCE / mV slope / mV 
1d 1150 326 146 
1e 1200 339 141 
1b 1500 338 152 
1a 2100 330 204 
FeCl2 - 380 205 
Ferrocene - 525 61 
 
Due to the influence of the axial ligand a change or 
different coordination of the porphyrins at the axial 
positions results in a shift of potential (with an excess of 
chlorid the potentials shift to lower values with higher 
reversibility).15 The half-wave potentials for the first 
oxidation step resulting from the measurements under these 
conditions are presented in Table 5. Under conditions 
identical with those for the porphyrins the 
ferrocenium/ferrocene couple has a half-wave potential of 
525 mV and a slope of 61 mV (E1/2 = 480 mV in 0.1 mol/L 
TBA PF6 / CH2Cl2).18 With the half-wave potentials of the 
Fe-porphyrins no correlation with the TOF can be found. In 
addition following our standard protocol the formation of 
the pre-catalyst was studied by in situ mass spectroscopy. 
After stirring  FeCl2 and ligand 1a for 16 hours at 65 °C the 
corresponding iron complex19 formed by elimination of 2 
equiv. of HCl was detected, which is in agreement with 
previous reports.20 Unfortunately, no other catalyst 
intermediate could be unambiguously identified. Thus, the 
detailed mechanism of the Fe-based hydrogenation 
catalysts is still unclear. 
In conclusion, we have demonstrated the successful 
extension of the Fe-catalyzed transferhydrogenation to α- 
hydroxy-protected hydroxyketones. Under optimized 
conditions turnover frequencies up to 2500 h-1 were 
achieved. The scope and limitation of the catalyst were 
demonstrated on reduction of ten different ketones with 
good to excellent yields. 
 
3. Experimental Section 
 
3.1. General 
 
1H and 13C NMR spectra were recorded on Bruker 
Spectrometer 400 and 300 (1H: 400.13 MHz, and 300.13 
MHz; 13C: 100.6 MHz, and 75.5 MHz). The calibration of 
1H and 13C spectra was carried out either on solvent signals 
(δ CDCl3) = 7.25 and 77.0) or TMS. Mass spectra were 
recorded on an AMD 402 spectrometer. IR spectra were 
recorded as KBr pellets or Nujol mulls on a Nicolet Magna 
550. All manipulations were performed under argon 
atmosphere using standard Schlenk techniques. Unless 
specified, all chemicals are commercially available and 
used as received. 2-Propanol was used without further 
purification (purchased from Fluka, dried over molecular 
sieves). Sodium 2-propylate and sodium t-butylate were 
prepared by reacting sodium with 2-propanol or t-butanol, 
respectively, under an argon atmosphere (stock solution). 
Ketone 8 was dried over CaH2, distilled in vacuum and 
stored under argon. Substrates 18 and 19 were used without 
further purifications. Porphyrins 1a and 1d were 
synthesized according to literature protocols.21 Fe(III)citrate 
was recrystallized from water/ethanol before use since it 
was purchased in technical grade. 
 
3.2. General procedure for the synthesis of substrates:  
 
A solution of 2-bromo ketone (10.1 mmol), phenol (10.1 
mmol), K2CO3 (15 mmol) in acetone (15 mL) was refluxed 
for 3 hours. The solvent was removed in vacuum and the 
residue dissolved in ethyl acetate / diethyl ether and washed 
with water and brine. After drying over Na2SO4 the solvent 
was removed and the crude product was purified by 
crystallization.  
 
2-Phenoxy-acetophenone (10): 10.1 mmol scale, flash 
column chromatography (eluent: ethyl acetate/n-hexane 
4:1), recrystallized from 2-propanol. Yield: 39% (white 
crystals). Mp = 60–61 °C. 1H NMR (300 MHz, CDCl3) δ = 
8.02–7.98 (m, 2H); 7.64–7.58 (m, 1H); 7.53–7.46 (m, 2H); 
7.31–7.22 (m, 2H); 7.01–6.90 (m, 3H); 5.28 (s, 2H, CH2). 
13C NMR (75.5 MHz, CDCl3): δ = 194.5; 157.9; 134.5; 
133.8; 129.5; 128.8; 128.1; 121.6; 114.7; 70.7. IR (KBr): 
3387 w; 3060 w; 2897 w; 2843 w; 2749 w; 1928 w; 1708 s; 
1599 s; 1499 s; 1480 m; 1449 m; 1433 m; 1386 w; 1341 w; 
1303 m; 1292 m; 1250 s; 1228 s; 1189 m; 1175 m; 1094 m; 
1076 m; 1028 w; 1001 m; 975 m; 921 w; 886 w; 872 m; 
751 s; 688 s; 665 m; 614 w; 584 w; 555 w; 511 m; 414 w. 
MS (EI): m/z (%) = 212 ([M+], 26); 105 (100); 77 (43); 51 
(12). HRMS calculated for C14H14O2: 214.09883; Found: 
214.098506. 
 
2-(4-Chlorophenoxy)-acetophenone (11): 7.8 mmol scale, 
refluxing time: 12 h, crystallized from 2-propanol. Yield: 
73% (white plates). Mp = 87–88 °C. 1H NMR (300 MHz, 
CDCl3) δ = 8.01–7.96 (m, 2H); 7.66–7.56 (m, 1H); 7.54–
7.47 (m, 2H); 7.26–7.20 (m, 2H); 6.90–6.83 (m, 2H); 5.26 
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(s, 2H, CH2). 13C NMR (75.5 MHz, CDCl3): δ = 194.0; 
156.6; 134.3; 134.0; 129.4; 128.9; 128.0; 126.5; 116.1; 
70.9. IR (KBr): 3375 w; 3060 w; 2901 w; 2851 w; 2737 w;  
1699 s; 1596 s; 1581 m; 1490 s; 1448 m; 1437 s; 1409 w; 
1385 w; 1338 w; 1317 w; 1289 s; 1231 s; 1172 m; 1106 m; 
1096 m; 1089 m; 1075 m; 1001 m; 983 s; 921 w; 870 w; 
830 s; 813 m; 786 w; 756 s; 701 w; 686 s; 634 w; 587 m; 
508 m; 476 w; 457 w; 441 w; 422 w; 406 w. MS (EI): m/z 
(%) = 246 ([M+], 15); 105 (100); 77 (30). HRMS calculated 
for C14H11ClO2: 246.04421; Found: 246.044678. 
 
2-(2-tert-Butyl-4-methylphenoxy)-acetophenone (12): 6.0 
mmol scale, refluxing time: 12 h, crystallized from 2-
propanol. Yield: 44% (white needles). Mp = 94–95 °C. 1H 
NMR (300 MHz, CDCl3) δ = 8.05–8.00 (m, 2H); 7.66–7.59 
(m, 1H); 7.55–7.48 (m, 2H); 7.13 (d, 1H, J = 2.26 Hz); 6.96 
(ddd, 1H, J = 8.10 Hz, J = 2.26 Hz, J = 0.75 Hz); 6.76 (d, 
1H, J = 8.22 Hz); 5.29 (s, 2H, CH2); 2.30 (s, 3H, CH3); 
1.43 (s, 9H, C(CH3)3). 13C NMR (75.5 MHz, CDCl3): δ = 
194.5; 154.8; 138.4; 134.7; 133.7; 130.3; 128.8; 128.1; 
127.8; 127.1; 112.3; 71.0; 34.7; 29.9; 20.8. IR (KBr): 3399 
w; 3051 w; 2958 s; 2901 m; 2856 m; 2733 w; 1709 s; 1598 
m; 1581 w; 1499 s; 1448 m; 1439 m; 1404 w; 1386 m; 
1357 w; 1287 m; 1266 m; 1244 m; 1226 s; 1181 w; 1156 
w; 1107 m; 1074 w; 1020 w; 1001 m; 980 s; 930 w; 919 w; 
876 w; 861 m; 802 s; 751 s; 687 s; 655 m; 584 m; 491 m. 
MS (EI): m/z (%) = 282 ([M+], 64); 267 (21); 249 (21); 161 
(11); 121 (13); 119 (16); 117 (14); 105 (100); 91 (33); 77 
(29). HRMS calculated for C19H22O2: 28216143; Found: 
282.162186. 
 
2-(2,6-Di-iso-propylphenoxy)-acetophenone (13): 5.6 
mmol scale, refluxing time: 12 h, crystallized from 2-
propanol. Yield: 34% (yellow crystals). Mp = 60–65 °C. 1H 
NMR (300 MHz, CDCl3) δ = 8.01–7.95 (m, 2H); 7.66–7.59 
(m, 1H); 7.55–7.47 (m, 2H); 7.16 (s, 3H); 5.12 (s, 2H, 
CH2); 3.34 (sept, 2H, J = 6.91 Hz, CH); 1.25 (d, 12H, J = 
6.87 Hz, CH3). 13C NMR (75.5 MHz, CDCl3): δ = 193.9; 
153.0; 141.6; 133.7; 128.8; 127.8; 125.2; 124.3; 76.7; 26.5; 
24.1. IR (KBr): 3442 br; 3063 w; 3028 w; 2967 s; 2868 m; 
1706 s; 1597 m; 1580 w; 1451 m; 1429 m; 1381 w; 1371 
w; 1360 m; 1334 m; 1255 m; 1227 m; 1185 s; 1163 m; 
1100 m; 1085 m; 1075 w; 1058 w; 1042 w; 1001 w; 992 w; 
972 m; 934 w; 854 w; 801 m; 763 m; 755 s; 692 m; 648 w; 
617 w; 586 w; 556 w; 521 w; 472 w; 434 w. MS (EI): m/z 
(%) = 296 ([M+], 10); 176 (83); 161 (100); 147 (20); 133 
(16); 105 (59); 91 (44); 77 (28); 43 (11). HRMS calculated 
for C20H24O2: 296.17708; Found: 296.176483. 
 
2-Phenoxy-2,3-dihydro-1H-inden-1-one (14): 9.5 mmol 
scale, refluxing time: 16 h, Yield: 56% (off-white crystals). 
Mp = 75–78 °C. 1H NMR (300 MHz, CDCl3) δ = 7.85 (d, 
1H, J = 7.72 Hz); 7.67 (dt, 1H, J = 7.44 Hz, J = 1.13 Hz); 
7.50–7.41 (m, 2H); 7.37–6.99 (m, 2H); 7.10–6.99 (m, 3H); 
5.09 (dd, 1H, J = 7.54 Hz, J = 4.52 Hz, CH); 3.73 (dd, 1H, 
J = 7.54 Hz, J = 16.95 Hz, CH2); 3.19 (dd, 1H, J = 16.95 
Hz, J = 4.33 Hz, CH2). 13C NMR (75.5 MHz, CDCl3): δ = 
201.7; 157.9; 150.6; 135.9; 134.6; 129.5; 128.2; 126.7; 
124.6; 121.7; 115.7; 77.8; 34.1. IR (KBr): 3413 br; 3063 w; 
3039 w; 3028 w; 2916 w; 2906 w; 1716 s; 1608 m; 1597 
m; 1587 m; 1493 m; 1474 m; 1464 m; 1431 w; 1325 w; 
1299 m; 1276 m; 1250 m; 1233 s; 1208 w; 1174 w; 1156 
w; 1080 m; 1070 m; 1038 w; 1020 w; 1005 m; 956 w; 913 
m; 889 w; 753 s; 725 m; 691 m; 618 w; 607 w; 502 w; 455 
w. MS (EI): m/z (%) = 224 ([M+], 53); 131 (100); 103 (32); 
94 (11); 77 (25). HRMS calculated for C15H12O2: 
224.08318; Found: 224.083160. 
 
3,3-Dimethyl-1-phenoxybutan-2-one (15): 11.2 mmol 
scale, refluxing time: 16 h. Yield: 92% (off-white crystals). 
Mp = 33–36 °C. 1H NMR (300 MHz, CDCl3) δ = 7.32–
7.24 (m, 2H); 7.00–6.93 (m, 1H); 6.91–6.84 (m, 2H); 4.87 
(s, 2H, CH2); 1.25 (s, 9H, C(CH3)3). 13C NMR (75.5 MHz, 
CDCl3): δ = 209.4; 158.0; 129.5; 121.4; 114.6; 68.8; 43.1; 
26.3. IR (KBr): 3420 br; 3105 w; 3065 w; 3043 w; 2973 m; 
2931 m; 2872 w; 2846 w; 2747 w; 1721 s; 1678 w; 1599 
m; 1587 m; 1494 s; 1461 m; 1446 m; 1431 m; 1386 w; 
1365 m; 1329 w; 1291 m; 1234 s; 1179 m; 1152 w; 1113 
m; 1078 w; 1052 s; 1026 w; 1000 m; 990 s; 962 m; 935 w; 
880 m; 825 m; 766 s; 759 s; 693 m; 587 w; 545 w; 522 m. 
MS (EI): m/z (%) = 192 ([M+], 33); 108 (13); 77 (26); 57 
(100); 41 (16). HRMS calculated for C12H16O2: 192.11448; 
Found: 192.114302. 
 
2-Phenoxy-4´-methylacetophenone (16): 9.4 mmol scale, 
refluxing time: 16 h, crystallized from 2-propanol. Yield: 
51% (colourless crystals). Mp = 62–63 °C. 1H NMR (300 
MHz, CDCl3) δ = 7.94–7.88 (m, 2H); 7.33–7.24 (m, 4H); 
7.02–6.91 (m, 3H); 5.25 (s, 2H, CH2); 2.43 (s, 3H, CH3). 
13C NMR (75.5 MHz, CDCl3): δ = 194.1; 158.0; 144.8; 
132.1; 129.54; 129.48; 128.2; 121.6; 114.6; 70.7; 21.8. IR 
(KBr): 3441 br, 3063 w; 3036 w; 2919 w; 2902 w; 2847 w; 
1695 s; 1606 s; 1587 m; 1576 m; 1498 s; 1455 w; 1433 m; 
1411 m; 1385 w; 1292 m; 1254 m; 1236 s; 1208 m; 1192 
m; 1174 m; 1149 w; 1124 w; 1113 w; 1092 m; 1075 w; 
1044 w; 1027 w; 1001 m; 979 m; 885 m; 871 m; 816m; 
749 s; 711 w; 690 m; 609 w; 584 m; 551 w; 517 w; 498 w; 
461 w. MS (EI): m/z (%) = 226 ([M+], 15); 119 (100); 91 
(24); 77 (10). HRMS calculated for C15H14O2: 226.09883; 
Found: 226.099202. 
 
2-Phenoxy-4´-methoxyacetophenone (17): 8.7 mmol 
scale, refluxing time: 16 h, crystallized from 2-propanol. 
Yield: 74% (off-white needles). Mp = 54–55 °C. 1H NMR 
(300 MHz, CDCl3) δ = 7.96–7.89 (m, 2H); 7.24–7.16 (m, 
2H); 6.93–6.84 (m, 5H); 5.13 (s, 2H, CH2); 3.80 (s, 3H, 
CH3). 13C NMR (75.5 MHz, CDCl3): δ = 193.1; 164.0; 
158.0; 130.5; 129.0; 127.6; 121.5; 114.7; 114.0; 70.7; 55.5. 
IR (KBr): 3442 br; 3056 w; 3006 w; 2955 w; 2934 w; 2840 
w; 1960 m; 1687 s; 1653 w; 1601 s; 1511 m; 1497 s; 1459 
m; 1419 w; 1368 m; 1314 m; 1265 s; 1245 m; 1226 s; 1171 
s; 1154 w; 1116 m; 1075 m; 1032 m; 976 s; 884 m; 835 m; 
789 m; 769 m; 751 s; 691 m; 631 w; 608 m; 582 m; 543 w; 
511 w; 492 w. MS (EI): m/z (%) = 242 ([M+], 10); 135 
(100); 77 (18). HRMS calculated for C15H14O3: 242.09375; 
Found: 242.093706. 
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2-Oxo-2-phenylethyl acetate (18): 2–Hydroxy–1–
phenylethanone (8.0 mmol) was dissolved in 
dichloromethane (10 mL) and acetic anhydride (8.0 mmol), 
pyridine (8.5 mmol) and 4–dimethylaminopyridine (0.08 
mmol) were added. The solution was stirred for 2 hours 
under refluxing conditions. The mixture was washed with 
water and brine. After drying over Na2SO4 the solvent was 
removed and yellow crystals were obtained. Yield: 83%. 
Mp = 48–50 °C. 1H NMR (300 MHz, CDCl3) δ = 7.93–
7.88 (m, 2H); 7.63–7.56 (m, 1H); 7.51–7.44 (m, 2H); 5.34 
(s, 2H, CH2); 2.22 (s, 3H, CH3). 13C NMR (75.5 MHz, 
CDCl3): δ = 192.0; 170.3; 134.1; 133.8; 128.7; 127.6; 65.9; 
20.4. IR (KBr): 3460 w; 3375 w; 3064 m; 2982 w; 2937 m; 
1741 s; 1699 s; 1599 m; 1581 w; 1493 w; 1452 m; 1423 m; 
1374 m; 1321 w; 1280 m; 1244 s; 1228 s; 1185 m; 1087 m; 
1077 m; 1047 m; 1020 m; 996 m; 970 m; 849 m; 812 m; 
757 m; 688 m; 634 m; 597 m; 566 m; 483 m; 443 w; 414 
w. MS (EI): m/z (%) = 178 ([M+], 1); 105 (100); 77 (34); 
51 (10); 43 (14). HRMS calculated for C15H14O3: 
178.06245; Found: 178.063004. 
 
2-(tert-Butyldimethylsilyloxy)-1-phenylethanone (19): 2–
Hydroxy–1–phenylethanone (8.0 mmol) was dissolved in 
dichloromethane (10 mL) and imidazole (8.5 mmol) was 
added. After stirring for 10 minutes at room temperature 
tert–butyldimethylchlorosilane (8.5 mmol) was added 
dropwise, while rapidly a white precipitate was formed. 
The mixture was stirred for 5 hours at room temperature. 
Water was added and the organic layer was washed with 
water and brine. After removal of the solvent a yellow oil 
was obtained. Yield: 89%. 1H NMR (300 MHz, CDCl3) δ = 
7.95–7.89 (m, 2H); 7.61–7.42 (m, 3H); 4.93 (s, 2H, CH2); 
0.94 (s, 9H, C(CH3)3); 0.13 (s, 6H, Si(CH3)2). 13C NMR 
(75.5 MHz, CDCl3): δ = 197.4; 134.9; 132.2; 128.6; 127.9; 
67.4; 25.8; 18.5; -5.4. IR (KBr): 2953 w; 2929 m; 2885 w; 
2856 m;1705 s; 1599 m; 1581 w; 1472 m; 1449 m; 1390 w; 
1362 w; 1288 m; 1254 m; 1229 m; 1151 s; 1025 w; 1002 
m; 974 s; 939 w; 834 s; 777 s; 753 s; 712 m; 688 s; 670 s. 
MS (EI): m/z (%) = 251 ([M++H], 16); 193 (66); 181 (10); 
149 (12); 135 (13); 105 (100); 75 (73). 
 
2-Morpholino-acetophenone (22): Morpholine (62 mmol) 
was added dropwise to a solution of 2–bromoacetophenone 
(7.5 mmol) in THF (15 mL). A white precipitate was 
formed while the mixture was refluxed for one day. An 
aqueous solution of NaHCO3 was added. After extraction 
with diethyl ether the organic layer was washed with 
aqueous solution of NaOH and dried over Na2SO4. The 
crude product was purified by flash column 
chromatography (eluent: ethyl acetate/n–hexane 1:1) to 
yield a brownish oil. Yield: 89%. 1H NMR (300 MHz, 
CDCl3) δ = 8.02–7.97 (m, 2H); 7.60–7.55 (m, 1H); 7.50–
7.43 (m, 2H); 3.83 (s, 2H, C(O)CH2); 3.79 (m, 4H, CH2); 
2.62 (m, 4H, CH2). 13C NMR (75.5 MHz, CDCl3): δ = 
172.0; 160.9; 131.9; 129.6; 128.1; 67.1; 66.4; 64.4; 41.7; 
40.6. IR (KBr): 3415 w; 3060 m; 2970 m; 2852 m; 2762 w; 
1924 w; 1674 s; 1598 s; 1558 m; 1493 w; 1449 s; 1384 s; 
1314 m; 1300 m; 1271 s; 1230 m; 1176 m; 1113 s; 1069 m; 
1047 w; 1022 m; 1006 m; 981 w; 931 w; 876 w; 840 w; 
812 w; 788 w; 757 w; 722 m; 693 w; 674 w; 593 w; 547 w; 
449 w. MS (EI): m/z (%) = 205 ([M+], 2); 100 (100); 77 
(18); 56 (21). HRMS calculated for C12H15O2N: 205.10973; 
Found: 205.109149. Rf (ethyl acetate/n-hexane 1:1) = 0.14.  
 
General procedure for the catalytic transfer 
hydrogenation: In a 10 mL Schlenk tube, the in situ 
catalyst (0.0038 mmol) is prepared stirring a solution of 
FeCl2 (0.0038 mmol) and porphyrin (0.0038 mmol) in 1.0 
mL 2-propanol for 16 h at 65 °C. The pre-catalyst system is 
reacted with sodium hydroxide (0.38 mmol in 0.5 mL 2-
propanol) and 2-methoxyacetophenone (0.38 mmol in 0.5 
mL 2-propanol) for 2 h at 100 °C. The solution is cooled to 
r.t. and filtered over a plug of silica. The conversion was 
measured by GC without further manipulations and the 
products were isolated by column chromatography or 
crystallization.  
 
2-Phenoxy-1-phenylethanol (10a): Mp = 48–50 °C (white 
crystals). 1H NMR (300 MHz, CDCl3) δ = 7.40–7.15 (m, 
7H, Ph); 6.92–6.80 (m, 3H, Ph); 5.03 (dd, 1H, J = 8.67 Hz, 
J = 3.20 Hz, CH); 4.03–3.88 (m, 2H, CH2); 2.55 (br, 1H, 
OH). 13C NMR (75.5 MHz, CDCl3): δ = 158.3; 139.6; 
129.5; 128.5; 128.2; 126.3; 121.3; 114.6; 73.2; 72.5. IR 
(KBr): 3302 br; 3060 w; 3028 w; 2932 w; 2877 w; 1598 s; 
1585 M; 1498 s; 1453 M; 1389 w; 1346 w; 1303 m; 1292 
m; 1249 s; 1196 m; 1172 m; 1152 w; 1098 m; 1078 m; 
1067 m; 1046 m; 1028 m; 995 w; 917 m; 884 w; 863 m; 
792 w; 754 s; 701 s; 692 s; 637 m; 615 m; 594 m; 541 m; 
512 m. MS (EI): m/z (%) = 214 ([M+], 12); 108 (100); 94 
(46); 79 (60); 51 (18). HRMS calculated for C14H14O2: 
214.09883; Found: 214.098407. 
 
2-(4-Chlorophenoxy)-1-phenylethanol (11a): Mp = 46–
48 °C (white crystals). 1H NMR (300 MHz, CDCl3) δ = 
7.48–7.19 (m, 7H); 6.87–6.80 (m, 2H); 5.11 (dd, 1H, J = 
8.48 Hz, J = 3.38 Hz, CH); 4.08–3.95 (m, 2H, CH2); 2.70 
(br, 1H, OH). 13C NMR (75.5 MHz, CDCl3): δ = 157.0; 
139.4; 129.4; 128.6; 128.3; 126.2; 126.1; 115.8; 72.6; 72.5. 
IR (KBr): 3313 br; 3059 w; 3032 w; 2933 w; 2875 w; 1596 
m; 1581 m; 1491 s; 1453 m; 1388 w; 1345 w; 1290 m; 
1242 s; 1196 w; 1169 m; 1093 m; 1066 m; 1039 m; 1006 
m; 914 m; 864 w; 825 m; 801 m; 749 m; 700 m; 671 m; 
633 w; 616 m; 559 w; 507 m. MS (EI): m/z (%) = 248 
([M+], 21); 142 (34); 128 (70); 107 (100); 91 (12); 79 (31). 
HRMS calculated for C14H13ClO2: 248.05986; Found: 
248.059204. 
 
2-(2-tert-Butyl-4-methylphenoxy)-1-phenylethanol 
(12a): Mp = 61–64 °C (colourless crystals). 1H NMR (300 
MHz, CDCl3) δ = 7.53–7.32 (m, 5H, Ph); 7.13 (d, 1H, J = 
2.13 Hz, Ph); 6.98 (ddd, 1H, J = 8.29 Hz, J = 2.26 Hz, J = 
0.75 Hz, Ph); 6.78 (d, 1H, J = 8.09 Hz, Ph); 5.21 (dd, 1H, J 
= 7.35 Hz, J = 4.71 Hz, CH); 4.18–4.08 (m, 2H, CH2); 2.67 
(br, 1H, OH); 2.31 (s, 3H, CH3); 1.41 (s, 9H, C(CH3)3). 13C 
NMR (75.5 MHz, CDCl3): δ = 155.0; 139.9; 137.7; 129.9; 
128.5; 128.1; 127.7; 127.1; 126.3; 112.2; 73.5; 72.9; 34.7; 
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30.0; 20.8. IR (KBr): 3570 m; 3030 w; 2994 w; 2856 m; 
2917 m; 2867 m; 1605 w; 1581 w; 1497 s; 1451 s; 1406 m; 
1389 m; 1359 m; 1327 w; 1294 m; 1264 m; 1228 s; 1198 
m; 1151 m; 1095 m; 1060 m; 1033 s; 1001 w; 934 w; 911 
m; 881 w; 854 m; 809 m; 764 m; 702 s; 624 w; 602 w; 592 
w; 553 w; 516 w; 493 w. MS (EI): m/z (%) = 284 ([M+], 
27); 164 (31); 149 (100); 121 (18); 107 (17); 91 (21); 77 
(16). HRMS calculated for C19H24O2: 284.17708; Found: 
284.176978. 
 
2-(2,6-Di-iso-propylphenoxy)-1-phenylethanol (13a): Mp 
= 67–69 °C (colourless crystals). 1H NMR (300 MHz, 
CDCl3) δ = 7.46–7.26 (m, 5H); 7.09 (s, 3H); 5.16 (dd, 1H, 
J = 7.53 Hz, J = 4.40 Hz, CH); 3.92–3.82 (m, 2H, CH2); 
3.29 (sept, 2H, J = 6.91 Hz, CH(CH3)2); 3.10 (br, 1H); 1.22 
(dd, 12H, J = 6.90 Hz, J = 1.29 Hz). 13C NMR (75.5 MHz, 
CDCl3): δ = 152.4; 141.6; 139.8; 128.4; 128.0; 126.1; 
125.8; 124.9; 79.3; 73.3; 26.4; 24.04; 24.00. IR (KBr): 
3064 m; 3030 m; 2963 s; 2927 s; 2868 m; 1604 w; 1589 w; 
1454 s; 1384 m; 1362 m; 1327 m; 1255 m; 1182 s; 1100 m; 
1047 s; 1020 s; 936 w; 913 m; 861 w; 834 w; 802 m; 755 
m; 700 s; 682 w; 623 w; 590 w; 527 w. MS (EI): m/z (%) = 
298 ([M+], 8); 178 (51); 163 (100); 107 (15); 91 (16); 77 
(11). HRMS calculated for C20H26O2: 298.19273; Found: 
298.192353. 
 
2-Phenoxy-2,3-dihydro-1H-inden-1-ol (14a): colourless 
crystals. During the reaction a mixture of diastereomers 
were formed in a ratio of 1:3 (D1:D2). 1H NMR (400 MHz, 
CDCl3) δ = 7.56–6.93 (m); 5.34 (d, 1H, J = 4.12 Hz, D1); 
5.28 (d, J = 5.22 Hz, D2); 5.08–5.02 (m, 1H, D2); 4.98–
4.89 (m, 1H, D1); 3.53 (dd, 1H, J = 16.37 Hz, J = 6.92 Hz, 
D1); 3.20 (d, 2H, J = 4.40 Hz, D2); 2.98 (dd, 1H, J = 16.37 
Hz, J = 5.32 Hz, D1); 2.81 (br, OH). 13C NMR (100.6 
MHz, CDCl3): δ = 157.7; 142.4; 139.5; 139.2; 129.6; 
129.5; 128.9; 128.6; 127.3; 125.1; 125.0; 124.8; 124.5; 
121.7; 121.6; 121.0; 115.8; 115.5; 85.4; 80.3; 75.6; 36.4; 
35.9. IR (Nujol): 3182 w; 2723 w; 1598 m; 1585 m; 1496 
m; 1459 s; 1377 s; 1291 m; 1250 s; 1207 w; 1170 w; 1155 
w; 1118 m; 1073 w; 1050 w; 1020 w; 1001 w; 879 w; 849 
w; 779 w; 746 s; 723 m; 693 m; 639 w; 511 w; 413 w. MS 
(EI): m/z (%) = 226 ([M+], 19); 133 (100); 115 (21); 103 
(21); 94 (61); 77 (29); 65 (11). HRMS calculated for 
C15H14O2: 226.09883; Found: 226.099031. 
 
3,3-Dimethyl-1-phenoxybutan-2-ol (15a): Mp = 31–33 °C 
(colourless crystals). 1H NMR (300 MHz, CDCl3) δ = 
7.33–7.24 (m, 2H); 7.00–6.88 (m, 3H); 4.14 (dd, 1H, J = 
9.23 Hz, J = 2.45 Hz, CH); 3.86 (m, 2H, CH2); 2.35 (br, 
1H, OH); 1.01 (s, 9H, C(CH3)3). 13C NMR (75.5 MHz, 
CDCl3): δ = 158.6; 129.5; 121.1; 114.6; 77.2; 69.3; 33.5; 
26.0. IR (KBr): 3272 br; 3035 w; 2954 s; 2876 m; 1601 m; 
1586 m; 1499 s; 1459 m; 1393 w; 1366 m; 1338 m; 1296 
m; 1245 s; 1190 w; 1174 m; 1152 w; 1095 m; 1079 m; 
1044 m; 1020 m; 1020 m; 1005 m; 992 w; 942 w; 926 m; 
902 m; 895 m; 821 w; 754 s; 692 m; 598 w; 572 w; 513 m; 
402 w. MS (EI): m/z (%) = 194 ([M+], 26); 119 (10); 108 
(63); 94 (100); 87 (19); 77 (22); 69 (14); 57 (24); 41 (17). 
HRMS calculated for C12H18O2: 194.13013; Found: 194. 
129870. 
 
2-Phenoxy-1-(4´-methylphenyl)ethanol (16a): Mp = 50–
51 °C (colourless crystals). 1H NMR (300 MHz, CDCl3) δ 
= 7.34–7.14 (m, 6H); 6.98–6.85 (m, 3H); 5.05 (dd, 1H, J = 
8.64 Hz, J = 3.36 Hz, CH); 4.04 –3.97 (m, 2H, CH2); 2.87 
(br, 1H, OH); 2.34 (s, 3H, CH3). 13C NMR (75.5 MHz, 
CDCl3): δ = 158.3; 137.8; 136.7; 129.5; 129.2; 126.2; 
121.1; 114.5; 73.2; 72.3; 21.1. IR (KBr): 3297 br; 3027 w; 
2912 w; 2880 w; 1932 w; 1599 m; 1586 m; 1514 m; 1498 
s; 1460 m; 1388 m; 1340 m; 1293 m; 1250 s; 1195 m; 1180 
m; 1172 m; 1151 w; 1090 s; 1045 m; 1021 m; 995 w; 975 
w; 943 w; 916 m; 886 w; 868 m; 838 w; 815 m; 756 s; 716 
w; 693 m; 616 w; 597 m; 575 w; 537 m; 513 m; 487 w; 464 
w; 403 w. MS (EI): m/z (%) = 228 ([M+], 6); 121 (100); 
108 (68); 105 (15); 65 (11). HRMS calculated for 
C15H16O2: 228.11448; Found: 228.114429. 
 
2-Phenoxy-1-(4´-methoxyphenyl)ethanol (17a): yellow 
oil. 1H NMR (300 MHz, CDCl3) δ = 7.32–7.15 (m, 4H); 
6.92–6.77 (m, 5H); 4.98 (dd, 1H, J = 8.67 Hz, J = 3.39 Hz, 
CH); 4.00–3.87 (m, 2H, CH2); 3.73 (s, 3H, CH3); 2.77 (br, 
1H). 13C NMR (75.5 MHz, CDCl3): δ = 159.4; 158.3; 
131.7; 129.5; 127.5; 121.2; 114.6; 113.9; 73.2; 72.1; 55.3. 
IR (KBr): 3440 br; 3072 w; 3044 w; 2999 w; 2929 m; 2831 
w; 1728 w; 1612 m; 1600 m; 1587 m; 1514 s; 1497 s; 1456 
m; 1303 m; 1245 s; 1174 m; 1154 w; 1114 w; 1080 m; 
1036 m; 912 w; 867 w; 832 m; 755 m; 692 m; 639 w; 596 
w; 552 w; 511 w. MS (EI): m/z (%) = 244 ([M+], 2); 137 
(100); 121 (10); 108 (23); 94 (12); 77 (21). HRMS 
calculated for C15H16O3: 244.10940; Found: 244.109218. 
 
3.3. Electrochemical measurements 
 
The electrochemical workstation is composed of an 
Autolab PGSTAT 10 potentiostat from ECO Chemie and a 
P-450 PC with GPES 4.9 software. A three-electrode 
arrangement with a platinum microelectrode (25 µm 
diameter) as the working electrode, a saturated calomel 
electrode (SCE) as reference electrode and a platinum 
counter electrode (16 mm2 area) was used. All potentials in 
the following are cited against SCE. All measurements 
were carried out in 2-PrOH at room temperature. As 
supporting electrolyte we used 0.1 mol/L tetra-n-
butylammonium tetrafluoraborate. Due to the low solubility 
at r.t. all solutions of porphyrins with FeCl2 were saturated 
solutions. For some porphyrins (e.g. compound 3) 
solubility was too low to see any currents. Reversibility 
was determined by plotting E vs. log[(Ia-I)/I-Ic] for the 
nearly linear range of the forward scan and determining the 
slope for the quasi-reversible electrode reactions. Anodic 
diffusion current (Ia) and cathodic diffusion current (Ic) are 
determined from the results of a sigmoidal fit with 
Microcal Origin 7.5. 
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Novel ruthenium carbene complexes have been in situ generated and tested for the transfer hydrogenation of ketones. Applying
Ru(cod)(methylallyl)2 in the presence of imidazolium salts in 2-propanol and sodium-2-propanolate as base, turnover frequencies up
to 346 h1 have been obtained for reduction of acetophenone. A comparative study involving ruthenium carbene and ruthenium phos-
phine complexes demonstrated the higher activity of ruthenium carbene complexes.
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The preparation of alcohols has become an important
field of activity for transition metal catalyzed reactions
[1]. Within the different catalytic approaches developed,
for instance addition of organometallic reagents to car-
bonyl compounds, hydroxylation of olefins, functionaliza-
tion reactions of epoxides, the hydrogenation of ketones
or aldehydes is the most powerful tool with respect to
industrial applications. In particular, transfer hydrogena-
tions represent a potent strategy, because of high atom effi-
ciency, no need of pressure, and economic as well as
environmental advantages [2]. In more detail, a broad
scope of alcohols is accessible by transfer hydrogenation
using non-toxic hydrogen donors under mild reaction con-
ditions in the presence of various metal catalysts, such as
Ir, Rh or Ru [2d]. Noteworthy, a prerequisite for achieving
high activity and selectivity is the fine tuning of the metal
catalyst by introduction of ligands. So far the development
of new ligands for catalytic reductions focused predomi-
nantly on phosphines and amines.0022-328X/$ - see front matter  2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.jorganchem.2006.07.013
* Corresponding author. Tel.: +49 381 1281 0; fax: +49 381 1281 5000.
E-mail address: matthias.beller@ifok-rostock.de (M. Beller).More recently carbene ligands found increasing interest
for exploiting new catalytic reactions [3]. Stable N-hetero-
cyclic carbenes (NHC) were first introduced in the early
1990’s by Arduengo et al. [4]. Since the mid 1990’s Herr-
mann et al. [5] and then the groups of Bertrand [6], Blechert
[7], Cavell [8], Fu¨rstner [9]. Glorius [10], Grubbs [11],
Nolan [12] and others [13] demonstrated the catalytic
potential of NHC metal complexes. In this context we
reported that palladium carbene complexes are excellent
catalysts for different coupling reactions of aryl halides
and telomerizations [14].
With regard to transfer hydrogenations different carbene
or carbene-phosphine-systems containing Rh [15], Ir
[15,16], Ru [17] and Ni [18] have been reported. Excellent
turnover frequencies up to 120,000 h1 were reported by
the groups of Baratta and Herrmann applying a ruthe-
nium-carbene-phosphine-catalysts [19]. However, for
reduction of a typical substrate, e.g. acetophenone, with
phosphine-free ruthenium-carbene catalysts lower turnover
frequencies (TOF 333 h1) [17e] were achieved in compar-
ison to iridium (500 h1) [16c] and rhodium systems
(583 h1) [15b]. Due to the economical benefit of ruthe-
nium metal compared to rhodium or iridium and the
advantages of phosphine-free systems, it is an important
Table 1
Screening of various ruthenium sources and yield-temperature dependency
for the transfer hydrogenation of acetophenone (13)a
O
[Ru]/(1), Na-2-OPr
OH
2-PrOH, 1h
13 13a
Entry Source Temperature (C) Yield (%)b
1 [RuCl2(C6H6)]2 90 9
2 [RuCl2(C6H6)]2 100 80
3 Ru3(CO)12 90 40
4 Ru3(CO)12 100 16
5 Ru(cod)(methylallyl)2 70 2
6 Ru(cod)(methylallyl)2 80 43
7 Ru(cod)(methylallyl)2 90 55
8 Ru(cod)(methylallyl)2 100 >99
a Reaction conditions: in situ catalyst: 1.3 · 106 mol Ru3(CO)12,
1.9 · 106 mol [RuCl2(C6H6)]2 or 3.8 · 106 mol Ru(cod)(methylallyl)2,
3.8 · 106 mol imidazolium salt 1 and 1.9 · 105 mol Na–2-OPr in 2.0 mL
2-propanol for 16 h at 65 C, addition of 3.8 · 104 mol acetophenone
(13), reaction 1 h at described temperature.
b Conversion is determined by GC analysis (50 m Lipodex E, 95–200 C)
with diglyme as internal standard.
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Herein, we report the application of novel in situ prepared
ruthenium carbene catalysts in the reduction of different
ketones.
2. Results and discussion
Based on our experience in the synthesis of carbene
ligands and their application in homogeneous catalysis,
we became interested in demonstrating the usefulness of
carbene-complexes in ruthenium-catalyzed transfer hydro-
genations [20]. From a practical point of view the applica-
tion of in situ prepared catalysts has significant advantages.
Thus, we used a small library of various imidazolium salts
(Scheme 1, 1–12) as carbene precursors. In exploratory
experiments, 2-propanol-based transfer hydrogenation of
acetophenone was examined. In order to ensure complete
formation of the active catalyst a 2-propanol solution of
1 mol% ruthenium-source and 1 mol% 1,3-bis(2,6-di-i-pro-
pylphenyl)-imidazolium chloride (1) is stirred in the pres-
ence of 5 mol% sodium 2-propylate for 16 h at 65 C.
Initial investigations showed a crucial effect on reactivity
by using different ruthenium sources such as [RuCl2-
(C6H6)]2, Ru3(CO)12, and Ru(cod)(methylallyl)2 in combi-
nation with imidazolium salt 1 (Table 1). Best conversion
and yield are obtained for Ru(cod)(methylallyl)2/1 at
100 C (Table 1, entry 8). Noteworthy, there is a significant
temperature effect on the reaction rate (Table 1, entries 5–8).N
N+
N
N+
N
N+
Cl-
N
N+
BF4-
Br-
N
N+
Cl-
N
N+
(CH2)2
Cl- Cl-
1 2
5 6
9 10
Scheme 1. Selection ofIt is well-known that transfer hydrogenations are sensi-
tive to the nature of the base. Thus, the influence of sodium
2-propylate, potassium tert-butylate, potassium carbonate
and sodium hydroxide on selectivity and conversion was
investigated. In all cases excellent selectivity (>99%) isN
N+
BF4-
N
N+
Cl-
N
N+
Cl
Cl
Cl-
N
N+
N
N+
N
N+
Br- Br-
3 4
7 8
11 12
Tos-
imidazolium salts.
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in the presence of sodium 2-propylate (>99%) and potas-
sium tert-butylate (95%). However, poor yields of 1-pheny-
lethanol are achieved with potassium carbonate (53%).
Interestingly, sodium hydroxide, one of the most common
bases for transfer hydrogenation, induced only low conver-
sion (62%). By increasing the amount of base a further
acceleration of reaction rate is recorded, while no reaction
occurred in the absence of base.
Next, the influence of the ligand concentration was
investigated by variation of the metal to ligand-ratio. When
increasing the equivalents of ligand per metal a negative
effect on the reaction rate is observed (Table 2). We assume
a catalyst deactivation by more than one carbene ligand,
due to suppressing the metal hydride formation or blocking
the active binding site for the substrate. However, 1 equiv.Table 2
Influence of metal-ligand-ratio on the reduction of acetophenone (13)
O
Ru(cod)methylally
2-PrOH, 1
13
Entry Carbene:metal Substrate:metal Base:
1a 0 100 5
2a 1 100 5
3a 2 100 5
4a 10 100 5
5b 1 5000 100
6b 2 5000 100
7b 10 5000 100
a Reaction conditions: in situ catalyst: 3.8 · 106 mol Ru(cod)(methylallyl)2, 3
2-propanol for 16 h at 65 C, addition of 3.8 · 104 mol acetophenone (13), re
b Reaction conditions: in situ catalyst: 9.7 · 107 mol Ru(cod)(methylallyl)2, 9
2-propanol for 16 h at 65 C, addition of 4.85 · 103 mol acetophenone (13),
c Conversion is determined by GC analysis (50 m Lipodex E, 95–200 C) wi
d Turnover frequency = mol product/(mol catalyst · time), determined after
O Ru(cod)(methylallyl)2
Na-2-OPr
2-PrOH, 100 
13
0
20
40
60
80
100
0 2 4
tim
yi
el
d 
(%
)
Carben (1)
PPh3
PCy3
Fig. 1. Comparative study using imidazolium salt 1 and PPh3 as ligands. Note:
9.7 · 107 mol imidazolium salt 1 or PPh3 and 9.7 · 105 mol Na-2-OPr in 5.0 m
(13), reaction at 100 C. Conversion is determined by GC analysis (50 m Lipoof ligand is necessary for achieving good conversion.
Hence, transfer hydrogenations in absence of the carbene
gave only moderate yield (Table 2, entry 1).
The stability of metal carbene complexes against mois-
ture and oxygen has been documented [13]. Thus, the addi-
tion of water (10 mol%) to the reaction mixture decreased
only slightly the conversion to 73% (TOF: 73 h1). Even
in the presence of 100 mol% of water the catalyst showed
significant activity (TOF: 54 h1).
To classify the potential of our catalytic system we com-
pared Ru(cod)(methylallyl)2/1 with Ru(cod)(methylallyl)2/
PPh3 and Ru(cod)(methylallyl)2/PCy3 (Fig. 1). More
specifically, we studied the behaviour of Ru(cod)(methylal-
lyl)2/1 and Ru(cod)(methylallyl)2/PPh3 by monitoring the
conversion at different reaction times. The results showed
similar catalytic behaviour at the beginning of the reaction.l2/(1), Na-2-OPr
OH
00 ˚C
13a
metal Time (h) Yield (%)c TOF (h1)d
1 41 41
1 >99 99
1 61 61
1 57 57
12 83 346
12 81 338
12 67 279
.8 · 106 mol imidazolium salt 1 and 1.9 · 105 mol Na–2-OPr in 2.0 mL
action temperature 100 C.
.7 · 107 mol imidazolium salt 1 and 9.7 · 105 mol Na–2-OPr in 5.0 mL
reaction temperature 100 C.
th diglyme as internal standard.
12 h.
/(1) or PPh3,
OH
˚C
13a
6 8 10 12
e (h)
Reaction conditions: in situ catalyst: 9.7 · 107 mol Ru(cod)(methylallyl)2,
L 2-propanol for 16 h at 65 C, addition of 4.85 · 103 mol acetophenone
dex E, 95–200 C) with diglyme as internal standard.
Table 4
Scope and limitations of Ru(cod)(methylallyl)2/1-system-catalyzed ketone
reductiona
R1 R2
O
Ru(cod)(methylallyl)2/(1), Na-2-OPr
R1 R2
OH
2-PrOH, 100 ˚C, 12h
14-22 14a-22a
Entry Compound Ketone Conversion (%)b TOF (h1)c
1 14 O
Cl
68 [96] 285
2 15
O
MeO
41 171
3 16
O
H3C
62 [92] 258
O
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the PPh3-system is detected, which resulted in a lower yield
of 1-phenylethanol after 12 h (68% vs 83%). The
Ru(cod)(methylallyl)2/PCy3 yielded comparable amounts
of 1-phenylethanol to Ru(cod)(methylallyl)2/1.
As shown in Table 3 we examined 12 examples out of
the growing number of carbene precursors (1–12) under
the previously optimized conditions for the transfer hydro-
genation of acetophenone (13). In order to estimate differ-
ences between the various carbene precursors we applied
low catalyst loadings (0.02 mol%) at 100 C. After 12 h
average turnover frequencies up to 346 h1 are achieved
for the preparation of 1-phenylethanol applying ligand 1.
Summarizing the activities of 4,5-dihydroimidazolium
salts, no pronounced influence is observed by variation of
substitutents at the nitrogen atoms (2,6-di-iso-propylphe-
nyl or mesitylene groups) or by changing the anion of the
imidazolium salt (Table 3, entries 2–4). On the other hand
by introduction of methyl groups in the 4,5-position of the
imidazolium unit a depletion of activity is monitored
(Table 3, entries 5 and 6).
In general, application of N-alkyl carbenes led to a
lower activity compared to N-aryl carbenes (Scheme 1, 8–
12). In the presence of 1-ethyl-3-methylimidazolium bro-
mide ([EMIM]Br, 11) and 1-butyl-3-methylimidazolium
bromide ([BMIM]Br, 12), which are usually used as ionic
liquids [21], the recorded yields were lower (Table 3, entries
11 and 12).Table 3
Variation of imidazolium salts in the transfer hydrogenation of acetoph-
enone (13)a
O
Ru(cod)(methylallyl)2/(1-12), Na-2-OPr
OH
2-PrOH, 100 ˚C, 12h
13 13a
Entry Imidazolium salt Yield (%)b TOF (h1)c TONd
1 1 83 346 4150
2 2 75 313 3750
3 3 68 283 3400
4 4 73 304 3650
5 5 53 221 2650
6 6 61 254 3050
7 7 62 258 3100
8 8 67 279 3350
9 9 77 320 3850
10 10 69 288 3450
11 11 54 225 2700
12 12 38 158 1900
a Reaction conditions: in situ catalyst: 9.7 · 107 mol Ru(cod)(methylal-
lyl)2, 9.7 · 107 mol imidazolium salt and 9.7 · 105 mol Na-2-OPr in
5.0 mL 2-propanol for 16 h at 65 C, addition of 4.85 · 103 mol ace-
tophenone (13), reaction for 12 h at 100 C.
b Conversion is determined by GC analysis (50 m Lipodex E, 95–200 C)
with diglyme as internal standard.
c Turnover frequency = mol product/(mol catalyst · time), determined
after 12 h.
d Turnover number = mol product/mol catalyst, determined after 12 h.In order to demonstrate the usefulness of the catalysts in
a more general manner we employed the catalyst system
Ru(cod)(methylallyl)2/1 in the transfer hydrogenation of
nine aromatic and aliphatic ketones (Table 4).
In general, all substrates were hydrogenated with excel-
lent chemoselectivity (>99%). Best activity (TOF up to
338 h1) is achieved with dialkyl ketones (Table 4, entries4 17
OMe
68 [97] 283
5 18
O
67 [93] 281
6 19
O
Cl 2 6
7 20
O
40 166
8 21
O
77 321
9 22
O
81 338
a Reaction conditions: in situ catalyst: 9.7 · 107 mol Ru(cod)(methylal-
lyl)2, 9.7 · 107 mol imidazolium salt 1 and 9.7 · 105 mol Na-2-OPr in
5.0 mL 2-propanol for 16 h at 65 C, addition of 4.85 · 103 mol ketone,
reaction for 12 h at 100 C.
b Conversion is determined by GC analysis (14 (25 m Lipodex E,
100 C), 15 (50 m Lipodex E, 90–105 C), 16 (25 m Lipodex E, 80–180 C),
17 (30 m HP Agilent Technologies 50–300 C), 18 (25 m Lipodex E, 90–
180 C), 19 (50 m Lipodex E, 90–180 C), 20–22 (30 m HP Agilent Tech-
nologies 50–300 C)) with diglyme as internal standard. In brackets the
conversion after 24 h is given.
c Turnover frequency = mol product/(mol catalyst · time), determined
after 12 h.
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containing an electron-withdrawing group (Table 4, entry
1) showed better conversion than para-substituted sub-
strates with an electron-donating group (Table 4, entry
2). Noteworthy, by changing the electron-donating group
from para- to ortho-position a significant increase of the
yield is detected (Table 4, entries 2 and 4). We assume
for 17 a possible second coordination site at the metal cen-
ter. No major change in activity is observed for substitu-
tion adjacent to the carbonyl group by an ethyl group,
whereas introduction of a chloromethyl deactivated the
catalyst (Table 4, entries 5 and 6). Moderate activity is
monitored when increasing the bulkiness next to the active
center by a cyclopropyl group (Table 4, entry 7).
Finally, we were interested in mechanistic aspects. In
general, for transition metal catalyzed transfer hydrogena-
tion two mechanisms are accepted, designated as direct
hydrogen transfer, via formation of a six-membered cyclic
transition state composed of donor, metal and acceptor,
and the hydridic route which shows two possible pathways,
the monohydride or dihydride mechanism. In more detail,
formation of a monohydride-metal-complex promoted an
exclusive hydride transfer from carbon (donor) to carbonyl
carbon (acceptor) (Scheme 2, pathway A), whereas a
hydride transfer from carbon (donor) to carbonyl carbon
(acceptor) as well as to the carbonyl oxygen (acceptor)
was proposed for a dihydride-metal-complex formation
(Scheme 2, pathway B). Indications for both pathways
were published by Ba¨ckvall et al. and other groups, when
following the hydride transfer catalyzed by various metal
complexes [22].
Mechanistic studies have been mostly published for cat-
alysts containing phosphines, amines or cyclopentadienyls
as ligands [22a]. For transition metal complexes containing
carbene ligands Faller and Crabtree described investiga-
tions on an iridium dicarbene system [16c]. They assumed2-PrOH-d8, 100 ˚C
OO
D
D Ru(cod)(methylallyl)2/1,
23
Na-2-OPr-d7
Ru
>99%
13
Scheme 3. Deuterium incorporation into acetophenone catalyze
O O
*H
H
[M-H*]
OOH
H*
pathway A
-acetone
Scheme 2. Comparison of monohydride and dihya monohydride mechanism, because the hydride is mainly
transferred in the 1-position of acetophenone. So far there
is no mechanistic investigation known in transfer hydroge-
nations applying Ru carbene catalysts.
Reaction of ketone 20 (‘‘radical clock’’-substrate) with
2-propanol in the presence of 1 mol% Ru(cod)(methylal-
lyl)2/1 gave only the corresponding cyclopropyl phenyl
alcohol (>99% by 1H NMR). Apparently, there is no
radical induced reduction [23]. Owing to this a radical
reduction mechanism promoted by sodium alkoxides can
be also excluded, whereby the transition metal plays only
a marginal role [24]. This assumption is also confirmed
by performing the reduction of acetophenone (13) in the
presence of base and in the absence of ruthenium catalyst.
Here, no reduction product was detected.
Next, we followed the transfer of hydrogen from the
donor molecule into the product by applying a deuterated
donor [25]. The catalytic precursor is generated by stirring
a solution of 2-propanol-d8, Ru(cod)(methylallyl)2 and imi-
dazolium salt 1 in the presence of sodium 2-propanolate-d7
for 16 h at 65 C. Then, acetophenone (13) was added and
the solution was stirred for 30 min at 100 C. As main
product (>99%) 23 was observed by 1H NMR (Scheme
3) [26]. The result showed an exclusive transfer of the deu-
terium into the carbonyl group, so that no C–H activation
on the substrate occurred under the described conditions.
Furthermore, this result rules out enol formation in the cat-
alytic cycle [27].
To clarify the transfer of hydrogen from the hydrogen
donor into the substrate the reaction was run with 2-propa-
nol-d1 (hydroxy-group deuterated) as solvent/donor and
sodium 2-propylate as base. In the transfer hydrogenation
of acetophenone (13) we obtained a mixture of two differ-
ent deuterated 1-phenylethanols (Scheme 2, 24a and 24b).
Here, a scrambling of the transferred proton and deuteride
is found (24a and 24b = 1:1). In conclusion the non-specificO
H
D
O
D
H
2-PrOD, 100 ˚C
 Na-2-OPr
24a 24b
+
(cod)(methylallyl)2/1,
50% 50%
d by Ru(cod)(methylallyl)2/1-system in the presence of base.
O
*H
H
[H-M-H*]
OH
H*
OH*
H
pathway B
-acetone
50% 50%
dride mechanism for transfer hydrogenations.
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implying a formation of metal dihydride species in the cat-
alytic cycle [2d].3. Summary
We demonstrated the successful application of in situ
prepared ruthenium catalysts containing carbene ligands
in the transfer hydrogenation of various ketones. In the
reduction of acetophenone (13) turnover frequencies up
to 346 h1 were found for a catalyst system containing
Ru(cod)(methylallyl)2/1,3-bis(2,6-di-i-propylphenyl)-imi-
dazolium chloride (1). Mechanistic experiments indicated
the transfer of hydrogen from the donor molecule into
the substrate via a dihydride mechanism.4. Experimental section
4.1. General
All manipulations were performed under argon atmo-
sphere using standard Schlenk techniques. Unless specified,
all chemicals are commercially available and used as
received. Sodium 2-propylate was prepared by reacting
sodium with 2-propanol under an argon atmosphere. 2-
Propanol was used without further purification (purchased
from Fluka, dried over molecular sieves). Imidazolium
salts 1, 2, 5, 6, 8 and 9 were synthesized according to the
published protocols [4,28]. Imidazolium salts 11 and 12
were a gift by Solvent Innovation. Imidazolium salts 3, 4,
7 and 10 are commercially available by Strem. All ketones
were dried over CaH2, distilled in vacuum and stored under
argon, except ketones 17 and 19, which were cycled with
vacuum-argon and stored under argon.
4.2. General procedure for catalytic transfer hydrogenation
of ketones
In a 10 mL Schlenk tube, the in situ catalyst (9.7 ·
107 mol) was prepared by stirring a solution of
Ru(cod)(methylallyl)2 (9.7 · 107 mol), imidazolium salt
(9.7 · 107 mol) and sodium 2-propylate (4.85 · 106 mol)
in 1.0 mL 2-propanol for 16 h at 65 C. After addition of
the corresponding ketone (4.85 · 103 mol) and the internal
standard diglyme in 4.0 mL 2-propanol the Schlenk tube
was sealed and the reaction mixture was heated to 100 C.
After 12 h the conversion was measured by GC without fur-
ther purification. In the case of 1H NMR determination of
the yield, the solvent was removed in vacuum and the resi-
due was dissolved in CDCl3 and submitted to
1H NMR.
4.3. Procedure for transfer hydrogenation of acetophenone
with 2-propanol-d8 as hydride source
In a 10 mL Schlenk tube, Ru(cod)(methylallyl)2 (3.8 ·
106 mol), imidazolium salt 1 (3.8 · 106 mol) and sodium2-propylate-d7 (1.9 · 105 mol, prepared by reacting
sodium with 2-propanol-d8) was solved in 1.0 mL 2-propa-
nol-d8 and stirred for 16 h at 65 C. After addition of the
acetophenone (13) (3.8 · 104 mol) in 2.0 mL 2-propanol-
d8 the reaction mixture was heated to 100 C for 30 min.
The solution was cooled to r.t. and filtrated over a plug
of silica. The conversion was determined by 1H NMR.
4.4. Procedure for transfer hydrogenation of acetophenone
with 2-propanol-d1 as hydride source
In a 10 mL Schlenk tube, Ru(cod)(methylallyl)2 (3.8 ·
106 mol), imidazolium salt 1 (3.8 · 106 mol) and sodium
2-propylate (1.9 · 105 mol, prepared by reacting sodium
with 2-propanol) was solved in 1.0 mL 2-propanol-d1 (deu-
terium fixed as hydroxyl proton) and stirred for 16 h at
65 C. The reaction mixture was heated to 100 C for
10 min after addition of the acetophenone (13) (3.8 ·
104 mol) in 2.0 mL 2-propanol-d1. (To avoid side effects
reaction was not run to full conversion.) The solution
was cooled to r.t. and filtrated over a plug of silica. The sol-
vent was removed in vacuum and the residue was solved in
CDCl3. The conversion was determined by
1H NMR.
4.5. Product characterization
The obtained alcohols are known compounds. They
were characterized by comparison with authentic samples
and mass spectroscopy (Agilent Technologies 6890N,
MSD 5973) or 1H NMR (Bruker ARX-400). Product
13a: m/z (%) = 122 (M+, 21); 107 (72); 79 (100); 51 (34);
43 (36); 39 (13); 32 (15). Product 14a: m/z (%) = 156
(M+, 26); 141 (100); 121 (14); 113 (33); 103 (9); 77 (85);
51 (12); 43 (22). Product 15a: m/z (%) = 152 (M+, 24);
137 (100); 134 (32); 119 (20); 109 (48); 94 (38); 91 (34); 77
(46); 65 (31); 51 (16); 43 (37); 39 (21). Product 16a: m/z
(%) = 136 (M+, 32); 121 (100); 117 (14); 91 (94); 77 (53);
65 (29); 51 (16); 43 (57); 39 (23). Product 17a: m/z
(%) = 152 (M+, 31); 137 (100); 134 (20); 119 (10); 109
(46); 94 (29); 91 (16); 77 (28); 65 (12); 43 (13). Product
18a: m/z (%) = 152 (M+, 11); 107 (100); 79 (79); 51 (13).
Product 19a: m/z (%) = 156 (M+, 3); 107 (100); 91 (7); 79
(67); 77 (50); 51 (19). Product 20a: 1H NMR (400 MHz,
CDCl3) d (ppm) = 0.34 (1H, m); 0.44 (1H, m); 0.51 (1H,
m); 0.58 (1H, m); 1.00 (1H, m); 2.31 (1H, s); 3.98 (1H, d,
J = 8.16 Hz); 7.24 (3H, m); 7.99 (1H, d, J = 7.52 Hz).
Product 21a: m/z (%) = 128 (M+, 17); 110 (34); 95 (18);
81 (100); 67 (71); 55 (78); 41 (46). Product 22a: m/z
(%) = 102 (M+, 3); 87 (26); 57 (100); 45 (83); 41 (53).
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Abstract: Tridentate N,N,N-pyridinebisimidazolines
have been studied as new ligands for the enantiose-
lective transfer hydrogenation of prochiral ketones.
High yields and excellent enantioselectivity up to
>99% ee have been achieved with an in situ gener-
ated catalytic system containing dichlorotris(triphe-
nylphosphine)ruthenium and 2,6-bis-([4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine
(3a) in the presence of sodium isopropoxide.
Keywords: asymmetric transfer hydrogenation; ke-
tones; phosphines; ruthenium; tridentate nitrogen
ligands
Enantiomerically pure alcohols have a wide range of
applications, for example, building blocks and syn-
thons for pharmaceuticals, agrochemicals, polymers,
syntheses of natural compounds, auxiliaries, ligands
and key intermediates in organic syntheses.[1] Within
the different molecular transformations to chiral alco-
hols, transition metal-catalyzed reactions offer effi-
cient and versatile strategies, such as addition of or-
ganometallic compounds to aldehydes, hydrosilyla-
tion, and hydrogenation of prochiral ketones.[2] From
an economic and environmental point of view the
asymmetric hydrogenation, in particular the transfer
hydrogenation, represents a powerful tool for their
synthesis because of its high atom economy and
safety advantages.[3] Here, NoyoriCs ruthenium-based
catalysts comprising chiral tosylated diamines consti-
tute state-of-the-art transfer hydrogenation sys-
tems.[3d,4] Based on this seminal work an increasing
number of ruthenium catalysts with chiral bidentate
N,N-ligands were developed in the last decade.[3] Sig-
nificantly fewer systems are known in which transfer
of chiral information is promoted by tridentate li-
gands.[5,6] Up to now only a limited number of auspi-
cious tridentate nitrogen-containing N,N,N ligands
were established in the field of transfer hydrogena-
tion. For example (R)-phenyl-ambox (1)[5] and differ-
ent pyridinebisoxazoline (pybox) ligands (2)[6] have
been applied for the reduction of acetophenone
(Scheme 1).
Recently, we reported the synthesis of a new class
of chiral tridentate amines.[7] The preparation and
tunability of these pyridinebisimidazolines (3) (so-
called pybim ligands, Scheme 1) are easier and more
flexible compared to the popular pyboxes, making the
former a suitable ligand tool box for various asym-
metric transformations. To date there is no report on
the performance of these ligands in hydrogenation re-
actions. The resemblance between pybim (3) and
pybox (2) stimulated our research to study the poten-
tial of this class of ligands in the transfer hydrogena-
tion of aromatic and aliphatic ketones.
In exploratory experiments, isopropyl alcohol-based
transfer hydrogenation of acetophenone was exam-
ined using a simple in situ catalyst system composed
of [RuCl2ACHTUNGTRENNUNG(C6H6)]2, 2,6-bis-([4R,5R]-4,5-diphenyl-4,5-
Scheme 1. N,N,N-Tridentate ligands.
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dihydro-1H-imidazol-2-yl)-pyridine (3) and triphenyl-
phosphine. To ensure complete formation of the
active catalyst and avoid an induction period the reac-
tion mixture was heated for 10 min at 100 8C in the
presence of base followed by addition of acetophe-
none. First, studies for optimizing the reaction condi-
tions were carried out with 1 mol% of pre-catalyst
and 5 mol% of base. It is well-known that transfer hy-
drogenations are sensitive to the nature of the base.
Thus, the influence of different bases on selectivity
and conversion was investigated initially (Table 1).
Best results were obtained for sodium isopropoxide
and K2CO3 with conversions up to 95% and enantio-
meric excesses up to 94% (Table 1, entries 1 and 8).
Interestingly, NaOH and KOH the most commonly
used bases for transfer hydrogenations gave only
moderate enantioselectivity (78% and 80%, Table 1,
entries 3 and 4). In addition, we tested some organic
nitrogen-containing systems such as DBU, DABCO,
NEt3, N ACHTUNGTRENNUNG(i-Pr)2Et and pyridine, but only with N ACHTUNGTRENNUNG(i-
Pr)2Et did we obtain significant amounts of product
in a reasonable time (Table 1, entry 10). Next, the
concentration of sodium isopropoxide was varied at
different temperatures. As expected, the increase of
the amount of base led to an acceleration of reaction
rate; however, this was accompanied by an unaccepta-
ble decrease of enantioselectivity (Table 1, entries 13–
15). In contrast, improved ee is obtained by reducing
the amount of base to a ruthenium-to-base ratio of 1
to 0.5 (Table 1, entries 16 and 17). Notably, in the ab-
sence of base the transfer of hydrogen did not occur.
Based on these results we investigated the behavior
of the metal precursor.
Applying different ruthenium sources such as
[RuCl2ACHTUNGTRENNUNG(PPh3)3], [RuHCl ACHTUNGTRENNUNG(PPh3)3],
[8] RuCl3·x H2O,
Ru3(CO)12 and RuACHTUNGTRENNUNG(cod)(methylallyl)2, lower conver-
sion and/or poor selectivity were achieved. Neverthe-
less, [RuCl2ACHTUNGTRENNUNG(PPh3)3] showed an enantiomeric excess of
>99%, which is to our knowledge the highest enan-
tioselectivity in this model reaction for a chiral triden-
tate ligand (Table 1, entry 17). However, a slight
excess of pybim 3a, 3 equivs. with respect to 1 equiv.
Table 1. Transfer hydrogenation of acetophenone in the presence of pybim ligand 3a and different bases.[a]
Entry Base Base:Metal Temp. [8C] Conv. [%][b] ee [%][b]
1 NaO-i-Pr 5 100 80 94 (S)
2 KO-t-Bu 5 100 99 9 (S)
3 NaOH 5 100 79 78 (S)
4 KOH 5 100 85 80 (S)
5 LiOH 5 100 72 80 (S)
6 K3PO4 5 100 65 70 (S)
7 K2HPO4 5 100 19 96 (S)
8 K2CO3 5 100 95 93 (S)
9 Cs2CO3 5 100 45 67 (S)
10 N ACHTUNGTRENNUNG(i-Pr)2Et 5 100 18 90 (S)
11 NaO-i-Pr 5 60 93 84 (S)[c]
12 NaO-i-Pr 5 80 91 83 (S)[d]
13 NaO-i-Pr 5 90 91 88 (S)
14 NaO-i-Pr 50 90 98 87 (S)
15 NaO-i-Pr 250 90 99 44 (S)
16 NaO-i-Pr 0.5 100 88 95 (S)
17 NaO-i-Pr 0.5 100 96 >99 (S)[e]
18 NaO-i-Pr 0.5 110 58 84 (S)
[a] Reaction conditions: in situ catalyst A {1.9O106 mol [RuCl2ACHTUNGTRENNUNG(C6H6)]2, 3.8O10
6 mol ligand 3a, 3.8O106 mol PPh3}; addi-
tion of the corresponding base: entries 1–13: 1.9O105 mol, entry 14: 1.9O104 mol, entry 15: 9.5O104 mol and for en-
tries 16–18: 1.9O106 mol in 2.0 mL isopropyl alcohol, 10 min at corresponding temperature then addition of 3.8O104
mol acetophenone, 1 h at corresponding temperature.
[b] Conversion and ee were determined by chiral GC (50 m Lipodex E, 95–200 8C) analysis with diglyme as internal stan-
dard.
[c] Reaction time 14 h.
[d] Reaction time 4 h.
[e] In situ catalyst B {3.8O106 mol [RuCl2ACHTUNGTRENNUNG(PPh3)3], 1.14O10
5 mol 3a}. Conversion was determined by GC (30 m HPAgilent
Technologies 50–300 8C) with diglyme as internal standard and ee was determined by chiral HPLC (Chiralcel OB-H,
eluent: n-hexane/ethanol, 99:1, flow rate: 2 mLmin1) analysis.
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of ruthenium, was necessary to achieve high enantio-
selectivity. To compare the difference of catalyst
system A and catalyst system B, we investigated the
conversion-time and the enantioselectivity-time de-
pendency (Scheme 2). No significant change of enan-
tioselectivity was observed in the shown time frame,
while after 24 h full racemization occurred with cata-
lyst A. Noteworthy, the analysis of the conversion-
time behavior proved a higher catalyst activity for cat-
alyst B, while for catalyst A a slight deceleration was
monitored. We assume a better stabilization of the
active species by an excess of 3a and PPh3.
As shown in Table 2 we also examined different
pybox ligands (2a–c), but only unsatisfying results
were obtained demonstrating the advantage of 3a
(Table 2, entries 1–3).
Noyori et al. proposed a metal-ligand bifunctional
mechanism for the hydride transfer process (“NH ef-
fect”).[4,13b] Hence, the NH group of the imidazoline
rings could be involved in the selectivity transfer and
increase the coordination affinity between substrate
and catalyst. Due to the formation of a second bind-
ing site, a more favorable position for transferring the
chiral information is attained.[5,9,13]
In order to understand the role of the free NH
functionality for our pybim ligand 3a, different substi-
tutions at the imidazoline units were carried out. The
corresponding monoprotected ligands 3b, c were syn-
thesized by reaction of 3a with one equivalent of 3,5-
di-tert-butylbenzoic acid chloride or Ph2P(O)Cl. We
presumed that the resulting unsymmetrical complexes
would direct the substrate to occupy a specific orien-
tation in the transition state and thereby induce in-
creased selectivity during catalysis. However, 3,5-(t-
Bu)2C6H3)CO (3b) or Ph2PO substitution (3c) de-
creased the enantioselectivity in the model reaction
significantly (Table 2, entries 5 and 6). To confirm the
results of the monosubstituted ligands an exchange of
both hydrogens with Boc (3d) or Bz (3e) protecting
groups was carried out. A further decrease of enantio-
selectivity was observed (Table 2, entries 7 and 8).
Thus, there is a crucial necessity of both NH function-
alities for obtaining high enantioselectivity in the
transfer hydrogenation of acetophenone. Interestingly,
the NH group is not necessary to achieve significant
conversions (Table 2, entry 8), which is in contrast to
previous reports by Noyori et al. , for example cata-
lysts containing N-dimethylamino alcohols are com-
pletely inactive compared to their N-monomethyl
counterparts.[3d,13b] To estimate the influence of the li-
gands in more detail we varied also the phosphorus
ligand part (Table 3). Among the different achiral li-
gands best results were obtained with PPh3, (p-MeO-
C6H4)3P and (p-Me-C6H4)3P (Table 3, entries 1, 3 and
Scheme 2. Conversion-time and enantioselectivity-time be-
havior of catalyst A and catalyst B. Reaction conditions: in
situ catalyst A (1.9O106 mol [RuCl2ACHTUNGTRENNUNG(C6H6)]2, 3.8O10
6 mol
ligand 3a, 3.8O106 mol PPh3) or in situ catalyst B (3.8O
106 mol [RuCl2ACHTUNGTRENNUNG(PPh3)3], 1.14O10
5 mol 3a); addition of
sodium isopropoxide (1.9O106 mol) in 2.0 mL 2-propanol,
10 min at 100 8C then addition of 3.8O104 mol acetophe-
none, reaction temperature: 100 8C. Conversion was deter-
mined by GC (30 m HP Agilent Technologies 50–300 8C)
with diglyme as internal standard and ee was determined by
chiral HPLC (Chiralcel OB-H, eluent: n-hexane/ethanol,
99:1, flow rate: 2 mLmin1) analysis.
Table 2. Transfer hydrogenation of acetophenone in the
presence of different pybox and pybim ligands.[a]
Entry Ligand Time [h] Conv. [%][b] ee [%][b]
1 2a 1 6 11 (R)
2 2b 1 10 18 (S)
3 2c 1 22 8 (R)
4 3a 1 83 98 (S)
5 3b 2 95 26 (R)
6 3c 2 74 29 (S)
7 3d 1 4 7 (R)
8 3e 1 77 7 (S)
[a] Reaction conditions: 3.8O106 mol [RuCl2ACHTUNGTRENNUNG(PPh3)3], 1.14O
105 mol ligand, 3.8O106 mol PPh3, 1.9O10
6 mol NaO-
i-Pr, 2.0 mL isopropyl alcohol, 10 min at 100 8C then ad-
dition of 3.8O104 mol acetophenone.
[b] Conversion and ee were determined by chiral GC (50 m
Lipodex E, 95–200 8C) analysis with diglyme as internal
standard.
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5). Methyl substitution in the o-position of arylphos-
phines decreased the enantioselectivity dramatically
compared to that at the p-position (from 97% ee to
rac, entries 4 and 5). Moderate conversion and selec-
tivity were obtained for electron-poor substituted ar-
ylphosphines (Table 3, entries 6 and 7). Interestingly,
also more basic and sterically hindered alkylphos-
phines such as PCy3, P ACHTUNGTRENNUNG(t-Bu)3, and n-BuPAd2 showed
only low activity (Table 3, entries 8–10).
Furthermore, we applied chelating arylphosphine li-
gands. For bis(diphenylphosphino)methane (DPPM)
only disappointing conversion and selectivity were ob-
tained (Table 3, entry 12). By increasing the number
of CH2 groups in the bridge an increase of the enan-
tiomeric excess was detected (Table 3, entries 13–15),
probably due to a weaker coordination of the second
phosphine group to the ruthenium. In addition, to im-
prove the enantioselectivity and to increase the enan-
tiomeric differentiation in the shape of the catalysts,
we investigated the influence of chiral phosphines.
Therefore, we tested chiral monodentate ligands (S)-4
and (S)-5 in the transfer hydrogenation of acetophe-
none in combination with pybim ligand 3a. Recently,
we have demonstrated the successful application of
such chiral monodentate 4,5-dihydro-3H-dinaphtho-
[2,1-c ;1’,2’-e]phosphepines in various asymmetric hy-
drogenations using molecular hydrogen.[10] Further-
more, Gladiali and co-workers reported previously
the application of this ligand class in the rhodium-cat-
alyzed asymmetric hydrogenation of C=C bonds.[21]
However, only ligand (S)-4 showed comparable enan-
tioselectivity to PPh3 of 95% ee, while (S)-5 gave
poor selectivity and conversion, due to a similar basic-
ity to achiral alkylphosphines (Table 3, entry 16 and
17).
Next, we explored the influence of the concentra-
tion of PPh3. The results indicated a necessity of
1 equiv. of PPh3 relating to 1 equiv. of ruthenium,
while the reaction with more than 1 equiv. of PPh3 or
in the absence of PPh3 resulted in a decrease of enan-
tioselectivity (Table 3, entries 1 and 2). Noteworthy,
the use of an excess of PPh3 has no disordered effect
on selectivity while a negative influence was reported
for other catalytic systems when PPh3 was not re-
moved.[5,6] In analogy to Gimeno et al.[6,11] and Yu
et al.[12] we assume a cis-coordination of the phos-
phine with respect to the N-N-N plane, which forms
after removal of the cis-coordinated chlorides (with
respect to each other) a highly selective vacancy for
substrate coordination and chirality transfer.
To demonstrate the usefulness of the novel catalysts
we employed system A ([RuCl2ACHTUNGTRENNUNG(C6H6)]2/pybim/PPh3)
and B ([RuCl2ACHTUNGTRENNUNG(PPh3)3]/pybim) in the asymmetric
transfer hydrogenation of six aromatic and one ali-
phatic ketones (Table 4). In general, catalyst system
A gave some higher enantioselectivities compared to
catalyst B. Substituted acetophenones and propiophe-
none gave enantioselectivities up to 98% ee (Table 4,
entries 1–5). In the case of methoxy-substitution the
position of the substituent plays an important role,
because ortho-substitution was favored (Table 4, en-
tries 3 and 4). A chloro substituent in the a-position
to the carbonyl group proved to be problematic and
deactivated both catalysts (Table 4, entry 6). Com-
pared to aromatic ketones, aliphatic ketones are more
challenging substrates. Nevertheless, 1-cyclohexyletha-
none was reduced by catalyst A in good yield and
enantioselectivity (Table 4, entry 7).
Table 3. Influence of different phosphorus ligands on the trans-
fer hydrogenation of acetophenone.[a]
Entry P Ligand Temp.
[8C]
Conv.
[%][b]
ee
[%][b]
1 Ph3P 100 80 94 (S)
2 without 100 61 7 (S)
3 (p-MeO-C6H4)3P 90 91 87 (S)
[c]
4 (o-Me-C6H4)3P 100 20 rac
5 (p-Me-C6H4)3P 100 41 97 (S)
6 ACHTUNGTRENNUNG[3,4-ACHTUNGTRENNUNG(CF3)2-C6H3]3P 90 24 66 (S)
[c]
7 ACHTUNGTRENNUNG(p-F-C6H4)3P 100 53 76 (S)
8 Cy3P 90 2 15 (S)
[c]
9 t-Bu3P 100 1 12 (S)
10 n-BuPAd2 100 4 5 (S)
11 ACHTUNGTRENNUNG(i-PrO)3P 100 28 75 (S)
12 Ph2P ACHTUNGTRENNUNG(CH2)PPh2 100 37 rac
13 Ph2P ACHTUNGTRENNUNG(CH2)2PPh2 100 43 rac
14 Ph2P ACHTUNGTRENNUNG(CH2)5PPh2 100 43 6 (S)
15 Ph2P ACHTUNGTRENNUNG(CH2)6PPh2 100 15 37 (S)
16 90 90 95 (S)[c]
17 90 8 24 (S)
[a] Reaction conditions: in situ catalyst {1.9O106 mol [RuCl2
ACHTUNGTRENNUNG(C6H6)]2, 3.8O10
6 mol 3a, 3.8O106 mol of the correspond-
ing P ligand}, 1.9O105 mol NaO-i-Pr, 2.0 mL isopropyl alco-
hol, 10 min at described temperature then addition of 3.8O
104 mol acetophenone, 1 h at described temperature.
[b] Conversion and ee were determined by chiral GC (50 m Lip-
odex E, 95–200 8C) analysis with diglyme as internal stan-
dard.
[c] Experiments also performed at 100 8C, but only low enantio-
selectivities or conversions were obtained.
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Various methods (1H, 13C, 31P and 15N NMR, COSY
NMR, HMQC NMR and MS) were used for charac-
terization of the pre-catalyst, but unfortunately no
precise structure has been proven. The 31P NMR spec-
trum of the pre-catalyst in CDCl3 indicated a single
compound, because a singlet appeared at 30 ppm
(free PPh3: 6 ppm and O=PPh3: 27 ppm). Further-
more, the composition of the pre-catalyst was con-
firmed by HR-MS as [RuCl2ACHTUNGTRENNUNG(PPh3)(3a)] (calculated
mass: 953.17549, detected mass: 953.17572). However,
the coordination abilities of ligand 3a are so far un-
clear, because a rapid exchange of NH protons was
detected, which causes a broad signal in the 1H NMR
spectrum for the four protons adjacent to the nitrogen
atoms and furthermore one signal for the correspond-
ing carbons in the 13C NMR spectrum.
Next, we focused our attention on a deeper com-
prehension of the reaction mechanism. For metal-cat-
alyzed transfer hydrogenation two general mecha-
nisms are accepted, designated as direct hydrogen
transfer via formation of a six-membered cyclic transi-
tion state composed of metal, hydrogen donor and ac-
ceptor, and the hydridic route, which is subdivided
into two pathways, the monohydride and dihydride
mechanism (Scheme 3). More specifically, the forma-
tion of monohydride-metal complexes promotes an
Table 4. Transfer hydrogenation of prochiral ketones.[a]
Entry Alcohol Catalyst A[b,c,d] Catalyst B[b,c,d]
Conv. [%] ee [%] Conv. [%] ee [%]
1 89 89 (S) >99 85 (S)
2 84 94 (S) >99 89 (S)
3 86[e] 72 (S) 68[f] 74 (S)
4 >99 98 () 99 g] 70 ()
5 >99 97 (S) 98[e] 87 (S)
6 12[g] 70 (R) <2[f] 12 (R)
7 91 82 (S) 96[f] 72 (S)
[a] Reaction conditions: in situ catalyst A {1.9O106 mol [RuCl2ACHTUNGTRENNUNG(C6H6)]2, 3.8O10
6 mol 3a, 3.8O106 mol PPh3), 1.9O10
5 mol
NaO-i-Pr, 2.0 mL isopropyl alcohol, 10 min at 100 8C then addition of 3.8O104 mol substrate, 1 h at 100 8C.
[b] Conversion and ee were determined by chiral GC (entry 1: 25 m Lipodex E, 80–180 8C; entry 2: 25 m Lipodex E, 100 8C;
entry 3: 50 m Lipodex E, 90–105 8C; entry 4: 50 m Lipodex E, 90–180 8C; entry 5: 25 m Lipodex E, 90–180 8C; entry 6:
50 m Lipodex E, 95–180 8C; entry 7: 25 m Lipodex E, 100 8C) analysis with diglyme as internal standard.
[c] In situ catalyst B {3.8O106 mol [RuCl2ACHTUNGTRENNUNG(PPh3)3], 1.14O10
5 mol 3a}.
[d] The absolute configurations were determined by comparing the sign of specific rotation with reported data.
[e] 4 h.
[f] 8 h.
[g] 24 h.
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exclusive hydride transfer from carbon (donor) to car-
bonyl carbon (acceptor) (Scheme 3), whereas a hy-
dride transfer via dihydride-metal complexes leads to
no accurate prediction of hydride resting state, be-
cause the former hydride was transferred to the car-
bonyl carbon (acceptor) as well as to the carbonyl
oxygen (acceptor) (Scheme 3). Indications for both
pathways (hydridic route) have been established by
various research groups, when following the hydride
transfer catalyzed by metal complexes, e.g., Ru, Rh or
Ir.[13]
Reaction of cyclopropyl phenyl ketone (“radical
clock”-substrate) with isopropyl alcohol in the pres-
ence of 1 mol% catalyst A gave exclusively the corre-
sponding cyclopropylphenyl alcohol (>99% by
1H NMR). Apparently there is no radical reduction
induced by the transition metal or by sodium alkox-
ides.[14] The second assumption is also confirmed by
performing the reduction of acetophenone in the
presence of base and in the absence of the ruthenium
catalyst. Here, no product at all was detected.
Next, we followed the incorporation of hydrogen
from the donor molecule (isopropyl alcohol) into the
product by applying a deuterated donor.[15] The pre-
catalyst (1 mol%) is generated by stirring a solution
of isopropyl alcohol-d8, 0.5 equivs. of [RuCl2ACHTUNGTRENNUNG(C6H6)]2,
ligand 3a and PPh3 for 16 h at 65 8C. Then, sodium
isopropoxide-d7 was added and the solution was stir-
red for 10 min at 100 8C. The reaction mixture was
charged with acetophenone and after 1 h compound
13 was observed as main product (>99%) by
1H NMR (Scheme 4).[16] The result proved an exclu-
sive transfer of the deuterium into the carbonyl
group, therefore a CH activation of the substrate/
product under the described conditions did not occur.
Furthermore, this result rules out an enol formation
in the catalytic cycle.[17]
To specify the position and the nature of the trans-
ferred hydride, the reaction was performed with iso-
propyl alcohol-d1 (hydroxy group deuterated) as sol-
vent/donor and sodium isopropoxide as base under
identical reaction conditions. In the transfer hydroge-
nation of acetophenone we obtained a mixture of two
deuterated 1-phenylethanols (Scheme 4, 14a and
14b).The ratio between 14a and 14b (85:15) indicated
a specific migration of the hydride, albeit some scram-
bling was detected.[18] This was probably caused by re-
arrangement of the hydride complex, starting from
HNRuD via N=Ru(HD) to DNRuH and subse-
quent transfer process into acetophenone yielding
14b. In conclusion the incorporation is in agreement
with the monohydride mechanism, implying the for-
mation of a metal hydride species in the catalytic
cycle (Scheme 3). Furthermore, this indication is con-
firmed by the above-mentioned influence of the NH
groups. In conclusion, the transfer of hydrogen, in the
case of catalyst A, is subdivided into the hydride
transfer by the metal and the proton transfer by the
NH group in analogy to the metal-ligand bifunctional
catalysis.[13r]
We demonstrated for the first time the successful
application of chiral tridentate pyridinebisimidazoline
ligands in the asymmetric ruthenium-catalyzed trans-
fer hydrogenation of aliphatic and aromatic ketones.
Enantioselectivities up to >99% ee were obtained
under optimized reaction conditions. Comparison ex-
periments of 3a with monoprotected pybims and
pybox ligands displayed the crucial influence of the
free NH functionality. Mechanistic experiments indi-
cated the transfer of hydrogen from the donor mole-
cule into the substrate via a metal-ligand bifunctional
mechanism.
Scheme 3.Monohydride and dihydride mechanisms for
transfer hydrogenations.
Scheme 4. Deuterium incorporation into acetophenone catalyzed by catalyst system A.
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Experimental Section
General Remarks
All manipulations were performed under an argon atmos-
phere using standard Schlenk techniques. Isopropyl alcohol
was used without further purification (purchased from
Fluka, dried over molecular sieves). Sodium isopropoxide
was prepared by reacting sodium with isopropyl alcohol
under an argon atmosphere (stock solution). All ketones
were dried over CaH2, distilled in vacuum and stored under
argon, except 4’-methoxyacetophenone and phenacyl chlo-
ride, which were used without further purification.
BuP(Ad)2
[19] and N-phenyl-2-(di-tert-butylphosphino)-pyr-
role[20] were synthesized according to literature protocols.
General Procedure for the Transfer Hydrogenation of
Ketones
In a 10-mL Schlenk tube, the in situ catalyst was prepared
by stirring a solution of [RuCl2ACHTUNGTRENNUNG(C6H5)]2 (1.9O10
6 mmol),
ligand 3a (3.8O106 mmol) and PPh3 (3.8O10
6 mmol) in
1.0 mL isopropyl alcohol for 16 h at 65 8C. To this mixture
sodium isopropoxide (1.9O105 mmol in 0.5 mL isopropyl al-
cohol (stock solution)) was added and the solution stirred at
100 8C for 10 min. After addition of the corresponding
ketone (0.38 mmol in 0.5 mL isopropyl alcohol (stock solu-
tion)) the reaction mixture was stirred for 1 h at 100 8C. The
solution was cooled to room temperature and filtered over a
plug of silica. The conversion and ee were measured by GC
without further manipulations.
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7. Summary 
7.1. Application of monodentate phosphines in asymmetric hydrogenations 
 
Since previous works have proven an excellent behaviour of ligands containing 4,5–dihydro–
3H–dinaphtho[2,1–c;1´,2´–e]phosphepine motif in asymmetric hydrogenation of α–amino 
acid precursors, itaconic acid derivatives and β–ketoesters, we extended the scope and 
limitation in the reduction of unsaturated C–C bonds. The rhodium–catalyzed asymmetric 
hydrogenation of different N–acyl enamides to give N–acyl protected optically active amines 
has been examined for the first time in detail in the presence of chiral monodentate 4,5–
dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine (Scheme 1). The enantioselectivity is 
largely dependent on the nature of the substituent at the phosphorous atom and the enamide 
structure. Under optimized conditions up to 95% ee and catalyst activity up to 2000 h-1 have 
been achieved. 
 
P R
H2 (2.5 bar), 
toluene, 30 °C, 6 h
HN
O
[Rh(cod)2]BF4 + 2.1 (L) HN
O
R1 R1
R2R2
(L)
up to 95% ee  
Scheme 1. Asymmetric hydrogenation of N–acyl enamides. 
 
Furthermore the potential of presented monophosphine ligands were shown in the rhodium–
catalyzed asymmetric hydrogenation of various β–dehydroamino acid derivatives to give 
optically active β–amino acids (Scheme 2). Here enantioselectivities up to 94% ee were 
obtained after optimization of reaction conditions. Noteworthy, contradictory performance 
was observed for the E– and Z–isomer and different reaction conditions were necessary to 
achieve best enantioselectivity. In addition a switch of product configuration was observed 
depending on the nature of the double bond, which has been scarcely reported. 
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Scheme 2. Asymmetric hydrogenation of β–dehydroamino acid derivates. 
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Based on the pioneering work of Feringa, de Vries, Minnaard and co–workers the rhodium–
catalyzed asymmetric hydrogenation of different acyclic and cyclic enol carbamates to yield 
optically active carbamates has been studied in the presence of chiral monodentate ligands 
based on a 4,5–dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine scaffold (Scheme 3). 
Various reaction parameters have been investigated in detail and enantioselectivities up to 
96% ee have been achieved with an in situ catalyst. Noteworthy, high thermal stability of the 
catalyst in the range of 10–90 °C was noticed with respect to enantioselectivity (94–96% ee).  
 
P R
(L)
MeOH, 24 h, H2 (25 bar)
O [Rh(cod)2]BF4 + 2.1 (L)O
N
O O
N
up to 96% ee  
 
Scheme 3. Asymmetric hydrogenation of enol carbamates. 
 
 
7.2. Transfer hydrogenation 
 
In situ generated homogeneous iron complexes catalyze the transfer hydrogenation of 
aliphatic and aromatic ketones utilizing 2–propanol as hydrogen donor in the presence of 
base. The influence of different reaction parameters on the catalytic activity was investigated 
in detail applying a three component catalyst system, composed of an iron salt, 2,2´:6´,2´´–
terpyridine and PPh3 (Scheme 4). The scope and limitations of the described catalyst have 
been shown in the reduction of eleven different ketones. In most cases high conversion and 
excellent chemoselectivity are achieved. Mechanistic studies indicate a monohydride reaction 
pathway for the homogeneous iron catalyst. 
 
O
1/3 Fe3(CO)12/terpy/PPh3
Na-2-OPr, 2-PrOH, 100 °C, 7 h
OH
 
 
Scheme 4. Homogeneous iron catalyst for reduction of ketones. 
 
Furthermore, for the first time in situ generated iron porphyrins have been applied as 
homogeneous catalysts for the transfer hydrogenation of ketones. Using 2–propanol as 
hydrogen source various ketones are reduced to the corresponding alcohols in good to 
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excellent yield and selectivity. Under optimized reaction conditions high catalyst turnover 
frequencies up to 642 h-1 were achieved (Scheme 5). 
 
O
1/3 Fe3(CO)12/1
Na-2-OPr, 2-PrOH, 100 °C, 7 h
OH
N
NH N
HN
R
R
R
R
1
conversions up to >99%
TOF up to 642 h-1
 
Scheme 5. Transfer hydrogenation of ketones in the presence of biomimetic iron porphyrin 
catalysts. 
 
In situ generated iron porphyrins have been furthermore applied as homogeneous catalysts for 
the transfer hydrogenation of α–substituted ketones. Using 2–propanol as hydrogen donor 
various hydroxyl-protected 1,2–hydroxyketones are reduced to the corresponding mono 
protected 1,2–diols in good to excellent yield. Under optimized reaction conditions catalyst 
turnover frequencies up to 2500 h-1 have been achieved (Scheme 6).  
 
N
NH N
HN
R
R
R
R
R1
O
 FeCl2/1
NaOH, 2-PrOH, 100 °C
1 conversions up to >99%
TOF up to 2500 h-1
OR3
R2
R1
OH
OR3
R2
 
 
Scheme 6. Transfer hydrogenation of α–substituted ketones in the presence of biomimetic 
iron porphyrin catalysts. 
 
Novel ruthenium carbene complexes have been in situ generated and tested for the transfer 
hydrogenation of ketones. Applying Ru(cod)(methylallyl)2 in the presence of imidazolium 
salts in 2–propanol and sodium–2–propanolate as base, turnover frequencies up to 346 h-1 
have been obtained for the reduction of acetophenone (Scheme 7). A comparative study 
involving ruthenium carbene and ruthenium phosphine complexes demonstrated higher 
activity of ruthenium carbene complexes. 
7. Summary 146
O OH
Na-2-OPr, 2-PrOH, 100 °C
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conversion up to >99%
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N
N+
Cl-
 
 
Scheme 7. Transfer hydrogenation of ketones in the presence of ruthenium carbene catalysts. 
 
Tridentate N,N,N–pyridinebisimidazolines have been studied as new ligands for the 
enantioselective transfer hydrogenation of prochiral ketones. High yield and excellent 
enantioselectivity up to >99% ee have been achieved with an in situ generated catalytic 
system containing dichlorotris(triphenylphosphine)ruthenium and 2,6–bis–([4R,5R]–4,5–
diphenyl–4,5–dihydro–1H–imidazol–2–yl)–pyridine in the presence of sodium 2–propanolate 
(Scheme 8). 
 
O
*
OH
Na-2-OPr, 2-PrOH, 100 °C, 1 h
[RuCl2(PPh3)3]/3L
NN
N N
N
PhPh
Ph Ph
H H
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Scheme 8. New ruthenium catalysts for asymmetric transfer hydrogenation of prochiral 
ketones. 
 
 
 
 
 
 
Abstract 
Abstract 
 
Die vorliegende Dissertation beschäftigte sich mit der Anwendung von monodentaten 
Phosphinliganden in der asymmetrischen Hydrierung von C–C Doppelbindungen. Dabei 
konnte die Wirksamkeit von Rhodiumkatalysatoren, die Phosphinliganden mit der 4,5–
Dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepin–Struktureinheit enthielten, gezeigt werden. 
Verschiedenste prochirale Substratklassen, wurden mit exzellenten Enantioselektivitäten von 
bis zu 96% ee zu den entsprechenden ungesättigten Derivaten reduziert. Ein zweiter 
Schwerpunkt der Arbeit lag in der Entwicklung neuartiger eisenbasierter Hydrierkatalysatoren 
und deren Anwendung in der Transferhydrierung von Ketonen, wobei Katalysatoraktivitäten 
von bis zu 2500 h-1 (TOF) erzielt werden konnten. 
 
 
This dissertation deals with the application of monodentate phosphine ligands in asymmetric 
hydrogenation of C–C double bonds. The usefulness of rhodium catalysts containing 
phosphines based on the 4,5–Dihydro–3H–dinaphtho[2,1–c;1´,2´–e]phosphepine scaffold was 
demonstrated in the reduction of various prochiral substrates, since excellent 
enantioselectivities up to 96% ee were achieved. Furthermore, the properties of iron–based 
catalysts were studied in the field of transfer hydrogenation. Here high catalyst activities up to 
2500 h-1 were obtained in the reduction of ketones. 
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